SS.LEW-(D1Rat211-D1Rat18)/Mco |
systolic blood pressure |
controlled sodium content diet (2 %) (between 24 and 28 days) |
Joe B, et al., J Hypertens 2003 Nov;21(11):2077-84. |
arterial blood pressure trait |
male |
63 days-70 days |
20 |
|
|
180.0 |
mmHg |
2.8 |
12.52 |
tail cuff plethysmography |
|
0 |
|
0 |
|
|
average of 4days |
|
65488 |
611 |
SS.LEW-(D1Mco4-D1Rat18)/Mco |
systolic blood pressure |
controlled sodium content diet (2 %) (between 24 and 28 days) |
Joe B, et al., J Hypertens 2003 Nov;21(11):2077-84. |
arterial blood pressure trait |
male |
63 days-70 days |
20 |
|
|
178.0 |
mmHg |
2.3 |
10.29 |
tail cuff plethysmography |
|
0 |
|
0 |
|
|
average of 4days |
|
65489 |
611 |
SS/Jr |
absolute change in systolic blood pressure |
controlled sodium content diet (2 %) (between 34 and 38 days) then controlled exposure to darkness then controlled exposure to ambient light |
Joe B, et al., J Hypertens 2003 Nov;21(11):2077-84. |
arterial blood pressure trait |
male |
73 days-80 days |
8 |
|
|
22.6 |
mmHg |
1.05 |
2.97 |
intra-aortic abdominal radiotelemetry |
|
10 |
|
0 |
|
|
diurnal difference |
|
65497 |
611 |
SS.LEW-(D1Rat211-D1Rat18)/Mco |
absolute change in systolic blood pressure |
controlled sodium content diet (2 %) (between 34 and 38 days) then controlled exposure to darkness then controlled exposure to ambient light |
Joe B, et al., J Hypertens 2003 Nov;21(11):2077-84. |
arterial blood pressure trait |
male |
73 days-80 days |
8 |
|
|
14.4 |
mmHg |
1.63 |
4.61 |
intra-aortic abdominal radiotelemetry |
|
10 |
|
0 |
|
|
diurnal difference |
|
65502 |
611 |
SS.LEW-(D1Rat211-D1Rat18)/Mco |
pulse pressure |
controlled sodium content diet (2 %) (between 34 and 38 days) |
Joe B, et al., J Hypertens 2003 Nov;21(11):2077-84. |
arterial blood pressure trait |
male |
73 days-80 days |
8 |
|
|
49.0 |
mmHg |
0.74 |
2.09 |
intra-aortic abdominal radiotelemetry |
|
10 |
|
0 |
|
|
average of 24 hr |
|
65500 |
611 |
SS-Nox4em2Mcwi-/+ |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
2 |
|
|
337.5 |
beats/min |
6.5 |
9.19 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66625 |
717 |
SS-Ncf2em1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
5 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
130.6 |
mmHg |
8.03 |
17.95 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66646 |
717 |
SS-Cybaem1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
5 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
114.8 |
mmHg |
7.13 |
15.94 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66652 |
717 |
SS-Mmp2em1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
1 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
137.0 |
mmHg |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66654 |
717 |
SS-Gpr183em1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
3 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
140.33 |
mmHg |
10.48 |
18.15 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66653 |
717 |
SS.BN-(D13Rat20-D13Got22)/Mcwi-Nckap5em4Mcwi-/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
1 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
133.0 |
mmHg |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66650 |
717 |
SS-Apoeem7Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
5 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
127.0 |
mmHg |
6.16 |
13.77 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66656 |
717 |
SS-Nckap5em1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
5 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
143.8 |
mmHg |
8.4 |
18.78 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66657 |
717 |
SS-Rag1em2Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
7 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
123.14 |
mmHg |
6.08 |
16.08 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66661 |
717 |
SS-Alms1em1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
1 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
134.0 |
mmHg |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66667 |
717 |
SS-Chr 5BN-Cyp4a2em1Mcwi-/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
3 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
116.67 |
mmHg |
6.74 |
11.68 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66668 |
717 |
SS-Renem1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
4 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
155.25 |
mmHg |
12.05 |
24.1 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66671 |
717 |
SS-Acad10em2Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
5 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
137.0 |
mmHg |
3.78 |
8.46 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66686 |
717 |
SS-Chr 5BN-Cyp4a2em1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
6 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
124.67 |
mmHg |
2.17 |
5.32 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66681 |
717 |
SS-Nox4em2Mcwi-/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
2 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
122.0 |
mmHg |
1.0 |
1.41 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66687 |
717 |
SS-Ulk4em3Mcwi-/- |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
4 |
|
|
11.99 |
mg/d |
0.77 |
1.54 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66695 |
717 |
SS-Chr 5BN-Cyp4a2em1Mcwi+/+ |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
3 |
|
|
12.82 |
mg/d |
0.99 |
1.71 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66711 |
717 |
SS-Cybaem1Mcwi+/+ |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
2 |
|
|
10.62 |
mg/d |
0.03 |
0.04 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66737 |
717 |
SS-Nox4em2Mcwi-/- |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
5 |
|
|
10.89 |
mg/d |
0.69 |
1.53 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66730 |
717 |
SS-Rag1em2Mcwi+/+ |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
1 |
|
|
10.32 |
mg/d |
|
|
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66735 |
717 |
FHH.BN-(D1Hmgc14-D1Hmgc15)/Mcwi-Rab38em1Mcwi-/- |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
2 |
|
|
8.94 |
mg/d |
1.17 |
1.65 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66738 |
717 |
SS-Alms1em1Mcwi-/- |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
6 |
|
|
1.27 |
g |
0.08 |
0.2 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66753 |
717 |
SS-Ulk4em3Mcwi-/- |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
4 |
|
|
1.55 |
g |
0.09 |
0.18 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66756 |
717 |
SS-Nckap5em2Mcwi-/- |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
8 |
|
|
1.71 |
g |
0.05 |
0.14 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66767 |
717 |
SS-Nckap5em1Mcwi-/- |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
7 |
|
|
1.48 |
g |
0.08 |
0.21 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66762 |
717 |
SS-Ncf2em1Mcwi+/+ |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
5 |
|
|
1.44 |
g |
0.03 |
0.07 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66769 |
717 |
SS-Ets1em1Mcwi+/+ |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
4 |
|
|
1.57 |
g |
0.06 |
0.11 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66778 |
717 |
SS.BN-(D13Rat20-D13Got22)/Mcwi-Nckap5em4Mcwi-/- |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
4 |
|
|
1.41 |
g |
0.05 |
0.1 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66793 |
717 |
SS-Tfdp2em2Mcwi-/- |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
3 |
|
|
1.37 |
g |
0.01 |
0.02 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66798 |
717 |
SS-Renem1Mcwi+/+ |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
4 |
|
|
1.51 |
g |
0.07 |
0.14 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66794 |
717 |
SS-Ncf2em1Mcwi-/- |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
6 |
|
|
11.43 |
mEq/d |
0.64 |
1.56 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66812 |
717 |
SS-Mmp2em1Mcwi-/- |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
6 |
|
|
4.75 |
mEq/d |
0.62 |
1.51 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66814 |
717 |
SS-Bcas3em4Mcwi-/- |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
3 |
|
|
5.79 |
mEq/d |
1.3 |
2.25 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66827 |
717 |
SS/JrHsdMcwi |
diastolic blood pressure |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
92 days-94 days |
12 |
|
serial mean |
126.0 |
mmHg |
5.0 |
17.32 |
vascular indwelling catheter method |
left femoral artery |
0 |
|
0 |
|
|
|
|
65465 |
151 |
SS/JrHsdMcwi |
heart rate |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
heart pumping trait |
female |
93 days
| 12 |
|
serial mean |
427.0 |
beats/min |
6.0 |
20.78 |
vascular indwelling catheter method |
left femoral artery |
0 |
|
0 |
|
|
|
|
65469 |
151 |
BN/NHsdMcwi |
plasma renin activity level |
controlled sodium content diet (0.4 %) (for 35 days) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
renin activity |
female |
95 days
| 11 |
|
|
9.6 |
ng/ml/h |
1.0 |
3.32 |
ex vivo blood analysis |
|
0 |
|
0 |
|
|
|
|
65474 |
151 |
SS/JrRkb |
heart right ventricle weight to body weight ratio |
controlled sodium content diet (4 %) (for 56 days) |
Wendt N, et al., J Hypertens. 2007 Jan;25(1):95-102. |
heart right ventricle mass |
male |
98 days
| 14 |
|
|
0.58 |
mg/g |
0.02 |
0.07 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
66091 |
669 |
SS-Apoeem7Mcwi+/+ |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
3 |
|
|
12.51 |
mEq/d |
2.26 |
3.92 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66836 |
717 |
SS-Nox4em2Mcwi-/- |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
5 |
|
|
9.51 |
mEq/d |
0.72 |
1.61 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66853 |
717 |
SS-Nckap5em3Mcwi+/+ |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
2 |
|
|
10.65 |
mEq/d |
0.47 |
0.67 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66867 |
717 |
SS-Renem1Mcwi-/- |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
5 |
|
|
7.06 |
mEq/d |
1.41 |
3.15 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66863 |
717 |
SS-Ube2q2em3Mcwi-/- |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
2 |
|
|
11.4 |
mEq/d |
1.5 |
2.13 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66872 |
717 |
SS-Ube2q2em3Mcwi+/+ |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
1 |
|
|
147.98 |
mg/d |
|
|
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66880 |
717 |
SS-Nox4em2Mcwi-/- |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
5 |
|
|
17.0 |
mg/d |
2.3 |
5.13 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66914 |
717 |
FHH.BN-(D1Hmgc14-D1Hmgc15)/Mcwi-Rab38em1Mcwi-/- |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
2 |
|
|
29.99 |
mg/d |
10.31 |
14.58 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66922 |
717 |
SS-Mthfrem1Mcwi-/+ |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
8 |
|
|
73.13 |
mg/d |
19.06 |
53.91 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66929 |
717 |
SS-Ube2q2em3Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
1 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
163.0 |
mmHg |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66941 |
717 |
SS-Nckap5em1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
6 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
130.67 |
mmHg |
5.46 |
13.38 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66946 |
717 |
SS-Tgfb1em3Mcwi+/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
3 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
119.67 |
mmHg |
10.14 |
17.56 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66945 |
717 |
SS-Apoeem8Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
3 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
144.0 |
mmHg |
8.08 |
14.0 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66950 |
717 |
SS-Ncf2em1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
5 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
126.2 |
mmHg |
6.27 |
14.03 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66953 |
717 |
SS-Apoeem7Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
3 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
123.0 |
mmHg |
2.08 |
3.61 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66962 |
717 |
SS-Mmp2em2Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
5 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
142.0 |
mmHg |
14.32 |
32.03 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66968 |
717 |
SS-Rag1em1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
4 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
137.0 |
mmHg |
6.1 |
12.19 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66971 |
717 |
SS-Tfdp2em2Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
3 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
142.0 |
mmHg |
12.58 |
21.79 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66980 |
717 |
SS-Renem1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
5 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
119.8 |
mmHg |
7.3 |
16.32 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66984 |
717 |
SS-Ube2q2em3Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
2 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
122.5 |
mmHg |
10.5 |
14.85 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66993 |
717 |
SS-Apoeem8Mcwi-/- |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
5 |
|
|
1.18 |
g |
0.09 |
0.2 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
67010 |
717 |
SS-Apoeem7Mcwi-/- |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
5 |
|
|
1.1 |
g |
0.03 |
0.06 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
67023 |
717 |
SS-Mas1em1Mcwi-/- |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
6 |
|
|
1.16 |
g |
0.03 |
0.09 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
67033 |
717 |
SS-Renem1Mcwi-/- |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
5 |
|
|
0.99 |
g |
0.04 |
0.09 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
67046 |
717 |
SS-Nckap5em3Mcwi+/+ |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
2 |
|
|
1.15 |
g |
0.11 |
0.16 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
67050 |
717 |
FHH.BN-(D1Hmgc14-D1Hmgc15)/Mcwi-Rab38em1Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
4 |
|
|
397.0 |
beats/min |
10.23 |
20.46 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
67057 |
717 |
SS-Alms1em1Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
5 |
|
|
357.2 |
beats/min |
13.07 |
29.22 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
67059 |
717 |
SS-Gpr183em1Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
6 |
|
|
360.83 |
beats/min |
12.35 |
30.26 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
67061 |
717 |
SS-Ube2q2em3Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
1 |
|
|
383.0 |
beats/min |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
67063 |
717 |
SS-Gpr183em2Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
9 |
|
|
368.67 |
beats/min |
12.2 |
36.59 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
67070 |
717 |
SS-Nckap5em2Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
6 |
|
|
365.33 |
beats/min |
11.89 |
29.12 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
67073 |
717 |
SS-Cybaem1Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
5 |
|
|
360.2 |
beats/min |
10.44 |
23.35 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
67080 |
717 |
SS-Nox4em2Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
3 |
|
|
374.33 |
beats/min |
5.7 |
9.87 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
67087 |
717 |
SS-Rag1em2Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
6 |
|
|
343.0 |
beats/min |
14.92 |
36.56 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
67088 |
717 |
SS-Apoeem8Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
1 |
|
|
336.0 |
beats/min |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
67091 |
717 |
SS-Rag1em1Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
4 |
|
|
353.0 |
beats/min |
22.92 |
45.83 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
67093 |
717 |
SS-Chr 5BN-Cyp4a2em1Mcwi-/+ |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
3 |
|
|
360.67 |
beats/min |
2.67 |
4.62 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
67095 |
717 |
SS-Renem1Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
4 |
|
|
358.0 |
beats/min |
4.08 |
8.16 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
67098 |
717 |
SS-Cybaem1Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
2 |
|
|
327.0 |
beats/min |
11.0 |
15.56 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
67103 |
717 |
SS.LEW-(D18Rat61-D18Rat45)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart left ventricle mass |
male |
98 days
| 6 |
|
|
2.61 |
mg/g |
0.08 |
0.2 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
64900 |
226 |
SS.LEW-(D17Chm14-D17Rat181)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart left ventricle mass |
male |
98 days
| 5 |
|
|
2.7 |
mg/g |
0.1 |
0.22 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
64906 |
226 |
SS.LEW-(D18Rat61-D18Rat45)/Ayd |
heart right ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart right ventricle mass |
male |
98 days
| 6 |
|
|
0.57 |
mg/g |
0.01 |
0.02 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
64901 |
226 |
SS.LEW-(D10Chm10-D10Rat11)/Ayd |
heart right ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart right ventricle mass |
male |
98 days
| 7 |
|
|
0.57 |
mg/g |
0.01 |
0.03 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
64917 |
226 |
BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 28 days) then controlled sodium content diet (8 %) (for 30 days) then controlled exposure to ambient light (for 12 hours) then controlled exposure to darkness (for 12 hours) |
Cowley AW Jr, et al., Physiol Genomics 2000 Apr 27;2(3):107-15. |
arterial blood pressure trait |
male |
91 days-93 days |
42 |
|
continuous mean |
4.5 |
mmHg |
2.0 |
12.96 |
vascular indwelling catheter method |
femoral artery |
0.0 |
|
0 |
|
left femoral artery |
increase |
|
64928 |
229 |
SS.LEW-(D3Rat61-D3Wox1)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart left ventricle mass |
male |
98 days
| 5 |
|
|
2.33 |
mg/g |
0.04 |
0.09 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
64939 |
226 |
SS.LEW-(D3Mco21-D3Rat17)/Ayd |
heart right ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart right ventricle mass |
male |
98 days
| 4 |
|
|
0.6 |
mg/g |
0.0 |
0.01 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
64947 |
226 |
SS.SR-(D3Arb14-D3Mco36)(D7Mco19-D7Mco7)/Mco |
diastolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) then controlled sodium content diet (4 %) (between 39 and 40 days) |
Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2. |
arterial blood pressure trait |
male |
107 days-109 days |
4 |
|
|
148.8 |
mmHg |
4.1 |
8.2 |
intra-aortic abdominal radiotelemetry |
|
86400 |
|
0 |
|
|
|
|
65065 |
283 |
SS.SR-(D3Arb14-D3Mco36)/Mco |
diastolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) then controlled sodium content diet (4 %) (between 46 and 47 days) |
Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2. |
arterial blood pressure trait |
male |
114 days-116 days |
4 |
|
|
165.3 |
mmHg |
4.6 |
9.2 |
intra-aortic abdominal radiotelemetry |
|
86400 |
|
0 |
|
|
|
|
65067 |
283 |
SS.SR-(D3Arb14-D3Mco36)/Mco |
plasma urea nitrogen level |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) then controlled sodium content diet (4 %) (between 46 and 48 days) |
Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2. |
blood urea nitrogen amount |
male |
114 days-118 days |
6 |
|
|
9.3 |
mmol/l |
0.7 |
1.71 |
plasma urea nitrogen analysis |
|
0 |
|
0 |
|
|
|
|
65089 |
283 |
SS/Jr |
plasma glucose level |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) then controlled sodium content diet (4 %) (between 46 and 48 days) |
Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2. |
blood glucose amount |
male |
114 days-118 days |
4 |
|
|
142.2 |
mg/dl |
19.8 |
39.6 |
blood glucose analysis |
|
0 |
|
0 |
|
|
|
|
65092 |
283 |
SS.SR-(D3Arb14-D3Mco36)(D7Mco19-D7Mco7)/Mco |
body weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) then controlled sodium content diet (4 %) (between 46 and 48 days) |
Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2. |
body mass |
male |
114 days-118 days |
6 |
|
|
384.2 |
g |
7.3 |
17.88 |
body weighing method |
|
0 |
|
0 |
|
|
|
|
65098 |
283 |
FHH.BN-(D1Hmgc14-D1Hmgc15)/Mcwi-Rab38em1Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
3 |
|
|
386.33 |
beats/min |
5.84 |
10.12 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
67117 |
717 |
SS-Ncf2em1Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
5 |
|
|
356.4 |
beats/min |
6.38 |
14.28 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
67135 |
717 |
SS-Gpr183em2Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
2 |
|
|
379.0 |
beats/min |
13.0 |
18.38 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
67134 |
717 |
FHH-Chr 1BN-Sorcs1em1Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
7 |
|
|
363.0 |
beats/min |
22.2 |
58.73 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
67136 |
717 |
SS-Nckap5em2Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
2 |
|
|
351.0 |
beats/min |
18.0 |
25.46 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
67151 |
717 |
SS-Gpr183em3Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
4 |
|
|
361.5 |
beats/min |
12.22 |
24.45 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
67147 |
717 |
SS-Alms1em1Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
1 |
|
|
358.0 |
beats/min |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
67156 |
717 |
SS-Rag1em1Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
4 |
|
|
354.0 |
beats/min |
13.83 |
27.65 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
67154 |
717 |
SS-Bcas3em4Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
1 |
|
|
391.0 |
beats/min |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
67162 |
717 |
SS-Nckap5em3Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
3 |
|
|
362.33 |
beats/min |
27.96 |
48.43 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
67169 |
717 |
SS-Itga9em1Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
4 |
|
|
375.25 |
beats/min |
16.68 |
33.36 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
67167 |
717 |
F344/DuCrl |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
glomerular filtration trait |
male |
87 days-120 days |
7 |
|
|
1.34 |
ml/min |
0.23 |
0.62 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51684 |
481 |
GH/OmrMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
6 |
|
|
15.4 |
beats/min |
7.93 |
19.42 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51694 |
481 |
BN/NHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
4 |
|
|
-74.95 |
beats/min |
19.95 |
39.89 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51701 |
481 |
SS-Chr 9BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
14 |
|
|
-64.96 |
beats/min |
12.05 |
45.09 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51708 |
481 |
SS-Chr 20BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
15 |
|
|
-4.99 |
beats/min |
8.54 |
33.06 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51719 |
481 |
SHR/NCrl |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
4 |
|
|
10.79 |
beats/min |
17.8 |
35.6 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51723 |
481 |
FHH/EurMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
6 |
|
|
8.33 |
beats/min |
25.63 |
62.79 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51728 |
481 |
SS/JrHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
4 |
|
|
14.83 |
mmHg |
6.29 |
12.58 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51736 |
481 |
SS-Chr 18BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
2 |
|
|
14.06 |
mmHg |
2.07 |
2.92 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51738 |
481 |
SS-Chr 18BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
2 |
|
|
115.62 |
mmHg |
3.34 |
4.72 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51744 |
481 |
SS-Chr 16BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
7 |
|
|
126.47 |
mmHg |
2.33 |
6.16 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51745 |
481 |
GH/OmrMcwi |
urine total protein excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
total urine protein amount |
male |
87 days-120 days |
8 |
|
|
15.69 |
mg/d |
3.09 |
8.73 |
automated urine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51756 |
481 |
BN/NHsdMcwi |
urine total protein excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
total urine protein amount |
female |
87 days-120 days |
10 |
|
|
19.71 |
mg/d |
4.56 |
14.41 |
automated urine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51762 |
481 |
BN/NHsdMcwi |
urine total protein excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
total urine protein amount |
male |
87 days-120 days |
10 |
|
|
10.61 |
mg/d |
1.41 |
4.46 |
automated urine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51761 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
5 |
|
|
27.25 |
mmHg |
4.3 |
9.62 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51770 |
481 |
WKY/NCrl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
7 |
|
|
21.82 |
mmHg |
4.54 |
12.02 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
51784 |
481 |
WKY/NCrl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
6 |
|
|
22.37 |
mmHg |
3.79 |
9.28 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
51787 |
481 |
SS/JrHsdMcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
glomerular filtration trait |
male |
87 days-120 days |
14 |
|
|
1.94 |
ml/min |
0.2 |
0.73 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51797 |
481 |
FHH/EurMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
8 |
|
|
15.53 |
beats/min |
17.94 |
50.74 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51795 |
481 |
BN/NHsdMcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
glomerular filtration trait |
female |
87 days-120 days |
2 |
|
|
1.65 |
ml/min |
0.23 |
0.32 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51804 |
481 |
Hsd:SD |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
blood creatinine amount |
male |
87 days-120 days |
7 |
|
|
0.33 |
mg/dl |
0.01 |
0.02 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
51808 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
2 |
|
|
24.8 |
mmHg |
0.3 |
0.42 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51815 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
5 |
|
|
28.68 |
mmHg |
3.5 |
7.83 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51817 |
481 |
SS/JrHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
18 |
|
|
135.0 |
mmHg |
5.04 |
21.4 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51821 |
481 |
SS-Chr 16BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
6 |
|
|
129.19 |
mmHg |
3.08 |
7.55 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51822 |
481 |
SHR/NCrl |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
8 |
|
|
127.98 |
mmHg |
2.2 |
6.22 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51825 |
481 |
GH/OmrMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
8 |
|
|
146.56 |
mmHg |
2.45 |
6.94 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51827 |
481 |
FHH/EurMcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
renin activity |
female |
87 days-120 days |
5 |
|
|
8.51 |
ng/ml/h |
2.42 |
5.42 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51832 |
481 |
SS-Chr 18BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
renin activity |
female |
87 days-120 days |
3 |
|
|
0.84 |
ng/ml/h |
0.08 |
0.14 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51836 |
481 |
SHR/NCrl |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
renin activity |
male |
87 days-120 days |
6 |
|
|
1.23 |
ng/ml/h |
0.27 |
0.66 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51838 |
481 |
SHR/NCrl |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
renin activity |
female |
87 days-120 days |
6 |
|
|
0.65 |
ng/ml/h |
0.25 |
0.6 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51841 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
7 |
|
|
-26.49 |
beats/min |
16.87 |
44.63 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51849 |
481 |
GH/OmrMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
8 |
|
|
22.21 |
beats/min |
6.03 |
17.04 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51855 |
481 |
Hsd:SD |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
7 |
|
|
21.95 |
mmHg |
2.41 |
6.38 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
51861 |
481 |
SS-Chr 18BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
9 |
|
|
21.98 |
mmHg |
3.61 |
10.83 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51862 |
481 |
SHR/NCrl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
1 |
|
|
31.77 |
mmHg |
|
|
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51868 |
481 |
SS-Chr 18BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
1 |
|
|
3.0 |
mmHg |
|
|
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51866 |
481 |
SS/JrHsdMcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
urine sodium amount |
male |
87 days-120 days |
19 |
|
|
11.47 |
mEq/d |
0.98 |
4.28 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51882 |
481 |
LEW/Crl |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
7 |
|
|
103.93 |
mmHg |
3.0 |
7.95 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
51879 |
481 |
WKY/NCrl |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
7 |
|
|
115.67 |
mmHg |
1.6 |
4.24 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
51880 |
481 |
BN/NHsdMcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
urine sodium amount |
female |
87 days-120 days |
10 |
|
|
10.9 |
mEq/d |
0.8 |
2.54 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51894 |
481 |
F344/DuCrl |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
blood creatinine amount |
female |
87 days-120 days |
9 |
|
|
0.22 |
mg/dl |
0.01 |
0.03 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51898 |
481 |
F344/DuCrl |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
blood creatinine amount |
male |
87 days-120 days |
7 |
|
|
0.29 |
mg/dl |
0.01 |
0.02 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51896 |
481 |
SS-Chr 16BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
blood creatinine amount |
female |
87 days-120 days |
5 |
|
|
0.31 |
mg/dl |
0.02 |
0.04 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51902 |
481 |
SS-Chr 16BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
blood creatinine amount |
male |
87 days-120 days |
6 |
|
|
0.3 |
mg/dl |
0.01 |
0.02 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51904 |
481 |
LEW/Crl |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
9 |
|
|
105.63 |
mmHg |
1.68 |
5.03 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
51908 |
481 |
SS-Chr 20BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
1 |
|
|
-0.2 |
beats/min |
|
|
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51919 |
481 |
F344/DuCrl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
1 |
|
|
18.8 |
mmHg |
|
|
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51913 |
481 |
SS-Chr 9BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
9 |
|
|
-3.32 |
beats/min |
20.7 |
62.1 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51918 |
481 |
SS-Chr 18BN/Mcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
glomerular filtration trait |
male |
87 days-120 days |
6 |
|
|
1.5 |
ml/min |
0.11 |
0.27 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51930 |
481 |
FHH/EurMcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
glomerular filtration trait |
female |
87 days-120 days |
7 |
|
|
1.61 |
ml/min |
0.15 |
0.38 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51932 |
481 |
Hsd:SD |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
urine sodium amount |
male |
87 days-120 days |
15 |
|
|
15.59 |
mEq/d |
0.52 |
2.03 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
51941 |
481 |
BN/NHsdMcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
glomerular filtration trait |
male |
87 days-120 days |
3 |
|
|
1.49 |
ml/min |
0.16 |
0.28 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51955 |
481 |
SHR/NCrl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
1 |
|
|
24.43 |
mmHg |
|
|
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51965 |
481 |
FHH/EurMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
7 |
|
|
13.53 |
mmHg |
3.99 |
10.56 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51969 |
481 |
BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
4 |
|
|
8.94 |
mmHg |
2.68 |
5.36 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51971 |
481 |
SS-Chr 20BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
13 |
|
|
124.79 |
mmHg |
2.58 |
9.3 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51998 |
481 |
SHR/NCrl |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
6 |
|
|
156.06 |
mmHg |
6.95 |
17.02 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
52002 |
481 |
GH/OmrMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
9 |
|
|
160.79 |
mmHg |
5.64 |
16.93 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51999 |
481 |
SS-Chr 20BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
14 |
|
|
122.5 |
mmHg |
2.84 |
10.64 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
52006 |
481 |
SS/JrHsdMcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
urine sodium amount |
male |
87 days-120 days |
20 |
|
|
9.28 |
mEq/d |
1.19 |
5.33 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
52012 |
481 |
SS-Chr 16BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
urine sodium amount |
female |
87 days-120 days |
6 |
|
|
14.22 |
mEq/d |
0.96 |
2.35 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
52013 |
481 |
LEW/Crl |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
7 |
|
|
394.18 |
beats/min |
3.77 |
9.98 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
52032 |
481 |
WKY/NCrl |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
female |
87 days-120 days |
5 |
|
|
0.94 |
ml/min |
0.17 |
0.39 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
|
52030 |
481 |
FHH/EurMcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
blood creatinine amount |
female |
87 days-120 days |
7 |
|
|
0.27 |
mg/dl |
0.0 |
0.01 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
52037 |
481 |
SS-Chr 16BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
blood creatinine amount |
female |
87 days-120 days |
6 |
|
|
0.35 |
mg/dl |
0.01 |
0.03 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
52038 |
481 |
GH/OmrMcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
blood creatinine amount |
male |
87 days-120 days |
8 |
|
|
0.27 |
mg/dl |
0.01 |
0.03 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
52046 |
481 |
SHR/NCrl |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
6 |
|
|
-11.07 |
beats/min |
14.76 |
36.15 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
52056 |
481 |
LEW/Crl |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
9 |
|
|
-25.42 |
beats/min |
8.98 |
26.95 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
52076 |
481 |
FHH/EurMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
2 |
|
|
125.91 |
mmHg |
2.56 |
3.62 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
52085 |
481 |
SHR/NCrl |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
1 |
|
|
136.28 |
mmHg |
|
|
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
52086 |
481 |
FHH/EurMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
7 |
|
|
133.43 |
mmHg |
3.83 |
10.15 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
52090 |
481 |
FHH-Chr 15BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
male |
80 days-99 days |
9 |
|
|
232.75 |
mg/d |
44.36 |
133.08 |
automated urine total protein analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52095 |
482 |
FHH-Chr 3BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
female |
80 days-99 days |
2 |
|
|
259.8 |
mg/d |
89.85 |
127.07 |
automated urine total protein analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52099 |
482 |
FHH-Chr 5BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
female |
80 days-99 days |
6 |
|
|
110.21 |
mg/d |
29.1 |
71.27 |
automated urine total protein analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52100 |
482 |
FHH-Chr 6BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
male |
80 days-99 days |
11 |
|
|
409.4 |
mg/d |
67.83 |
224.98 |
automated urine total protein analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52103 |
482 |
FHH-Chr 6BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
female |
80 days-99 days |
8 |
|
|
162.2 |
mg/d |
70.89 |
200.51 |
automated urine total protein analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52105 |
482 |
FHH-Chr 10BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
female |
80 days-99 days |
9 |
|
|
343.27 |
mg/d |
52.78 |
158.34 |
automated urine total protein analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52121 |
482 |
FHH-Chr 7BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
male |
80 days-99 days |
13 |
|
|
379.56 |
mg/d |
75.35 |
271.67 |
automated urine total protein analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52138 |
482 |
SS-Chr 17BN/Mcwi |
creatinine clearance |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
glomerular filtration trait |
male |
80 days-99 days |
5 |
|
|
2.41 |
ml/min |
0.57 |
1.27 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52151 |
482 |
SS-Chr 17BN/Mcwi |
creatinine clearance |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
glomerular filtration trait |
female |
80 days-99 days |
5 |
|
|
3.45 |
ml/min |
1.21 |
2.69 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52153 |
482 |
FHH-Chr 12BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
male |
80 days-99 days |
11 |
|
|
14.16 |
mEq/d |
1.75 |
5.8 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52799 |
482 |
FHH-Chr 10BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
female |
80 days-99 days |
9 |
|
|
19.48 |
mEq/d |
1.49 |
4.46 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52807 |
482 |
FHH-Chr 4BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
female |
80 days-99 days |
9 |
|
|
14.41 |
mEq/d |
2.04 |
6.13 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52813 |
482 |
BN/NHsdMcwi |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
female |
80 days-99 days |
11 |
|
|
15.99 |
mEq/d |
2.14 |
7.08 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52821 |
482 |
FHH-Chr 7BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
male |
80 days-99 days |
11 |
|
|
14.23 |
mEq/d |
3.75 |
12.43 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52824 |
482 |
SS.BN-(D12Arb13-D12Rat79)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
male |
80 days-99 days |
10 |
|
|
190.68 |
mmHg |
5.29 |
16.74 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52830 |
482 |
SS-Chr 10BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
male |
80 days-99 days |
10 |
|
|
171.08 |
mmHg |
6.65 |
21.04 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52829 |
482 |
SS-Chr 6BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
female |
80 days-99 days |
9 |
|
|
160.76 |
mmHg |
6.88 |
20.63 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52832 |
482 |
SS-Chr 6BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
male |
80 days-99 days |
10 |
|
|
176.2 |
mmHg |
5.38 |
17.0 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52837 |
482 |
SS-Chr 16BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
female |
80 days-99 days |
8 |
|
|
135.4 |
mmHg |
3.37 |
9.54 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52846 |
482 |
SS-Chr 20BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
male |
80 days-99 days |
7 |
|
|
147.43 |
mmHg |
7.77 |
20.57 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52853 |
482 |
SS-Chr YBN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
male |
80 days-99 days |
15 |
|
|
163.31 |
mmHg |
4.36 |
16.88 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52857 |
482 |
SS-Chr 1BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
male |
80 days-99 days |
14 |
|
|
130.52 |
mmHg |
1.16 |
4.35 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52860 |
482 |
SS-Chr 12BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
male |
80 days-99 days |
7 |
|
|
162.57 |
mmHg |
8.34 |
22.07 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52868 |
482 |
SS.BN-(D8Rat163-D8Rat81)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
male |
80 days-99 days |
20 |
|
|
156.0 |
mmHg |
7.15 |
31.98 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52872 |
482 |
BN/NHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
female |
80 days-99 days |
18 |
|
|
112.49 |
mmHg |
2.77 |
11.74 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52875 |
482 |
SS-Chr 2BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
male |
80 days-99 days |
9 |
|
|
174.74 |
mmHg |
5.35 |
16.04 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52877 |
482 |
BN/NHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
male |
80 days-99 days |
9 |
|
|
110.84 |
mmHg |
1.12 |
3.36 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52874 |
482 |
FHH-Chr 3BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
renin activity |
female |
80 days-99 days |
1 |
|
|
1.17 |
ng/ml/h |
|
|
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52883 |
482 |
FHH-Chr 2BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
renin activity |
female |
80 days-99 days |
5 |
|
|
0.4 |
ng/ml/h |
0.07 |
0.16 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52885 |
482 |
FHH-Chr 5BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
renin activity |
male |
80 days-99 days |
7 |
|
|
1.16 |
ng/ml/h |
0.33 |
0.88 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52890 |
482 |
FHH-Chr XBN/Mcwi |
plasma renin activity level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
renin activity |
male |
80 days-99 days |
6 |
|
|
2.25 |
ng/ml/h |
0.51 |
1.25 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52913 |
482 |
BN/NHsdMcwi |
plasma renin activity level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
renin activity |
female |
80 days-99 days |
7 |
|
|
1.61 |
ng/ml/h |
0.88 |
2.33 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52919 |
482 |
FHH-Chr 9BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
renin activity |
male |
80 days-99 days |
4 |
|
|
2.48 |
ng/ml/h |
0.69 |
1.38 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52921 |
482 |
SS.BN-(D12Arb13-D12Rat79)/Mcwi |
urine potassium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine potassium amount |
male |
80 days-99 days |
12 |
|
|
1.33 |
mEq/d |
0.07 |
0.25 |
flame atomic emission spectrometry |
|
|
|
0 |
|
urine potassium analysis |
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52928 |
482 |
SS-Chr 9BN/Mcwi |
urine potassium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine potassium amount |
male |
80 days-99 days |
10 |
|
|
1.44 |
mEq/d |
0.12 |
0.39 |
flame atomic emission spectrometry |
|
|
|
0 |
|
urine potassium analysis |
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52931 |
482 |
SS-Chr 17BN/Mcwi |
urine potassium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine potassium amount |
male |
80 days-99 days |
9 |
|
|
1.49 |
mEq/d |
0.07 |
0.22 |
flame atomic emission spectrometry |
|
|
|
0 |
|
urine potassium analysis |
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52937 |
482 |
SS-Chr 15BN/Mcwi |
urine potassium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine potassium amount |
male |
80 days-99 days |
7 |
|
|
1.97 |
mEq/d |
0.89 |
2.35 |
flame atomic emission spectrometry |
|
|
|
0 |
|
urine potassium analysis |
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52945 |
482 |
SS-Chr 3BN/Mcwi |
urine potassium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine potassium amount |
male |
80 days-99 days |
9 |
|
|
1.14 |
mEq/d |
0.14 |
0.41 |
flame atomic emission spectrometry |
|
|
|
0 |
|
urine potassium analysis |
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52947 |
482 |
BN/NHsdMcwi |
urine potassium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine potassium amount |
male |
80 days-99 days |
10 |
|
|
1.47 |
mEq/d |
0.11 |
0.36 |
flame atomic emission spectrometry |
|
|
|
0 |
|
urine potassium analysis |
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52972 |
482 |
SS-Chr 13BN/Mcwi |
creatinine clearance |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
glomerular filtration trait |
female |
80 days-99 days |
18 |
|
|
1.39 |
ml/min |
0.09 |
0.38 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52163 |
482 |
SS-Chr 20BN/Mcwi |
creatinine clearance |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
glomerular filtration trait |
male |
80 days-99 days |
7 |
|
|
2.03 |
ml/min |
0.27 |
0.71 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52165 |
482 |
SS-Chr 12BN/Mcwi |
creatinine clearance |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
glomerular filtration trait |
female |
80 days-99 days |
3 |
|
|
2.21 |
ml/min |
0.03 |
0.06 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52185 |
482 |
SS-Chr 18BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
female |
80 days-99 days |
8 |
|
|
0.33 |
mg/dl |
0.03 |
0.09 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52223 |
482 |
SS-Chr 4BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
male |
80 days-99 days |
7 |
|
|
0.34 |
mg/dl |
0.02 |
0.05 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52225 |
482 |
BN/NHsdMcwi |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
female |
80 days-99 days |
15 |
|
|
0.35 |
mg/dl |
0.02 |
0.08 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52236 |
482 |
FHH-Chr 15BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
male |
80 days-99 days |
9 |
|
|
0.32 |
mg/dl |
0.01 |
0.03 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52244 |
482 |
LE/BluGill |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
female |
80 days-99 days |
9 |
|
|
0.33 |
mg/dl |
0.02 |
0.07 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
52239 |
482 |
FHH-Chr 5BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
female |
80 days-99 days |
5 |
|
|
0.32 |
mg/dl |
0.03 |
0.06 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52249 |
482 |
FHH-Chr 20BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
male |
80 days-99 days |
7 |
|
|
0.24 |
mg/dl |
0.02 |
0.06 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52258 |
482 |
FHH-Chr 16BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
female |
80 days-99 days |
6 |
|
|
0.49 |
mg/dl |
0.1 |
0.25 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52271 |
482 |
FHH-Chr 17BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
male |
80 days-99 days |
6 |
|
|
0.61 |
mg/dl |
0.09 |
0.21 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52274 |
482 |
FHH-Chr 4BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
female |
80 days-99 days |
7 |
|
|
0.4 |
mg/dl |
0.02 |
0.06 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52276 |
482 |
FHH-Chr 11BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
male |
80 days-99 days |
3 |
|
|
0.31 |
mg/dl |
0.05 |
0.09 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52277 |
482 |
FHH-Chr 10BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
male |
80 days-99 days |
4 |
|
|
0.46 |
mg/dl |
0.04 |
0.08 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52282 |
482 |
FHH-Chr 9BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
male |
80 days-99 days |
4 |
|
|
0.39 |
mg/dl |
0.05 |
0.1 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52286 |
482 |
FHH-Chr 16BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
male |
80 days-99 days |
7 |
|
|
0.43 |
mg/dl |
0.04 |
0.1 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52288 |
482 |
FHH-Chr 7BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
male |
80 days-99 days |
8 |
|
|
0.51 |
mg/dl |
0.05 |
0.14 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52287 |
482 |
FHH-Chr 15BN/Mcwi |
urine potassium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine potassium amount |
male |
80 days-99 days |
9 |
|
|
1.44 |
mEq/d |
0.05 |
0.16 |
flame atomic emission spectrometry |
|
|
|
0 |
|
urine potassium analysis |
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52293 |
482 |
FHH-Chr 14BN/Mcwi |
urine potassium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine potassium amount |
female |
80 days-99 days |
6 |
|
|
2.0 |
mEq/d |
0.31 |
0.75 |
flame atomic emission spectrometry |
|
|
|
0 |
|
urine potassium analysis |
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52300 |
482 |
FHH-Chr 8BN/Mcwi |
urine potassium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine potassium amount |
male |
80 days-99 days |
4 |
|
|
1.17 |
mEq/d |
0.1 |
0.2 |
flame atomic emission spectrometry |
|
|
|
0 |
|
urine potassium analysis |
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52305 |
482 |
FHH-Chr 13BN/Mcwi |
urine potassium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine potassium amount |
male |
80 days-99 days |
10 |
|
|
0.91 |
mEq/d |
0.11 |
0.34 |
flame atomic emission spectrometry |
|
|
|
0 |
|
urine potassium analysis |
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52308 |
482 |
FHH-Chr 2BN/Mcwi |
urine potassium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine potassium amount |
male |
80 days-99 days |
5 |
|
|
1.34 |
mEq/d |
0.07 |
0.15 |
flame atomic emission spectrometry |
|
|
|
0 |
|
urine potassium analysis |
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52318 |
482 |
BN/NHsdMcwi |
urine potassium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine potassium amount |
female |
80 days-99 days |
11 |
|
|
0.77 |
mEq/d |
0.09 |
0.29 |
flame atomic emission spectrometry |
|
|
|
0 |
|
urine potassium analysis |
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52333 |
482 |
FHH-Chr 2BN/Mcwi |
creatinine clearance |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
glomerular filtration trait |
female |
80 days-99 days |
5 |
|
|
1.71 |
ml/min |
0.2 |
0.44 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52346 |
482 |
FHH-Chr 14BN/Mcwi |
creatinine clearance |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
glomerular filtration trait |
female |
80 days-99 days |
4 |
|
|
1.09 |
ml/min |
0.1 |
0.21 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52347 |
482 |
FHH-Chr 5BN/Mcwi |
creatinine clearance |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
glomerular filtration trait |
male |
80 days-99 days |
7 |
|
|
1.6 |
ml/min |
0.12 |
0.32 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52351 |
482 |
FHH-Chr 13BN/Mcwi |
creatinine clearance |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
glomerular filtration trait |
male |
80 days-99 days |
10 |
|
|
1.17 |
ml/min |
0.23 |
0.73 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52355 |
482 |
FHH-Chr 17BN/Mcwi |
creatinine clearance |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
glomerular filtration trait |
male |
80 days-99 days |
6 |
|
|
0.89 |
ml/min |
0.26 |
0.64 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52370 |
482 |
FHH-Chr 15BN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine albumin amount |
male |
80 days-99 days |
9 |
|
|
73.05 |
mg/d |
23.6 |
70.81 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52387 |
482 |
FHH-Chr 2BN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine albumin amount |
female |
80 days-99 days |
7 |
|
|
24.31 |
mg/d |
6.0 |
15.88 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52393 |
482 |
FHH-Chr 19BN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine albumin amount |
female |
80 days-99 days |
8 |
|
|
31.83 |
mg/d |
11.92 |
33.71 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52396 |
482 |
FHH-Chr XBN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine albumin amount |
male |
80 days-99 days |
7 |
|
|
204.89 |
mg/d |
18.57 |
49.14 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52421 |
482 |
SS-Chr 9BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
renin activity |
male |
80 days-99 days |
8 |
|
|
0.29 |
ng/ml/h |
0.04 |
0.13 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52439 |
482 |
SS-Chr 10BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
renin activity |
female |
80 days-99 days |
8 |
|
|
3.82 |
ng/ml/h |
0.85 |
2.41 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52444 |
482 |
SS-Chr 5BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
renin activity |
female |
80 days-99 days |
7 |
|
|
0.44 |
ng/ml/h |
0.08 |
0.2 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52448 |
482 |
SS-Chr 7BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
renin activity |
male |
80 days-99 days |
9 |
|
|
0.51 |
ng/ml/h |
0.12 |
0.37 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52446 |
482 |
SS-Chr 20BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
renin activity |
female |
80 days-99 days |
8 |
|
|
1.66 |
ng/ml/h |
0.38 |
1.07 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52451 |
482 |
SS-Chr 3BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
renin activity |
male |
80 days-99 days |
8 |
|
|
0.42 |
ng/ml/h |
0.07 |
0.2 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52455 |
482 |
SS-Chr 18BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
renin activity |
male |
80 days-99 days |
9 |
|
|
0.75 |
ng/ml/h |
0.15 |
0.45 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52464 |
482 |
SS/JrHsdMcwi |
plasma renin activity level |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
renin activity |
male |
80 days-99 days |
55 |
|
|
0.68 |
ng/ml/h |
0.12 |
0.9 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52465 |
482 |
SS-Chr 18BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
renin activity |
female |
80 days-99 days |
8 |
|
|
1.04 |
ng/ml/h |
0.18 |
0.51 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52468 |
482 |
SS-Chr 1BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
renin activity |
female |
80 days-99 days |
14 |
|
|
0.67 |
ng/ml/h |
0.2 |
0.76 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52469 |
482 |
SS-Chr 2BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
renin activity |
female |
80 days-99 days |
10 |
|
|
0.99 |
ng/ml/h |
0.13 |
0.43 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52477 |
482 |
SS-Chr 12BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
renin activity |
female |
80 days-99 days |
5 |
|
|
0.88 |
ng/ml/h |
0.15 |
0.33 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52479 |
482 |
FHH-Chr 6BN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
male |
80 days-99 days |
9 |
|
|
411.53 |
beats/min |
7.04 |
21.12 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52493 |
482 |
FHH-Chr 19BN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
female |
80 days-99 days |
6 |
|
|
434.17 |
beats/min |
11.32 |
27.72 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52494 |
482 |
FHH-Chr 20BN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
male |
80 days-99 days |
7 |
|
|
386.33 |
beats/min |
10.29 |
27.22 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52499 |
482 |
FHH-Chr 20BN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
female |
80 days-99 days |
6 |
|
|
439.71 |
beats/min |
5.33 |
13.06 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52502 |
482 |
FHH-Chr 14BN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
male |
80 days-99 days |
8 |
|
|
405.62 |
beats/min |
14.94 |
42.25 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52508 |
482 |
FHH-Chr 15BN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
female |
80 days-99 days |
7 |
|
|
396.79 |
beats/min |
11.52 |
30.48 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52506 |
482 |
FHH/EurMcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
male |
80 days-99 days |
48 |
|
|
431.04 |
beats/min |
4.26 |
29.51 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52505 |
482 |
FHH-Chr 10BN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
female |
80 days-99 days |
7 |
|
|
443.07 |
beats/min |
4.2 |
11.1 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52511 |
482 |
BN/NHsdMcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
male |
80 days-99 days |
8 |
|
|
349.72 |
beats/min |
7.76 |
21.94 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52524 |
482 |
FHH-Chr 16BN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
male |
80 days-99 days |
8 |
|
|
414.64 |
beats/min |
10.79 |
30.52 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52529 |
482 |
FHH-Chr 14BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
female |
80 days-99 days |
6 |
|
|
156.03 |
mmHg |
5.11 |
12.52 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52539 |
482 |
FHH-Chr 20BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
male |
80 days-99 days |
7 |
|
|
148.57 |
mmHg |
5.32 |
14.08 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52546 |
482 |
SS-Chr 10BN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine albumin amount |
male |
80 days-99 days |
11 |
|
|
85.48 |
mg/d |
21.9 |
72.63 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52580 |
482 |
SS-Chr 5BN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine albumin amount |
female |
80 days-99 days |
8 |
|
|
11.82 |
mg/d |
2.27 |
6.41 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52593 |
482 |
SS-Chr 9BN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine albumin amount |
female |
80 days-99 days |
9 |
|
|
24.49 |
mg/d |
5.25 |
15.74 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52587 |
482 |
SS-Chr 13BN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine albumin amount |
male |
80 days-99 days |
16 |
|
|
10.59 |
mg/d |
2.08 |
8.32 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52606 |
482 |
SS-Chr XBN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine albumin amount |
female |
80 days-99 days |
7 |
|
|
49.97 |
mg/d |
10.84 |
28.67 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52612 |
482 |
SS.BN-(D8Rat163-D8Rat81)/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine albumin amount |
female |
80 days-99 days |
13 |
|
|
9.97 |
mg/d |
1.58 |
5.68 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52617 |
482 |
SS-Chr 9BN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
female |
80 days-99 days |
8 |
|
|
418.44 |
beats/min |
6.84 |
19.34 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52638 |
482 |
SS-Chr 6BN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
male |
80 days-99 days |
10 |
|
|
427.88 |
beats/min |
12.27 |
38.8 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52639 |
482 |
SS-Chr 17BN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
male |
80 days-99 days |
9 |
|
|
404.73 |
beats/min |
7.16 |
21.49 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52641 |
482 |
SS-Chr 3BN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
male |
80 days-99 days |
9 |
|
|
408.25 |
beats/min |
5.72 |
17.16 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52651 |
482 |
SS-Chr 1BN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
male |
80 days-99 days |
14 |
|
|
411.34 |
beats/min |
5.76 |
21.55 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52662 |
482 |
SS/JrHsdMcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
male |
80 days-99 days |
59 |
|
|
400.39 |
beats/min |
4.05 |
31.09 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52661 |
482 |
SS-Chr 18BN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
female |
80 days-99 days |
10 |
|
|
406.58 |
beats/min |
6.69 |
21.14 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52664 |
482 |
SS-Chr 18BN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
male |
80 days-99 days |
8 |
|
|
407.55 |
beats/min |
8.67 |
24.52 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52660 |
482 |
SS-Chr 4BN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
male |
80 days-99 days |
7 |
|
|
399.08 |
beats/min |
14.32 |
37.89 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52666 |
482 |
SS-Chr 19BN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
female |
80 days-99 days |
6 |
|
|
384.16 |
beats/min |
17.74 |
43.46 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52671 |
482 |
SS-Chr 12BN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
female |
80 days-99 days |
6 |
|
|
379.27 |
beats/min |
8.81 |
21.58 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52675 |
482 |
SS-Chr 9BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
male |
80 days-99 days |
10 |
|
|
170.39 |
mg/d |
23.75 |
75.12 |
automated urine total protein analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52684 |
482 |
SS-Chr 17BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
female |
80 days-99 days |
7 |
|
|
288.64 |
mg/d |
67.49 |
178.56 |
automated urine total protein analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52692 |
482 |
SS-Chr 13BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
female |
80 days-99 days |
20 |
|
|
63.79 |
mg/d |
6.53 |
29.18 |
automated urine total protein analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52702 |
482 |
SS-Chr 3BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
female |
80 days-99 days |
7 |
|
|
95.55 |
mg/d |
11.55 |
30.56 |
automated urine total protein analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52703 |
482 |
SS-Chr YBN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
male |
80 days-99 days |
17 |
|
|
152.58 |
mg/d |
15.5 |
63.93 |
automated urine total protein analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52708 |
482 |
SS-Chr 11BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
female |
80 days-99 days |
19 |
|
|
87.31 |
mg/d |
7.52 |
32.76 |
automated urine total protein analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52705 |
482 |
SS-Chr 4BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
female |
80 days-99 days |
8 |
|
|
62.33 |
mg/d |
6.17 |
17.45 |
automated urine total protein analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52721 |
482 |
SS-Chr XBN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
male |
80 days-99 days |
6 |
|
|
270.3 |
mg/d |
64.55 |
158.12 |
automated urine total protein analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52727 |
482 |
SS-Chr 14BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
female |
80 days-99 days |
11 |
|
|
11.05 |
mEq/d |
2.27 |
7.51 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52733 |
482 |
SS-Chr 13BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
male |
80 days-99 days |
16 |
|
|
11.92 |
mEq/d |
1.33 |
5.31 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52757 |
482 |
SS-Chr 1BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
female |
80 days-99 days |
19 |
|
|
10.57 |
mEq/d |
1.46 |
6.38 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52765 |
482 |
SS-Chr 18BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
male |
80 days-99 days |
9 |
|
|
12.51 |
mEq/d |
0.99 |
2.97 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52760 |
482 |
SS-Chr 20BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
male |
80 days-99 days |
9 |
|
|
15.96 |
mEq/d |
2.07 |
6.2 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52755 |
482 |
SS-Chr 4BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
male |
80 days-99 days |
7 |
|
|
15.25 |
mEq/d |
2.49 |
6.59 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52766 |
482 |
BN/NHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
4 |
|
|
20.6 |
beats/min |
13.45 |
26.91 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50513 |
481 |
SS/JrHsdMcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
17 |
|
|
406.36 |
beats/min |
7.25 |
29.89 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50523 |
481 |
SHR/NCrl |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
9 |
|
|
356.76 |
beats/min |
13.66 |
40.98 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50528 |
481 |
SHR/NCrl |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
8 |
|
|
423.68 |
beats/min |
13.94 |
39.43 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50531 |
481 |
FHH/EurMcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
renin activity |
male |
87 days-120 days |
6 |
|
|
7.97 |
ng/ml/h |
1.02 |
2.5 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50541 |
481 |
Crl:CD(SD) |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
4 |
|
|
3.0 |
mmHg |
3.86 |
7.72 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
50542 |
481 |
LEW/Crl |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
9 |
|
|
9.34 |
beats/min |
8.51 |
25.54 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
50552 |
481 |
SS/JrHsdMcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
male |
87 days-120 days |
2 |
|
|
1.95 |
ng/ml/h |
0.95 |
1.34 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50566 |
481 |
SS-Chr 16BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
male |
87 days-120 days |
6 |
|
|
2.26 |
ng/ml/h |
0.6 |
1.47 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50570 |
481 |
LEW/Crl |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
glomerular filtration trait |
male |
87 days-120 days |
4 |
|
|
1.83 |
ml/min |
0.27 |
0.53 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
|
50574 |
481 |
LEW/Crl |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
glomerular filtration trait |
female |
87 days-120 days |
6 |
|
|
1.17 |
ml/min |
0.1 |
0.25 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
|
50573 |
481 |
F344/DuCrl |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
9 |
|
|
410.92 |
beats/min |
6.97 |
20.92 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
50577 |
481 |
SS-Chr 9BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
9 |
|
|
-34.01 |
beats/min |
27.27 |
81.82 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50580 |
481 |
BN/NHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
8 |
|
|
-47.96 |
beats/min |
18.32 |
51.83 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50589 |
481 |
BN/NHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
4 |
|
|
-24.45 |
beats/min |
31.16 |
62.33 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50590 |
481 |
SS-Chr 18BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
9 |
|
|
2.83 |
mmHg |
1.4 |
4.19 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50598 |
481 |
FHH/EurMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
8 |
|
|
-52.77 |
beats/min |
23.98 |
67.84 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50597 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
12 |
|
|
3.2 |
mmHg |
1.6 |
5.56 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50603 |
481 |
SHR/NCrl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
6 |
|
|
1.29 |
mmHg |
2.0 |
4.9 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50607 |
481 |
SHR/NCrl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
8 |
|
|
-25.11 |
mmHg |
3.07 |
8.68 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50631 |
481 |
SS-Chr 16BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
6 |
|
|
133.26 |
mmHg |
2.16 |
5.28 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50641 |
481 |
SS-Chr 16BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
10 |
|
|
136.5 |
mmHg |
3.86 |
12.21 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50644 |
481 |
SHR/NCrl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
9 |
|
|
45.88 |
mmHg |
2.54 |
7.63 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50661 |
481 |
SS/JrHsdMcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
4 |
|
|
411.76 |
beats/min |
26.24 |
52.48 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50667 |
481 |
BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
8 |
|
|
39.82 |
mmHg |
2.4 |
6.8 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50665 |
481 |
SS-Chr 16BN/Mcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
7 |
|
|
387.4 |
beats/min |
19.95 |
52.79 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50670 |
481 |
SS/JrHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
3 |
|
|
118.36 |
mmHg |
3.5 |
6.07 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50673 |
481 |
SS-Chr 16BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
2 |
|
|
129.46 |
mmHg |
0.32 |
0.45 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50675 |
481 |
FHH/EurMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
7 |
|
|
-5.23 |
beats/min |
21.31 |
56.37 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50686 |
481 |
WKY/NCrl |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
blood creatinine amount |
male |
87 days-120 days |
9 |
|
|
0.32 |
mg/dl |
0.01 |
0.04 |
radioimmunoassay |
|
|
|
0 |
|
|
|
|
50690 |
481 |
BN/NHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
8 |
|
|
2.83 |
beats/min |
19.88 |
56.24 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50687 |
481 |
SS-Chr 18BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
6 |
|
|
-0.89 |
mmHg |
3.73 |
9.15 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50698 |
481 |
BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
7 |
|
|
0.72 |
mmHg |
2.7 |
7.14 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50706 |
481 |
WKY/NCrl |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
renin activity |
male |
87 days-120 days |
9 |
|
|
0.76 |
ng/ml/h |
0.14 |
0.41 |
radioimmunoassay |
|
|
|
0 |
|
|
|
|
50712 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
12 |
|
|
-31.9 |
beats/min |
21.48 |
74.43 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50721 |
481 |
WKY/NCrl |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
7 |
|
|
-27.44 |
beats/min |
13.68 |
36.19 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
50729 |
481 |
SS/JrHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
18 |
|
|
144.0 |
mmHg |
3.04 |
12.89 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50734 |
481 |
BN/NHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
8 |
|
|
-25.21 |
beats/min |
19.43 |
54.97 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50728 |
481 |
BN/NHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
8 |
|
|
101.3 |
mmHg |
2.17 |
6.14 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50745 |
481 |
SHR/NCrl |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
8 |
|
|
173.36 |
mmHg |
5.88 |
16.63 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50739 |
481 |
FHH/EurMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
5 |
|
|
32.74 |
mmHg |
4.09 |
9.15 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50748 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
10 |
|
|
30.25 |
mmHg |
4.03 |
12.74 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50753 |
481 |
SHR/NCrl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
8 |
|
|
27.55 |
mmHg |
4.09 |
11.58 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50757 |
481 |
SS/JrHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
5 |
|
|
-8.98 |
mmHg |
4.38 |
9.8 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50762 |
481 |
LEW/Crl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
7 |
|
|
4.89 |
mmHg |
4.16 |
11.0 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
50769 |
481 |
WKY/NCrl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
9 |
|
|
24.53 |
mmHg |
3.8 |
11.4 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
50768 |
481 |
LEW/Crl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
9 |
|
|
-0.91 |
mmHg |
3.29 |
9.86 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
50770 |
481 |
FHH/EurMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
7 |
|
|
0.93 |
mmHg |
2.33 |
6.16 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50780 |
481 |
SS-Chr 18BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
6 |
|
|
124.3 |
mmHg |
1.8 |
4.42 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50793 |
481 |
Hsd:SD |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
14 |
|
|
16.67 |
beats/min |
10.47 |
39.18 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
50791 |
481 |
SS/JrHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
15 |
|
|
-12.57 |
mmHg |
1.76 |
6.83 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50801 |
481 |
GH/OmrMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
9 |
|
|
-11.35 |
mmHg |
4.78 |
14.34 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50803 |
481 |
SS-Chr 18BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
5 |
|
|
-3.43 |
mmHg |
1.25 |
2.78 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50804 |
481 |
BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
5 |
|
|
-7.15 |
mmHg |
2.83 |
6.32 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50812 |
481 |
Hsd:SD |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
20 |
|
|
30.61 |
mmHg |
1.78 |
7.98 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
50826 |
481 |
LEW/Crl |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
9 |
|
|
-6.9 |
beats/min |
15.96 |
47.88 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
50834 |
481 |
LEW/Crl |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
4 |
|
|
96.06 |
mmHg |
2.3 |
4.61 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
50838 |
481 |
Crl:CD(SD) |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
4 |
|
|
394.6 |
beats/min |
13.13 |
26.26 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
50861 |
481 |
Crl:CD(SD) |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
4 |
|
|
16.23 |
mmHg |
3.7 |
7.41 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
50859 |
481 |
Crl:CD(SD) |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
4 |
|
|
11.78 |
mmHg |
2.52 |
5.04 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
50857 |
481 |
Crl:CD(SD) |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
4 |
|
|
-48.95 |
beats/min |
23.61 |
47.22 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
50865 |
481 |
GH/OmrMcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
9 |
|
|
419.89 |
beats/min |
5.87 |
17.6 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50880 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
2 |
|
|
34.12 |
mmHg |
1.84 |
2.6 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50900 |
481 |
SS-Chr 18BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
5 |
|
|
28.03 |
mmHg |
6.24 |
13.95 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50901 |
481 |
SS/JrHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
3 |
|
|
43.55 |
mmHg |
0.46 |
0.79 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50898 |
481 |
Hsd:SD |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
17 |
|
|
383.46 |
beats/min |
6.17 |
25.44 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
50923 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
5 |
|
|
3.68 |
mmHg |
1.76 |
3.94 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50928 |
481 |
SS-Chr 18BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
6 |
|
|
131.22 |
mmHg |
4.62 |
11.33 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50942 |
481 |
SHR/NCrl |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
9 |
|
|
137.12 |
mmHg |
4.62 |
13.86 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50947 |
481 |
Hsd:SD |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
14 |
|
|
394.94 |
beats/min |
8.93 |
33.43 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
50956 |
481 |
GH/OmrMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
7 |
|
|
28.71 |
mmHg |
4.76 |
12.59 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50967 |
481 |
BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
8 |
|
|
33.35 |
mmHg |
3.43 |
9.71 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50973 |
481 |
SS-Chr 20BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
13 |
|
|
25.74 |
beats/min |
10.93 |
39.41 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50978 |
481 |
FHH/EurMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
4 |
|
|
36.95 |
beats/min |
7.33 |
14.67 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50987 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
5 |
|
|
4.14 |
mmHg |
2.16 |
4.83 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50992 |
481 |
FHH/EurMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
8 |
|
|
4.37 |
mmHg |
1.82 |
5.15 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50995 |
481 |
F344/DuCrl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
7 |
|
|
-2.5 |
mmHg |
2.9 |
7.67 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
50997 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
10 |
|
|
11.67 |
mmHg |
1.81 |
5.73 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51024 |
481 |
FHH/EurMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
8 |
|
|
-0.58 |
mmHg |
2.12 |
5.98 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51029 |
481 |
BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
4 |
|
|
7.32 |
mmHg |
3.21 |
6.42 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51030 |
481 |
Hsd:SD |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
15 |
|
|
33.82 |
mmHg |
2.59 |
10.04 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
51033 |
481 |
F344/DuCrl |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
7 |
|
|
-55.8 |
beats/min |
16.75 |
44.32 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51035 |
481 |
SS/JrHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
4 |
|
|
-1.55 |
mmHg |
1.88 |
3.77 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51081 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
7 |
|
|
0.65 |
mmHg |
2.07 |
5.48 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51084 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
10 |
|
|
21.46 |
beats/min |
11.94 |
37.77 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51091 |
481 |
SHR/NCrl |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
8 |
|
|
-6.87 |
beats/min |
2.38 |
6.72 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51092 |
481 |
GH/OmrMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
8 |
|
|
0.56 |
beats/min |
2.95 |
8.35 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51094 |
481 |
SS-Chr 18BN/Mcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
9 |
|
|
407.56 |
beats/min |
12.77 |
38.31 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51112 |
481 |
BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
8 |
|
|
0.6 |
mmHg |
0.68 |
1.94 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51111 |
481 |
SS-Chr 16BN/Mcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
12 |
|
|
394.2 |
beats/min |
10.18 |
35.26 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51117 |
481 |
GH/OmrMcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
7 |
|
|
390.4 |
beats/min |
15.58 |
41.22 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51120 |
481 |
SS-Chr 20BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
1 |
|
|
15.03 |
mmHg |
|
|
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51128 |
481 |
BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
4 |
|
|
8.88 |
mmHg |
3.75 |
7.51 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51137 |
481 |
SHR/NCrl |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
9 |
|
|
145.23 |
mmHg |
3.65 |
10.96 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51146 |
481 |
FHH/EurMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
8 |
|
|
129.62 |
mmHg |
2.92 |
8.27 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51150 |
481 |
GH/OmrMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
7 |
|
|
-15.83 |
beats/min |
10.21 |
27.01 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51160 |
481 |
FHH/EurMcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
female |
87 days-120 days |
7 |
|
|
0.28 |
mg/dl |
0.01 |
0.03 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51173 |
481 |
FHH/EurMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
6 |
|
|
14.94 |
mmHg |
4.87 |
11.93 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51194 |
481 |
BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
8 |
|
|
18.33 |
mmHg |
3.71 |
10.49 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51196 |
481 |
GH/OmrMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
6 |
|
|
10.97 |
beats/min |
9.95 |
24.37 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51202 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
10 |
|
|
-34.17 |
beats/min |
7.73 |
24.44 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51203 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
5 |
|
|
-25.02 |
beats/min |
12.07 |
26.99 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51213 |
481 |
SS-Chr 18BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
2 |
|
|
-22.91 |
beats/min |
7.09 |
10.03 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51214 |
481 |
FHH/EurMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
8 |
|
|
-9.45 |
beats/min |
15.69 |
44.36 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51216 |
481 |
SS/JrHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
15 |
|
|
10.55 |
beats/min |
16.42 |
63.61 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51233 |
481 |
SS-Chr 9BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
15 |
|
|
-15.78 |
beats/min |
13.94 |
54.0 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51238 |
481 |
SS/JrHsdMcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
10 |
|
|
407.56 |
beats/min |
6.03 |
19.06 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51250 |
481 |
Crl:CD(SD) |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
6 |
|
|
18.95 |
beats/min |
7.34 |
17.98 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51260 |
481 |
SS/JrHsdMcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
male |
87 days-120 days |
20 |
|
|
1.46 |
mEq/d |
0.2 |
0.9 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51266 |
481 |
SS-Chr 16BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
female |
87 days-120 days |
6 |
|
|
1.4 |
mEq/d |
0.14 |
0.34 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51267 |
481 |
Hsd:SD |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
male |
87 days-120 days |
11 |
|
|
0.32 |
mg/dl |
0.03 |
0.11 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
51277 |
481 |
BN/NHsdMcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
8 |
|
|
408.04 |
beats/min |
7.45 |
21.07 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51291 |
481 |
SS/JrHsdMcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
urine sodium amount |
male |
87 days-120 days |
5 |
|
|
9.79 |
mEq/d |
1.85 |
4.14 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51294 |
481 |
Hsd:SD |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
14 |
|
|
121.87 |
mmHg |
1.99 |
7.45 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
51300 |
481 |
FHH/EurMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
2 |
|
|
50.5 |
beats/min |
43.3 |
61.24 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51308 |
481 |
SS-Chr 20BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
female |
87 days-120 days |
11 |
|
|
0.32 |
mg/dl |
0.02 |
0.06 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51311 |
481 |
BN/NHsdMcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
female |
87 days-120 days |
3 |
|
|
0.3 |
mg/dl |
0.02 |
0.04 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51322 |
481 |
FHH/EurMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
7 |
|
|
133.34 |
mmHg |
4.01 |
10.6 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51325 |
481 |
F344/DuCrl |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
7 |
|
|
-7.69 |
beats/min |
11.36 |
30.07 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51331 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
10 |
|
|
19.93 |
mmHg |
2.87 |
9.07 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51340 |
481 |
BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
9 |
|
|
20.68 |
mmHg |
2.71 |
8.13 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51347 |
481 |
SS-Chr 20BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
15 |
|
|
-27.23 |
beats/min |
9.2 |
35.65 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51350 |
481 |
SHR/NCrl |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
9 |
|
|
-35.62 |
beats/min |
11.0 |
33.01 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51357 |
481 |
BN/NHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
7 |
|
|
-19.96 |
beats/min |
18.9 |
50.01 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51360 |
481 |
Crl:CD(SD) |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
4 |
|
|
109.0 |
mmHg |
4.18 |
8.37 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51390 |
481 |
LEW/Crl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
7 |
|
|
2.21 |
mmHg |
3.42 |
9.04 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
51395 |
481 |
Hsd:SD |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
14 |
|
|
8.24 |
beats/min |
8.8 |
32.91 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
51401 |
481 |
Crl:CD(SD) |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
7 |
|
|
16.77 |
mmHg |
3.57 |
9.46 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51417 |
481 |
Crl:CD(SD) |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
5 |
|
|
10.13 |
mmHg |
4.49 |
10.03 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51415 |
481 |
LEW/Crl |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
7 |
|
|
2.2 |
beats/min |
15.19 |
40.18 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
51412 |
481 |
SHR/NCrl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
9 |
|
|
41.75 |
mmHg |
2.35 |
7.05 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51426 |
481 |
BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
4 |
|
|
39.47 |
mmHg |
5.6 |
11.2 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51431 |
481 |
SHR/NCrl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
8 |
|
|
30.72 |
mmHg |
3.16 |
8.94 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51429 |
481 |
SS-Chr 18BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
total urine protein amount |
female |
87 days-120 days |
4 |
|
|
19.43 |
mg/d |
3.2 |
6.4 |
automated urine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51437 |
481 |
GH/OmrMcwi |
urine total protein excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
total urine protein amount |
male |
87 days-120 days |
9 |
|
|
40.1 |
mg/d |
4.15 |
12.45 |
automated urine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51442 |
481 |
FHH/EurMcwi |
urine albumin excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
urine albumin amount |
male |
87 days-120 days |
8 |
|
|
10.1 |
mg/d |
2.04 |
5.77 |
automated urine analysis |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51460 |
481 |
SS/JrHsdMcwi |
urine albumin excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
urine albumin amount |
male |
87 days-120 days |
21 |
|
|
14.0 |
mg/d |
3.02 |
13.86 |
automated urine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51466 |
481 |
SS-Chr 20BN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
urine albumin amount |
female |
87 days-120 days |
19 |
|
|
6.82 |
mg/d |
0.97 |
4.22 |
automated urine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51467 |
481 |
FHH/EurMcwi |
urine albumin excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
urine albumin amount |
male |
87 days-120 days |
7 |
|
|
1.94 |
mg/d |
0.47 |
1.24 |
automated urine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51476 |
481 |
BN/NHsdMcwi |
urine albumin excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
urine albumin amount |
male |
87 days-120 days |
10 |
|
|
0.44 |
mg/d |
0.07 |
0.22 |
automated urine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51477 |
481 |
SS-Chr 20BN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
urine albumin amount |
male |
87 days-120 days |
18 |
|
|
12.74 |
mg/d |
2.79 |
11.82 |
automated urine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51475 |
481 |
SS-Chr 18BN/Mcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
6 |
|
|
386.26 |
beats/min |
6.07 |
14.87 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51481 |
481 |
BN/NHsdMcwi |
urine albumin excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
urine albumin amount |
female |
87 days-120 days |
10 |
|
|
0.31 |
mg/d |
0.05 |
0.17 |
automated urine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51478 |
481 |
Hsd:SD |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
15 |
|
|
18.91 |
mmHg |
2.36 |
9.14 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
51480 |
481 |
SS-Chr 16BN/Mcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
5 |
|
|
402.6 |
beats/min |
5.87 |
13.12 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51484 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
5 |
|
|
20.44 |
mmHg |
5.29 |
11.82 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51490 |
481 |
SS/JrHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
3 |
|
|
9.52 |
mmHg |
0.72 |
1.24 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51495 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
7 |
|
|
-28.06 |
beats/min |
17.7 |
46.83 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51504 |
481 |
SS-Chr 18BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
1 |
|
|
-81.81 |
beats/min |
|
|
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51505 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
10 |
|
|
-41.61 |
beats/min |
8.9 |
28.13 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51507 |
481 |
GH/OmrMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
8 |
|
|
3.18 |
beats/min |
9.27 |
26.21 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51510 |
481 |
SS/JrHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
12 |
|
|
-46.0 |
beats/min |
14.52 |
50.29 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51509 |
481 |
FHH/EurMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
8 |
|
|
-22.2 |
beats/min |
16.32 |
46.15 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51512 |
481 |
SS-Chr 9BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
female |
87 days-120 days |
16 |
|
|
1.32 |
mEq/d |
0.12 |
0.49 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51523 |
481 |
FHH/EurMcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
male |
87 days-120 days |
5 |
|
|
0.8 |
mEq/d |
0.21 |
0.46 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51526 |
481 |
F344/DuCrl |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
7 |
|
|
-48.94 |
beats/min |
12.72 |
33.65 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51530 |
481 |
SS-Chr 18BN/Mcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
male |
87 days-120 days |
6 |
|
|
1.92 |
ml/min |
0.12 |
0.28 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51540 |
481 |
SHR/NCrl |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
female |
87 days-120 days |
7 |
|
|
1.08 |
ml/min |
0.08 |
0.2 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51544 |
481 |
FHH/EurMcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
male |
87 days-120 days |
9 |
|
|
2.23 |
ml/min |
0.08 |
0.25 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51547 |
481 |
FHH/EurMcwi |
urine total protein excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
total urine protein amount |
male |
87 days-120 days |
8 |
|
|
59.56 |
mg/d |
16.55 |
46.8 |
automated urine analysis |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51558 |
481 |
SS-Chr 16BN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
urine albumin amount |
female |
87 days-120 days |
8 |
|
|
12.87 |
mg/d |
2.1 |
5.94 |
automated urine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51562 |
481 |
SS/JrHsdMcwi |
urine albumin excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
urine albumin amount |
female |
87 days-120 days |
11 |
|
|
17.56 |
mg/d |
3.43 |
11.37 |
automated urine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51567 |
481 |
GH/OmrMcwi |
urine albumin excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
urine albumin amount |
male |
87 days-120 days |
9 |
|
|
1.63 |
mg/d |
0.26 |
0.77 |
automated urine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51568 |
481 |
FHH/EurMcwi |
urine albumin excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
urine albumin amount |
male |
87 days-120 days |
10 |
|
|
12.24 |
mg/d |
2.4 |
7.59 |
automated urine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51570 |
481 |
SS-Chr 16BN/Mcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
10 |
|
|
365.3 |
beats/min |
2.73 |
8.62 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51581 |
481 |
SHR/NCrl |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
8 |
|
|
361.82 |
beats/min |
5.01 |
14.16 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51585 |
481 |
SS-Chr 18BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
9 |
|
|
5.23 |
mmHg |
1.96 |
5.87 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51589 |
481 |
F344/DuCrl |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
renin activity |
female |
87 days-120 days |
8 |
|
|
2.16 |
ng/ml/h |
0.24 |
0.68 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51606 |
481 |
FHH/EurMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
6 |
|
|
-19.53 |
beats/min |
25.96 |
63.58 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51609 |
481 |
SS-Chr 16BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
5 |
|
|
131.21 |
mmHg |
4.02 |
8.99 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51629 |
481 |
SS-Chr 18BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
blood creatinine amount |
female |
87 days-120 days |
5 |
|
|
0.26 |
mg/dl |
0.01 |
0.02 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51647 |
481 |
GH/OmrMcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
blood creatinine amount |
female |
87 days-120 days |
10 |
|
|
0.33 |
mg/dl |
0.03 |
0.08 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51646 |
481 |
GH/OmrMcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
blood creatinine amount |
male |
87 days-120 days |
8 |
|
|
0.31 |
mg/dl |
0.01 |
0.03 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51650 |
481 |
BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
8 |
|
|
23.04 |
mmHg |
2.89 |
8.17 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51666 |
481 |
F344/DuCrl |
urine albumin excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
urine albumin amount |
female |
87 days-120 days |
10 |
|
|
0.7 |
mg/d |
0.25 |
0.8 |
automated urine analysis |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51672 |
481 |
Crl:CD(SD) |
urine albumin excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
urine albumin amount |
male |
87 days-120 days |
9 |
|
|
0.59 |
mg/d |
0.08 |
0.25 |
automated urine analysis |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51669 |
481 |
Crl:CD(SD) |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
4 |
|
|
4.15 |
beats/min |
23.97 |
47.94 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51673 |
481 |
SHR/NCrl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
6 |
|
|
26.33 |
mmHg |
3.02 |
7.4 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51668 |
481 |
Hsd:SD |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
20 |
|
|
405.19 |
beats/min |
8.56 |
38.28 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
51677 |
481 |
SS-Chr 9BN/Mcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
9 |
|
|
414.38 |
beats/min |
10.05 |
30.15 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50321 |
481 |
F344/DuCrl |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
1 |
|
|
8.4 |
beats/min |
|
|
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51676 |
481 |
SS-Chr 18BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
2 |
|
|
-91.71 |
beats/min |
8.29 |
11.72 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50346 |
481 |
SS/JrHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
4 |
|
|
-71.27 |
beats/min |
21.14 |
42.27 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50344 |
481 |
WKY/NCrl |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
male |
87 days-120 days |
9 |
|
|
0.4 |
mg/dl |
0.02 |
0.06 |
radioimmunoassay |
|
|
|
0 |
|
|
|
|
50409 |
481 |
SS/JrHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
12 |
|
|
-47.58 |
beats/min |
14.04 |
48.64 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50424 |
481 |
BN/NHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
8 |
|
|
-8.48 |
beats/min |
15.29 |
43.23 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50429 |
481 |
WKY/NCrl |
urine total protein excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
total urine protein amount |
female |
87 days-120 days |
8 |
|
|
16.23 |
mg/d |
3.74 |
10.59 |
automated urine analysis |
|
|
|
0 |
|
|
|
|
50443 |
481 |
WKY/NCrl |
urine total protein excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
total urine protein amount |
male |
87 days-120 days |
9 |
|
|
21.67 |
mg/d |
3.9 |
11.7 |
automated urine analysis |
|
|
|
0 |
|
|
|
|
50440 |
481 |
SS/JrHsdMcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
3 |
|
|
356.33 |
beats/min |
4.7 |
8.14 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50445 |
481 |
SS/JrHsdMcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
renin activity |
male |
87 days-120 days |
14 |
|
|
0.93 |
ng/ml/h |
0.15 |
0.56 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50456 |
481 |
SHR/NCrl |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
renin activity |
male |
87 days-120 days |
7 |
|
|
0.83 |
ng/ml/h |
0.23 |
0.6 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50464 |
481 |
LEW/Crl |
urine albumin excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
urine albumin amount |
female |
87 days-120 days |
8 |
|
|
0.56 |
mg/d |
0.12 |
0.34 |
automated urine analysis |
|
|
|
0 |
|
|
|
|
50467 |
481 |
SS-Chr 9BN/Mcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
6 |
|
|
414.07 |
beats/min |
11.47 |
28.11 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50478 |
481 |
Hsd:SD |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
15 |
|
|
8.67 |
mmHg |
1.66 |
6.43 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
50499 |
481 |
LEW |
both kidneys wet weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
kidney mass |
male |
98 days
| 6 |
|
|
7.91 |
g/kg |
0.09 |
0.22 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
64771 |
226 |
SS-Chr 5BN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
male |
80 days-99 days |
7 |
|
|
368.73 |
beats/min |
6.96 |
18.42 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52646 |
482 |
SHR/NCrl |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
1 |
|
|
23.0 |
beats/min |
|
|
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50508 |
481 |
SS.LEW-(D16Got3-D16Rat112)/Ayd |
both kidneys wet weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
kidney mass |
male |
98 days
| 9 |
|
|
10.1 |
g/kg |
0.2 |
0.6 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
64780 |
226 |
FHH/EurMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
9 |
|
|
-24.77 |
beats/min |
14.96 |
44.88 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50512 |
481 |
SS.LEW-(D10Chm128-D10Chm169)/Ayd |
both kidneys wet weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
kidney mass |
male |
98 days
| 8 |
|
|
10.0 |
g/kg |
0.3 |
0.85 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
64783 |
226 |
SS.LEW-(D10Rat24-Igfbp4)/Ayd |
both kidneys wet weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
kidney mass |
male |
98 days
| 5 |
|
|
10.0 |
g/kg |
0.4 |
0.89 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
64786 |
226 |
SS.LEW-(D8Chm14-D8Rat16)/Ayd |
both kidneys wet weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
kidney mass |
male |
98 days
| 7 |
|
|
9.5 |
g/kg |
0.2 |
0.53 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
64789 |
226 |
SS.LEW-(D2Rat199-D2Mco17)/Ayd |
both kidneys wet weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
kidney mass |
male |
98 days
| 8 |
|
|
11.4 |
g/kg |
0.6 |
1.7 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
64799 |
226 |
SS.MNS-(D2Chm25-D2Rat131)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart left ventricle mass |
male |
98 days
| 5 |
|
|
2.85 |
mg/g |
0.09 |
0.2 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
64958 |
226 |
SS.LEW-(D2Rat199-D2Mco17)/Ayd |
heart right ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart right ventricle mass |
male |
98 days
| 8 |
|
|
0.7 |
mg/g |
0.03 |
0.08 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
64963 |
226 |
SS.LEW-(D2Rat18-D2Chm277)/Ayd |
heart right ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart right ventricle mass |
male |
98 days
| 6 |
|
|
0.66 |
mg/g |
0.02 |
0.05 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
64965 |
226 |
SS.BN-(D13Rat151-D13Rat197)/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (for 18 days) |
Moreno et al. Physiol Genomics 2007 Oct 22;31(2):228-35. Epub 2007 Jun 12. |
urine albumin amount |
male |
84 days-88 days |
12 |
|
|
49.3 |
mg/d |
3.7 |
12.82 |
urine analysis |
|
86400 |
|
0 |
|
|
|
|
65249 |
15 |
SS/Jr |
body weight |
controlled sodium content diet (4 %) (for 28 days) |
Garrett MR, et al., Physiol Genomics 2000 Jun 29;3(1):33-8. |
body mass |
male |
53 days-81 days |
10 |
|
|
344.0 |
g |
5.1 |
16.13 |
body weighing method |
|
0 |
|
0 |
|
|
|
|
66109 |
691 |
SS.SR-(D3Mco78-D3Got130)/Jr |
systolic blood pressure |
controlled sodium content diet (0.4 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days) |
Lee SJ, et al., Genetics 2006 Dec;174(4):2203-13. |
arterial blood pressure trait |
male |
64 days-72 days |
20 |
|
serial mean |
209.1 |
mmHg |
4.8 |
21.47 |
tail cuff plethysmography |
|
345600 |
|
0 |
|
Rats warmed to 28 degrees C for measurement. |
|
|
65799 |
237 |
SS/Jr |
heart wet weight |
controlled sodium content diet (2 %) (for 24 days) |
Rapp JP, et al., Genomics 1998 Jul 15;51(2):191-6 |
heart mass |
male |
62 days
| 20 |
|
|
1.36 |
g |
0.01 |
0.06 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
65834 |
633 |
BN/NHsdMcwi |
urine total protein excretion rate |
controlled sodium content diet (0.4 %) (for 35 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
total urine protein amount |
female |
90 days-94 days |
20 |
|
|
8.6 |
mg/d |
2.2 |
9.84 |
urine total protein analysis |
|
0 |
|
0 |
|
|
|
|
66151 |
151 |
SS.BN-(D13Rat111-D13Got22)/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (for 18 days) |
Moreno et al. Physiol Genomics 2007 Oct 22;31(2):228-35. Epub 2007 Jun 12. |
urine albumin amount |
male |
84 days-88 days |
12 |
|
|
45.0 |
mg/d |
16.7 |
57.85 |
urine analysis |
|
86400 |
|
0 |
|
|
|
|
65210 |
15 |
SS.BN-(D13Rat20-D13Got22)/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (for 18 days) |
Moreno et al. Physiol Genomics 2007 Oct 22;31(2):228-35. Epub 2007 Jun 12. |
urine albumin amount |
male |
84 days-88 days |
12 |
|
|
76.6 |
mg/d |
14.8 |
51.27 |
urine analysis |
|
86400 |
|
0 |
|
|
|
|
65213 |
15 |
SS.BN-(D13Hmgc64-RN34_13048990782)/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (for 18 days) |
Moreno et al. Physiol Genomics 2007 Oct 22;31(2):228-35. Epub 2007 Jun 12. |
urine albumin amount |
female |
84 days-88 days |
12 |
|
|
30.5 |
mg/d |
6.3 |
21.82 |
urine analysis |
|
86400 |
|
0 |
|
|
|
|
65219 |
15 |
SS.BN-(D13Rat115-D13Rat61)/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (for 18 days) |
Moreno et al. Physiol Genomics 2007 Oct 22;31(2):228-35. Epub 2007 Jun 12. |
urine albumin amount |
male |
84 days-88 days |
12 |
|
|
45.4 |
mg/d |
6.5 |
22.52 |
urine analysis |
|
86400 |
|
0 |
|
|
|
|
65221 |
15 |
SS.BN-(D13Rat91-D13Rat179)/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (for 18 days) |
Moreno et al. Physiol Genomics 2007 Oct 22;31(2):228-35. Epub 2007 Jun 12. |
urine albumin amount |
female |
84 days-88 days |
12 |
|
|
45.9 |
mg/d |
6.6 |
22.86 |
urine analysis |
|
86400 |
|
0 |
|
|
|
|
65227 |
15 |
SS.BN-(D13Rat91-D13Got45)/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (for 18 days) |
Moreno et al. Physiol Genomics 2007 Oct 22;31(2):228-35. Epub 2007 Jun 12. |
urine albumin amount |
female |
84 days-88 days |
12 |
|
|
43.6 |
mg/d |
4.1 |
14.2 |
urine analysis |
|
86400 |
|
0 |
|
|
|
|
65224 |
15 |
SS.BN-(D13Rat101-D13Rat46)/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (for 18 days) |
Moreno et al. Physiol Genomics 2007 Oct 22;31(2):228-35. Epub 2007 Jun 12. |
urine albumin amount |
female |
84 days-88 days |
12 |
|
|
29.2 |
mg/d |
5.4 |
18.71 |
urine analysis |
|
86400 |
|
0 |
|
|
|
|
65235 |
15 |
SS.BN-(D13Rat57-D13Rat192)/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (for 18 days) |
Moreno et al. Physiol Genomics 2007 Oct 22;31(2):228-35. Epub 2007 Jun 12. |
urine albumin amount |
male |
84 days-88 days |
12 |
|
|
62.8 |
mg/d |
3.9 |
13.51 |
urine analysis |
|
86400 |
|
0 |
|
|
|
|
65246 |
15 |
SS.BN-(D13Rat57-D13Rat192)/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (for 18 days) |
Moreno et al. Physiol Genomics 2007 Oct 22;31(2):228-35. Epub 2007 Jun 12. |
urine albumin amount |
female |
84 days-88 days |
12 |
|
|
50.8 |
mg/d |
7.7 |
26.67 |
urine analysis |
|
86400 |
|
0 |
|
|
|
|
65247 |
15 |
SS.LEW-(D3Chm64-D3Rat17)/Ayd |
diastolic blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 42 days) |
Palijan A, et al., Physiol Genomics 2003 Sep 29;15(1):1-8. |
arterial blood pressure trait |
male |
66 days-77 days |
8 |
measurement taken every 4 hours during a 24-hour period |
serial mean |
167.0 |
mmHg |
9.0 |
25.46 |
radiotelemetry |
|
86400.0 |
|
0 |
|
|
|
|
65557 |
615 |
SS/Jr |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 42 days) |
Palijan A, et al., Physiol Genomics 2003 Sep 29;15(1):1-8. |
arterial blood pressure trait |
male |
66 days-77 days |
15 |
measurement taken every 4 hours during a 24-hour period |
serial mean |
175.0 |
mmHg |
3.0 |
11.62 |
radiotelemetry |
|
86400.0 |
|
0 |
|
|
|
|
65559 |
615 |
SS.LEW-(D3Mco21-D3Rat17)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 42 days) |
Palijan A, et al., Physiol Genomics 2003 Sep 29;15(1):1-8. |
arterial blood pressure trait |
male |
66 days-77 days |
6 |
measurement taken every 4 hours during a 24-hour period |
serial mean |
166.0 |
mmHg |
9.0 |
22.05 |
radiotelemetry |
|
86400.0 |
|
0 |
|
|
|
|
65565 |
615 |
SS.BN-(D13Rat111-D13Got22)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 16 and 19 days) |
Moreno et al. Physiol Genomics 2007 Oct 22;31(2):228-35. Epub 2007 Jun 12. |
arterial blood pressure trait |
female |
86 days-89 days |
12 |
|
|
152.0 |
mmHg |
4.4 |
15.24 |
vascular fluid filled catheter |
left femoral artery |
14400 |
|
0 |
|
on 3 consecutive days |
|
|
5397 |
15 |
SS.BN-(D13Rat57-D13Rat192)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 16 and 19 days) |
Moreno et al. Physiol Genomics 2007 Oct 22;31(2):228-35. Epub 2007 Jun 12. |
arterial blood pressure trait |
male |
86 days-89 days |
12 |
|
|
181.0 |
mmHg |
2.7 |
9.35 |
vascular fluid filled catheter |
left femoral artery |
14400 |
|
0 |
|
on 3 consecutive days |
|
|
5402 |
15 |
SS/JrHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 16 and 19 days) |
Moreno et al. Physiol Genomics 2007 Oct 22;31(2):228-35. Epub 2007 Jun 12. |
arterial blood pressure trait |
female |
86 days-89 days |
12 |
|
|
177.0 |
mmHg |
5.0 |
17.32 |
vascular fluid filled catheter |
left femoral artery |
14400 |
|
0 |
|
on 3 consecutive days |
|
|
5405 |
15 |
SS.LEW-(D5Mit9-D5Mco10)/Jr |
body weight |
controlled sodium content diet (2 %) (between 24 and 27 days) |
Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23 |
body mass |
not specified |
64 days-71 days |
40 |
|
|
282.0 |
g |
1.8 |
11.38 |
body weighing method |
|
0 |
|
0 |
|
|
|
4 rats per cage, 2 SR/Jr 2 LEW/NCrl |
64717 |
222 |
SS/Jr |
heart left ventricle end-systolic diameter |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 29 days) then controlled sodium content diet (4 %) (between 40 and 41 days) |
Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2. |
heart left ventricle end-systolic diameter |
male |
109 days-112 days |
6 |
|
|
4.2 |
mm |
0.4 |
0.98 |
transthoracic echocardiography |
|
0 |
|
0 |
|
|
|
|
65745 |
283 |
SS.SR-(D3Arb14-D3Mco36)/Mco |
heart left ventricle fractional shortening |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 29 days) then controlled sodium content diet (4 %) (between 40 and 41 days) |
Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2. |
heart left ventricle end-diastolic diameter |
male |
109 days-112 days |
7 |
|
|
54.0 |
% |
3.0 |
7.94 |
transthoracic echocardiography |
|
0 |
|
0 |
|
|
|
|
65750 |
283 |
LEW/Crl |
percent change in ventilation |
controlled sodium content diet (0 %) then controlled air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
20 |
%change=VE during7-9 min hypoxia/control during standard conditions |
|
133.06 |
% |
6.62 |
29.59 |
stop flow air displacement plethysmography |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
17339 |
381 |
F344/DuCrl |
percent change in ventilation |
controlled sodium content diet (0 %) then controlled air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
18 |
%change=VE during7-9 min hypoxia/control during standard conditions |
|
128.94 |
% |
5.94 |
25.2 |
stop flow air displacement plethysmography |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
17341 |
381 |
SS/JrSeac |
body weight |
controlled sodium content diet (0.3 %) (for 35 days) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
body mass |
not specified |
77 days
| 5 |
|
|
247.0 |
g |
7.6 |
17.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
67253 |
733 |
SS/JrSeac |
heart left ventricle wet weight |
controlled sodium content diet (0.3 %) (for 35 days) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
heart left ventricle mass |
not specified |
77 days
| 5 |
|
|
1.0 |
g |
0.09 |
0.2 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
67257 |
733 |
SS/HsdMcwiCrl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (0.15 %) (for 21 days) then dihydrocapsaicin (30 ug/kg) and pentobarbital (50 mg/kg) |
Gao F and Wang DH, Hypertension. 2010 Apr;55(4):1018-25. Epub 2010 Mar 1. |
arterial blood pressure trait |
male |
35 days-56 days |
0 |
|
|
-28.0 |
mmHg |
4.0 |
|
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
DR strain is from Charles River Laboratory, Wilmington, MA |
67262 |
731 |
SR/Hsd |
absolute change in mean arterial blood pressure |
controlled sodium content diet (0.15 %) then ruthenium red (3 mg/kg) |
Gao F and Wang DH, Hypertension. 2010 Apr;55(4):1018-25. Epub 2010 Mar 1. |
arterial blood pressure trait |
male |
35 days-56 days |
0 |
|
|
7.0 |
mmHg |
1.0 |
|
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
DR strain is from Charles River Laboratory, Wilmington, MA |
67269 |
731 |
BN/NHsdMcwi |
heart left ventricle wet weight |
controlled sodium content diet (0.4 %) (for 35 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
heart left ventricle mass |
female |
97 days-101 days |
22 |
|
|
0.45 |
g |
0.01 |
0.05 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
67297 |
151 |
SS/JrHsdMcwi |
plasma total cholesterol level |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
blood cholesterol amount |
female |
92 days-94 days |
12 |
|
|
76.0 |
mg/dl |
4.4 |
15.24 |
plasma total cholesterol measurement test |
|
0.0 |
|
0 |
|
|
|
|
67290 |
151 |
SS/JrHsdMcwi |
absolute change in mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then angiotensin II (200 ng/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
13 |
|
serial mean |
34.0 |
mmHg |
3.0 |
10.82 |
vascular indwelling catheter method |
left femoral artery |
0.0 |
|
0 |
|
|
|
|
67300 |
151 |
SS/Jr |
systolic blood pressure |
controlled sodium content diet (0.4 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days) |
Lee SJ, et al., Genetics 2006 Dec;174(4):2203-13. |
arterial blood pressure trait |
male |
64 days-72 days |
20 |
|
serial mean |
210.6 |
mmHg |
3.4 |
15.21 |
tail cuff plethysmography |
|
345600 |
|
0 |
|
Rats warmed to 28 degrees C for measurement. |
|
|
65792 |
237 |
SS.SR-(Cyp11b1)/Jr |
systolic blood pressure |
controlled sodium content diet (0.2 %) (for 7 days) then controlled sodium content diet (4 %) (for 24 days) |
Cicila GT, et al., Mamm Genome 1997 Dec;8(12):896-902. |
arterial blood pressure trait |
female |
61 days
| 12 |
|
serial mean |
215.5 |
mmHg |
8.5 |
29.44 |
tail cuff plethysmography |
|
|
|
0 |
|
|
|
|
11794 |
146 |
SS.SR-(D7Rat16-D7Mgh5)/Jr |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 27 days) |
Cicila GT, et al., Genomics 2001 Feb 15;72(1):51-60. |
arterial blood pressure trait |
male |
68 days-70 days |
20 |
|
serial mean |
210.5 |
mmHg |
2.8 |
12.52 |
tail cuff plethysmography |
|
|
|
0 |
|
|
average of 12 readings from 4 daily sessions |
|
11796 |
147 |
SS/Jr |
body weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 27 days) |
Cicila GT, et al., Genomics 2001 Feb 15;72(1):51-60. |
body mass |
male |
68 days-70 days |
20 |
|
|
298.2 |
g |
4.2 |
18.78 |
body weighing method |
|
|
|
0 |
|
|
|
|
11799 |
147 |
SS/Jr |
heart wet weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 27 days) |
Cicila GT, et al., Genomics 2001 Feb 15;72(1):51-60. |
heart mass |
male |
68 days-70 days |
20 |
|
|
1.22 |
g |
0.02 |
0.08 |
post excision weight measurement |
|
|
|
0 |
|
|
|
|
11797 |
147 |
SS.SR-(D7Rat16-D7Rat189)/Jr |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 27 days) |
Cicila GT, et al., Genomics 2001 Feb 15;72(1):51-60. |
arterial blood pressure trait |
male |
68 days-70 days |
20 |
|
serial mean |
219.0 |
mmHg |
3.4 |
15.21 |
tail cuff plethysmography |
|
|
|
0 |
|
|
average of 12 readings from 4 daily sessions |
|
11802 |
147 |
SS/Jr |
heart wet weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 27 days) |
Cicila GT, et al., Genomics 2001 Feb 15;72(1):51-60. |
heart mass |
male |
68 days-70 days |
20 |
|
|
1.25 |
g |
0.02 |
0.09 |
post excision weight measurement |
|
|
|
0 |
|
|
|
|
11809 |
147 |
SS/Jr |
body weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 27 days) |
Cicila GT, et al., Genomics 2001 Feb 15;72(1):51-60. |
body mass |
male |
68 days-70 days |
20 |
|
|
289.8 |
g |
3.2 |
14.31 |
body weighing method |
|
|
|
0 |
|
|
|
|
11817 |
147 |
SS/Jr |
heart wet weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 27 days) |
Cicila GT, et al., Genomics 2001 Feb 15;72(1):51-60. |
heart mass |
male |
68 days-70 days |
20 |
|
|
1.24 |
g |
0.01 |
0.07 |
post excision weight measurement |
|
|
|
0 |
|
|
|
|
11821 |
147 |
SS.MNS-(D10Mco14-D10Mit11)/Jr |
systolic blood pressure |
controlled sodium content diet (2 %) (between 25 and 28 days) |
Dukhanina OI, et al., Mamm Genome 1997 Apr;8(4):229-35. |
arterial blood pressure trait |
not specified |
64 days-68 days |
20 |
|
serial mean |
175.0 |
mmHg |
1.7 |
7.6 |
tail cuff plethysmography |
|
|
|
0 |
|
|
average of 12 readings from 4 daily sessions |
|
11832 |
148 |
SS.WKY-(D2N35-Mme)/Mco |
systolic blood pressure |
controlled sodium content diet (0.2 %) (between 15 and 18 days) then controlled sodium content diet (2 %) (between 25 and 28 days) |
Rapp JP, et al., J Clin Invest 1998 Apr 15;101(8):1591-5. |
arterial blood pressure trait |
male |
70 days-76 days |
24 |
|
serial mean |
185.0 |
mmHg |
1.8 |
8.82 |
tail cuff plethysmography |
|
|
|
0 |
|
|
|
|
11846 |
150 |
SR/Jr |
diastolic blood pressure |
controlled sodium content diet (8 %) (between 48 and 55 days) then controlled exposure to ambient light |
St. Lezin EM, et al., J Clin Invest 1996 Jan 15;97(2):522-7 |
arterial blood pressure trait |
male |
70 days-77 days |
7 |
|
serial mean |
95.0 |
mmHg |
4.0 |
10.58 |
intra-aortic abdominal radiotelemetry |
|
604800.0 |
|
0 |
|
5 s every 5 min daily for a week |
|
|
11698 |
119 |
SS.SR-(D7Rat16-D7Rat189)/Jr |
body weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 27 days) |
Cicila GT, et al., Genomics 2001 Feb 15;72(1):51-60. |
body mass |
male |
68 days-70 days |
20 |
|
|
296.3 |
g |
3.0 |
13.42 |
body weighing method |
|
|
|
0 |
|
|
|
|
11806 |
147 |
SS.MNS-(D2Chm51-D2Rat341)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
arterial blood pressure trait |
male |
68 days-98 days |
8 |
|
|
144.0 |
mmHg |
2.0 |
5.66 |
radiotelemetry |
|
30 |
|
0 |
|
|
|
|
11937 |
226 |
SS.LEW-(D10Chm10-D10Rat11)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
arterial blood pressure trait |
male |
68 days-98 days |
7 |
|
|
150.0 |
mmHg |
2.0 |
5.29 |
radiotelemetry |
|
30 |
|
0 |
|
|
|
|
11956 |
226 |
SS.LEW-(D17Rat65-D17Chm2)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
arterial blood pressure trait |
male |
68 days-98 days |
5 |
|
|
171.0 |
mmHg |
8.0 |
17.89 |
radiotelemetry |
|
30 |
|
0 |
|
|
|
|
11963 |
226 |
SS.LEW-(D17Chm9-D17Rat97)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
arterial blood pressure trait |
male |
68 days-98 days |
10 |
|
|
169.0 |
mmHg |
7.0 |
22.14 |
radiotelemetry |
|
30 |
|
0 |
|
|
|
|
11964 |
226 |
SS/Jr |
body weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Saad Y, et al., Hypertension. 2007 |
body mass |
male |
64 days-66 days |
0 |
|
|
310.0 |
g |
2.38 |
|
body weighing method |
|
|
|
0 |
|
|
|
|
11976 |
205 |
SS.LEW-(D10Mco113-D10Got93)/Mco |
body weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Saad Y, et al., Hypertension. 2007 |
body mass |
male |
64 days-66 days |
0 |
|
|
337.0 |
g |
2.09 |
|
body weighing method |
|
|
|
0 |
|
|
|
|
11977 |
205 |
SS.LEW-(D10Mco84-D10Mco143)/Mco |
body weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Saad Y, et al., Hypertension. 2007 |
body mass |
male |
64 days-66 days |
0 |
|
|
335.0 |
g |
3.0 |
|
body weighing method |
|
|
|
0 |
|
|
|
|
11979 |
205 |
SS.LEW-(D10Mco84-D10Rat58)/Mco |
body weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Saad Y, et al., Hypertension. 2007 |
body mass |
male |
64 days-66 days |
0 |
|
|
311.0 |
g |
4.21 |
|
body weighing method |
|
|
|
0 |
|
|
|
|
11980 |
205 |
SS.LEW-(D10Mco84-D10Mco129)/Mco |
body weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Saad Y, et al., Hypertension. 2007 |
body mass |
male |
64 days-66 days |
0 |
|
|
308.0 |
g |
5.3 |
|
body weighing method |
|
|
|
0 |
|
|
|
|
11981 |
205 |
SS/JrHsdMcwi |
systolic blood pressure |
controlled sodium content diet (0.1 %) (for 28 days) then controlled sodium content diet (8 %) (for 31 days) and controlled exposure to ambient light (for 12 hours) |
Cowley AW Jr, et al., Physiol Genomics 2000 Apr 27;2(3):107-15. |
arterial blood pressure trait |
male |
91 days-94 days |
35 |
|
continuous mean |
206.0 |
mmHg |
6.0 |
35.5 |
vascular indwelling catheter method |
femoral artery |
259200.0 |
|
0 |
|
3 h per day |
|
|
11984 |
229 |
SS/Jr |
heart weight to body weight ratio |
controlled sodium content diet (2 %) (between 24 and 27 days) |
Garrett MR, et al., Hypertension 2001 Oct;38(4):779-85 |
heart mass |
male |
64 days-69 days |
20 |
|
|
4.09 |
g/kg |
0.03 |
0.14 |
post excision weight measurement |
|
|
|
0 |
|
|
|
|
11994 |
221 |
SS/JrHsdMcwi |
diastolic blood pressure |
controlled sodium content diet (0.1 %) (for 28 days) then controlled sodium content diet (8 %) (for 31 days) and controlled exposure to ambient light (for 12 hours) |
Cowley AW Jr, et al., Physiol Genomics 2000 Apr 27;2(3):107-15. |
arterial blood pressure trait |
male |
91 days-94 days |
35 |
|
continuous mean |
167.0 |
mmHg |
4.0 |
23.66 |
vascular indwelling catheter method |
femoral artery |
259200.0 |
|
0 |
|
3 h per day |
|
|
12002 |
229 |
SS.LEW-(D10Mit10-D10Rat24)/Jr |
heart weight to body weight ratio |
controlled sodium content diet (2 %) (between 24 and 27 days) |
Garrett MR, et al., Hypertension 2001 Oct;38(4):779-85 |
heart mass |
male |
64 days-69 days |
20 |
|
|
3.89 |
g/kg |
0.02 |
0.09 |
post excision weight measurement |
|
|
|
0 |
|
|
|
|
12015 |
221 |
SS.MNS-(D10M11Mit119-D10Mit11)/Jr |
heart weight to body weight ratio |
controlled sodium content diet (2 %) (between 24 and 27 days) |
Garrett MR, et al., Hypertension 2001 Oct;38(4):779-85 |
heart mass |
male |
64 days-69 days |
20 |
|
|
3.84 |
g/kg |
0.04 |
0.19 |
post excision weight measurement |
|
|
|
0 |
|
|
|
|
12026 |
221 |
SS.MNS-(D10Mco70-D10Mit11)/Jr |
heart weight to body weight ratio |
controlled sodium content diet (2 %) (between 24 and 27 days) |
Garrett MR, et al., Hypertension 2001 Oct;38(4):779-85 |
heart mass |
male |
64 days-69 days |
20 |
|
|
4.28 |
g/kg |
0.05 |
0.21 |
post excision weight measurement |
|
|
|
0 |
|
|
|
|
12036 |
221 |
SS/Jr |
heart weight to body weight ratio |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Saad Y, et al., Hypertension. 2007 |
heart mass |
male |
64 days-66 days |
0 |
|
|
3.9 |
g/kg |
0.04 |
|
post excision weight measurement |
|
|
|
0 |
|
|
|
|
12039 |
205 |
SS.LEW-(D3Got33-D3Chm68)/Ayd |
body weight |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
body mass |
male |
98 days
| 10 |
|
|
389.0 |
g |
6.0 |
18.97 |
body weighing method |
|
0 |
|
0 |
|
|
|
|
12042 |
226 |
SS.LEW-(D10Mco113-D10Got93)/Mco |
heart weight to body weight ratio |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Saad Y, et al., Hypertension. 2007 |
heart mass |
male |
64 days-66 days |
0 |
|
|
3.91 |
g/kg |
0.04 |
|
post excision weight measurement |
|
|
|
0 |
|
|
|
|
12050 |
205 |
SS.LEW-(D10Chm10-D10Rat11)/Ayd |
body weight |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
body mass |
male |
98 days
| 7 |
|
|
375.0 |
g |
5.0 |
13.23 |
body weighing method |
|
0 |
|
0 |
|
|
|
|
12061 |
226 |
SS.LEW-(D10Rat27-Igfbp4)/Ayd |
body weight |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
body mass |
male |
98 days
| 7 |
|
|
388.0 |
g |
6.0 |
15.87 |
body weighing method |
|
0 |
|
0 |
|
|
|
|
12058 |
226 |
SS.LEW-(D10Chm128-D10Chm169)/Ayd |
body weight |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
body mass |
male |
98 days
| 8 |
|
|
369.0 |
g |
6.0 |
16.97 |
body weighing method |
|
0 |
|
0 |
|
|
|
|
12063 |
226 |
SS.LEW-(D17Chm14-D17Rat181)/Ayd |
body weight |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
body mass |
male |
98 days
| 5 |
|
|
377.0 |
g |
9.0 |
20.12 |
body weighing method |
|
0 |
|
0 |
|
|
|
|
12069 |
226 |
SS.LEW-(D18Chm41-D18Rat92)/Ayd |
body weight |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
body mass |
male |
98 days
| 5 |
|
|
386.0 |
g |
5.0 |
11.18 |
body weighing method |
|
0 |
|
0 |
|
|
|
|
12076 |
226 |
SS.LEW-(D18Chm91-D18Rat67)/Ayd |
body weight |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
body mass |
male |
98 days
| 5 |
|
|
389.0 |
g |
8.0 |
17.89 |
body weighing method |
|
0 |
|
0 |
|
|
|
|
12077 |
226 |
SS.LEW-(D10Chm224-D10Chm6)/Ayd |
body weight |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
body mass |
male |
98 days
| 11 |
|
|
382.0 |
g |
6.0 |
19.9 |
body weighing method |
|
0 |
|
0 |
|
|
|
|
12082 |
226 |
SS.MNS-(D2Wox27-Adh1)/Ayd |
heart weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart mass |
male |
98 days
| 5 |
|
|
3.7 |
g/kg |
0.2 |
0.45 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12094 |
226 |
SS.MNS-(D2Chm25-Fgg)/Ayd |
heart weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart mass |
male |
98 days
| 9 |
|
|
3.54 |
g/kg |
0.09 |
0.27 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12096 |
226 |
SS.LEW-(D3Mco21-D3Rat17)/Ayd |
heart weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart mass |
male |
98 days
| 4 |
|
|
3.64 |
g/kg |
0.08 |
0.16 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12098 |
226 |
SS.LEW-(D8Rat56-D8Rat51)/Ayd |
heart weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart mass |
male |
98 days
| 9 |
|
|
4.7 |
g/kg |
0.4 |
1.2 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12107 |
226 |
SS.MNS-(Adh1-D2Mit5)/Mco |
systolic blood pressure |
controlled sodium content diet (2 %) (between 25 and 28 days) |
Deng AY, et al., Hypertension 1997 Aug;30(2 Pt 1):199-202 |
arterial blood pressure trait |
male |
65 days-68 days |
20 |
|
|
181.1 |
mmHg |
1.9 |
8.5 |
tail cuff photoplethysmography |
tail |
|
|
0 |
|
average of 4 days, 3 to 4 consistent readings each day, IITC |
|
|
12108 |
231 |
SS.LEW-(D18Chm56-D18Rat55)/Ayd |
heart weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart mass |
male |
98 days
| 5 |
|
|
3.9 |
g/kg |
0.2 |
0.45 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12123 |
226 |
SS.MNS-(D10Mco30-D10Got91)/3Mco |
systolic blood pressure |
controlled sodium content diet (2 %) (for 24 days) |
Saad Y, et al., Mamm Genome. 2008 Jan 4 |
arterial blood pressure trait |
male |
64 days-68 days |
20 |
|
|
193.0 |
mmHg |
3.5 |
15.65 |
tail cuff plethysmography |
tail |
345600.0 |
|
0 |
|
warm up to 28 C |
Average of 3-4 consistent measurements taken each day over 4 consecutive days |
|
12140 |
232 |
SS/Jr |
heart wet weight |
controlled sodium content diet (2 %) (for 24 days) |
Saad Y, et al., Mamm Genome. 2008 Jan 4 |
heart mass |
male |
64 days-68 days |
20 |
|
|
1.31 |
g |
0.01 |
0.04 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12154 |
232 |
LEW/NCrl |
systolic blood pressure |
controlled sodium content diet (0.2 %) (for 168 days) |
Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23 |
arterial blood pressure trait |
male |
203 days
| 8 |
|
serial mean |
131.0 |
mmHg |
3.3 |
9.33 |
tail cuff plethysmography |
tail |
0 |
|
0 |
|
|
|
|
12174 |
222 |
LEW/NCrl |
systolic blood pressure |
controlled sodium content diet (0.2 %) (for 5 days) then controlled sodium content diet (8 %) (for 168 days) |
Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23 |
arterial blood pressure trait |
male |
203 days
| 8 |
|
serial mean |
140.0 |
mmHg |
2.5 |
7.07 |
tail cuff plethysmography |
tail |
0 |
|
0 |
|
|
|
|
12178 |
222 |
SR/Jr |
body weight |
controlled sodium content diet (0.2 %) (for 56 days) |
Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23 |
body mass |
male |
91 days
| 10 |
|
|
313.0 |
g |
4.8 |
15.18 |
body weighing method |
|
0 |
|
0 |
|
|
|
4 rats per cage, 2 SR/Jr 2 LEW/NCrl |
12181 |
222 |
SR/Jr |
body weight |
controlled sodium content diet (0.2 %) (for 5 days) then controlled sodium content diet (8 %) (for 168 days) |
Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23 |
body mass |
male |
203 days
| 10 |
|
|
407.0 |
g |
5.7 |
18.02 |
body weighing method |
|
0 |
|
0 |
|
|
|
4 rats per cage, 2 SR/Jr 2 LEW/NCrl |
12189 |
222 |
LEW/NCrl |
body weight |
controlled sodium content diet (0.2 %) (for 5 days) then controlled sodium content diet (8 %) (for 112 days) |
Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23 |
body mass |
male |
147 days
| 8 |
|
|
409.0 |
g |
5.1 |
14.42 |
body weighing method |
|
0 |
|
0 |
|
|
|
4 rats per cage, 2 SR/Jr 2 LEW/NCrl |
12199 |
222 |
SS.MNS-(D10Mco62-D10Mco30)/Mco |
heart wet weight |
controlled sodium content diet (2 %) (for 24 days) |
Saad Y, et al., Mamm Genome. 2008 Jan 4 |
heart mass |
male |
64 days-68 days |
20 |
|
|
1.37 |
g |
0.03 |
0.13 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12205 |
232 |
SS.MNS-(D10Mco30-D10Got91)/1Mco |
heart wet weight |
controlled sodium content diet (2 %) (for 24 days) |
Saad Y, et al., Mamm Genome. 2008 Jan 4 |
heart mass |
male |
64 days-68 days |
20 |
|
|
1.21 |
g |
0.02 |
0.09 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12208 |
232 |
SS.MNS-(D10Mco30-D10Got91)/3Mco |
heart wet weight |
controlled sodium content diet (2 %) (for 24 days) |
Saad Y, et al., Mamm Genome. 2008 Jan 4 |
heart mass |
male |
64 days-68 days |
20 |
|
|
1.13 |
g |
0.01 |
0.04 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12210 |
232 |
SS/Jr |
heart weight to body weight ratio |
controlled sodium content diet (2 %) (for 24 days) |
Saad Y, et al., Mamm Genome. 2008 Jan 4 |
heart mass |
male |
64 days-68 days |
20 |
|
|
4.08 |
g/kg |
0.05 |
0.22 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12219 |
232 |
SS.MNS-(D10Mco62-D10Got99)/Mco |
heart weight to body weight ratio |
controlled sodium content diet (2 %) (for 24 days) |
Saad Y, et al., Mamm Genome. 2008 Jan 4 |
heart mass |
male |
64 days-68 days |
20 |
|
|
4.09 |
g/kg |
0.03 |
0.13 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12221 |
232 |
SS/Jr |
heart wet weight |
controlled sodium content diet (0.4 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days) |
Lee SJ, et al., Genetics 2006 Dec;174(4):2203-13. |
heart mass |
male |
70 days-72 days |
20 |
|
|
1.12 |
g |
0.02 |
0.07 |
post excision weight measurement |
|
|
|
0 |
|
|
|
|
12275 |
237 |
SS-Tg(ApoC3-CETP)53Opaz |
plasma total cholesterol level |
controlled sodium content diet (0.3 %) (for 180 days) then fasting (for 16 hours) |
Herrera VL, et al., J Hypertens. 2007 Aug;25(8):1608-12 |
blood cholesterol amount |
male |
180 days
| 5 |
|
|
577.61 |
mg/dl |
170.66 |
381.6 |
plasma total cholesterol measurement test |
|
|
|
0 |
|
|
|
|
12284 |
238 |
SS.SR-(D3Mco78-D3Got130)/Jr |
body weight |
controlled sodium content diet (0.4 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days) |
Lee SJ, et al., Genetics 2006 Dec;174(4):2203-13. |
body mass |
male |
70 days-72 days |
20 |
|
|
296.3 |
g |
3.0 |
13.42 |
body weighing method |
|
|
|
0 |
|
|
|
|
12288 |
237 |
SS.SR-(D3Mco24-D3Got130)/Jr |
body weight |
controlled sodium content diet (0.4 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days) |
Lee SJ, et al., Genetics 2006 Dec;174(4):2203-13. |
body mass |
male |
70 days-72 days |
19 |
|
|
307.7 |
g |
1.9 |
8.28 |
body weighing method |
|
|
|
0 |
|
|
|
|
12297 |
237 |
SS.SR-(D3Mco36-D3Mco46)/Jr |
both kidneys wet weight |
controlled sodium content diet (0.4 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days) |
Lee SJ, et al., Genetics 2006 Dec;174(4):2203-13. |
kidney mass |
male |
70 days-72 days |
40 |
|
|
2.83 |
g |
0.04 |
0.23 |
post excision weight measurement |
|
|
|
0 |
|
|
|
|
12309 |
237 |
SS-Tg(ApoC3-CETP)53Opaz |
plasma triglyceride level |
controlled sodium content diet (0.3 %) (for 180 days) then fasting (for 16 hours) |
Herrera VL, et al., J Hypertens. 2007 Aug;25(8):1608-12 |
blood triglyceride amount |
male |
180 days
| 5 |
|
|
53.43 |
mmol/l |
20.19 |
45.15 |
plasma triglyceride analysis |
|
|
|
0 |
|
|
|
\ |
12307 |
238 |
SS/Jr |
both kidneys wet weight |
controlled sodium content diet (0.4 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days) |
Lee SJ, et al., Genetics 2006 Dec;174(4):2203-13. |
kidney mass |
male |
70 days-72 days |
41 |
|
|
3.04 |
g |
0.03 |
0.19 |
post excision weight measurement |
|
|
|
0 |
|
|
|
|
12318 |
237 |
SR/Hsd |
plasma high density lipoprotein cholesterol level |
controlled sodium content diet (0.3 %) then fasting (for 16 hours) |
Herrera VL, et al., Circ Res 2004 Mar 5; 94(4):446-52 |
blood HDL cholesterol amount |
male |
180 days
| 6 |
|
|
27.8 |
mg/dl |
1.16 |
2.84 |
plasma high-density lipoprotein-cholesterol measurement test |
|
|
|
0 |
|
|
|
|
11892 |
204 |
SS/Jr |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Saad Y, et al., Hypertension. 2007 |
arterial blood pressure trait |
male |
64 days-66 days |
0 |
|
|
221.0 |
mmHg |
3.95 |
|
tail cuff plethysmography |
|
|
|
0 |
|
warm up to 28 C |
Average of 3-4 consistent measurements taken each day over 4 consecutive days |
|
11913 |
205 |
SS/Jr |
heart weight to body weight ratio |
controlled sodium content diet (2 %) (between 24 and 27 days) |
Garrett MR, et al., Hypertension 2001 Oct;38(4):779-85 |
heart mass |
male |
64 days-69 days |
20 |
|
|
4.16 |
g/kg |
0.05 |
0.21 |
post excision weight measurement |
|
|
|
0 |
|
|
|
|
11914 |
221 |
SS.LEW-(D10Arb9-D10Got101)/Jr |
heart wet weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) |
Saad Y, et al., Genomics. 2007 Mar;89(3):343-53. Epub 2007 Jan 10. |
heart mass |
male |
68 days-70 days |
20 |
|
|
1.22 |
g |
0.01 |
0.04 |
digital scale post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12681 |
282 |
SS.LEW-(D10Mco89-D10Got101)/Mco |
heart wet weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) |
Saad Y, et al., Genomics. 2007 Mar;89(3):343-53. Epub 2007 Jan 10. |
heart mass |
male |
68 days-70 days |
20 |
|
|
1.18 |
g |
0.01 |
0.05 |
digital scale post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12686 |
282 |
SS.LEW-(D10Arb9-D10Got101)/Jr |
body weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) |
Saad Y, et al., Genomics. 2007 Mar;89(3):343-53. Epub 2007 Jan 10. |
body mass |
male |
68 days-70 days |
20 |
|
|
303.0 |
g |
1.14 |
5.1 |
whole body digital scale |
|
0 |
|
0 |
|
|
|
|
12696 |
282 |
SS.LEW-(D10Arb9-D10Mco84)/Mco |
body weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) |
Saad Y, et al., Genomics. 2007 Mar;89(3):343-53. Epub 2007 Jan 10. |
body mass |
male |
68 days-70 days |
20 |
|
|
315.0 |
g |
2.77 |
12.39 |
whole body digital scale |
|
0 |
|
0 |
|
|
|
|
12702 |
282 |
SS/Jr |
heart weight to body weight ratio |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) |
Saad Y, et al., Genomics. 2007 Mar;89(3):343-53. Epub 2007 Jan 10. |
heart mass |
male |
68 days-70 days |
20 |
|
|
3.85 |
g/kg |
0.05 |
0.21 |
digital scale post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12712 |
282 |
SS.LEW-(D10Arb9-D10Rat57)/Mco |
heart weight to body weight ratio |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) |
Saad Y, et al., Genomics. 2007 Mar;89(3):343-53. Epub 2007 Jan 10. |
heart mass |
male |
68 days-70 days |
20 |
|
|
3.68 |
g/kg |
0.03 |
0.14 |
digital scale post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12716 |
282 |
SS.LEW-(D10Mco30-D10Got107)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (between 31 and 50 days) |
Chauvet C, et al., J Hypertens. 2008 May;26(5):893-901. |
arterial blood pressure trait |
male |
66 days-78 days |
5 |
|
serial mean |
168.0 |
mmHg |
6.0 |
13.42 |
intra-aortic abdominal radiotelemetry |
abdominal aorta |
1036800 |
|
0 |
|
telemetry probe model PA-D70, Data Sciences, St. Paul, MN |
average of 24 hour averages over 12 days |
|
12738 |
304 |
SS.LEW-(D10Chm10-D10Rat11)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (between 31 and 50 days) |
Chauvet C, et al., J Hypertens. 2008 May;26(5):893-901. |
arterial blood pressure trait |
male |
66 days-78 days |
16 |
|
serial mean |
150.0 |
mmHg |
6.0 |
24.0 |
intra-aortic abdominal radiotelemetry |
abdominal aorta |
1036800 |
|
0 |
|
telemetry probe model PA-D70, Data Sciences, St. Paul, MN |
average of 24 hour averages over 12 days |
|
12741 |
304 |
SS.LEW-(D10Mco15-D10Mgh1)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (between 31 and 50 days) |
Chauvet C, et al., J Hypertens. 2008 May;26(5):893-901. |
arterial blood pressure trait |
male |
66 days-78 days |
6 |
|
serial mean |
180.0 |
mmHg |
6.0 |
14.7 |
intra-aortic abdominal radiotelemetry |
abdominal aorta |
1036800 |
|
0 |
|
telemetry probe model PA-D70, Data Sciences, St. Paul, MN |
average of 24 hour averages over 12 days |
|
12742 |
304 |
SS.LEW-(D10Chm10-D10Chm14)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (between 31 and 50 days) |
Chauvet C, et al., J Hypertens. 2008 May;26(5):893-901. |
arterial blood pressure trait |
male |
66 days-78 days |
5 |
|
serial mean |
168.0 |
mmHg |
6.0 |
13.42 |
intra-aortic abdominal radiotelemetry |
abdominal aorta |
1036800 |
|
0 |
|
telemetry probe model PA-D70, Data Sciences, St. Paul, MN |
average of 24 hour averages over 12 days |
|
12743 |
304 |
SS.LEW-(D10Rat194-D10Chm243)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (between 31 and 50 days) |
Chauvet C, et al., J Hypertens. 2008 May;26(5):893-901. |
arterial blood pressure trait |
male |
66 days-78 days |
8 |
|
serial mean |
128.0 |
mmHg |
6.0 |
16.97 |
intra-aortic abdominal radiotelemetry |
abdominal aorta |
1036800 |
|
0 |
|
telemetry probe model PA-D70, Data Sciences, St. Paul, MN |
average of 24 hour averages over 12 days |
|
12746 |
304 |
SS/Jr |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7. |
arterial blood pressure trait |
male |
64 days-66 days |
20 |
|
|
195.0 |
mmHg |
3.27 |
14.62 |
tail cuff plethysmography |
|
4 |
|
0 |
|
semi- automatic equipment from IITC, Woodland Hills, CA |
average of 2-3 readings/day over 4 days |
|
12807 |
313 |
SS/Jr |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7. |
arterial blood pressure trait |
male |
64 days-66 days |
20 |
|
|
194.0 |
mmHg |
3.38 |
15.12 |
tail cuff plethysmography |
|
4 |
|
0 |
|
semi- automatic equipment from IITC, Woodland Hills, CA |
average of 2-3 readings/day over 4 days |
|
12808 |
313 |
SS.LEW-(D1Mco36-D1Rat131)/1Mco |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7. |
arterial blood pressure trait |
male |
64 days-66 days |
20 |
|
|
178.0 |
mmHg |
2.22 |
9.93 |
tail cuff plethysmography |
|
4 |
|
0 |
|
semi- automatic equipment from IITC, Woodland Hills, CA |
average of 2-3 readings/day over 4 days |
|
12817 |
313 |
SS.LEW-(D1Mco36-D1Mco77)/Mco |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7. |
arterial blood pressure trait |
male |
64 days-66 days |
20 |
|
|
184.0 |
mmHg |
3.07 |
13.73 |
tail cuff plethysmography |
|
4 |
|
0 |
|
semi- automatic equipment from IITC, Woodland Hills, CA |
average of 2-3 readings/day over 4 days |
|
12819 |
313 |
SS.LEW-(D1Mco99-D1Rat49)/Mco |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7. |
arterial blood pressure trait |
male |
64 days-66 days |
20 |
|
|
197.0 |
mmHg |
3.99 |
17.84 |
tail cuff plethysmography |
|
4 |
|
0 |
|
semi- automatic equipment from IITC, Woodland Hills, CA |
average of 2-3 readings/day over 4 days |
|
12823 |
313 |
SS.SHR-(D9Mco74-D9Rat64)/Mco |
diastolic blood pressure |
controlled sodium content diet (2 %) (between 35 and 37 days) |
Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41. |
arterial blood pressure trait |
male |
75 days-79 days |
5 |
|
serial mean |
108.0 |
mmHg |
1.32 |
2.95 |
intra-aortic abdominal radiotelemetry |
lower abdominal aorta |
172800 |
|
0 |
|
C-40 transmitter (Data Sciences International, St. Paul, MN) |
average of 12 4-hour averages over 48 hours using 5 or 6 rats |
|
13033 |
305 |
SS.SHR-(D9Mco72-D9Mco93)/Mco |
mean arterial blood pressure |
controlled sodium content diet (2 %) (between 35 and 37 days) |
Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41. |
arterial blood pressure trait |
male |
75 days-79 days |
5 |
|
serial mean |
125.0 |
mmHg |
1.28 |
2.86 |
intra-aortic abdominal radiotelemetry |
lower abdominal aorta |
172800 |
|
0 |
|
C-40 transmitter (Data Sciences International, St. Paul, MN) |
average of 12 4-hour averages over 48 hours using 5 or 6 rats |
|
13038 |
305 |
SS/Jr |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days) |
Saad Y, et al., Genomics. 2007 Mar;89(3):343-53. Epub 2007 Jan 10. |
arterial blood pressure trait |
male |
64 days-70 days |
20 |
|
serial mean |
215.0 |
mmHg |
3.72 |
16.64 |
tail cuff photoplethysmography |
tail |
345600 |
|
0 |
|
|
average of 4 daily averages of 3-4 measurements/day |
|
13084 |
282 |
SHR/Fub |
urine albumin excretion rate |
controlled sodium content diet (0.2 %) |
Poyan Mehr A, et al., Physiol Genomics 2003 Aug 15;14(3):209-16. |
urine albumin amount |
not specified |
28 days
| 11 |
|
|
0.03 |
mg/d |
|
|
enzyme linked immunosorbent assay |
urine |
0.0 |
|
0 |
|
rat albumin ELISA |
|
|
13282 |
335 |
SS/Jr |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days) |
Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14. |
arterial blood pressure trait |
male |
64 days-70 days |
20 |
|
|
235.0 |
mmHg |
4.8 |
21.47 |
tail cuff plethysmography |
|
|
|
0 |
|
average of 3-4 consistent readings |
|
|
12456 |
266 |
SS.LEW-(D1Mco38-D1Rat49)/Jr |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days) |
Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14. |
arterial blood pressure trait |
male |
64 days-70 days |
20 |
|
|
181.0 |
mmHg |
3.03 |
13.55 |
tail cuff plethysmography |
|
|
|
0 |
|
average of 3-4 consistent readings |
|
|
12464 |
266 |
SS.LEW-(D1Rat35-D1Rat49)/Jr |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days) |
Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14. |
arterial blood pressure trait |
male |
64 days-70 days |
20 |
|
|
195.0 |
mmHg |
2.87 |
12.84 |
tail cuff plethysmography |
|
|
|
0 |
|
average of 3-4 consistent readings |
|
|
12462 |
266 |
SS.LEW-(D17Rat65-Prl)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (2 %) (between 43 and 47 days) |
Grondin M, et al., Physiol Genomics 2005 Mar 21;21(1):112-6. Epub 2005 Jan 4. |
arterial blood pressure trait |
male |
88 days-92 days |
5 |
|
|
139.0 |
mmHg |
5.0 |
11.18 |
intra-aortic abdominal radiotelemetry |
|
|
|
0 |
|
|
measure every 2 min for 24 hrs |
|
12466 |
261 |
SS.LEW-(D1Uia8-D1Mco38)/Jr |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days) |
Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14. |
arterial blood pressure trait |
male |
64 days-70 days |
20 |
|
|
205.0 |
mmHg |
1.76 |
7.87 |
tail cuff plethysmography |
|
|
|
0 |
|
average of 3-4 consistent readings |
|
|
12470 |
266 |
SS/Jr |
body weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) |
Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14. |
body mass |
male |
68 days-70 days |
20 |
|
|
314.0 |
g |
1.72 |
7.69 |
body weighing method |
|
|
|
0 |
|
|
|
|
12486 |
266 |
SS/Jr |
body weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) |
Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14. |
body mass |
male |
68 days-70 days |
20 |
|
|
308.0 |
g |
1.68 |
7.51 |
body weighing method |
|
|
|
0 |
|
|
|
|
12489 |
266 |
SS.LEW-(D1Rat35-D1Rat49)/Jr |
body weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) |
Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14. |
body mass |
male |
68 days-70 days |
20 |
|
|
304.0 |
g |
2.97 |
13.28 |
body weighing method |
|
|
|
0 |
|
|
|
|
12496 |
266 |
SS.LEW-(D1Rat196-D1Mgh7)/Jr |
body weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) |
Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14. |
body mass |
male |
68 days-70 days |
20 |
|
|
294.0 |
g |
3.72 |
16.64 |
body weighing method |
|
|
|
0 |
|
|
|
|
12501 |
266 |
SS.LEW-(D1Rat196-D1Mco36)/Jr |
body weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) |
Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14. |
body mass |
male |
68 days-70 days |
20 |
|
|
303.0 |
g |
2.91 |
13.01 |
body weighing method |
|
|
|
0 |
|
|
|
|
12502 |
266 |
SS.LEW-(D1Uia8-D1Rat124)/Mco |
body weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) |
Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14. |
body mass |
male |
68 days-70 days |
20 |
|
|
298.0 |
g |
2.53 |
11.31 |
body weighing method |
|
|
|
0 |
|
|
|
|
12506 |
266 |
SS.LEW-(D1Mco36-D1Rat49)/Jr |
heart weight to body weight ratio |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) |
Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14. |
heart mass |
male |
68 days-70 days |
20 |
|
|
3.74 |
g/kg |
0.04 |
0.17 |
post excision weight measurement |
|
|
|
0 |
|
|
|
|
12561 |
266 |
SS.LEW-(D1Uia2-D1Rat49)/Jr |
heart weight to body weight ratio |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) |
Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14. |
heart mass |
male |
68 days-70 days |
20 |
|
|
3.94 |
g/kg |
0.03 |
0.14 |
post excision weight measurement |
|
|
|
0 |
|
|
|
|
12563 |
266 |
SS.LEW-(D18Rat61-D18Rat45)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 21 days) |
Charron S, et al., Hum Mol Genet. 2005 Dec 15;14(24):3877-84. Epub 2005 Nov 8. |
arterial blood pressure trait |
male |
56 days
| 6 |
|
|
141.0 |
mmHg |
3.0 |
7.35 |
intra-aortic abdominal radiotelemetry |
aorta |
|
|
0 |
|
|
|
|
12599 |
269 |
SS/Jr |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 21 and 25 days) |
Roman RJ, et al., Am J Physiol Renal Physiol. 2006 Jun;290(6):F1463-71. Epub 2006 Jan 5. |
arterial blood pressure trait |
male |
82 days-86 days |
69 |
|
serial mean |
187.0 |
mmHg |
|
|
vascular fluid filled catheter |
femoral artery |
345600 |
|
0 |
|
connected to solid-state transducer (Argon Medical Technologies, Athens, TX) |
5 hr recording session - 1 min. averages, averaged over 4 days |
|
12613 |
272 |
SS.LEW-(D5Rat130-D5Rat72)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 21 and 25 days) |
Roman RJ, et al., Am J Physiol Renal Physiol. 2006 Jun;290(6):F1463-71. Epub 2006 Jan 5. |
arterial blood pressure trait |
male |
82 days-86 days |
32 |
|
serial mean |
190.0 |
mmHg |
|
|
vascular fluid filled catheter |
femoral artery |
345600 |
|
0 |
|
connected to solid-state transducer (Argon Medical Technologies, Athens, TX) |
5 hr recording session - 1 min. averages, averaged over 4 days |
|
12614 |
272 |
SS/Jr |
heart wet weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7. |
heart mass |
male |
64 days-66 days |
30 |
|
|
1.3 |
g |
0.01 |
0.07 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12846 |
313 |
SS.LEW-(D1Mco36-D1Rat131)/2Mco |
heart wet weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7. |
heart mass |
male |
64 days-66 days |
20 |
|
|
1.11 |
g |
0.01 |
0.06 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12854 |
313 |
SS/Jr |
body weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7. |
body mass |
male |
64 days-66 days |
20 |
|
|
314.0 |
g |
2.23 |
9.97 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
12863 |
313 |
SS.LEW-(D1Mco36-D1Rat131)/1Mco |
body weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7. |
body mass |
male |
64 days-66 days |
20 |
|
|
305.0 |
g |
2.4 |
10.73 |
body weighing method |
|
0 |
|
0 |
|
|
|
|
12873 |
313 |
SS.LEW-(D1Mco85-D1Rat49)/Mco |
body weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7. |
body mass |
male |
64 days-66 days |
20 |
|
|
316.0 |
g |
2.87 |
12.84 |
body weighing method |
|
0 |
|
0 |
|
|
|
|
12878 |
313 |
SS/Jr |
heart weight to body weight ratio |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7. |
heart mass |
male |
64 days-66 days |
20 |
|
|
3.89 |
g/kg |
0.02 |
0.1 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12884 |
313 |
SS/Jr |
heart weight to body weight ratio |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7. |
heart mass |
male |
64 days-66 days |
30 |
|
|
3.98 |
g/kg |
0.03 |
0.16 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12886 |
313 |
SS/Jr |
heart wet weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) |
Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14. |
heart mass |
male |
68 days-70 days |
20 |
|
|
1.25 |
g |
0.02 |
0.07 |
post excision weight measurement |
|
|
|
0 |
|
|
|
|
12517 |
266 |
SS/Jr |
heart wet weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) |
Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14. |
heart mass |
male |
68 days-70 days |
20 |
|
|
1.29 |
g |
0.02 |
0.08 |
post excision weight measurement |
|
|
|
0 |
|
|
regression of heart weight on body weight |
|
12522 |
266 |
SS.LEW-(D1Mco2-D1Rat49)/Jr |
heart wet weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) |
Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14. |
heart mass |
male |
68 days-70 days |
20 |
|
|
1.14 |
g |
0.01 |
0.05 |
post excision weight measurement |
|
|
|
0 |
|
|
|
|
12525 |
266 |
SS.LEW-(D1Uia8-D1Rat18)/Mco |
heart wet weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) |
Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14. |
heart mass |
male |
68 days-70 days |
20 |
|
|
1.19 |
g |
0.01 |
0.06 |
post excision weight measurement |
|
|
|
0 |
|
|
regression of heart weight on body weight |
|
12535 |
266 |
SS/Jr |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 21 days) |
Charron S, et al., Hum Mol Genet. 2005 Dec 15;14(24):3877-84. Epub 2005 Nov 8. |
arterial blood pressure trait |
male |
56 days
| 10 |
|
|
175.0 |
mmHg |
4.0 |
12.65 |
intra-aortic abdominal radiotelemetry |
aorta |
|
|
0 |
|
|
|
|
12544 |
269 |
SS/Jr |
heart weight to body weight ratio |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) |
Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14. |
heart mass |
male |
68 days-70 days |
20 |
|
|
4.32 |
g/kg |
0.06 |
0.25 |
post excision weight measurement |
|
|
|
0 |
|
|
|
|
12545 |
266 |
SHRSP |
systolic blood pressure |
controlled sodium content diet (0.4 %) (for 63 days) |
Inomata H, et al., Hypertens Res 2005 Mar;28(3):273-81. |
arterial blood pressure trait |
male |
91 days
| 4 |
|
serial mean |
219.5 |
mmHg |
7.65 |
15.3 |
tail cuff photoplethysmography |
|
0 |
|
0 |
|
UR1000; Ueda |
average of 3 consistent readings |
|
12556 |
268 |
SS/Jr |
heart weight to body weight ratio |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) |
Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14. |
heart mass |
male |
68 days-70 days |
20 |
|
|
3.85 |
g/kg |
0.06 |
0.26 |
post excision weight measurement |
|
|
|
0 |
|
|
|
|
12555 |
266 |
SS.LEW-(D1Uia8-D1Rat18)/Mco |
heart weight to body weight ratio |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) |
Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14. |
heart mass |
male |
68 days-70 days |
20 |
|
|
3.89 |
g/kg |
0.04 |
0.19 |
post excision weight measurement |
|
|
|
0 |
|
|
|
|
12567 |
266 |
SS.LEW-(D1Uia8-D1Rat213)/Mco |
heart weight to body weight ratio |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) |
Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14. |
heart mass |
male |
68 days-70 days |
20 |
|
|
3.45 |
g/kg |
0.06 |
0.26 |
post excision weight measurement |
|
|
|
0 |
|
|
|
|
12570 |
266 |
WKY |
body weight |
controlled sodium content diet (0.4 %) (for 122 days) then controlled sodium content diet (1.4 %) (for 210 days) |
Inomata H, et al., Hypertens Res 2005 Mar;28(3):273-81. |
body mass |
female |
360 days
| 4 |
|
|
200.8 |
g |
3.45 |
6.9 |
body weighing method |
|
0 |
|
0 |
|
|
|
|
12589 |
268 |
SS/Jr |
heart wet weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) |
Saad Y, et al., Genomics. 2007 Mar;89(3):343-53. Epub 2007 Jan 10. |
heart mass |
male |
68 days-70 days |
20 |
|
|
1.26 |
g |
0.03 |
0.13 |
digital scale post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12669 |
282 |
SS/Jr |
heart wet weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) |
Saad Y, et al., Genomics. 2007 Mar;89(3):343-53. Epub 2007 Jan 10. |
heart mass |
male |
68 days-70 days |
20 |
|
|
1.25 |
g |
0.01 |
0.04 |
digital scale post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12671 |
282 |
SS/Jr |
heart wet weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) |
Saad Y, et al., Genomics. 2007 Mar;89(3):343-53. Epub 2007 Jan 10. |
heart mass |
male |
68 days-70 days |
30 |
|
|
1.25 |
g |
0.01 |
0.07 |
digital scale post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12677 |
282 |
SS/Jr |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 33 days) |
Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7. |
arterial blood pressure trait |
male |
73 days-75 days |
10 |
|
|
211.0 |
mmHg |
2.05 |
6.48 |
radiotelemetry |
|
345600 |
|
0 |
|
C-40 transmitter (Data Sciences International, St. Paul, MN) |
aveerage of 4-hour interval averages over 4 days |
|
12915 |
313 |
SS/Jr |
pulse pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 33 days) |
Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7. |
arterial blood pressure trait |
male |
73 days-75 days |
10 |
|
|
58.0 |
mmHg |
0.38 |
1.2 |
radiotelemetry |
|
345600 |
|
0 |
|
C-40 transmitter (Data Sciences International, St. Paul, MN) |
aveerage of 4-hour interval averages over 4 days |
|
12922 |
313 |
SS/Jr |
body weight |
controlled sodium content diet (2 %) (for 28 days) |
Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41. |
body mass |
male |
68 days-70 days |
20 |
|
|
311.0 |
g |
1.63 |
7.29 |
body weighing method |
|
|
|
0 |
|
|
|
|
12944 |
305 |
SS/Jr |
body weight |
controlled sodium content diet (2 %) (for 28 days) |
Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41. |
body mass |
male |
68 days-70 days |
20 |
|
|
339.0 |
g |
3.0 |
13.42 |
body weighing method |
|
|
|
0 |
|
|
|
|
12945 |
305 |
SS/Jr |
body weight |
controlled sodium content diet (2 %) (for 28 days) |
Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41. |
body mass |
male |
68 days-70 days |
20 |
|
|
316.0 |
g |
3.93 |
17.58 |
body weighing method |
|
|
|
0 |
|
|
|
|
12942 |
305 |
SS/Jr |
body weight |
controlled sodium content diet (2 %) (for 28 days) |
Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41. |
body mass |
male |
68 days-70 days |
20 |
|
|
318.0 |
g |
2.09 |
9.35 |
body weighing method |
|
|
|
0 |
|
|
|
|
12947 |
305 |
SS.SHR-(D9Mco74-D9Rat64)/Mco |
body weight |
controlled sodium content diet (2 %) (for 28 days) |
Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41. |
body mass |
male |
68 days-70 days |
20 |
|
|
321.0 |
g |
6.99 |
31.26 |
body weighing method |
|
|
|
0 |
|
|
|
|
12955 |
305 |
SS/Jr |
heart wet weight |
controlled sodium content diet (2 %) (for 28 days) |
Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41. |
heart mass |
male |
68 days-70 days |
20 |
|
|
1.4 |
g |
0.03 |
0.12 |
post excision weight measurement |
|
|
|
0 |
|
|
|
|
12966 |
305 |
SS/Jr |
heart wet weight |
controlled sodium content diet (2 %) (for 28 days) |
Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41. |
heart mass |
male |
68 days-70 days |
6 |
|
|
1.39 |
g |
0.03 |
0.08 |
post excision weight measurement |
|
|
|
0 |
|
|
|
|
12964 |
305 |
SS.SHR-(D9Wox16-D9Rat76)/Mco |
heart wet weight |
controlled sodium content diet (2 %) (for 28 days) |
Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41. |
heart mass |
male |
68 days-70 days |
20 |
|
|
1.5 |
g |
0.02 |
0.09 |
post excision weight measurement |
|
|
|
0 |
|
|
|
|
12969 |
305 |
SS/Jr |
heart weight to body weight ratio |
controlled sodium content diet (2 %) (for 28 days) |
Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41. |
heart mass |
male |
68 days-70 days |
3 |
|
|
4.32 |
g/kg |
0.24 |
0.42 |
post excision weight measurement |
|
|
|
0 |
|
|
|
|
12984 |
305 |
SS.SHR-(D9Mco74-D9Rat64)/Mco |
heart weight to body weight ratio |
controlled sodium content diet (2 %) (for 28 days) |
Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41. |
heart mass |
male |
68 days-70 days |
5 |
|
|
3.47 |
g/kg |
0.06 |
0.13 |
post excision weight measurement |
|
|
|
0 |
|
|
|
|
12997 |
305 |
SS.MNS-(D2Chm25-D2Rat131)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (2 %) (between 21 and 37 days) |
Dutil J, et al., Hypertension 2005 Apr;45(4):557-64. Epub 2005 Feb 28. |
arterial blood pressure trait |
male |
56 days-72 days |
5 |
|
|
139.0 |
mmHg |
8.0 |
17.89 |
intra-aortic abdominal radiotelemetry |
|
|
|
0 |
|
|
|
|
12358 |
242 |
SS.MNS-(D2Rat183-D2Chm113)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (2 %) (between 21 and 37 days) |
Dutil J, et al., Hypertension 2005 Apr;45(4):557-64. Epub 2005 Feb 28. |
arterial blood pressure trait |
male |
56 days-72 days |
8 |
|
|
145.0 |
mmHg |
4.0 |
11.31 |
intra-aortic abdominal radiotelemetry |
|
|
|
0 |
|
|
|
|
12355 |
242 |
SHR/NHsd |
serum triglyceride level |
controlled sodium content diet (0.3 %) |
Packard M, et al., Am J Physiol Renal Physiol. 2009 Apr;296(4):F839-46. Epub 2009 Jan 28. |
blood triglyceride amount |
male |
28 days-84 days |
8 |
|
|
51.0 |
mg/dl |
3.7 |
10.47 |
automated blood analysis |
|
0 |
|
0 |
|
|
|
|
12402 |
246 |
SS.LEW-(D10Rat29-D10Got93)/Mco |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days) |
Saad Y, et al., Genomics. 2007 Mar;89(3):343-53. Epub 2007 Jan 10. |
arterial blood pressure trait |
male |
64 days-70 days |
20 |
|
serial mean |
184.0 |
mmHg |
3.05 |
13.64 |
tail cuff photoplethysmography |
tail |
345600 |
|
0 |
|
|
average of 4 daily averages of 3-4 measurements/day |
|
13131 |
282 |
BN/NHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 28 days) then controlled sodium content diet (8 %) (for 31 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 1.5 days) then controlled exposure to ambient light (for 12 hours) |
Cowley AW Jr, et al., Physiol Genomics 2000 Apr 27;2(3):107-15. |
arterial blood pressure trait |
male |
96 days
| 21 |
|
continuous mean |
96.0 |
mmHg |
3.0 |
13.75 |
vascular indwelling catheter method |
femoral artery |
10800.0 |
|
0 |
|
left femoral artery |
|
|
13275 |
229 |
SS.LEW-(D10Chm10-D10Rat11)/Ayd |
plasma sodium level |
controlled sodium content diet (8 %) (between 8 and 10 days) |
Huang BS, et al., Hypertension. 2007 Apr 9;. |
blood sodium amount |
male |
43 days-52 days |
10 |
|
|
147.0 |
mmol/l |
3.0 |
9.49 |
sodium ion-selective electrode method |
|
|
|
0 |
|
sodium ion-selective electrode |
|
|
13320 |
344 |
SS/JrHsdMcwi |
plasma renin activity level |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
renin activity |
female |
92 days
| 7 |
|
|
2.2 |
ng/ml/h |
0.58 |
1.53 |
ex vivo blood analysis |
|
0.0 |
|
0 |
|
enzyme assay |
|
|
13307 |
151 |
SS.SHR-(D9Mco72-D9Rat89)/Mco |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days) |
Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4. |
arterial blood pressure trait |
not specified |
65 days-70 days |
0 |
|
|
183.0 |
mmHg |
7.72 |
|
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
|
67510 |
749 |
SS.SHR-(D9Mco72-D9Mco109)/Mco |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days) |
Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4. |
arterial blood pressure trait |
not specified |
65 days-70 days |
0 |
|
|
188.0 |
mmHg |
3.21 |
|
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
|
67514 |
749 |
SS.SHR-(D9Rat7-D9Mco91)/Mco |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days) |
Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4. |
arterial blood pressure trait |
not specified |
65 days-70 days |
0 |
|
|
208.0 |
mmHg |
5.78 |
|
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
|
67525 |
749 |
SS/Jr |
body weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days) |
Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4. |
body mass |
not specified |
0 days
| 0 |
|
|
353.0 |
g |
6.24 |
|
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
67537 |
749 |
SS.SHR-(D9Mco72-D9Rat55)/Mco |
heart weight to body weight ratio |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) |
Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4. |
heart mass |
not specified |
0 days
| 0 |
|
|
3.99 |
g/kg |
0.04 |
|
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
67563 |
749 |
SS/Jr |
urine total protein excretion rate |
controlled sodium content diet (2 %) (between 30 and 33 days) |
Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4. |
total urine protein amount |
not specified |
78 days-83 days |
0 |
|
|
102.0 |
mg/d |
6.81 |
|
pyrogallol red-molybdate complex-based urine total protein analysis |
|
0.0 |
|
0 |
|
|
|
|
67580 |
749 |
SS.SHR-(D9Rat7-D9Rat52)/Mco |
heart weight to body weight ratio |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) |
Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4. |
heart mass |
not specified |
0 days
| 0 |
|
|
4.12 |
g/kg |
0.07 |
|
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
67577 |
749 |
SS.SHR-(D9Mco72-D9Rat89)/Mco |
urine total protein excretion rate |
controlled sodium content diet (2 %) (between 30 and 33 days) |
Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4. |
total urine protein amount |
not specified |
78 days-83 days |
0 |
|
|
72.0 |
mg/d |
5.44 |
|
pyrogallol red-molybdate complex-based urine total protein analysis |
|
0.0 |
|
0 |
|
|
|
|
67579 |
749 |
SS/Jr |
heart weight to body weight ratio |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) |
Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4. |
heart mass |
not specified |
0 days
| 0 |
|
|
4.36 |
g/kg |
0.07 |
|
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
67572 |
749 |
SS/Jr |
urine total protein excretion rate |
controlled sodium content diet (2 %) (between 30 and 33 days) |
Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4. |
total urine protein amount |
not specified |
78 days-83 days |
0 |
|
|
94.0 |
mg/d |
7.54 |
|
pyrogallol red-molybdate complex-based urine total protein analysis |
|
0.0 |
|
0 |
|
|
|
|
67584 |
749 |
SS.LEW-(D5Mit9-D5Mco10)/Jr |
heart wet weight |
controlled sodium content diet (2 %) (between 24 and 27 days) |
Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23 |
heart mass |
not specified |
64 days-71 days |
40 |
|
|
1.07 |
g |
0.01 |
0.06 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
4 rats per cage, 2 SR/Jr 2 LEW/NCrl |
64761 |
222 |
SS-Chr 16BN/Mcwi |
percent change in ventilation |
controlled sodium content diet (0 %) then controlled air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
7 |
%change=VE during7-9 min hypoxia/control during standard conditions |
|
167.62 |
% |
15.92 |
42.13 |
stop flow air displacement plethysmography |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
17915 |
381 |
BN/NHsdMcwi |
percent change in ventilation |
controlled sodium content diet (0 %) then controlled air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
9 |
%change=VE during7-9 min hypoxia/control during standard conditions |
|
113.63 |
% |
4.18 |
12.54 |
stop flow air displacement plethysmography |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
17920 |
381 |
SS/Jr |
heart wet weight |
controlled sodium content diet (2 %) (between 24 and 27 days) |
Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23 |
heart mass |
not specified |
64 days-71 days |
19 |
|
|
1.21 |
g |
0.02 |
0.07 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
4 rats per cage, 2 SR/Jr 2 LEW/NCrl |
64764 |
222 |
SS.LEW-(D10Mit10-D10Mgh1)/Jr |
heart wet weight |
controlled sodium content diet (2 %) (between 24 and 27 days) |
Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23 |
heart mass |
not specified |
64 days-71 days |
20 |
|
|
1.1 |
g |
0.01 |
0.05 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
4 rats per cage, 2 SR/Jr 2 LEW/NCrl |
64763 |
222 |
SHR/NCrl |
percent change in ventilation |
controlled sodium content diet (0 %) then controlled air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
10 |
%change=VE during7-9 min hypoxia/control during standard conditions |
|
136.37 |
% |
4.67 |
14.76 |
stop flow air displacement plethysmography |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
17923 |
381 |
SS.LEW-(D17Mco3-D17Mco10)/Jr |
heart wet weight |
controlled sodium content diet (2 %) (between 24 and 27 days) |
Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23 |
heart mass |
not specified |
64 days-71 days |
20 |
|
|
1.19 |
g |
0.02 |
0.07 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
4 rats per cage, 2 SR/Jr 2 LEW/NCrl |
64765 |
222 |
SS.LEW-(D18Rat30-D18Chm29)/Ayd |
heart weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart mass |
male |
98 days
| 8 |
|
|
3.5 |
g/kg |
0.1 |
0.28 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
64802 |
226 |
SS.SHR-(D9Mco72-D9Mco93)/Mco |
heart rate |
controlled sodium content diet (2 %) (for 37 days) |
Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41. |
heart pumping trait |
male |
75 days-79 days |
5 |
|
|
389.0 |
beats/min |
9.6 |
21.47 |
intra-aortic abdominal radiotelemetry |
|
172800 |
|
0 |
|
|
|
|
64989 |
305 |
LEW |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 23 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
arterial blood pressure trait |
male |
56 days-60 days |
6 |
|
|
95.0 |
mmHg |
1.22 |
3.0 |
radiotelemetry |
|
86400 |
|
0 |
|
|
two 24 hours widely separated periods, data represent averages of all readings over the 24-h measurements |
|
64994 |
542 |
SS.LEW-(D18Chm41-D18Rat92)/Ayd |
body weight |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
body mass |
male |
77 days
| 8 |
|
|
326.1 |
g |
3.22 |
9.1 |
body weighing method |
|
0 |
|
0 |
|
|
|
|
65007 |
542 |
SS.LEW-(D18Rat29-D18Rat55)/Ayd |
heart left ventricle wet weight |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle mass |
male |
77 days
| 11 |
|
|
0.89 |
g |
0.03 |
0.11 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
65029 |
542 |
GH/OmrMcwi |
percent change in ventilation |
controlled sodium content diet (0 %) then controlled air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
8 |
%change=VE during7-9 min hypoxia/control during standard conditions |
|
142.36 |
% |
11.33 |
32.05 |
stop flow air displacement plethysmography |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
18371 |
381 |
SS-Chr 16BN/Mcwi |
percent change in ventilation |
controlled sodium content diet (0 %) then controlled air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
5 |
%change=VE during7-9 min hypoxia/control during standard conditions |
|
133.83 |
% |
7.44 |
16.65 |
stop flow air displacement plethysmography |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
18372 |
381 |
SS/JrHsdMcwi |
percent change in ventilation |
controlled sodium content diet (0 %) then controlled air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
15 |
%change=VE during7-9 min hypoxia/control during standard conditions |
|
127.69 |
% |
6.86 |
26.56 |
stop flow air displacement plethysmography |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
18368 |
381 |
F344-Nrg1Tn(sb-T2/Bart3)2.183Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body mass |
female |
70 days-84 days |
5 |
|
|
157.0 |
g |
3.3 |
7.38 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
63649 |
529 |
FHH-Egln3m1Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body mass |
female |
70 days-84 days |
14 |
|
|
189.86 |
g |
2.91 |
10.9 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
63647 |
529 |
BN/NHsdMcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body mass |
female |
70 days-84 days |
29 |
|
|
153.38 |
g |
1.84 |
9.91 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
63651 |
529 |
FHH-Agtr1bm1Mcwi |
body length, nose to tail |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
male |
70 days-84 days |
12 |
|
|
40.63 |
cm |
0.89 |
3.08 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63662 |
529 |
FHH-Lcatm1Mcwi |
body length, nose to tail |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
female |
70 days-84 days |
15 |
|
|
38.3 |
cm |
0.31 |
1.21 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63666 |
529 |
FHH-F10m1Mcwi |
body length, nose to tail |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
female |
70 days-84 days |
10 |
|
|
38.45 |
cm |
0.22 |
0.69 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63676 |
529 |
F344-Brinp3Tn(sb-T2/Bart3)2.189Mcwi |
body length, nose to tail |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
male |
70 days-84 days |
3 |
|
|
35.83 |
cm |
0.33 |
0.58 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63677 |
529 |
FHH-Nr4a1m1Mcwi |
body length, nose to tail |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
male |
70 days-84 days |
14 |
|
|
41.0 |
cm |
0.54 |
2.04 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63684 |
529 |
FHH/EurMcwi |
body length, nose to tail |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
female |
70 days-84 days |
28 |
|
|
38.84 |
cm |
0.42 |
2.22 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63698 |
529 |
F344-Fam19a2Tn(sb-T2/Bart3)2.184Mcwi |
body length, nose to tail |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
female |
70 days-84 days |
3 |
|
|
35.0 |
cm |
0.58 |
1.0 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63701 |
529 |
FHH-Ghsrm1Mcwi |
body length, nose to tail |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
male |
70 days-84 days |
15 |
|
|
42.73 |
cm |
0.2 |
0.78 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63704 |
529 |
F344-AbatTn(sb-T2/Bart3)2.163Mcwi |
body length, nose to tail |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
female |
70 days-84 days |
5 |
|
|
35.0 |
cm |
0.45 |
1.0 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63711 |
529 |
FHH-Tlr4m1Mcwi |
body length, nose to tail |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
female |
70 days-84 days |
11 |
|
|
37.91 |
cm |
0.32 |
1.07 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63717 |
529 |
FHH-Slc8a2m1Mcwi |
heart left ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart left ventricle mass |
female |
70 days-84 days |
13 |
|
|
0.51 |
g |
0.01 |
0.05 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63739 |
529 |
F344-Elmod3Tn(sb-T2/Bart3)2.42Mcwi |
heart left ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart left ventricle mass |
female |
70 days-84 days |
3 |
|
|
0.36 |
g |
0.01 |
0.02 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63740 |
529 |
F344-Plce1Tn(sb-T2/Bart3)2.146Mcwi |
heart left ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart left ventricle mass |
female |
70 days-84 days |
5 |
|
|
0.4 |
g |
0.01 |
0.03 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63745 |
529 |
FHH-F10m2Mcwi |
heart left ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart left ventricle mass |
female |
70 days-84 days |
10 |
|
|
0.52 |
g |
0.01 |
0.04 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63762 |
529 |
FHH-F10m1Mcwi |
heart left ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart left ventricle mass |
male |
70 days-84 days |
10 |
|
|
0.65 |
g |
0.01 |
0.05 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63763 |
529 |
F344-Plcb3Tn(sb-T2/Bart3)2.69Mcwi |
heart left ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart left ventricle mass |
male |
70 days-84 days |
1 |
|
|
0.49 |
g |
|
|
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63772 |
529 |
F344-DccTn(sb-T2/Bart3)2.205Mcwi |
heart left ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart left ventricle mass |
male |
70 days-84 days |
7 |
|
|
0.53 |
g |
0.04 |
0.09 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63778 |
529 |
FHH-Adipoqm3Mcwi |
heart left ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart left ventricle mass |
female |
70 days-84 days |
7 |
|
|
0.55 |
g |
0.01 |
0.03 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63779 |
529 |
FHH-Adra1am1Mcwi |
heart left ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart left ventricle mass |
female |
70 days-84 days |
9 |
|
|
0.55 |
g |
0.01 |
0.02 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63784 |
529 |
FHH-Adra1am1Mcwi |
heart left ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart left ventricle mass |
male |
70 days-84 days |
9 |
|
|
0.7 |
g |
0.01 |
0.03 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63782 |
529 |
F344-Stxbp5lTn(sb-T2/Bart3)2.202Mcwi |
heart left ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart left ventricle mass |
female |
70 days-84 days |
2 |
|
|
0.37 |
g |
0.01 |
0.02 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63787 |
529 |
Hsd:SD |
percent change in ventilation |
controlled sodium content diet (0 %) then controlled air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
5 |
%change=VE during 2-3 min hypoxia/control during standard conditions |
|
187.88 |
% |
14.16 |
31.67 |
stop flow air displacement plethysmography |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
19300 |
381 |
LEW/Crl |
percent change in ventilation |
controlled sodium content diet (0 %) then controlled air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
20 |
%change=VE during 2-3 min hypoxia/control during standard conditions |
|
138.23 |
% |
5.11 |
22.86 |
stop flow air displacement plethysmography |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
19306 |
381 |
LE/BluGill |
percent change in ventilation |
controlled sodium content diet (0 %) then controlled air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
13 |
%change=VE during 2-3 min hypoxia/control during standard conditions |
|
151.33 |
% |
5.57 |
20.09 |
stop flow air displacement plethysmography |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
19309 |
381 |
SHR/NHsd |
serum total cholesterol level |
controlled sodium content diet (0.3 %) |
Packard M, et al., Am J Physiol Renal Physiol. 2009 Apr;296(4):F839-46. Epub 2009 Jan 28. |
blood cholesterol amount |
male |
84 days
| 8 |
|
|
54.0 |
mg/dl |
2.4 |
6.79 |
automated blood analysis |
|
0 |
|
0 |
|
|
|
|
64811 |
246 |
SS/Jr |
serum albumin level |
controlled sodium content diet (0.3 %) |
Packard M, et al., Am J Physiol Renal Physiol. 2009 Apr;296(4):F839-46. Epub 2009 Jan 28. |
blood albumin amount |
male |
84 days
| 8 |
|
|
2.9 |
g/dl |
0.06 |
0.17 |
automated blood analysis |
|
0 |
|
0 |
|
|
|
|
64820 |
246 |
SS.BN-(D13Rat20-D13Rat127)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 16 and 19 days) |
Moreno et al. Physiol Genomics 2007 Oct 22;31(2):228-35. Epub 2007 Jun 12. |
arterial blood pressure trait |
female |
86 days-89 days |
12 |
|
|
153.0 |
mmHg |
4.7 |
16.28 |
vascular fluid filled catheter |
left femoral artery |
14400 |
|
0 |
|
on 3 consecutive days |
|
|
65168 |
15 |
SS.BN-(D13Rat127-D13Rat77)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 16 and 19 days) |
Moreno et al. Physiol Genomics 2007 Oct 22;31(2):228-35. Epub 2007 Jun 12. |
arterial blood pressure trait |
male |
86 days-89 days |
12 |
|
|
175.0 |
mmHg |
4.4 |
15.24 |
vascular fluid filled catheter |
left femoral artery |
14400 |
|
0 |
|
on 3 consecutive days |
|
|
65182 |
15 |
SS.BN-(D13Rat101-D13Rat46)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 16 and 19 days) |
Moreno et al. Physiol Genomics 2007 Oct 22;31(2):228-35. Epub 2007 Jun 12. |
arterial blood pressure trait |
female |
86 days-89 days |
12 |
|
|
149.0 |
mmHg |
3.7 |
12.82 |
vascular fluid filled catheter |
left femoral artery |
14400 |
|
0 |
|
on 3 consecutive days |
|
|
65187 |
15 |
SS.BN-(D13Rat61-D13GRat197)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 16 and 19 days) |
Moreno et al. Physiol Genomics 2007 Oct 22;31(2):228-35. Epub 2007 Jun 12. |
arterial blood pressure trait |
male |
86 days-89 days |
12 |
|
|
183.0 |
mmHg |
2.9 |
10.05 |
vascular fluid filled catheter |
left femoral artery |
14400 |
|
0 |
|
on 3 consecutive days |
|
|
65190 |
15 |
SS.BN-(D13Rat151-D13Rat197)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 16 and 19 days) |
Moreno et al. Physiol Genomics 2007 Oct 22;31(2):228-35. Epub 2007 Jun 12. |
arterial blood pressure trait |
male |
86 days-89 days |
12 |
|
|
172.0 |
mmHg |
3.6 |
12.47 |
vascular fluid filled catheter |
left femoral artery |
14400 |
|
0 |
|
on 3 consecutive days |
|
|
65198 |
15 |
SHR.BN-(D2Rat226-D2Rat294)/Jk |
heart rate |
controlled sodium content diet (1 %) (for 14 days) |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
heart pumping trait |
male |
87 days
| 22 |
|
continuous mean |
350.0 |
beats/min |
4.0 |
18.76 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
0 |
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
|
65421 |
306 |
SHR.BN-(D16Rat87-D16Mgh1)/Jk |
heart rate |
controlled sodium content diet (1 %) (for 14 days) |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
heart pumping trait |
male |
87 days
| 23 |
|
continuous mean |
354.0 |
beats/min |
8.0 |
38.37 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
0 |
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
|
65425 |
306 |
SHR.BN-(D2Rat114-D2Rat123)/Jk |
body weight |
controlled sodium content diet (1 %) (for 14 days) |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
body mass |
male |
87 days
| 23 |
|
|
273.0 |
g |
7.0 |
33.57 |
body weighing method |
|
0 |
|
0 |
|
|
|
|
65431 |
306 |
SHR.BN-(D16Rat87-D16Mgh1)/Jk |
body weight |
controlled sodium content diet (1 %) (for 14 days) |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
body mass |
male |
87 days
| 23 |
|
|
271.0 |
g |
5.0 |
23.98 |
body weighing method |
|
0 |
|
0 |
|
|
|
|
65437 |
306 |
SS-Klf4m3Mcwi |
heart wet weight |
controlled sodium content diet (1 %) (for 14 days) |
PhysGen General data |
heart mass |
male |
70 days-84 days |
9 |
|
|
1.08 |
g |
0.02 |
0.05 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63229 |
529 |
SS-Ghsrm3Mcwi |
heart wet weight |
controlled sodium content diet (1 %) (for 14 days) |
PhysGen General data |
heart mass |
female |
70 days-84 days |
2 |
|
|
0.8 |
g |
0.02 |
0.03 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63231 |
529 |
SS-Klf4m3Mcwi |
body weight |
controlled sodium content diet (1 %) (for 14 days) |
PhysGen General data |
body mass |
male |
70 days-84 days |
9 |
|
|
301.11 |
g |
5.71 |
17.14 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
63239 |
529 |
SS-Klf4m3Mcwi |
heart right ventricle wet weight |
controlled sodium content diet (1 %) (for 14 days) |
PhysGen General data |
heart right ventricle mass |
female |
70 days-84 days |
9 |
|
|
0.16 |
g |
0.0 |
0.01 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63248 |
529 |
SS/JrHsdMcwi |
heart right ventricle wet weight |
controlled sodium content diet (1 %) (for 14 days) |
PhysGen General data |
heart right ventricle mass |
female |
70 days-84 days |
17 |
|
|
0.13 |
g |
0.0 |
0.02 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63252 |
529 |
FHH-Nr0b2m1Mcwi |
heart right ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart right ventricle mass |
female |
70 days-84 days |
8 |
|
|
0.13 |
g |
0.01 |
0.02 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63264 |
529 |
FHH-Agtr1bm1Mcwi |
heart right ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart right ventricle mass |
male |
70 days-84 days |
15 |
|
|
0.19 |
g |
0.01 |
0.02 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63272 |
529 |
FHH-Tgfbr2m2Mcwi |
heart right ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart right ventricle mass |
female |
70 days-84 days |
14 |
|
|
0.13 |
g |
0.0 |
0.01 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63273 |
529 |
F344-Elmod3Tn(sb-T2/Bart3)2.42Mcwi |
heart right ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart right ventricle mass |
female |
70 days-84 days |
3 |
|
|
0.1 |
g |
0.0 |
0.01 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63278 |
529 |
FHH-Agtr1bm1Mcwi |
heart right ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart right ventricle mass |
female |
70 days-84 days |
14 |
|
|
0.16 |
g |
0.01 |
0.02 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63279 |
529 |
FHH-F10m1Mcwi |
heart right ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart right ventricle mass |
female |
70 days-84 days |
10 |
|
|
0.14 |
g |
0.0 |
0.01 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63286 |
529 |
FHH-Ccr2m1Mcwi |
heart right ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart right ventricle mass |
female |
70 days-84 days |
7 |
|
|
0.14 |
g |
0.01 |
0.01 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63285 |
529 |
F344/NHsd |
heart right ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart right ventricle mass |
male |
70 days-84 days |
10 |
|
|
0.11 |
g |
0.0 |
0.01 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63290 |
529 |
FHH-Nr4a1m1Mcwi |
heart right ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart right ventricle mass |
male |
70 days-84 days |
14 |
|
|
0.18 |
g |
0.01 |
0.03 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63294 |
529 |
FHH-F10m2Mcwi |
heart right ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart right ventricle mass |
female |
70 days-84 days |
10 |
|
|
0.17 |
g |
0.01 |
0.02 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63300 |
529 |
FHH-Nr4a1m1Mcwi |
heart right ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart right ventricle mass |
female |
70 days-84 days |
13 |
|
|
0.15 |
g |
0.0 |
0.01 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63302 |
529 |
FHH-Ghsrm1Mcwi |
heart right ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart right ventricle mass |
female |
70 days-84 days |
10 |
|
|
0.16 |
g |
0.0 |
0.02 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63306 |
529 |
F344-Myo9aTn(sb-T2/Bart3)2.186Mcwi |
heart right ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart right ventricle mass |
male |
70 days-84 days |
1 |
|
|
0.12 |
g |
|
|
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63304 |
529 |
F344-Plcb3Tn(sb-T2/Bart3)2.69Mcwi |
heart right ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart right ventricle mass |
female |
70 days-84 days |
4 |
|
|
0.1 |
g |
0.0 |
0.01 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63313 |
529 |
F344-DccTn(sb-T2/Bart3)2.205Mcwi |
heart right ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart right ventricle mass |
male |
70 days-84 days |
7 |
|
|
0.22 |
g |
0.05 |
0.12 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63316 |
529 |
FHH-Adipoqm3Mcwi |
heart right ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart right ventricle mass |
female |
70 days-84 days |
7 |
|
|
0.18 |
g |
0.01 |
0.02 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63317 |
529 |
BN/NHsdMcwi |
heart right ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart right ventricle mass |
female |
70 days-84 days |
29 |
|
|
0.11 |
g |
0.0 |
0.01 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63333 |
529 |
F344-Plce1Tn(sb-T2/Bart3)2.146Mcwi |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
kidney mass |
male |
70 days-84 days |
8 |
|
|
1.01 |
g |
0.02 |
0.05 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63346 |
529 |
FHH-Agtr1bm1Mcwi |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
kidney mass |
female |
70 days-84 days |
14 |
|
|
0.89 |
g |
0.02 |
0.08 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63351 |
529 |
FHH-Slc8a2m1Mcwi |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
kidney mass |
female |
70 days-84 days |
13 |
|
|
0.83 |
g |
0.02 |
0.08 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63349 |
529 |
F344-Plce1Tn(sb-T2/Bart3)2.146Mcwi |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
kidney mass |
female |
70 days-84 days |
5 |
|
|
0.62 |
g |
0.01 |
0.03 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63355 |
529 |
FHH-Ccr2m1Mcwi |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
kidney mass |
female |
70 days-84 days |
7 |
|
|
0.88 |
g |
0.02 |
0.05 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63357 |
529 |
FHH-Nr4a1m1Mcwi |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
kidney mass |
male |
70 days-84 days |
14 |
|
|
1.18 |
g |
0.02 |
0.09 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63366 |
529 |
F344-Myo9aTn(sb-T2/Bart3)2.186Mcwi |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
kidney mass |
male |
70 days-84 days |
1 |
|
|
0.85 |
g |
|
|
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63376 |
529 |
FHH-Nr4a1m1Mcwi |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
kidney mass |
female |
70 days-84 days |
13 |
|
|
0.94 |
g |
0.03 |
0.09 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63374 |
529 |
BN-Lcatm3Mcwi |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
kidney mass |
male |
70 days-84 days |
1 |
|
|
0.88 |
g |
|
|
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63384 |
529 |
FHH-Slc8a2m1Mcwi |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
kidney mass |
male |
70 days-84 days |
15 |
|
|
1.16 |
g |
0.02 |
0.08 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63398 |
529 |
FHH-Egln3m1Mcwi |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
kidney mass |
female |
70 days-84 days |
14 |
|
|
0.95 |
g |
0.03 |
0.11 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63401 |
529 |
FHH-Adipoqm1Mcwi |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart mass |
female |
70 days-84 days |
10 |
|
|
0.75 |
g |
0.02 |
0.06 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63409 |
529 |
F344-Trpc4Tn(sb-T2/Bart3)2.192Mcwi |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart mass |
male |
70 days-84 days |
2 |
|
|
0.83 |
g |
0.03 |
0.05 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63412 |
529 |
FHH-Agtr1bm1Mcwi |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart mass |
female |
70 days-84 days |
14 |
|
|
0.79 |
g |
0.02 |
0.06 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63423 |
529 |
FHH-Nr0b2m1Mcwi |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart mass |
male |
70 days-84 days |
10 |
|
|
1.0 |
g |
0.01 |
0.04 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63424 |
529 |
FHH-Nr4a1m1Mcwi |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart mass |
male |
70 days-84 days |
14 |
|
|
1.03 |
g |
0.03 |
0.11 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63438 |
529 |
FHH-F10m1Mcwi |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart mass |
male |
70 days-84 days |
10 |
|
|
0.96 |
g |
0.03 |
0.08 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63445 |
529 |
F344-Myo9aTn(sb-T2/Bart3)2.186Mcwi |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart mass |
male |
70 days-84 days |
1 |
|
|
0.87 |
g |
|
|
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63448 |
529 |
FHH/EurMcwi |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart mass |
female |
70 days-84 days |
28 |
|
|
0.79 |
g |
0.02 |
0.1 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63452 |
529 |
F344-Plcb3Tn(sb-T2/Bart3)2.69Mcwi |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart mass |
female |
70 days-84 days |
4 |
|
|
0.59 |
g |
0.02 |
0.03 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63457 |
529 |
F344-AbatTn(sb-T2/Bart3)2.163Mcwi |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart mass |
female |
70 days-84 days |
5 |
|
|
0.58 |
g |
0.02 |
0.04 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63465 |
529 |
F344-Stxbp5lTn(sb-T2/Bart3)2.202Mcwi |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart mass |
female |
70 days-84 days |
2 |
|
|
0.54 |
g |
0.01 |
0.02 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63469 |
529 |
FHH-Adra1am1Mcwi |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart mass |
female |
70 days-84 days |
9 |
|
|
0.79 |
g |
0.01 |
0.03 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63466 |
529 |
F344-Inpp4bTn(sb-T2/Bart3)2.143Mcwi |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart mass |
male |
70 days-84 days |
8 |
|
|
0.84 |
g |
0.03 |
0.08 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63474 |
529 |
SS-Klf4m3Mcwi |
heart left ventricle wet weight |
controlled sodium content diet (1 %) (for 14 days) |
PhysGen General data |
heart left ventricle mass |
female |
70 days-84 days |
9 |
|
|
0.55 |
g |
0.01 |
0.02 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63484 |
529 |
SS/JrHsdMcwi |
heart left ventricle wet weight |
controlled sodium content diet (1 %) (for 14 days) |
PhysGen General data |
heart left ventricle mass |
male |
70 days-84 days |
47 |
|
|
0.8 |
g |
0.02 |
0.13 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63482 |
529 |
SS-Sod3m1Mcwi |
heart left ventricle wet weight |
controlled sodium content diet (1 %) (for 14 days) |
PhysGen General data |
heart left ventricle mass |
female |
70 days-84 days |
13 |
|
|
0.63 |
g |
0.02 |
0.06 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63489 |
529 |
SS-Klf4m3Mcwi |
body length, nose to rump |
controlled sodium content diet (1 %) (for 14 days) |
PhysGen General data |
body length |
female |
70 days-84 days |
9 |
|
|
20.94 |
cm |
0.19 |
0.58 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63494 |
529 |
SS-Ghsrm3Mcwi |
body length, nose to rump |
controlled sodium content diet (1 %) (for 14 days) |
PhysGen General data |
body length |
female |
70 days-84 days |
2 |
|
|
20.0 |
cm |
1.0 |
1.41 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63497 |
529 |
FHH-Tgfbr2m2Mcwi |
body length, nose to rump |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
male |
70 days-84 days |
14 |
|
|
24.29 |
cm |
0.19 |
0.7 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63503 |
529 |
F344-Trpc4Tn(sb-T2/Bart3)2.192Mcwi |
body length, nose to rump |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
male |
70 days-84 days |
2 |
|
|
23.5 |
cm |
0.5 |
0.71 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63504 |
529 |
F344-Trpc4Tn(sb-T2/Bart3)2.192Mcwi |
body length, nose to rump |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
female |
70 days-84 days |
2 |
|
|
20.0 |
cm |
0.0 |
0.0 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63511 |
529 |
F344-Elmod3Tn(sb-T2/Bart3)2.42Mcwi |
body length, nose to rump |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
female |
70 days-84 days |
3 |
|
|
19.67 |
cm |
0.33 |
0.58 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63514 |
529 |
FHH-Nr0b2m1Mcwi |
body length, nose to rump |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
male |
70 days-84 days |
10 |
|
|
23.95 |
cm |
0.29 |
0.93 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63516 |
529 |
BN-Tgfbr2m1Mcwi |
body length, nose to rump |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
male |
70 days-84 days |
7 |
|
|
23.21 |
cm |
0.15 |
0.39 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63517 |
529 |
FHH-Htr1am1Mcwi |
body length, nose to rump |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
female |
70 days-84 days |
12 |
|
|
21.63 |
cm |
0.25 |
0.88 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63525 |
529 |
FHH-F10m1Mcwi |
body length, nose to rump |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
female |
70 days-84 days |
10 |
|
|
22.05 |
cm |
0.09 |
0.28 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63522 |
529 |
F344-Brinp3Tn(sb-T2/Bart3)2.189Mcwi |
body length, nose to rump |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
female |
70 days-84 days |
1 |
|
|
20.0 |
cm |
|
|
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63528 |
529 |
F344-Lims1Tn(sb-T2/Bart3)2.169Mcwi |
body length, nose to rump |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
male |
70 days-84 days |
4 |
|
|
22.5 |
cm |
1.54 |
3.08 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63534 |
529 |
FHH-Nr4a1m1Mcwi |
body length, nose to rump |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
female |
70 days-84 days |
13 |
|
|
21.65 |
cm |
0.2 |
0.72 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63538 |
529 |
F344-DccTn(sb-T2/Bart3)2.205Mcwi |
body length, nose to rump |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
female |
70 days-84 days |
6 |
|
|
20.42 |
cm |
0.2 |
0.49 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63539 |
529 |
FHH/EurMcwi |
body length, nose to rump |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
female |
70 days-84 days |
28 |
|
|
21.7 |
cm |
0.17 |
0.91 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63544 |
529 |
SS-Klf4m3Mcwi |
left kidney wet weight |
controlled sodium content diet (1 %) (for 14 days) |
PhysGen General data |
kidney mass |
male |
70 days-84 days |
9 |
|
|
1.33 |
g |
0.03 |
0.1 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63577 |
529 |
SS/JrHsdMcwi |
left kidney wet weight |
controlled sodium content diet (1 %) (for 14 days) |
PhysGen General data |
kidney mass |
male |
70 days-84 days |
47 |
|
|
1.43 |
g |
0.03 |
0.21 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63574 |
529 |
FHH-Lcatm1Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body mass |
male |
70 days-84 days |
13 |
|
|
254.77 |
g |
7.26 |
26.17 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
63587 |
529 |
FHH-Agtr1bm1Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body mass |
male |
70 days-84 days |
15 |
|
|
257.0 |
g |
5.04 |
19.51 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
63590 |
529 |
BN-Tgfbr2m1Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body mass |
female |
70 days-84 days |
3 |
|
|
148.33 |
g |
2.33 |
4.04 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
63588 |
529 |
BN-Tgfbr2m1Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body mass |
male |
70 days-84 days |
7 |
|
|
239.0 |
g |
5.67 |
14.99 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
63599 |
529 |
FHH-Htr1am1Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body mass |
female |
70 days-84 days |
13 |
|
|
180.77 |
g |
3.57 |
12.87 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
63607 |
529 |
FHH-Ccr2m1Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body mass |
male |
70 days-84 days |
10 |
|
|
260.1 |
g |
3.51 |
11.1 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
63611 |
529 |
F344-Lims1Tn(sb-T2/Bart3)2.169Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body mass |
female |
70 days-84 days |
8 |
|
|
172.88 |
g |
4.25 |
12.02 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
63614 |
529 |
F344/NHsd |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body mass |
female |
70 days-84 days |
10 |
|
|
128.5 |
g |
2.13 |
6.72 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
63617 |
529 |
F344-Myo9aTn(sb-T2/Bart3)2.186Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body mass |
female |
70 days-84 days |
4 |
|
|
139.75 |
g |
4.42 |
8.85 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
63623 |
529 |
F344-Fam19a2Tn(sb-T2/Bart3)2.184Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body mass |
male |
70 days-84 days |
7 |
|
|
274.57 |
g |
3.98 |
10.52 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
63625 |
529 |
F344-Fam19a2Tn(sb-T2/Bart3)2.184Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body mass |
female |
70 days-84 days |
3 |
|
|
165.33 |
g |
6.69 |
11.59 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
63629 |
529 |
FHH-Lcatm1Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
10 |
|
|
-8.22 |
null |
0.1 |
0.31 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
|
63066 |
528 |
F344-Elmod3Tn(sb-T2/Bart3)2.42Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
3 |
|
|
-8.07 |
null |
0.04 |
0.08 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
|
63068 |
528 |
FHH-Htr1am1Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
12 |
|
|
-8.03 |
null |
0.07 |
0.23 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
|
63079 |
528 |
FHH-Nr0b2m1Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
4 |
|
|
-8.24 |
null |
0.29 |
0.57 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
|
63070 |
528 |
F344-Brinp3Tn(sb-T2/Bart3)2.189Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
1 |
|
|
-8.24 |
null |
|
|
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
|
63082 |
528 |
FHH-Ccr2m1Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
8 |
|
|
-8.02 |
null |
0.11 |
0.3 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
|
63083 |
528 |
F344-Lims1Tn(sb-T2/Bart3)2.169Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
4 |
|
|
-8.21 |
null |
0.15 |
0.3 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
|
63088 |
528 |
F344-Myo9aTn(sb-T2/Bart3)2.186Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
1 |
|
|
-8.05 |
null |
|
|
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
|
63094 |
528 |
F344-Trpc4Tn(sb-T2/Bart3)2.192Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 14 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
2 |
|
|
0.85 |
g/mg |
0.07 |
0.1 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
63135 |
528 |
FHH-F10m1Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 14 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
7 |
|
|
1.41 |
g/mg |
0.09 |
0.23 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
63146 |
528 |
F344-DccTn(sb-T2/Bart3)2.205Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 14 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
3 |
|
|
1.27 |
g/mg |
0.32 |
0.55 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
63162 |
528 |
F344-Plcb3Tn(sb-T2/Bart3)2.69Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 14 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
1 |
|
|
1.22 |
g/mg |
|
|
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
63168 |
528 |
FHH-Egln3m1Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 14 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
6 |
|
|
1.39 |
g/mg |
0.09 |
0.23 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
63174 |
528 |
FHH-Tlr4m1Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 14 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
12 |
|
|
1.56 |
g/mg |
0.15 |
0.53 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
63181 |
528 |
SS-Cpt2m1Mcwi |
body weight |
controlled sodium content diet (1 %) (for 14 days) |
PhysGen Vascular data |
body mass |
male |
70 days-84 days |
5 |
|
|
309.6 |
g |
2.01 |
4.51 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
63195 |
528 |
SS/Jr |
heart wet weight |
controlled sodium content diet (2 %) (between 24 and 27 days) |
Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23 |
heart mass |
not specified |
64 days-71 days |
40 |
|
|
1.24 |
g |
0.01 |
0.05 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
4 rats per cage, 2 SR/Jr 2 LEW/NCrl |
64747 |
222 |
SS.SR-(D13N1-D13Mit1)/Jr |
systolic blood pressure |
controlled sodium content diet (0.2 %) (for 24 days) then controlled sodium content diet (4 %) (for 24 days) |
Zhang QY, et al., Mamm Genome 1997 Sep;8(9):636-41 |
arterial blood pressure trait |
not specified |
65 days-68 days |
26 |
data obtained at three consistent sessions per day |
serial mean |
217.0 |
mmHg |
|
|
tail cuff plethysmography |
|
345600 |
|
0 |
|
|
|
|
66029 |
650 |
SS-Chr 19SHR/Rkb |
body weight |
controlled sodium content diet (0.2 %) (for 56 days) |
Wendt N, et al., J Hypertens. 2007 Jan;25(1):95-102. |
body mass |
male |
98 days
| 20 |
|
|
355.0 |
g |
8.0 |
35.78 |
body weighing method |
|
0 |
|
0 |
|
|
|
|
66084 |
669 |
SS-Chr 19SHR/Rkb |
body weight |
controlled sodium content diet (4 %) (for 56 days) |
Wendt N, et al., J Hypertens. 2007 Jan;25(1):95-102. |
body mass |
male |
98 days
| 20 |
|
|
355.0 |
g |
9.0 |
40.25 |
body weighing method |
|
0 |
|
0 |
|
|
|
|
66085 |
669 |
FHH.BN-(D1Hmgc14-D1Hmgc15)/Mcwi-Rab38em1Mcwi+/+ |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
5 |
|
|
1.17 |
g |
0.06 |
0.12 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66203 |
717 |
SS-Gpr183em1Mcwi-/- |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
6 |
|
|
1.57 |
g |
0.07 |
0.18 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66207 |
717 |
SS-Mthfrem1Mcwi+/+ |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
1 |
|
|
1.61 |
g |
|
|
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66211 |
717 |
SS-Gpr183em2Mcwi-/- |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
9 |
|
|
1.58 |
g |
0.05 |
0.15 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66216 |
717 |
SS-Ncf2em1Mcwi+/+ |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
5 |
|
|
1.45 |
g |
0.04 |
0.08 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66221 |
717 |
SS.BN-(D13Rat20-D13Got22)/Mcwi-Nckap5em4Mcwi+/+ |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
2 |
|
|
1.46 |
g |
0.06 |
0.08 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66223 |
717 |
SS-Nckap5em1Mcwi+/+ |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
5 |
|
|
1.77 |
g |
0.11 |
0.24 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66232 |
717 |
SS-Apoeem7Mcwi-/- |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
5 |
|
|
1.42 |
g |
0.04 |
0.09 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66231 |
717 |
SS-Itga9em1Mcwi+/+ |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
4 |
|
|
1.49 |
g |
0.05 |
0.11 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66253 |
717 |
SS-Acad10em2Mcwi-/- |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
13 |
|
|
322.6 |
g |
4.1 |
14.6 |
whole body digital scale |
|
|
|
0 |
|
|
|
- |
66272 |
717 |
SS-Gpr183em1Mcwi-/- |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
6 |
|
|
296.2 |
g |
4.9 |
12.1 |
whole body digital scale |
|
|
|
0 |
|
|
|
- |
66269 |
717 |
SS-Tfdp2em2Mcwi+/+ |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
3 |
|
|
328.3 |
g |
6.4 |
11.2 |
whole body digital scale |
|
|
|
0 |
|
|
|
- |
66277 |
717 |
SS.BN-(D13Rat20-D13Got22)/Mcwi-Nckap5em4Mcwi+/+ |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
2 |
|
|
319.5 |
g |
2.5 |
3.5 |
whole body digital scale |
|
|
|
0 |
|
|
|
- |
66285 |
717 |
SS-Rag1em2Mcwi-/- |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
8 |
|
|
302.0 |
g |
8.6 |
24.4 |
whole body digital scale |
|
|
|
0 |
|
|
|
- |
66298 |
717 |
SS-Apoeem8Mcwi+/+ |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
2 |
|
|
332.5 |
g |
13.5 |
19.1 |
whole body digital scale |
|
|
|
0 |
|
|
|
- |
66301 |
717 |
SS-Ets1em1Mcwi-/+ |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
10 |
|
|
311.7 |
g |
11.4 |
36.0 |
whole body digital scale |
|
|
|
0 |
|
|
|
- |
66309 |
717 |
SS-Rag1em1Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
4 |
|
|
331.75 |
beats/min |
29.0 |
58.01 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66330 |
717 |
SS-Mmp2em1Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
5 |
|
|
362.0 |
beats/min |
6.58 |
14.71 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66328 |
717 |
SS-Mmp2em1Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
1 |
|
|
359.0 |
beats/min |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66352 |
717 |
SS-Ets1em1Mcwi-/+ |
heart rate |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
7 |
|
|
339.14 |
beats/min |
7.28 |
19.26 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66369 |
717 |
SS-Acad10em2Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
5 |
|
|
350.8 |
beats/min |
4.97 |
11.12 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66383 |
717 |
SS-Gpr183em1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
6 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
154.5 |
mmHg |
10.53 |
25.8 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66391 |
717 |
SS-Acad10em2Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
12 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
133.5 |
mmHg |
8.13 |
28.15 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66394 |
717 |
SS-Mthfrem1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
1 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
128.0 |
mmHg |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66395 |
717 |
SS-Apoeem8Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
5 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
136.4 |
mmHg |
6.02 |
13.46 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66402 |
717 |
SS-Gpr183em2Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
2 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
137.0 |
mmHg |
13.0 |
18.38 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66404 |
717 |
FHH-Chr 1BN-Sorcs1em1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
6 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
103.33 |
mmHg |
8.71 |
21.32 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66406 |
717 |
SS-Rag1em2Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
6 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
126.33 |
mmHg |
2.22 |
5.43 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66418 |
717 |
SS.BN-(D13Rat20-D13Got22)/Mcwi-Nckap5em4Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
3 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
130.33 |
mmHg |
5.21 |
9.02 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66427 |
717 |
SS-Tfdp2em2Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
3 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
135.33 |
mmHg |
12.39 |
21.46 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66432 |
717 |
SS-Nckap5em3Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
3 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
138.0 |
mmHg |
8.08 |
14.0 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66437 |
717 |
SS-Nckap5em3Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
2 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
127.5 |
mmHg |
2.5 |
3.54 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66440 |
717 |
SS-Mas1em1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
1 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
121.0 |
mmHg |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66442 |
717 |
SS-Bcas3em4Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
3 |
/3 systolic pressure + 2/3 diastolic pressure |
|
145.33 |
mmHg |
15.1 |
26.16 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66461 |
717 |
FHH-Chr 1BN-Sorcs1em1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
6 |
/3 systolic pressure + 2/3 diastolic pressure |
|
111.5 |
mmHg |
5.37 |
13.14 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66466 |
717 |
SS-Apoeem7Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
3 |
/3 systolic pressure + 2/3 diastolic pressure |
|
114.67 |
mmHg |
2.96 |
5.13 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66469 |
717 |
SS-Chr 5BN-Cyp4a2em1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
3 |
/3 systolic pressure + 2/3 diastolic pressure |
|
131.33 |
mmHg |
14.89 |
25.79 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66468 |
717 |
SS-Mmp2em2Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
1 |
/3 systolic pressure + 2/3 diastolic pressure |
|
161.0 |
mmHg |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66477 |
717 |
SS.BN-(D13Rat20-D13Got22)/Mcwi-Nckap5em4Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
3 |
/3 systolic pressure + 2/3 diastolic pressure |
|
136.0 |
mmHg |
6.51 |
11.27 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66487 |
717 |
SS-Mthfrem1Mcwi-/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
8 |
/3 systolic pressure + 2/3 diastolic pressure |
|
129.62 |
mmHg |
4.21 |
11.92 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66501 |
717 |
SS-Acad10em2Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
5 |
/3 systolic pressure + 2/3 diastolic pressure |
|
136.6 |
mmHg |
3.54 |
7.92 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66503 |
717 |
SS-Ncf2em1Mcwi-/- |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
6 |
|
|
90.75 |
mg/d |
13.96 |
34.19 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66506 |
717 |
SS-Tgfb1em3Mcwi+/- |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
3 |
|
|
90.77 |
mg/d |
21.1 |
36.55 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66517 |
717 |
SS-Gpr183em2Mcwi+/+ |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
2 |
|
|
105.13 |
mg/d |
2.81 |
3.97 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66524 |
717 |
SS-Nckap5em1Mcwi+/+ |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
5 |
|
|
210.12 |
mg/d |
50.65 |
113.25 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66536 |
717 |
SS-Rag1em2Mcwi-/- |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
8 |
|
|
56.65 |
mg/d |
5.76 |
16.3 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66539 |
717 |
SS-Apoeem8Mcwi+/+ |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
2 |
|
|
79.35 |
mg/d |
6.61 |
9.35 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66542 |
717 |
SS.BN-(D13Rat20-D13Got22)/Mcwi-Nckap5em4Mcwi-/- |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
4 |
|
|
85.9 |
mg/d |
4.77 |
9.54 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66548 |
717 |
SS-Alms1em1Mcwi+/+ |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
1 |
|
|
388.77 |
mg/d |
|
|
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66545 |
717 |
SS-Rag1em2Mcwi+/+ |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
1 |
|
|
95.7 |
mg/d |
|
|
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66552 |
717 |
SS-Tfdp2em2Mcwi-/- |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
3 |
|
|
119.9 |
mg/d |
40.27 |
69.76 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66553 |
717 |
SS-Nckap5em3Mcwi+/+ |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
2 |
|
|
87.01 |
mg/d |
23.91 |
33.82 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66561 |
717 |
SS-Ncf2em1Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
6 |
|
|
349.17 |
beats/min |
7.7 |
18.85 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66567 |
717 |
SS-Rag1em1Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
3 |
|
|
317.67 |
beats/min |
12.35 |
21.39 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66571 |
717 |
SS-Acad10em2Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
13 |
|
|
339.62 |
beats/min |
10.51 |
37.88 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66575 |
717 |
SS-Ets1em1Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
3 |
|
|
360.67 |
beats/min |
8.21 |
14.22 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66594 |
717 |
SS-Nckap5em3Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
3 |
|
|
353.0 |
beats/min |
14.5 |
25.12 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66618 |
717 |
SS-Ube2q2em3Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
2 |
|
|
320.5 |
beats/min |
28.5 |
40.31 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66626 |
717 |
SS-Mmp2em1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
5 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
148.6 |
mmHg |
10.55 |
23.59 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66629 |
717 |
SS-Ncf2em1Mcwi+/+ |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
5 |
|
|
1.16 |
g |
0.06 |
0.13 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
67013 |
717 |
SR/Hsd |
mean arterial blood pressure |
controlled sodium content diet (4 %) |
Gao F and Wang DH, Hypertension. 2010 Apr;55(4):1018-25. Epub 2010 Mar 1. |
arterial blood pressure trait |
male |
35 days-56 days |
0 |
|
|
110.0 |
mmHg |
4.0 |
|
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
DR strain is from Charles River Laboratory, Wilmington, MA |
67234 |
731 |
SS-Adra2aem1Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
8 |
|
|
358.13 |
beats/min |
7.03 |
19.89 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43443 |
421 |
SS-Wdr72em2Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
7 |
|
|
367.43 |
beats/min |
4.67 |
12.37 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43442 |
421 |
SS-Rasgrp3em1Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
4 |
|
|
364.25 |
beats/min |
5.76 |
11.53 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43444 |
421 |
SS-Hexim2em4Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
10 |
|
|
376.9 |
beats/min |
7.43 |
23.5 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43455 |
421 |
SS-Rasgrp3em1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
10 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
167.4 |
mmHg |
13.72 |
43.39 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43460 |
421 |
SS-Hexim2em4Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
2 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
139.5 |
mmHg |
0.5 |
0.71 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43465 |
421 |
SS-Ulk3em4Mcwi-/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
3 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
134.0 |
mmHg |
4.16 |
7.21 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43467 |
421 |
SS-Agtrapem4Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
3 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
152.0 |
mmHg |
8.74 |
15.13 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43468 |
421 |
SS-Rasgrp3em1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
4 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
126.75 |
mmHg |
4.94 |
9.88 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43475 |
421 |
SS-Adra2aem1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
8 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
126.88 |
mmHg |
3.12 |
8.82 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43474 |
421 |
SS-Wdr72em2Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
7 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
123.71 |
mmHg |
3.66 |
9.69 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43473 |
421 |
SS-Ulk3em4Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
14 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
130.43 |
mmHg |
5.11 |
19.14 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43481 |
421 |
SS-Sh2b3em1Mcwi-/- |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
18 |
|
|
315.9 |
g |
5.3 |
22.7 |
whole body digital scale |
|
|
|
0 |
|
|
|
- |
43487 |
421 |
SS-Sh2b3em1Mcwi-/+ |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
3 |
|
|
300.7 |
g |
1.8 |
3.1 |
whole body digital scale |
|
|
|
0 |
|
|
|
- |
43494 |
421 |
SS-Agtrapem4Mcwi-/- |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
7 |
|
|
326.6 |
g |
8.7 |
23.0 |
whole body digital scale |
|
|
|
0 |
|
|
|
- |
43500 |
421 |
SS-Rasgrp3em1Mcwi+/+ |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
6 |
|
|
83.33 |
mg/d |
11.28 |
27.64 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
43506 |
421 |
SS-Sh2b3em1Mcwi+/+ |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
1 |
|
|
86.52 |
mg/d |
|
|
automated urine analysis |
|
|
|
0 |
|
|
|
- |
43508 |
421 |
SS-Sh2b3em1Mcwi-/+ |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
3 |
|
|
56.13 |
mg/d |
4.75 |
8.22 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
43510 |
421 |
SS-Sh2b3em1Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
13 |
|
|
349.62 |
beats/min |
7.36 |
26.54 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43519 |
421 |
SS-Hexim2em4Mcwi-/- |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
10 |
|
|
101.7 |
mg/d |
15.79 |
49.93 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
43518 |
421 |
SS-Ulk3em4Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
2 |
|
|
357.5 |
beats/min |
10.5 |
14.85 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43527 |
421 |
SS-Ulk3em4Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
14 |
|
|
351.21 |
beats/min |
6.25 |
23.4 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43529 |
421 |
SS-Rasgrp3em1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
6 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
130.33 |
mmHg |
3.96 |
9.71 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43538 |
421 |
SS-Ulk3em4Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
15 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
126.53 |
mmHg |
2.65 |
10.27 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43545 |
421 |
SS-Ulk3em4Mcwi+/+ |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
2 |
|
|
10.65 |
mg/d |
0.35 |
0.49 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
43559 |
421 |
SS-Ulk3em4Mcwi-/- |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
19 |
|
|
10.36 |
mg/d |
0.29 |
1.25 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
43561 |
421 |
SS-Rasgrp3em1Mcwi+/+ |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
6 |
|
|
10.59 |
mEq/d |
1.06 |
2.59 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
43570 |
421 |
SS-Sh2b3em1Mcwi-/+ |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
3 |
|
|
16.02 |
mg/d |
3.39 |
5.88 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
43590 |
421 |
SS-Ulk3em4Mcwi-/- |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
18 |
|
|
33.71 |
mg/d |
4.51 |
19.14 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
43593 |
421 |
SS-Sh2b3em1Mcwi-/- |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
13 |
|
|
1.35 |
g |
0.03 |
0.12 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
43599 |
421 |
SS-Ulk3em4Mcwi-/- |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
18 |
|
|
1.41 |
g |
0.04 |
0.15 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
43607 |
421 |
SS-Wdr72em2Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
6 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
124.83 |
mmHg |
5.18 |
12.69 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43614 |
421 |
SS-Agtrapem4Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
7 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
133.06 |
mmHg |
6.76 |
17.89 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43626 |
421 |
SS-Adra2aem1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
4 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
105.0 |
mmHg |
9.26 |
18.51 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43627 |
421 |
SS-Ulk3em4Mcwi-/+ |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
4 |
|
|
1.35 |
g |
0.1 |
0.21 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
43638 |
421 |
SS-Hexim2em4Mcwi-/- |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
10 |
|
|
1.36 |
g |
0.03 |
0.11 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
43642 |
421 |
SS-Rasgrp3em1Mcwi-/- |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
10 |
|
|
1.18 |
g |
0.03 |
0.08 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
43647 |
421 |
SS-Rasgrp3em1Mcwi+/+ |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
6 |
|
|
1.13 |
g |
0.02 |
0.05 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
43646 |
421 |
SS-Ulk3em4Mcwi+/+ |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
2 |
|
|
1.16 |
g |
0.07 |
0.1 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
43649 |
421 |
SS-Agtrapem4Mcwi+/+ |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
3 |
|
|
1.15 |
g |
0.06 |
0.1 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
43653 |
421 |
SS-Hexim2em4Mcwi-/- |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
10 |
|
|
1.13 |
g |
0.02 |
0.07 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
43656 |
421 |
SS-Wdr72em2Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
6 |
|
|
379.17 |
beats/min |
7.66 |
18.76 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43658 |
421 |
SS-Rasgrp3em1Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
6 |
|
|
370.5 |
beats/min |
8.41 |
20.61 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43676 |
421 |
SS-Ulk3em4Mcwi-/+ |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
2 |
|
|
376.0 |
beats/min |
20.0 |
28.28 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43684 |
421 |
SS-Agtrapem4Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
6 |
|
|
354.24 |
beats/min |
6.81 |
16.69 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43686 |
421 |
LEW |
heart left ventricle wet weight |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle mass |
male |
77 days
| 14 |
|
|
0.72 |
g |
0.03 |
0.13 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
65027 |
542 |
SS/Jr |
heart left ventricle posterior wall thickness |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle posterior wall thickness |
male |
77 days
| 40 |
|
|
0.19 |
mm |
0.0 |
0.02 |
transthoracic echocardiography |
|
0 |
|
0 |
|
|
|
|
65115 |
542 |
SS.LEW-(D18Rat29-D18Rat55)/Ayd |
heart left ventricle posterior wall thickness |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle posterior wall thickness |
male |
77 days
| 11 |
|
|
0.18 |
mm |
0.01 |
0.02 |
transthoracic echocardiography |
|
0 |
|
0 |
|
|
|
|
65116 |
542 |
SS.LEW-(D3Rat52-D3Chm57)/Ayd |
heart left ventricle posterior wall thickness |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle posterior wall thickness |
male |
77 days
| 8 |
|
|
0.17 |
mm |
0.0 |
0.01 |
transthoracic echocardiography |
|
0 |
|
0 |
|
|
|
|
65121 |
542 |
SS/Jr |
heart wet weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 0 and 672 hours) then controlled sodium content diet (4 %) (between 46 and 48 days) |
Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2. |
heart mass |
male |
114 days-118 days |
4 |
|
|
1.67 |
g |
0.07 |
0.14 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
65129 |
283 |
WKY/Bbb |
diastolic blood pressure |
controlled sodium content diet |
Kreutz R, et al., Proc Natl Acad Sci U S A 1995 Sep 12;92(19):8778-82 |
arterial blood pressure trait |
not specified |
0 days
| 8 |
|
|
83.5 |
mmHg |
0.92 |
2.6 |
radiotelemetry |
|
0.0 |
|
0 |
|
|
|
|
67198 |
116 |
F344/NHsd |
serum glucose level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood glucose amount |
male |
70 days-84 days |
7 |
|
|
214.43 |
mg/dl |
16.34 |
43.24 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62473 |
527 |
F344-Brinp3Tn(sb-T2/Bart3)2.189Mcwi |
serum glucose level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood glucose amount |
female |
70 days-84 days |
1 |
|
|
129.0 |
mg/dl |
|
|
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62475 |
527 |
FHH-Htr1am1Mcwi |
serum glucose level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood glucose amount |
male |
70 days-84 days |
21 |
|
|
135.19 |
mg/dl |
9.0 |
41.25 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62480 |
527 |
F344-Fam19a2Tn(sb-T2/Bart3)2.184Mcwi |
serum glucose level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood glucose amount |
female |
70 days-84 days |
2 |
|
|
154.5 |
mg/dl |
2.5 |
3.54 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62494 |
527 |
F344-Myo9aTn(sb-T2/Bart3)2.186Mcwi |
serum glucose level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood glucose amount |
female |
70 days-84 days |
4 |
|
|
159.75 |
mg/dl |
15.93 |
31.86 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62488 |
527 |
F344-Plcb3Tn(sb-T2/Bart3)2.69Mcwi |
serum glucose level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood glucose amount |
male |
70 days-84 days |
1 |
|
|
156.0 |
mg/dl |
|
|
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62493 |
527 |
F344-AbatTn(sb-T2/Bart3)2.163Mcwi |
serum glucose level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood glucose amount |
male |
70 days-84 days |
3 |
|
|
164.33 |
mg/dl |
54.11 |
93.72 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62507 |
527 |
F344-Inpp4bTn(sb-T2/Bart3)2.143Mcwi |
serum glucose level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood glucose amount |
male |
70 days-84 days |
7 |
|
|
239.71 |
mg/dl |
47.38 |
125.36 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62513 |
527 |
FHH-Egln3m1Mcwi |
serum glucose level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood glucose amount |
female |
70 days-84 days |
14 |
|
|
166.14 |
mg/dl |
10.3 |
38.55 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62512 |
527 |
BN/NHsdMcwi |
serum glucose level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood glucose amount |
female |
70 days-84 days |
26 |
|
|
145.0 |
mg/dl |
3.68 |
18.76 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62516 |
527 |
F344-Stxbp5lTn(sb-T2/Bart3)2.202Mcwi |
serum glucose level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood glucose amount |
male |
70 days-84 days |
4 |
|
|
170.25 |
mg/dl |
8.14 |
16.28 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62518 |
527 |
FHH-Tgfbr2m2Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
10 |
|
|
75.7 |
% |
5.4 |
17.06 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62591 |
528 |
F344-Plce1Tn(sb-T2/Bart3)2.146Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
6 |
|
|
60.67 |
% |
4.18 |
10.25 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62597 |
528 |
FHH-Ccr2m1Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
6 |
|
|
70.0 |
% |
7.73 |
18.94 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62608 |
528 |
FHH-Adipoqm1Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
8 |
|
|
78.0 |
% |
4.92 |
13.93 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62605 |
528 |
F344-Brinp3Tn(sb-T2/Bart3)2.189Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
1 |
|
|
78.0 |
% |
|
|
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62614 |
528 |
F344/NHsd |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
8 |
|
|
54.13 |
% |
6.82 |
19.3 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62621 |
528 |
FHH-Adipoqm3Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
6 |
|
|
58.33 |
% |
7.06 |
17.28 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62636 |
528 |
FHH-Adra1am1Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
8 |
|
|
73.75 |
% |
5.49 |
15.53 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62641 |
528 |
FHH-Tlr4m1Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
11 |
|
|
65.18 |
% |
4.49 |
14.88 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62646 |
528 |
BN/NHsdMcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
8 |
|
|
66.75 |
% |
4.42 |
12.5 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62651 |
528 |
FHH-Tgfbr2m2Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
10 |
|
|
0.01 |
umol/l |
0.0 |
0.0 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62735 |
528 |
F344-Plce1Tn(sb-T2/Bart3)2.146Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
8 |
|
|
0.01 |
umol/l |
0.0 |
0.01 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62741 |
528 |
F344-Plce1Tn(sb-T2/Bart3)2.146Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
4 |
|
|
0.01 |
umol/l |
0.01 |
0.01 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62750 |
528 |
FHH-Procm1Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
8 |
|
|
0.06 |
umol/l |
0.02 |
0.06 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62755 |
528 |
F344/NHsd |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
9 |
|
|
0.01 |
umol/l |
0.0 |
0.01 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62757 |
528 |
FHH-Nr4a1m1Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
6 |
|
|
0.01 |
umol/l |
0.0 |
0.0 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62761 |
528 |
FHH-Ccr2m1Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
8 |
|
|
0.01 |
umol/l |
0.0 |
0.01 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62760 |
528 |
F344-Myo9aTn(sb-T2/Bart3)2.186Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
1 |
|
|
0.01 |
umol/l |
|
|
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62771 |
528 |
F344-Myo9aTn(sb-T2/Bart3)2.186Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
3 |
|
|
0.01 |
umol/l |
0.0 |
0.0 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62772 |
528 |
FHH-Adipoqm3Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
7 |
|
|
0.01 |
umol/l |
0.0 |
0.01 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62783 |
528 |
F344-AbatTn(sb-T2/Bart3)2.163Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
1 |
|
|
0.0 |
umol/l |
|
|
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62787 |
528 |
FHH-Slc8a2m1Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
15 |
|
|
0.02 |
umol/l |
0.01 |
0.03 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62792 |
528 |
F344-Erbb4Tn(sb-T2/Bart3)2.208Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
1 |
|
|
0.01 |
umol/l |
|
|
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62794 |
528 |
BN/NHsdMcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
8 |
|
|
0.01 |
umol/l |
0.0 |
0.01 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62798 |
528 |
BN/NHsdMcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
5 |
|
|
0.01 |
umol/l |
0.0 |
0.0 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62800 |
528 |
F344-Nrg1Tn(sb-T2/Bart3)2.183Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
5 |
|
|
0.01 |
umol/l |
0.0 |
0.0 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62799 |
528 |
SS-Sod3m1Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (1 %) (for 14 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
9 |
|
|
1.17 |
g/mg |
0.07 |
0.2 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62805 |
528 |
SS-Klf4m3Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (1 %) (for 14 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
8 |
|
|
1.32 |
g/mg |
0.07 |
0.19 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62807 |
528 |
FHH-Nr0b2m1Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
3 |
|
|
-7.0 |
null |
0.19 |
0.33 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62811 |
528 |
FHH-Lcatm1Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
8 |
|
|
-6.75 |
null |
0.14 |
0.39 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62816 |
528 |
BN-Tgfbr2m1Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
2 |
|
|
-7.13 |
null |
0.08 |
0.11 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62827 |
528 |
F344/NHsd |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
7 |
|
|
-6.61 |
null |
0.18 |
0.49 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62835 |
528 |
FHH-Ccr2m1Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
9 |
|
|
-7.03 |
null |
0.18 |
0.53 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62838 |
528 |
FHH-Procm1Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
15 |
|
|
-7.11 |
null |
0.13 |
0.49 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62840 |
528 |
FHH-Htr1am1Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
18 |
|
|
-6.72 |
null |
0.07 |
0.31 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62842 |
528 |
F344/NHsd |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
8 |
|
|
-6.84 |
null |
0.12 |
0.34 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62844 |
528 |
F344-DccTn(sb-T2/Bart3)2.205Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
5 |
|
|
-6.54 |
null |
0.08 |
0.18 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62848 |
528 |
F344-Fam19a2Tn(sb-T2/Bart3)2.184Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
2 |
|
|
-7.13 |
null |
0.12 |
0.17 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62851 |
528 |
F344-DccTn(sb-T2/Bart3)2.205Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
7 |
|
|
-6.88 |
null |
0.06 |
0.16 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62857 |
528 |
FHH-Adipoqm3Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
5 |
|
|
-6.53 |
null |
0.15 |
0.34 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62860 |
528 |
SS/JrHsdMcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (1 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
11 |
|
|
-7.7 |
null |
0.07 |
0.22 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
|
62890 |
528 |
FHH-Nr0b2m1Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Vascular data |
body mass |
female |
70 days-84 days |
3 |
|
|
167.33 |
g |
3.53 |
6.11 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
62898 |
528 |
FHH-Tgfbr2m2Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Vascular data |
body mass |
male |
70 days-84 days |
10 |
|
|
274.4 |
g |
6.51 |
20.58 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
62901 |
528 |
F344-Elmod3Tn(sb-T2/Bart3)2.42Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Vascular data |
body mass |
male |
70 days-84 days |
7 |
|
|
280.43 |
g |
7.61 |
20.14 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
62904 |
528 |
FHH-Tgfbr2m2Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Vascular data |
body mass |
female |
70 days-84 days |
9 |
|
|
177.78 |
g |
3.04 |
9.13 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
62906 |
528 |
FHH-Nr0b2m1Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Vascular data |
body mass |
male |
70 days-84 days |
4 |
|
|
269.0 |
g |
5.74 |
11.49 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
62913 |
528 |
FHH-Lcatm1Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Vascular data |
body mass |
female |
70 days-84 days |
10 |
|
|
173.7 |
g |
5.15 |
16.29 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
62909 |
528 |
FHH-Procm1Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Vascular data |
body mass |
female |
70 days-84 days |
8 |
|
|
215.38 |
g |
11.16 |
31.57 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
62921 |
528 |
FHH-Ccr2m1Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Vascular data |
body mass |
male |
70 days-84 days |
10 |
|
|
260.4 |
g |
3.58 |
11.32 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
62926 |
528 |
FHH/EurMcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Vascular data |
body mass |
female |
70 days-84 days |
6 |
|
|
183.0 |
g |
4.5 |
11.03 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
62940 |
528 |
FHH-Ghsrm1Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Vascular data |
body mass |
male |
70 days-84 days |
5 |
|
|
267.0 |
g |
19.31 |
43.19 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
62946 |
528 |
F344-Nrg1Tn(sb-T2/Bart3)2.183Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Vascular data |
body mass |
female |
70 days-84 days |
5 |
|
|
157.0 |
g |
3.3 |
7.38 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
62963 |
528 |
FHH-Egln3m1Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Vascular data |
body mass |
female |
70 days-84 days |
13 |
|
|
191.77 |
g |
2.68 |
9.66 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
62961 |
528 |
F344-Nrg1Tn(sb-T2/Bart3)2.183Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Vascular data |
body mass |
male |
70 days-84 days |
5 |
|
|
241.6 |
g |
8.86 |
19.81 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
62965 |
528 |
SS-Cpt2m1Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (1 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
5 |
|
|
0.02 |
umol/l |
0.0 |
0.01 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62969 |
528 |
SS-Klf4m3Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (1 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
9 |
|
|
0.02 |
umol/l |
0.01 |
0.02 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62972 |
528 |
SS/JrHsdMcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (1 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
11 |
|
|
71.64 |
% |
6.01 |
19.93 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62980 |
528 |
SS-Cpt2m1Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (1 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
1 |
|
|
100.0 |
% |
|
|
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62984 |
528 |
SS-Klf4m3Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (1 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
9 |
|
|
52.0 |
% |
3.62 |
10.86 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62983 |
528 |
FHH-Nr0b2m1Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
3 |
|
|
1.22 |
E-7mole |
0.57 |
0.99 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62988 |
528 |
F344-Elmod3Tn(sb-T2/Bart3)2.42Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
6 |
|
|
1.61 |
E-7mole |
0.29 |
0.72 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62994 |
528 |
FHH-Agtr1bm1Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
4 |
|
|
1.4 |
E-7mole |
0.69 |
1.37 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62995 |
528 |
FHH-Nr0b2m1Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
4 |
|
|
1.11 |
E-7mole |
0.43 |
0.86 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
63003 |
528 |
FHH-Slc8a2m1Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
13 |
|
|
1.55 |
E-7mole |
0.37 |
1.32 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
63000 |
528 |
FHH-Ccr2m1Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
6 |
|
|
1.06 |
E-7mole |
0.3 |
0.73 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
63008 |
528 |
FHH-F10m2Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
17 |
|
|
5.53 |
E-7mole |
3.97 |
16.35 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
63013 |
528 |
F344-Plcb3Tn(sb-T2/Bart3)2.69Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
1 |
|
|
2.84 |
E-7mole |
|
|
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
63030 |
528 |
F344-Plcb3Tn(sb-T2/Bart3)2.69Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
2 |
|
|
0.98 |
E-7mole |
0.28 |
0.39 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
63033 |
528 |
FHH-Adra1am1Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
8 |
|
|
1.46 |
E-7mole |
0.6 |
1.71 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
63039 |
528 |
FHH-Adra1am1Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
8 |
|
|
1.62 |
E-7mole |
0.44 |
1.25 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
63041 |
528 |
FHH-Tlr4m1Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
12 |
|
|
1.41 |
E-7mole |
0.22 |
0.78 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
63042 |
528 |
F344-Erbb4Tn(sb-T2/Bart3)2.208Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
1 |
|
|
1.98 |
E-7mole |
|
|
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
63047 |
528 |
FHH-Adipoqm2Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
15 |
|
|
-7.93 |
null |
0.09 |
0.37 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
|
63057 |
528 |
SS-Chr 16BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
5 |
|
|
0.04 |
umol/l |
0.01 |
0.02 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
57303 |
522 |
SS-Chr 14BN/Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
8 |
|
|
1.3 |
g/mg |
0.18 |
0.5 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
57314 |
522 |
SS-Chr 9BN/Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
10 |
|
|
1.53 |
g/mg |
0.18 |
0.56 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
57317 |
522 |
SS-Chr 6BN/Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
21 |
|
|
1.51 |
g/mg |
0.13 |
0.6 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
57316 |
522 |
FHH-Chr 19BN/Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
10 |
|
|
1.49 |
g/mg |
0.05 |
0.17 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
57347 |
522 |
SS-Chr 16BN/Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
15 |
|
|
0.99 |
g/mg |
0.13 |
0.5 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
57355 |
522 |
FHH-Chr 8BN/Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
10 |
|
|
0.95 |
g/mg |
0.09 |
0.28 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
57357 |
522 |
SS-Chr YBN/Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
20 |
|
|
1.32 |
g/mg |
0.09 |
0.39 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
57371 |
522 |
SS-Chr 18BN/Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
20 |
|
|
1.56 |
g/mg |
0.11 |
0.49 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
57377 |
522 |
FHH-Chr 1BN/Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
26 |
|
|
1.43 |
g/mg |
0.07 |
0.38 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
57376 |
522 |
SS-Chr 12BN/Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
10 |
|
|
0.56 |
g/mg |
0.07 |
0.23 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
57385 |
522 |
SS-Chr 19BN/Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
10 |
|
|
0.82 |
g/mg |
0.14 |
0.45 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
57388 |
522 |
BN/NHsdMcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
24 |
|
|
2.35 |
g/mg |
0.11 |
0.55 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
57395 |
522 |
FHH/EurMcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
7 |
|
|
-7.09 |
null |
0.15 |
0.41 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
57409 |
522 |
F344/DuCrl |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
20 |
|
|
0.03 |
umol/l |
0.0 |
0.02 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
57433 |
522 |
LEW/Crl |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
24 |
|
|
0.05 |
umol/l |
0.01 |
0.03 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
57431 |
522 |
FHH-Chr 16BN/Mcwi |
body weight |
controlled sodium content diet (4 %) (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70 days-84 days |
10 |
|
|
298.1 |
g |
3.1 |
9.8 |
whole body digital scale |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
55191 |
522 |
FHH-Chr 19BN/Mcwi |
body weight |
controlled sodium content diet (4 %) (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70 days-84 days |
10 |
|
|
236.8 |
g |
5.8 |
18.4 |
whole body digital scale |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
55193 |
522 |
SS-Chr 13BN/Mcwi |
body weight |
controlled sodium content diet (4 %) (for 21 days) |
PhysGen Vascular data |
body mass |
female |
70 days-84 days |
16 |
|
|
215.8 |
g |
4.0 |
15.8 |
whole body digital scale |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
55205 |
522 |
SS-Chr 11BN/Mcwi |
body weight |
controlled sodium content diet (4 %) (for 21 days) |
PhysGen Vascular data |
body mass |
female |
70 days-84 days |
10 |
|
|
190.6 |
g |
2.9 |
9.1 |
whole body digital scale |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
55211 |
522 |
FHH/EurMcwi |
body weight |
controlled sodium content diet (4 %) (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70 days-84 days |
51 |
|
|
234.9 |
g |
4.6 |
33.1 |
whole body digital scale |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
55212 |
522 |
FHH-Chr 1BN/Mcwi |
body weight |
controlled sodium content diet (4 %) (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70 days-84 days |
32 |
|
|
235.3 |
g |
3.8 |
21.5 |
whole body digital scale |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
55221 |
522 |
SS/JrHsdMcwi |
body weight |
controlled sodium content diet (4 %) (for 21 days) |
PhysGen Vascular data |
body mass |
female |
70 days-84 days |
15 |
|
|
207.8 |
g |
3.3 |
13.0 |
whole body digital scale |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
55225 |
522 |
FHH-Chr 11BN/Mcwi |
body weight |
controlled sodium content diet (4 %) (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70 days-84 days |
10 |
|
|
257.6 |
g |
8.2 |
25.8 |
whole body digital scale |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
55226 |
522 |
SS.BN-(D8Rat163-D8Rat81)/Mcwi |
body weight |
controlled sodium content diet (4 %) (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70 days-84 days |
10 |
|
|
260.1 |
g |
5.2 |
16.3 |
whole body digital scale |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
55237 |
522 |
Crl:CD(SD) |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
10 |
|
|
69.8 |
% |
9.65 |
30.53 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
55386 |
522 |
LEW/Crl |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
24 |
|
|
72.71 |
% |
3.92 |
19.21 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
55388 |
522 |
SS-Cpt2m1Mcwi |
serum glucose level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood glucose amount |
male |
70 days-84 days |
6 |
|
|
127.0 |
mg/dl |
12.76 |
31.26 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60614 |
527 |
SS/JrHsdMcwi |
serum glucose level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood glucose amount |
female |
70 days-84 days |
17 |
|
|
121.06 |
mg/dl |
2.95 |
12.18 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60621 |
527 |
FHH-Nr0b2m1Mcwi |
hematocrit |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
70 days-84 days |
6 |
|
|
40.55 |
% |
0.62 |
1.51 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60623 |
527 |
F344-Elmod3Tn(sb-T2/Bart3)2.42Mcwi |
hematocrit |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
70 days-84 days |
3 |
|
|
40.4 |
% |
2.95 |
5.1 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60637 |
527 |
F344-Plce1Tn(sb-T2/Bart3)2.146Mcwi |
hematocrit |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
70 days-84 days |
5 |
|
|
43.6 |
% |
0.74 |
1.65 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60642 |
527 |
FHH-Adipoqm2Mcwi |
hematocrit |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
70 days-84 days |
7 |
|
|
50.07 |
% |
2.08 |
5.51 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60643 |
527 |
FHH-F10m1Mcwi |
hematocrit |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
70 days-84 days |
11 |
|
|
40.59 |
% |
0.65 |
2.16 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60645 |
527 |
F344-Brinp3Tn(sb-T2/Bart3)2.189Mcwi |
hematocrit |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
70 days-84 days |
1 |
|
|
42.8 |
% |
|
|
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60651 |
527 |
FHH-F10m2Mcwi |
hematocrit |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
70 days-84 days |
16 |
|
|
42.78 |
% |
0.51 |
2.04 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60650 |
527 |
F344-Lims1Tn(sb-T2/Bart3)2.169Mcwi |
hematocrit |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
70 days-84 days |
7 |
|
|
44.84 |
% |
1.03 |
2.74 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60655 |
527 |
F344-Myo9aTn(sb-T2/Bart3)2.186Mcwi |
hematocrit |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
70 days-84 days |
4 |
|
|
46.13 |
% |
2.06 |
4.13 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60664 |
527 |
F344-DccTn(sb-T2/Bart3)2.205Mcwi |
hematocrit |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
70 days-84 days |
6 |
|
|
46.27 |
% |
0.79 |
1.94 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60675 |
527 |
FHH-Adra1am1Mcwi |
hematocrit |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
70 days-84 days |
9 |
|
|
41.77 |
% |
0.9 |
2.71 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60681 |
527 |
FHH-Egln3m1Mcwi |
hematocrit |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
70 days-84 days |
14 |
|
|
41.82 |
% |
0.56 |
2.09 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60688 |
527 |
SS/JrHsdMcwi |
serum alkaline phosphatase activity level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
male |
70 days-84 days |
41 |
|
|
70.76 |
U/l |
2.74 |
17.52 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60697 |
527 |
BN/NHsdMcwi |
hematocrit |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
70 days-84 days |
27 |
|
|
43.7 |
% |
0.34 |
1.76 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60692 |
527 |
SS-Cpt2m1Mcwi |
serum alkaline phosphatase activity level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
male |
70 days-84 days |
6 |
|
|
69.67 |
U/l |
3.86 |
9.46 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60696 |
527 |
SS-Klf4m3Mcwi |
serum alkaline phosphatase activity level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
70 days-84 days |
7 |
|
|
54.43 |
U/l |
2.75 |
7.28 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60699 |
527 |
SS-Klf4m3Mcwi |
serum alkaline phosphatase activity level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
male |
70 days-84 days |
8 |
|
|
83.25 |
U/l |
4.7 |
13.3 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60700 |
527 |
SS-Sod3m1Mcwi |
blood monocyte count |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
monocyte quantity |
male |
70 days-84 days |
10 |
|
|
0.42 |
x 1000 cells/ul |
0.1 |
0.32 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60708 |
527 |
SS/JrHsdMcwi |
blood monocyte count |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
monocyte quantity |
male |
70 days-84 days |
41 |
|
|
0.24 |
x 1000 cells/ul |
0.04 |
0.23 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60707 |
527 |
SS-Ghsrm3Mcwi |
blood monocyte count |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
monocyte quantity |
male |
70 days-84 days |
2 |
|
|
0.33 |
x 1000 cells/ul |
0.27 |
0.37 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60705 |
527 |
SS/JrHsdMcwi |
blood monocyte count |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
monocyte quantity |
female |
70 days-84 days |
17 |
|
|
0.15 |
x 1000 cells/ul |
0.04 |
0.16 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60713 |
527 |
SS-Ghsrm3Mcwi |
serum albumin level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood albumin amount |
female |
70 days-84 days |
1 |
|
|
3.6 |
g/dl |
|
|
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60722 |
527 |
SS-Cpt2m1Mcwi |
serum phosphate level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
70 days-84 days |
6 |
|
|
7.75 |
mg/dl |
0.19 |
0.47 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60726 |
527 |
SS-Klf4m3Mcwi |
serum phosphate level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
70 days-84 days |
8 |
|
|
8.44 |
mg/dl |
0.29 |
0.83 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60730 |
527 |
FHH-Adipoqm2Mcwi |
mean corpuscular volume |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
70 days-84 days |
7 |
|
|
51.87 |
fl |
0.31 |
0.82 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60755 |
527 |
FHH-Nr0b2m1Mcwi |
mean corpuscular volume |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
70 days-84 days |
10 |
|
|
52.07 |
fl |
0.22 |
0.7 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60751 |
527 |
FHH-Htr1am1Mcwi |
mean corpuscular volume |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte size trait |
female |
70 days-84 days |
13 |
|
|
54.68 |
fl |
0.75 |
2.7 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60760 |
527 |
FHH-Nr4a1m1Mcwi |
mean corpuscular volume |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
70 days-84 days |
11 |
|
|
54.23 |
fl |
1.01 |
3.34 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60765 |
527 |
FHH-Htr1am1Mcwi |
mean corpuscular volume |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
70 days-84 days |
21 |
|
|
52.41 |
fl |
0.36 |
1.64 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60768 |
527 |
FHH-F10m1Mcwi |
mean corpuscular volume |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
70 days-84 days |
10 |
|
|
51.48 |
fl |
0.31 |
0.97 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60772 |
527 |
F344-Fam19a2Tn(sb-T2/Bart3)2.184Mcwi |
mean corpuscular volume |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
70 days-84 days |
7 |
|
|
52.87 |
fl |
0.21 |
0.55 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60778 |
527 |
FHH/EurMcwi |
mean corpuscular volume |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte size trait |
female |
70 days-84 days |
25 |
|
|
53.59 |
fl |
0.31 |
1.55 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60779 |
527 |
F344-Fam19a2Tn(sb-T2/Bart3)2.184Mcwi |
mean corpuscular volume |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte size trait |
female |
70 days-84 days |
2 |
|
|
55.8 |
fl |
0.0 |
0.0 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60782 |
527 |
FHH-Adipoqm3Mcwi |
mean corpuscular volume |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
70 days-84 days |
5 |
|
|
54.04 |
fl |
0.93 |
2.09 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60789 |
527 |
F344-AbatTn(sb-T2/Bart3)2.163Mcwi |
mean corpuscular volume |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte size trait |
female |
70 days-84 days |
4 |
|
|
55.7 |
fl |
0.27 |
0.54 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60792 |
527 |
FHH-Adra1am1Mcwi |
mean corpuscular volume |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte size trait |
female |
70 days-84 days |
9 |
|
|
53.28 |
fl |
0.29 |
0.87 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60793 |
527 |
FHH-Adra1am1Mcwi |
mean corpuscular volume |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
70 days-84 days |
8 |
|
|
51.06 |
fl |
0.21 |
0.59 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60791 |
527 |
F344-Stxbp5lTn(sb-T2/Bart3)2.202Mcwi |
mean corpuscular volume |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte size trait |
female |
70 days-84 days |
2 |
|
|
54.85 |
fl |
2.65 |
3.75 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60796 |
527 |
FHH-Egln3m1Mcwi |
mean corpuscular volume |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte size trait |
female |
70 days-84 days |
14 |
|
|
55.6 |
fl |
0.45 |
1.69 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60800 |
527 |
SS-Ghsrm3Mcwi |
serum bicarbonate level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
70 days-84 days |
2 |
|
|
20.0 |
mmol/l |
1.0 |
1.41 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60807 |
527 |
SS/JrHsdMcwi |
serum bicarbonate level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
70 days-84 days |
41 |
|
|
19.34 |
mmol/l |
0.37 |
2.38 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60809 |
527 |
SS/JrHsdMcwi |
logarithm of the concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
11 |
|
|
-8.49 |
null |
0.13 |
0.42 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
55484 |
522 |
Hsd:SD |
concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
16 |
|
|
0.37 |
10E-7mol/l |
0.06 |
0.23 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
55503 |
522 |
FHH-Procm1Mcwi |
blood neutrophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
70 days-84 days |
8 |
|
|
0.73 |
x 1000 cells/ul |
0.2 |
0.56 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60851 |
527 |
FHH-Procm1Mcwi |
blood neutrophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
neutrophil quantity |
male |
70 days-84 days |
9 |
|
|
1.07 |
x 1000 cells/ul |
0.39 |
1.18 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60858 |
527 |
F344-Myo9aTn(sb-T2/Bart3)2.186Mcwi |
blood neutrophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
neutrophil quantity |
male |
70 days-84 days |
1 |
|
|
1.04 |
x 1000 cells/ul |
|
|
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60867 |
527 |
BN-Lcatm3Mcwi |
blood neutrophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
70 days-84 days |
2 |
|
|
1.3 |
x 1000 cells/ul |
0.53 |
0.74 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60872 |
527 |
F344-Fam19a2Tn(sb-T2/Bart3)2.184Mcwi |
blood neutrophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
neutrophil quantity |
male |
70 days-84 days |
7 |
|
|
1.3 |
x 1000 cells/ul |
0.15 |
0.39 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60870 |
527 |
FHH-Adra1am1Mcwi |
blood neutrophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
neutrophil quantity |
male |
70 days-84 days |
8 |
|
|
0.92 |
x 1000 cells/ul |
0.21 |
0.59 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60883 |
527 |
FHH-Adipoqm3Mcwi |
blood neutrophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
70 days-84 days |
6 |
|
|
0.54 |
x 1000 cells/ul |
0.16 |
0.4 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60880 |
527 |
FHH-Lcatm1Mcwi |
serum globulin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood globulin amount |
female |
70 days-84 days |
15 |
|
|
1.47 |
g/dl |
0.06 |
0.23 |
standard blood chemistry panel |
|
|
|
0 |
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
60921 |
527 |
FHH-Nr0b2m1Mcwi |
serum globulin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood globulin amount |
male |
70 days-84 days |
10 |
|
|
1.5 |
g/dl |
0.08 |
0.26 |
standard blood chemistry panel |
|
|
|
0 |
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
60925 |
527 |
FHH-Ccr2m1Mcwi |
serum globulin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood globulin amount |
female |
70 days-84 days |
5 |
|
|
1.58 |
g/dl |
0.09 |
0.19 |
standard blood chemistry panel |
|
|
|
0 |
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
60930 |
527 |
F344-Brinp3Tn(sb-T2/Bart3)2.189Mcwi |
serum globulin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood globulin amount |
male |
70 days-84 days |
3 |
|
|
1.97 |
g/dl |
0.09 |
0.15 |
standard blood chemistry panel |
|
|
|
0 |
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
60932 |
527 |
F344-DccTn(sb-T2/Bart3)2.205Mcwi |
serum globulin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood globulin amount |
female |
70 days-84 days |
4 |
|
|
1.9 |
g/dl |
0.04 |
0.08 |
standard blood chemistry panel |
|
|
|
0 |
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
60948 |
527 |
FHH-Ghsrm1Mcwi |
serum globulin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood globulin amount |
male |
70 days-84 days |
12 |
|
|
1.66 |
g/dl |
0.06 |
0.2 |
standard blood chemistry panel |
|
|
|
0 |
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
60959 |
527 |
FHH-Adra1am1Mcwi |
serum globulin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood globulin amount |
female |
70 days-84 days |
9 |
|
|
1.53 |
g/dl |
0.04 |
0.13 |
standard blood chemistry panel |
|
|
|
0 |
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
60967 |
527 |
F344-Stxbp5lTn(sb-T2/Bart3)2.202Mcwi |
serum globulin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood globulin amount |
female |
70 days-84 days |
2 |
|
|
2.1 |
g/dl |
0.2 |
0.28 |
standard blood chemistry panel |
|
|
|
0 |
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
60970 |
527 |
F344-Inpp4bTn(sb-T2/Bart3)2.143Mcwi |
serum globulin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood globulin amount |
male |
70 days-84 days |
7 |
|
|
2.14 |
g/dl |
0.08 |
0.21 |
standard blood chemistry panel |
|
|
|
0 |
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
60975 |
527 |
BN/NHsdMcwi |
serum globulin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood globulin amount |
male |
70 days-84 days |
44 |
|
|
1.93 |
g/dl |
0.03 |
0.17 |
standard blood chemistry panel |
|
|
|
0 |
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
60977 |
527 |
F344-Nrg1Tn(sb-T2/Bart3)2.183Mcwi |
serum globulin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood globulin amount |
female |
70 days-84 days |
5 |
|
|
1.9 |
g/dl |
0.07 |
0.16 |
standard blood chemistry panel |
|
|
|
0 |
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
60976 |
527 |
BN/NHsdMcwi |
serum globulin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood globulin amount |
female |
70 days-84 days |
27 |
|
|
1.55 |
g/dl |
0.03 |
0.14 |
standard blood chemistry panel |
|
|
|
0 |
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
60978 |
527 |
SS-Ghsrm3Mcwi |
hematocrit |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
70 days-84 days |
2 |
|
|
50.3 |
% |
1.4 |
1.98 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60981 |
527 |
SS/JrHsdMcwi |
hematocrit |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
70 days-84 days |
17 |
|
|
46.26 |
% |
0.61 |
2.53 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60989 |
527 |
SS-Ghsrm3Mcwi |
hematocrit |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
70 days-84 days |
1 |
|
|
48.8 |
% |
|
|
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60988 |
527 |
BN-Tgfbr2m1Mcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (for 14 days) then fasting (between 16 and 1 hours) |
PhysGen Biochemistry data |
blood creatinine amount |
female |
70 days-84 days |
3 |
|
|
0.27 |
mg/dl |
0.03 |
0.06 |
automated plasma creatinine analysis |
|
|
|
0 |
|
|
|
|
60997 |
527 |
FHH-Adipoqm2Mcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (for 14 days) then fasting (between 16 and 1 hours) |
PhysGen Biochemistry data |
blood creatinine amount |
female |
70 days-84 days |
12 |
|
|
0.28 |
mg/dl |
0.04 |
0.15 |
automated plasma creatinine analysis |
|
|
|
0 |
|
|
|
|
60993 |
527 |
F344-Plce1Tn(sb-T2/Bart3)2.146Mcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (for 14 days) then fasting (between 16 and 1 hours) |
PhysGen Biochemistry data |
blood creatinine amount |
male |
70 days-84 days |
6 |
|
|
0.42 |
mg/dl |
0.09 |
0.21 |
automated plasma creatinine analysis |
|
|
|
0 |
|
|
|
|
61001 |
527 |
F344-Elmod3Tn(sb-T2/Bart3)2.42Mcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (for 14 days) then fasting (between 16 and 1 hours) |
PhysGen Biochemistry data |
blood creatinine amount |
female |
70 days-84 days |
3 |
|
|
0.3 |
mg/dl |
0.0 |
0.0 |
automated plasma creatinine analysis |
|
|
|
0 |
|
|
|
|
61005 |
527 |
FHH-Nr4a1m1Mcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (for 14 days) then fasting (between 16 and 1 hours) |
PhysGen Biochemistry data |
blood creatinine amount |
male |
70 days-84 days |
11 |
|
|
0.24 |
mg/dl |
0.02 |
0.05 |
automated plasma creatinine analysis |
|
|
|
0 |
|
|
|
|
61021 |
527 |
SS-Chr 16BN/Mcwi |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
blood vessel smooth muscle dilation trait |
female |
70 days-84 days |
5 |
|
|
99.8 |
% |
0.2 |
0.45 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
55716 |
522 |
SS-Chr 18BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
10 |
|
|
-7.03 |
null |
0.07 |
0.21 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Dyets |
55718 |
522 |
FHH/EurMcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
8 |
|
|
-6.26 |
null |
0.09 |
0.24 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Dyets |
55726 |
522 |
Hsd:SD |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
10 |
|
|
69.0 |
% |
6.69 |
21.17 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
55730 |
522 |
Hsd:SD |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
14 |
|
|
85.5 |
% |
4.86 |
18.18 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
55731 |
522 |
F344-DccTn(sb-T2/Bart3)2.205Mcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (for 14 days) then fasting (between 16 and 1 hours) |
PhysGen Biochemistry data |
blood creatinine amount |
male |
70 days-84 days |
6 |
|
|
0.33 |
mg/dl |
0.03 |
0.08 |
automated plasma creatinine analysis |
|
|
|
0 |
|
|
|
|
61043 |
527 |
FHH/EurMcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (for 14 days) then fasting (between 16 and 1 hours) |
PhysGen Biochemistry data |
blood creatinine amount |
male |
70 days-84 days |
157 |
|
|
0.29 |
mg/dl |
0.01 |
0.12 |
automated plasma creatinine analysis |
|
|
|
0 |
|
|
|
|
61046 |
527 |
FHH-Adipoqm1Mcwi |
plasma anion gap |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
ion homeostasis trait |
male |
70 days-84 days |
8 |
|
|
26.38 |
mmol/l |
1.71 |
4.84 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61081 |
527 |
F344-Brinp3Tn(sb-T2/Bart3)2.189Mcwi |
plasma anion gap |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
ion homeostasis trait |
male |
70 days-84 days |
3 |
|
|
28.0 |
mmol/l |
0.0 |
0.0 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61086 |
527 |
FHH-Nr4a1m1Mcwi |
plasma anion gap |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
ion homeostasis trait |
female |
70 days-84 days |
10 |
|
|
24.3 |
mmol/l |
1.16 |
3.68 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61101 |
527 |
FHH/EurMcwi |
plasma anion gap |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
ion homeostasis trait |
male |
70 days-84 days |
154 |
|
|
24.54 |
mmol/l |
0.39 |
4.82 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61118 |
527 |
F344-AbatTn(sb-T2/Bart3)2.163Mcwi |
plasma anion gap |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
ion homeostasis trait |
male |
70 days-84 days |
3 |
|
|
27.33 |
mmol/l |
0.33 |
0.58 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61123 |
527 |
F344-Inpp4bTn(sb-T2/Bart3)2.143Mcwi |
plasma anion gap |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
ion homeostasis trait |
male |
70 days-84 days |
7 |
|
|
28.14 |
mmol/l |
1.32 |
3.48 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61129 |
527 |
BN/NHsdMcwi |
plasma anion gap |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
ion homeostasis trait |
male |
70 days-84 days |
44 |
|
|
23.16 |
mmol/l |
0.45 |
2.99 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61131 |
527 |
F344-Nrg1Tn(sb-T2/Bart3)2.183Mcwi |
plasma anion gap |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
ion homeostasis trait |
male |
70 days-84 days |
5 |
|
|
26.0 |
mmol/l |
0.55 |
1.22 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61133 |
527 |
F344-Stxbp5lTn(sb-T2/Bart3)2.202Mcwi |
plasma anion gap |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
ion homeostasis trait |
male |
70 days-84 days |
4 |
|
|
25.75 |
mmol/l |
1.25 |
2.5 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61134 |
527 |
F344-Trpc4Tn(sb-T2/Bart3)2.192Mcwi |
mean corpuscular hemoglobin concentration |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
70 days-84 days |
1 |
|
|
33.0 |
g/dl |
|
|
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61139 |
527 |
FHH-Lcatm1Mcwi |
mean corpuscular hemoglobin concentration |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
15 |
|
|
33.6 |
g/dl |
0.14 |
0.54 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61147 |
527 |
FHH-Agtr1bm1Mcwi |
mean corpuscular hemoglobin concentration |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
70 days-84 days |
15 |
|
|
33.93 |
g/dl |
0.12 |
0.45 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61143 |
527 |
FHH-Adipoqm2Mcwi |
mean corpuscular hemoglobin concentration |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
70 days-84 days |
7 |
|
|
33.1 |
g/dl |
0.31 |
0.83 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61155 |
527 |
FHH-F10m2Mcwi |
mean corpuscular hemoglobin concentration |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
12 |
|
|
32.78 |
g/dl |
0.15 |
0.53 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61171 |
527 |
F344-Lims1Tn(sb-T2/Bart3)2.169Mcwi |
mean corpuscular hemoglobin concentration |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
70 days-84 days |
2 |
|
|
32.45 |
g/dl |
0.25 |
0.35 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61169 |
527 |
F344-Fam19a2Tn(sb-T2/Bart3)2.184Mcwi |
mean corpuscular hemoglobin concentration |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
70 days-84 days |
7 |
|
|
32.34 |
g/dl |
0.17 |
0.45 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61178 |
527 |
BN-Lcatm3Mcwi |
mean corpuscular hemoglobin concentration |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
2 |
|
|
32.8 |
g/dl |
0.1 |
0.14 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61180 |
527 |
BN/NHsdMcwi |
mean corpuscular hemoglobin concentration |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
27 |
|
|
32.98 |
g/dl |
0.14 |
0.7 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61204 |
527 |
F344-Nrg1Tn(sb-T2/Bart3)2.183Mcwi |
mean corpuscular hemoglobin concentration |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
5 |
|
|
32.42 |
g/dl |
0.19 |
0.43 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61202 |
527 |
SS-Ghsrm3Mcwi |
serum aspartate aminotransferase activity level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
70 days-84 days |
2 |
|
|
148.5 |
U/l |
56.5 |
79.9 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61207 |
527 |
SS-Sod3m1Mcwi |
serum aspartate aminotransferase activity level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
70 days-84 days |
10 |
|
|
185.2 |
U/l |
37.4 |
118.26 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61210 |
527 |
SS-Cpt2m1Mcwi |
serum aspartate aminotransferase activity level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
70 days-84 days |
1 |
|
|
216.0 |
U/l |
|
|
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61213 |
527 |
SS/JrHsdMcwi |
serum aspartate aminotransferase activity level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
70 days-84 days |
16 |
|
|
174.31 |
U/l |
12.33 |
49.32 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61215 |
527 |
BN-Tgfbr2m1Mcwi |
serum total protein level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood total protein amount |
female |
70 days-84 days |
3 |
|
|
5.07 |
g/dl |
0.28 |
0.49 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61223 |
527 |
F344/DuCrl |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
13 |
|
|
1.8 |
E-7mole |
0.32 |
1.14 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
55981 |
522 |
FHH-Slc8a2m1Mcwi |
serum total protein level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood total protein amount |
female |
70 days-84 days |
12 |
|
|
5.21 |
g/dl |
0.05 |
0.19 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61230 |
527 |
FHH-F10m1Mcwi |
serum total protein level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood total protein amount |
male |
70 days-84 days |
10 |
|
|
5.61 |
g/dl |
0.1 |
0.31 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61254 |
527 |
F344-AbatTn(sb-T2/Bart3)2.163Mcwi |
serum total protein level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood total protein amount |
male |
70 days-84 days |
3 |
|
|
5.9 |
g/dl |
0.2 |
0.35 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61277 |
527 |
FHH-Tlr4m1Mcwi |
serum total protein level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood total protein amount |
female |
70 days-84 days |
9 |
|
|
5.19 |
g/dl |
0.07 |
0.2 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61280 |
527 |
F344-Trpc4Tn(sb-T2/Bart3)2.192Mcwi |
serum potassium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood potassium amount |
male |
70 days-84 days |
1 |
|
|
3.4 |
mmol/l |
|
|
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61293 |
527 |
FHH-Tgfbr2m2Mcwi |
serum potassium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood potassium amount |
male |
70 days-84 days |
12 |
|
|
5.18 |
mmol/l |
0.12 |
0.41 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61292 |
527 |
FHH-Adipoqm1Mcwi |
serum potassium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood potassium amount |
female |
70 days-84 days |
9 |
|
|
4.97 |
mmol/l |
0.14 |
0.43 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61290 |
527 |
FHH-Nr0b2m1Mcwi |
serum potassium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood potassium amount |
male |
70 days-84 days |
10 |
|
|
4.76 |
mmol/l |
0.24 |
0.75 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61305 |
527 |
FHH-Agtr1bm1Mcwi |
serum potassium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood potassium amount |
female |
70 days-84 days |
14 |
|
|
4.05 |
mmol/l |
0.13 |
0.47 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61304 |
527 |
FHH-Htr1am1Mcwi |
serum potassium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood potassium amount |
female |
70 days-84 days |
13 |
|
|
4.85 |
mmol/l |
0.28 |
1.0 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61314 |
527 |
F344-Lims1Tn(sb-T2/Bart3)2.169Mcwi |
serum potassium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood potassium amount |
male |
70 days-84 days |
2 |
|
|
4.95 |
mmol/l |
0.65 |
0.92 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61323 |
527 |
F344-Myo9aTn(sb-T2/Bart3)2.186Mcwi |
serum potassium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood potassium amount |
female |
70 days-84 days |
4 |
|
|
4.2 |
mmol/l |
0.32 |
0.65 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61330 |
527 |
BN-Lcatm3Mcwi |
serum potassium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood potassium amount |
male |
70 days-84 days |
1 |
|
|
4.6 |
mmol/l |
|
|
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61337 |
527 |
FHH-Adipoqm3Mcwi |
serum potassium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood potassium amount |
female |
70 days-84 days |
6 |
|
|
4.72 |
mmol/l |
0.34 |
0.84 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61342 |
527 |
FHH-Nr0b2m1Mcwi |
total white blood cell count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
70 days-84 days |
6 |
|
|
5.5 |
x 1000 cells/ul |
0.43 |
1.06 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61361 |
527 |
BN-Tgfbr2m1Mcwi |
total white blood cell count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
70 days-84 days |
3 |
|
|
7.13 |
x 1000 cells/ul |
0.6 |
1.04 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61367 |
527 |
FHH-Tgfbr2m2Mcwi |
total white blood cell count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
70 days-84 days |
14 |
|
|
4.66 |
x 1000 cells/ul |
0.43 |
1.6 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61370 |
527 |
FHH-F10m2Mcwi |
total white blood cell count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
70 days-84 days |
12 |
|
|
4.78 |
x 1000 cells/ul |
0.42 |
1.44 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61397 |
527 |
FHH-Egln3m1Mcwi |
total white blood cell count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
leukocyte quantity |
male |
70 days-84 days |
6 |
|
|
4.58 |
x 1000 cells/ul |
0.34 |
0.84 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61412 |
527 |
F344-AbatTn(sb-T2/Bart3)2.163Mcwi |
total white blood cell count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
leukocyte quantity |
male |
70 days-84 days |
3 |
|
|
5.67 |
x 1000 cells/ul |
0.23 |
0.4 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61421 |
527 |
FHH-Tlr4m1Mcwi |
total white blood cell count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
70 days-84 days |
9 |
|
|
3.71 |
x 1000 cells/ul |
0.3 |
0.9 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61424 |
527 |
BN/NHsdMcwi |
total white blood cell count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
leukocyte quantity |
male |
70 days-84 days |
43 |
|
|
7.07 |
x 1000 cells/ul |
0.29 |
1.91 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61429 |
527 |
F344-Inpp4bTn(sb-T2/Bart3)2.143Mcwi |
total white blood cell count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
leukocyte quantity |
male |
70 days-84 days |
7 |
|
|
5.76 |
x 1000 cells/ul |
0.11 |
0.29 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61427 |
527 |
FHH-Adipoqm1Mcwi |
serum alanine aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
female |
70 days-84 days |
9 |
|
|
81.22 |
U/l |
12.71 |
38.14 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61434 |
527 |
SS/JrHsdMcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
15 |
|
|
1.66 |
E-7mole |
0.39 |
1.51 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
54588 |
522 |
FHH/EurMcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
7 |
|
|
0.92 |
E-7mole |
0.52 |
1.37 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
54589 |
522 |
SS-Chr 18BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
10 |
|
|
3.86 |
E-7mole |
0.55 |
1.73 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
54592 |
522 |
WKY/NCrl |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
12 |
|
|
-7.4 |
null |
0.12 |
0.4 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
54743 |
522 |
LEW/Crl |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
24 |
|
|
-7.17 |
null |
0.06 |
0.32 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
54744 |
522 |
LEW/Crl |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
24 |
|
|
-6.98 |
null |
0.07 |
0.34 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
54749 |
522 |
SS-Chr 10BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
7 |
|
|
61.71 |
% |
7.17 |
18.97 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54755 |
522 |
FHH-Chr 14BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
9 |
|
|
81.78 |
% |
4.36 |
13.07 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54773 |
522 |
SS.BN-(D12Arb13-D12Rat79)/Mcwi |
logarithm of the concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
15 |
|
|
-8.57 |
null |
0.06 |
0.24 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56023 |
522 |
SS-Chr YBN/Mcwi |
logarithm of the concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
20 |
|
|
-8.7 |
null |
0.08 |
0.35 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56029 |
522 |
GH/OmrMcwi |
logarithm of the concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
5 |
|
|
-8.16 |
null |
0.06 |
0.14 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56036 |
522 |
WKY/NCrl |
body weight |
controlled sodium content diet (4 %) (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70 days-84 days |
15 |
|
|
256.8 |
g |
4.6 |
17.7 |
whole body digital scale |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
56068 |
522 |
SS-Chr 17BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
9 |
|
|
-7.05 |
null |
0.11 |
0.34 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56100 |
522 |
FHH-Chr 16BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
10 |
|
|
-8.01 |
null |
0.1 |
0.33 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56102 |
522 |
SS-Chr 15BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
9 |
|
|
-7.82 |
null |
0.14 |
0.42 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56122 |
522 |
FHH-Chr 13BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
13 |
|
|
-8.34 |
null |
0.09 |
0.33 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56127 |
522 |
FHH-Chr 18BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
10 |
|
|
-7.7 |
null |
0.17 |
0.53 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56133 |
522 |
SS-Chr 11BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
9 |
|
|
-7.73 |
null |
0.11 |
0.34 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56137 |
522 |
SS-Chr 18BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
21 |
|
|
-8.22 |
null |
0.14 |
0.64 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56144 |
522 |
SS-Chr XBN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
10 |
|
|
-8.24 |
null |
0.11 |
0.35 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56146 |
522 |
FHH-Chr 3BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
9 |
|
|
-8.28 |
null |
0.09 |
0.28 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56140 |
522 |
FHH-Chr YBN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
11 |
|
|
-7.78 |
null |
0.08 |
0.28 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56141 |
522 |
SS.BN-(D8Rat163-D8Rat81)/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
10 |
|
|
-7.98 |
null |
0.07 |
0.22 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56154 |
522 |
FHH-Chr 11BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
10 |
|
|
-8.2 |
null |
0.11 |
0.33 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56157 |
522 |
SS-Chr XBN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
9 |
|
|
-8.17 |
null |
0.13 |
0.38 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56167 |
522 |
FHH-Chr 1BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
26 |
|
|
-7.27 |
null |
0.14 |
0.73 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56171 |
522 |
SS-Chr 2BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
10 |
|
|
-7.52 |
null |
0.1 |
0.32 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56170 |
522 |
SS/JrHsdMcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
10 |
|
|
-7.15 |
null |
0.07 |
0.23 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
56181 |
522 |
Hsd:SD |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
14 |
|
|
1.7 |
E-7mole |
0.61 |
2.3 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
56212 |
522 |
SS-Cpt2m1Mcwi |
serum chloride level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood chloride amount |
male |
70 days-84 days |
6 |
|
|
102.83 |
mmol/l |
0.48 |
1.17 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62274 |
527 |
FHH-Adipoqm1Mcwi |
serum chloride level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood chloride amount |
female |
70 days-84 days |
9 |
|
|
104.22 |
mmol/l |
1.76 |
5.29 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62284 |
527 |
SS/JrHsdMcwi |
serum chloride level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood chloride amount |
female |
70 days-84 days |
17 |
|
|
103.06 |
mmol/l |
0.78 |
3.23 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62281 |
527 |
F344-Elmod3Tn(sb-T2/Bart3)2.42Mcwi |
serum chloride level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood chloride amount |
male |
70 days-84 days |
5 |
|
|
95.8 |
mmol/l |
1.74 |
3.9 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62290 |
527 |
F344-Trpc4Tn(sb-T2/Bart3)2.192Mcwi |
serum chloride level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood chloride amount |
female |
70 days-84 days |
2 |
|
|
99.5 |
mmol/l |
1.5 |
2.12 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62294 |
527 |
F344-Elmod3Tn(sb-T2/Bart3)2.42Mcwi |
serum chloride level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood chloride amount |
female |
70 days-84 days |
3 |
|
|
103.67 |
mmol/l |
0.67 |
1.15 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62297 |
527 |
FHH-Nr4a1m1Mcwi |
serum chloride level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood chloride amount |
male |
70 days-84 days |
11 |
|
|
105.0 |
mmol/l |
0.62 |
2.05 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62313 |
527 |
FHH-Htr1am1Mcwi |
serum chloride level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood chloride amount |
male |
70 days-84 days |
21 |
|
|
104.76 |
mmol/l |
0.81 |
3.73 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62316 |
527 |
F344-Fam19a2Tn(sb-T2/Bart3)2.184Mcwi |
serum chloride level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood chloride amount |
female |
70 days-84 days |
2 |
|
|
99.0 |
mmol/l |
0.0 |
0.0 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62330 |
527 |
FHH/EurMcwi |
serum chloride level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood chloride amount |
male |
70 days-84 days |
158 |
|
|
103.49 |
mmol/l |
0.27 |
3.39 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62338 |
527 |
FHH-Adra1am1Mcwi |
serum chloride level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood chloride amount |
female |
70 days-84 days |
9 |
|
|
104.89 |
mmol/l |
0.54 |
1.62 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62341 |
527 |
FHH-Nr0b2m1Mcwi |
serum total cholesterol level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
70 days-84 days |
6 |
|
|
55.33 |
mg/dl |
3.52 |
8.62 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62355 |
527 |
FHH-Adipoqm2Mcwi |
serum total cholesterol level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
70 days-84 days |
12 |
|
|
52.58 |
mg/dl |
2.18 |
7.55 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62357 |
527 |
F344-Elmod3Tn(sb-T2/Bart3)2.42Mcwi |
serum total cholesterol level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
70 days-84 days |
3 |
|
|
57.67 |
mg/dl |
2.03 |
3.51 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62369 |
527 |
FHH-F10m1Mcwi |
serum total cholesterol level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
70 days-84 days |
11 |
|
|
53.0 |
mg/dl |
2.66 |
8.82 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62377 |
527 |
FHH-Nr4a1m1Mcwi |
serum total cholesterol level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
70 days-84 days |
11 |
|
|
80.55 |
mg/dl |
5.16 |
17.11 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62385 |
527 |
F344-Lims1Tn(sb-T2/Bart3)2.169Mcwi |
serum total cholesterol level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
70 days-84 days |
7 |
|
|
80.71 |
mg/dl |
5.13 |
13.59 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62387 |
527 |
F344-Fam19a2Tn(sb-T2/Bart3)2.184Mcwi |
serum total cholesterol level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
70 days-84 days |
7 |
|
|
67.0 |
mg/dl |
2.28 |
6.03 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62398 |
527 |
F344-Plcb3Tn(sb-T2/Bart3)2.69Mcwi |
serum total cholesterol level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
70 days-84 days |
1 |
|
|
43.0 |
mg/dl |
|
|
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62401 |
527 |
F344-DccTn(sb-T2/Bart3)2.205Mcwi |
serum total cholesterol level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
70 days-84 days |
6 |
|
|
62.33 |
mg/dl |
4.17 |
10.21 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62407 |
527 |
FHH-Egln3m1Mcwi |
serum total cholesterol level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
70 days-84 days |
6 |
|
|
61.17 |
mg/dl |
3.03 |
7.41 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62406 |
527 |
FHH-Adipoqm3Mcwi |
serum total cholesterol level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
70 days-84 days |
5 |
|
|
67.2 |
mg/dl |
4.33 |
9.68 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62409 |
527 |
SS-Klf4m3Mcwi |
serum total bilirubin level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bilirubin amount |
male |
70 days-84 days |
8 |
|
|
0.1 |
mg/dl |
0.0 |
0.0 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62432 |
527 |
FHH-Tgfbr2m2Mcwi |
serum glucose level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood glucose amount |
male |
70 days-84 days |
13 |
|
|
131.46 |
mg/dl |
11.6 |
41.83 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62450 |
527 |
F344-Elmod3Tn(sb-T2/Bart3)2.42Mcwi |
serum glucose level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood glucose amount |
male |
70 days-84 days |
5 |
|
|
253.8 |
mg/dl |
10.75 |
24.04 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62454 |
527 |
FHH-Tgfbr2m2Mcwi |
serum glucose level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood glucose amount |
female |
70 days-84 days |
14 |
|
|
137.43 |
mg/dl |
7.74 |
28.95 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62456 |
527 |
F344-Trpc4Tn(sb-T2/Bart3)2.192Mcwi |
serum glucose level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood glucose amount |
female |
70 days-84 days |
2 |
|
|
157.0 |
mg/dl |
12.0 |
16.97 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62458 |
527 |
F344-Elmod3Tn(sb-T2/Bart3)2.42Mcwi |
serum glucose level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood glucose amount |
female |
70 days-84 days |
3 |
|
|
227.33 |
mg/dl |
30.44 |
52.73 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62461 |
527 |
FHH-Lcatm1Mcwi |
serum glucose level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood glucose amount |
female |
70 days-84 days |
15 |
|
|
146.13 |
mg/dl |
4.61 |
17.86 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62459 |
527 |
FHH-Chr 17BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
10 |
|
|
67.0 |
% |
6.65 |
21.03 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54780 |
522 |
SS-Chr 5BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
11 |
|
|
87.91 |
% |
3.41 |
11.32 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54782 |
522 |
FHH-Chr 13BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
|
72.22 |
% |
6.92 |
20.77 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54802 |
522 |
SS-Chr 11BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
|
82.11 |
% |
5.21 |
15.62 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54812 |
522 |
SS-Chr YBN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
18 |
|
|
50.67 |
% |
2.85 |
12.08 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54817 |
522 |
FHH-Chr 3BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
10 |
|
|
57.4 |
% |
6.81 |
21.55 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54815 |
522 |
SS-Chr 11BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
8 |
|
|
79.75 |
% |
6.46 |
18.27 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54818 |
522 |
SS-Chr 2BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
14 |
|
|
63.07 |
% |
5.21 |
19.51 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54837 |
522 |
BN/NHsdMcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
18 |
|
|
60.83 |
% |
3.75 |
15.89 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54840 |
522 |
SS-Chr 9BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
10 |
|
|
0.09 |
umol/l |
0.03 |
0.11 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54889 |
522 |
FHH-Chr 6BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
9 |
|
|
0.01 |
umol/l |
0.0 |
0.0 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54891 |
522 |
FHH-Chr 6BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
9 |
|
|
0.01 |
umol/l |
0.0 |
0.01 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54887 |
522 |
FHH-Chr 17BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
10 |
|
|
0.02 |
umol/l |
0.01 |
0.03 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54906 |
522 |
SS-Chr 7BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
11 |
|
|
0.01 |
umol/l |
0.0 |
0.0 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54911 |
522 |
FHH-Chr 20BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
10 |
|
|
0.02 |
umol/l |
0.0 |
0.01 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54935 |
522 |
SS-Chr 18BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
19 |
|
|
0.02 |
umol/l |
0.01 |
0.03 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54949 |
522 |
FHH-Chr 9BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
9 |
|
|
0.01 |
umol/l |
0.0 |
0.01 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54962 |
522 |
SS-Chr 2BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
16 |
|
|
0.06 |
umol/l |
0.01 |
0.02 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54963 |
522 |
SS-Chr 12BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
9 |
|
|
0.03 |
umol/l |
0.01 |
0.02 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54965 |
522 |
SS-Chr XBN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
9 |
|
|
0.01 |
umol/l |
0.0 |
0.01 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54968 |
522 |
SS.BN-(D12Arb13-D12Rat79)/Mcwi |
concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
14 |
|
|
0.04 |
10E-7mol/l |
0.0 |
0.01 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56230 |
522 |
SS-Chr 16BN/Mcwi |
concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
|
0.02 |
10E-7mol/l |
0.01 |
0.02 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56231 |
522 |
SS-Chr 9BN/Mcwi |
concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
10 |
|
|
0.04 |
10E-7mol/l |
0.0 |
0.01 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56233 |
522 |
SS-Chr 9BN/Mcwi |
concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
|
0.05 |
10E-7mol/l |
0.0 |
0.01 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56236 |
522 |
FHH-Chr 12BN/Mcwi |
concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
7 |
|
|
0.05 |
10E-7mol/l |
0.01 |
0.04 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56238 |
522 |
GH/OmrMcwi |
concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
5 |
|
|
0.08 |
10E-7mol/l |
0.01 |
0.02 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56245 |
522 |
SS-Chr 18BN/Mcwi |
concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
|
0.11 |
10E-7mol/l |
0.02 |
0.07 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56246 |
522 |
GH/OmrMcwi |
concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
5 |
|
|
0.07 |
10E-7mol/l |
0.01 |
0.02 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56248 |
522 |
BN/NHsdMcwi |
concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
16 |
|
|
0.02 |
10E-7mol/l |
0.0 |
0.02 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56253 |
522 |
SS-Chr 2BN/Mcwi |
concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
10 |
|
|
0.17 |
10E-7mol/l |
0.14 |
0.43 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56255 |
522 |
FHH-Chr 1BN/Mcwi |
concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
19 |
|
|
0.03 |
10E-7mol/l |
0.01 |
0.04 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56254 |
522 |
SS/JrHsdMcwi |
concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
11 |
|
|
0.05 |
10E-7mol/l |
0.01 |
0.03 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
56259 |
522 |
SS-Chr 9BN/Mcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
10 |
|
|
22.6 |
% |
5.26 |
16.65 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56276 |
522 |
SS-Chr 6BN/Mcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
8 |
|
|
36.25 |
% |
5.54 |
15.66 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56275 |
522 |
FHH/EurMcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
9 |
|
|
26.11 |
% |
3.86 |
11.59 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56283 |
522 |
FHH-Chr 1BN/Mcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
16 |
|
|
20.38 |
% |
3.17 |
12.67 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56287 |
522 |
SS-Chr 18BN/Mcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
5 |
|
|
40.0 |
% |
4.73 |
10.58 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56289 |
522 |
SS-Chr 16BN/Mcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
4 |
|
|
21.5 |
% |
1.04 |
2.08 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
56300 |
522 |
SS.BN-(D12Arb13-D12Rat79)/Mcwi |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
14 |
|
|
99.64 |
% |
0.36 |
1.34 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56305 |
522 |
SS-Chr 9BN/Mcwi |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
10 |
|
|
100.0 |
% |
0.0 |
0.0 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56308 |
522 |
SS-Chr YBN/Mcwi |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
20 |
|
|
99.65 |
% |
0.18 |
0.81 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56316 |
522 |
FHH-Chr 1BN/Mcwi |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
18 |
|
|
99.33 |
% |
0.35 |
1.5 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56319 |
522 |
SS.BN-(D8Rat163-D8Rat81)/Mcwi |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
6 |
|
|
99.17 |
% |
0.83 |
2.04 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56324 |
522 |
SS-Chr 2BN/Mcwi |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
10 |
|
|
90.7 |
% |
3.32 |
10.5 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56330 |
522 |
BN-Lcatm3Mcwi |
serum bicarbonate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
70 days-84 days |
1 |
|
|
14.0 |
mmol/l |
|
|
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61645 |
527 |
FHH-Adipoqm3Mcwi |
serum bicarbonate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bicarbonate amount |
female |
70 days-84 days |
6 |
|
|
17.0 |
mmol/l |
1.21 |
2.97 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61650 |
527 |
FHH/EurMcwi |
serum bicarbonate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
70 days-84 days |
155 |
|
|
17.23 |
mmol/l |
0.29 |
3.66 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61652 |
527 |
FHH-Adra1am1Mcwi |
serum bicarbonate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
70 days-84 days |
8 |
|
|
14.75 |
mmol/l |
0.92 |
2.6 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61653 |
527 |
F344-AbatTn(sb-T2/Bart3)2.163Mcwi |
serum bicarbonate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
70 days-84 days |
3 |
|
|
19.67 |
mmol/l |
0.67 |
1.15 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61657 |
527 |
FHH-Lcatm1Mcwi |
blood monocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
monocyte quantity |
female |
70 days-84 days |
15 |
|
|
0.19 |
x 1000 cells/ul |
0.04 |
0.15 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61681 |
527 |
FHH-F10m1Mcwi |
blood monocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
monocyte quantity |
male |
70 days-84 days |
10 |
|
|
0.15 |
x 1000 cells/ul |
0.03 |
0.11 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61706 |
527 |
BN-Lcatm3Mcwi |
blood monocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
monocyte quantity |
male |
70 days-84 days |
1 |
|
|
0.11 |
x 1000 cells/ul |
|
|
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61717 |
527 |
FHH-Adipoqm3Mcwi |
blood monocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
monocyte quantity |
female |
70 days-84 days |
6 |
|
|
0.18 |
x 1000 cells/ul |
0.06 |
0.13 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61722 |
527 |
FHH-Egln3m1Mcwi |
blood monocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
monocyte quantity |
male |
70 days-84 days |
6 |
|
|
0.18 |
x 1000 cells/ul |
0.05 |
0.13 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61720 |
527 |
FHH-Adipoqm3Mcwi |
blood monocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
monocyte quantity |
male |
70 days-84 days |
5 |
|
|
0.16 |
x 1000 cells/ul |
0.02 |
0.05 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61723 |
527 |
FHH-Adra1am1Mcwi |
blood monocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
monocyte quantity |
female |
70 days-84 days |
9 |
|
|
0.1 |
x 1000 cells/ul |
0.03 |
0.1 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61727 |
527 |
F344-Stxbp5lTn(sb-T2/Bart3)2.202Mcwi |
blood monocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
monocyte quantity |
female |
70 days-84 days |
2 |
|
|
0.21 |
x 1000 cells/ul |
0.15 |
0.21 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61730 |
527 |
SS-Klf4m3Mcwi |
serum potassium level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood potassium amount |
female |
70 days-84 days |
7 |
|
|
4.39 |
mmol/l |
0.22 |
0.59 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61755 |
527 |
FHH-Tgfbr2m2Mcwi |
serum sodium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood sodium amount |
male |
70 days-84 days |
12 |
|
|
140.0 |
mmol/l |
0.44 |
1.54 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61774 |
527 |
FHH-Nr0b2m1Mcwi |
serum sodium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood sodium amount |
female |
70 days-84 days |
6 |
|
|
138.33 |
mmol/l |
1.43 |
3.5 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61771 |
527 |
FHH-Agtr1bm1Mcwi |
serum sodium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood sodium amount |
male |
70 days-84 days |
14 |
|
|
141.57 |
mmol/l |
0.59 |
2.21 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61779 |
527 |
FHH-Tgfbr2m2Mcwi |
serum sodium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood sodium amount |
female |
70 days-84 days |
14 |
|
|
138.79 |
mmol/l |
0.59 |
2.23 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61780 |
527 |
F344-Plce1Tn(sb-T2/Bart3)2.146Mcwi |
serum sodium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood sodium amount |
female |
70 days-84 days |
5 |
|
|
140.6 |
mmol/l |
1.63 |
3.65 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61790 |
527 |
F344-Elmod3Tn(sb-T2/Bart3)2.42Mcwi |
serum sodium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood sodium amount |
female |
70 days-84 days |
3 |
|
|
139.33 |
mmol/l |
0.67 |
1.15 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61785 |
527 |
FHH-Procm1Mcwi |
serum sodium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood sodium amount |
female |
70 days-84 days |
8 |
|
|
138.75 |
mmol/l |
0.96 |
2.71 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61795 |
527 |
F344-Brinp3Tn(sb-T2/Bart3)2.189Mcwi |
serum sodium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood sodium amount |
female |
70 days-84 days |
1 |
|
|
144.0 |
mmol/l |
|
|
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61799 |
527 |
F344-Lims1Tn(sb-T2/Bart3)2.169Mcwi |
serum sodium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood sodium amount |
female |
70 days-84 days |
7 |
|
|
141.71 |
mmol/l |
1.48 |
3.9 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61803 |
527 |
FHH-Ghsrm1Mcwi |
serum sodium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood sodium amount |
female |
70 days-84 days |
9 |
|
|
139.78 |
mmol/l |
0.57 |
1.72 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61813 |
527 |
BN-Lcatm3Mcwi |
serum sodium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood sodium amount |
female |
70 days-84 days |
2 |
|
|
143.0 |
mmol/l |
1.0 |
1.41 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61816 |
527 |
F344-Fam19a2Tn(sb-T2/Bart3)2.184Mcwi |
serum sodium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood sodium amount |
female |
70 days-84 days |
2 |
|
|
140.0 |
mmol/l |
1.0 |
1.41 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61818 |
527 |
FHH-Adipoqm3Mcwi |
serum sodium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood sodium amount |
male |
70 days-84 days |
5 |
|
|
135.8 |
mmol/l |
1.93 |
4.32 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61825 |
527 |
FHH-Adra1am1Mcwi |
serum sodium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood sodium amount |
male |
70 days-84 days |
8 |
|
|
141.25 |
mmol/l |
0.77 |
2.19 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61827 |
527 |
SS-Klf4m3Mcwi |
mean corpuscular volume |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte size trait |
female |
70 days-84 days |
7 |
|
|
60.09 |
fl |
0.42 |
1.12 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61847 |
527 |
SS-Klf4m3Mcwi |
mean corpuscular volume |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
70 days-84 days |
8 |
|
|
57.94 |
fl |
0.74 |
2.09 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61848 |
527 |
WKY/NCrl |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
13 |
|
|
19.69 |
% |
2.95 |
10.65 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
54997 |
522 |
Crl:CD(SD) |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
|
42.78 |
% |
4.97 |
14.92 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
55001 |
522 |
Crl:CD(SD) |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
8 |
|
|
34.88 |
% |
6.15 |
17.41 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
54999 |
522 |
SS-Chr 20BN/Mcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
10 |
|
|
16.0 |
% |
5.83 |
18.42 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
55072 |
522 |
SS-Chr 9BN/Mcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
|
25.67 |
% |
5.47 |
16.42 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
55079 |
522 |
SS.BN-(D8Rat163-D8Rat81)/Mcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
7 |
|
|
25.57 |
% |
4.45 |
11.77 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
55094 |
522 |
SS-Chr 16BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
10 |
|
|
37.3 |
% |
5.34 |
16.88 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
55106 |
522 |
F344/DuCrl |
logarithm of the concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
14 |
|
|
-8.38 |
null |
0.09 |
0.32 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
55114 |
522 |
LE/BluGill |
logarithm of the concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
14 |
|
|
-8.48 |
null |
0.06 |
0.24 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
55116 |
522 |
LE/BluGill |
logarithm of the concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
14 |
|
|
-8.28 |
null |
0.06 |
0.24 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
55120 |
522 |
FHH-Chr 14BN/Mcwi |
body weight |
controlled sodium content diet (4 %) (for 21 days) |
PhysGen Vascular data |
body mass |
female |
70 days-84 days |
10 |
|
|
144.4 |
g |
7.2 |
22.7 |
whole body digital scale |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
55162 |
522 |
FHH-Chr 12BN/Mcwi |
body weight |
controlled sodium content diet (4 %) (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70 days-84 days |
17 |
|
|
247.3 |
g |
4.9 |
20.4 |
whole body digital scale |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
55173 |
522 |
SS-Chr 7BN/Mcwi |
body weight |
controlled sodium content diet (4 %) (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70 days-84 days |
8 |
|
|
277.8 |
g |
3.5 |
9.8 |
whole body digital scale |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
55181 |
522 |
SS-Chr 17BN/Mcwi |
body weight |
controlled sodium content diet (4 %) (for 21 days) |
PhysGen Vascular data |
body mass |
female |
70 days-84 days |
10 |
|
|
191.7 |
g |
4.4 |
13.9 |
whole body digital scale |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
55183 |
522 |
FHH-Chr 15BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
9 |
|
|
1.02 |
E-7mole |
0.2 |
0.59 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56493 |
522 |
SS-Chr 6BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
15 |
|
|
2.77 |
E-7mole |
1.53 |
5.92 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56502 |
522 |
FHH-Chr XBN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
10 |
|
|
1.02 |
E-7mole |
0.09 |
0.29 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56526 |
522 |
FHH-Chr 3BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
10 |
|
|
1.83 |
E-7mole |
0.28 |
0.89 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56536 |
522 |
SS-Chr 20BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
10 |
|
|
2.76 |
E-7mole |
0.36 |
1.14 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56550 |
522 |
FHH-Chr 13BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
|
1.56 |
E-7mole |
0.25 |
0.74 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56542 |
522 |
SS-Chr 13BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
9 |
|
|
1.93 |
E-7mole |
0.25 |
0.75 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56554 |
522 |
FHH-Chr 1BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
11 |
|
|
0.84 |
E-7mole |
0.09 |
0.31 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56562 |
522 |
SS-Chr 19BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
|
1.7 |
E-7mole |
0.22 |
0.67 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56574 |
522 |
BN/NHsdMcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
18 |
|
|
3.1 |
E-7mole |
0.51 |
2.18 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56580 |
522 |
SS-Chr 2BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
9 |
|
|
0.56 |
E-7mole |
0.09 |
0.28 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56585 |
522 |
F344-Elmod3Tn(sb-T2/Bart3)2.42Mcwi |
blood lymphocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
70 days-84 days |
3 |
|
|
4.29 |
x 1000 cells/ul |
0.87 |
1.51 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62061 |
527 |
F344-Brinp3Tn(sb-T2/Bart3)2.189Mcwi |
blood lymphocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
70 days-84 days |
3 |
|
|
4.22 |
x 1000 cells/ul |
0.17 |
0.29 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62070 |
527 |
FHH-Adipoqm3Mcwi |
blood lymphocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
70 days-84 days |
6 |
|
|
3.79 |
x 1000 cells/ul |
0.68 |
1.66 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62100 |
527 |
F344-AbatTn(sb-T2/Bart3)2.163Mcwi |
blood lymphocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
70 days-84 days |
4 |
|
|
3.78 |
x 1000 cells/ul |
0.24 |
0.48 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62104 |
527 |
FHH-Tlr4m1Mcwi |
blood lymphocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
70 days-84 days |
9 |
|
|
2.92 |
x 1000 cells/ul |
0.27 |
0.8 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62110 |
527 |
BN/NHsdMcwi |
blood lymphocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
70 days-84 days |
27 |
|
|
5.94 |
x 1000 cells/ul |
0.39 |
2.0 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62116 |
527 |
FHH-Adipoqm2Mcwi |
serum total bilirubin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bilirubin amount |
female |
70 days-84 days |
12 |
|
|
0.17 |
mg/dl |
0.04 |
0.14 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62121 |
527 |
FHH-Lcatm1Mcwi |
serum total bilirubin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bilirubin amount |
male |
70 days-84 days |
13 |
|
|
0.15 |
mg/dl |
0.03 |
0.1 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62124 |
527 |
F344-Trpc4Tn(sb-T2/Bart3)2.192Mcwi |
serum total bilirubin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bilirubin amount |
female |
70 days-84 days |
2 |
|
|
0.2 |
mg/dl |
0.0 |
0.0 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62130 |
527 |
FHH-Nr0b2m1Mcwi |
serum total bilirubin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bilirubin amount |
male |
70 days-84 days |
10 |
|
|
0.1 |
mg/dl |
0.0 |
0.0 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62135 |
527 |
FHH-Procm1Mcwi |
serum total bilirubin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bilirubin amount |
female |
70 days-84 days |
8 |
|
|
0.18 |
mg/dl |
0.03 |
0.07 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62143 |
527 |
F344-Myo9aTn(sb-T2/Bart3)2.186Mcwi |
serum total bilirubin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bilirubin amount |
male |
70 days-84 days |
1 |
|
|
0.1 |
mg/dl |
|
|
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62159 |
527 |
F344-Plcb3Tn(sb-T2/Bart3)2.69Mcwi |
serum total bilirubin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bilirubin amount |
male |
70 days-84 days |
1 |
|
|
0.1 |
mg/dl |
|
|
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62165 |
527 |
FHH-Adipoqm3Mcwi |
serum total bilirubin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bilirubin amount |
female |
70 days-84 days |
6 |
|
|
0.2 |
mg/dl |
0.0 |
0.0 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62172 |
527 |
F344-Stxbp5lTn(sb-T2/Bart3)2.202Mcwi |
serum total bilirubin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bilirubin amount |
female |
70 days-84 days |
2 |
|
|
0.2 |
mg/dl |
0.0 |
0.0 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62180 |
527 |
BN/NHsdMcwi |
serum total bilirubin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bilirubin amount |
female |
70 days-84 days |
27 |
|
|
0.11 |
mg/dl |
0.01 |
0.04 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62188 |
527 |
BN/NHsdMcwi |
serum total bilirubin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bilirubin amount |
male |
70 days-84 days |
44 |
|
|
0.1 |
mg/dl |
0.0 |
0.02 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62187 |
527 |
SS/JrHsdMcwi |
serum alanine aminotransferase activity level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
70 days-84 days |
41 |
|
|
40.71 |
U/l |
1.32 |
8.47 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62193 |
527 |
SS-Sod3m1Mcwi |
serum alanine aminotransferase activity level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
female |
70 days-84 days |
11 |
|
|
40.18 |
U/l |
4.77 |
15.81 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62200 |
527 |
F344-Trpc4Tn(sb-T2/Bart3)2.192Mcwi |
blood eosinophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
70 days-84 days |
1 |
|
|
0.0 |
x 1000 cells/ul |
|
|
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62205 |
527 |
FHH-Tgfbr2m2Mcwi |
blood eosinophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
eosinophil quantity |
female |
70 days-84 days |
14 |
|
|
0.05 |
x 1000 cells/ul |
0.02 |
0.06 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62210 |
527 |
FHH-Lcatm1Mcwi |
blood eosinophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
70 days-84 days |
13 |
|
|
0.04 |
x 1000 cells/ul |
0.02 |
0.07 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62206 |
527 |
FHH-Lcatm1Mcwi |
blood eosinophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
eosinophil quantity |
female |
70 days-84 days |
15 |
|
|
0.02 |
x 1000 cells/ul |
0.01 |
0.04 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62213 |
527 |
FHH-Agtr1bm1Mcwi |
blood eosinophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
eosinophil quantity |
female |
70 days-84 days |
14 |
|
|
0.06 |
x 1000 cells/ul |
0.01 |
0.05 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62216 |
527 |
BN-Tgfbr2m1Mcwi |
blood eosinophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
70 days-84 days |
7 |
|
|
0.11 |
x 1000 cells/ul |
0.04 |
0.12 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62218 |
527 |
FHH-Adipoqm2Mcwi |
blood eosinophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
70 days-84 days |
7 |
|
|
0.04 |
x 1000 cells/ul |
0.02 |
0.06 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62221 |
527 |
FHH-Htr1am1Mcwi |
blood eosinophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
eosinophil quantity |
female |
70 days-84 days |
13 |
|
|
0.06 |
x 1000 cells/ul |
0.02 |
0.06 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62226 |
527 |
F344-Brinp3Tn(sb-T2/Bart3)2.189Mcwi |
blood eosinophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
eosinophil quantity |
female |
70 days-84 days |
1 |
|
|
0.0 |
x 1000 cells/ul |
|
|
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62229 |
527 |
FHH-F10m2Mcwi |
blood eosinophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
eosinophil quantity |
female |
70 days-84 days |
12 |
|
|
0.04 |
x 1000 cells/ul |
0.02 |
0.07 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62237 |
527 |
FHH-Egln3m1Mcwi |
blood eosinophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
70 days-84 days |
6 |
|
|
0.02 |
x 1000 cells/ul |
0.01 |
0.03 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62252 |
527 |
FHH-Slc8a2m1Mcwi |
blood eosinophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
70 days-84 days |
9 |
|
|
0.05 |
x 1000 cells/ul |
0.03 |
0.08 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62263 |
527 |
SS-Cyp1a1em5Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
2 |
|
|
326.5 |
beats/min |
46.5 |
65.76 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43708 |
441 |
SS-Aldh2em2Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
6 |
|
|
364.17 |
beats/min |
7.78 |
19.06 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43736 |
441 |
SS-Ulk3em1Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
3 |
|
|
366.67 |
beats/min |
7.31 |
12.66 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43738 |
441 |
SS-Nppbem4Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
8 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
132.38 |
mmHg |
4.44 |
12.56 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43773 |
441 |
SS-Slc30a8em1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
4 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
137.0 |
mmHg |
2.04 |
4.08 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43776 |
441 |
SS-Wdr72em1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
1 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
112.0 |
mmHg |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43783 |
441 |
SS-Stk39em2Mcwi-/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
1 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
163.0 |
mmHg |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43781 |
441 |
SS-Ulk3em1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
11 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
140.73 |
mmHg |
4.63 |
15.36 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43784 |
441 |
SS-Plcd3em4Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
9 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
135.33 |
mmHg |
5.61 |
16.82 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43789 |
441 |
SS-Agtr1aem5Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
2 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
153.5 |
mmHg |
14.5 |
20.51 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43794 |
441 |
SS-Cyp1a1em5Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
2 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
127.5 |
mmHg |
1.5 |
2.12 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43797 |
441 |
SS-Wdr72em1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
2 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
127.5 |
mmHg |
1.5 |
2.12 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43809 |
441 |
SS-Slc30a8em1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
8 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
134.5 |
mmHg |
3.55 |
10.03 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43815 |
441 |
SS-Plcd3em4Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
2 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
143.5 |
mmHg |
17.5 |
24.75 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43824 |
441 |
SS-Prokr1em2Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
5 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
138.4 |
mmHg |
8.69 |
19.42 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43827 |
441 |
SS-Nppbem4Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
9 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
132.67 |
mmHg |
3.26 |
9.77 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43835 |
441 |
SS-Msraem4Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
4 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
138.5 |
mmHg |
10.46 |
20.92 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43834 |
441 |
SS-Tcf7l2em1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
4 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
137.0 |
mmHg |
6.79 |
13.59 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43842 |
441 |
SS-Cyp1a1em2Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
2 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
131.0 |
mmHg |
14.0 |
19.8 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43848 |
441 |
SS-Mstnem3Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
2 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
144.0 |
mmHg |
6.0 |
8.49 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43844 |
441 |
SS-Agtr1aem5Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
2 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
161.0 |
mmHg |
10.0 |
14.14 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43856 |
441 |
SS-Agtr1aem1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
9 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
142.67 |
mmHg |
4.37 |
13.11 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43878 |
441 |
SS-Kcnq1em14Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
1 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
168.0 |
mmHg |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43885 |
441 |
SS-Prokr1em1Mcwi+/+ |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
1 |
|
|
340.0 |
g |
|
|
whole body digital scale |
|
|
|
0 |
|
|
|
- |
43888 |
441 |
SS-Agtrapem8Mcwi-/- |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
10 |
|
|
327.4 |
g |
3.9 |
12.3 |
whole body digital scale |
|
|
|
0 |
|
|
|
- |
43899 |
441 |
SS-Nppbem2Mcwi+/+ |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
4 |
|
|
328.0 |
g |
8.6 |
17.3 |
whole body digital scale |
|
|
|
0 |
|
|
|
- |
43896 |
441 |
LEW/Crl |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (0 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
|
57.67 |
% |
4.67 |
14.0 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
56704 |
522 |
WKY/NCrl |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (0 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
10 |
|
|
71.9 |
% |
3.29 |
10.42 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
56710 |
522 |
FHH/EurMcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
10 |
|
|
46.3 |
% |
5.64 |
17.84 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
56721 |
522 |
LE/BluGill |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
15 |
|
|
-8.67 |
null |
0.04 |
0.17 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
56739 |
522 |
Crl:CD(SD) |
concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
10 |
|
|
0.05 |
10E-7mol/l |
0.01 |
0.02 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
56764 |
522 |
Crl:CD(SD) |
concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
|
0.03 |
10E-7mol/l |
0.0 |
0.01 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
56766 |
522 |
LE/BluGill |
concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
14 |
|
|
0.08 |
10E-7mol/l |
0.02 |
0.08 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
56771 |
522 |
Crl:CD(SD) |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
8 |
|
|
43.25 |
% |
7.16 |
20.26 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
56827 |
522 |
LEW/Crl |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
14 |
|
|
39.36 |
% |
4.67 |
17.46 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
56831 |
522 |
LE/BluGill |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
14 |
|
|
37.29 |
% |
4.05 |
15.17 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
56834 |
522 |
FHH-Nr0b2m1Mcwi |
serum urea nitrogen level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
female |
70 days-84 days |
6 |
|
|
17.5 |
mg/dl |
0.89 |
2.17 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60141 |
527 |
FHH-Agtr1bm1Mcwi |
serum urea nitrogen level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
70 days-84 days |
15 |
|
|
20.47 |
mg/dl |
0.71 |
2.75 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60149 |
527 |
F344-Plce1Tn(sb-T2/Bart3)2.146Mcwi |
serum urea nitrogen level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
70 days-84 days |
6 |
|
|
21.0 |
mg/dl |
2.25 |
5.51 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60151 |
527 |
F344-Plce1Tn(sb-T2/Bart3)2.146Mcwi |
serum urea nitrogen level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
female |
70 days-84 days |
5 |
|
|
21.2 |
mg/dl |
1.56 |
3.49 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60160 |
527 |
F344-Lims1Tn(sb-T2/Bart3)2.169Mcwi |
serum urea nitrogen level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
female |
70 days-84 days |
7 |
|
|
19.14 |
mg/dl |
0.88 |
2.34 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60173 |
527 |
F344-Plce1Tn(sb-T2/Bart3)2.146Mcwi |
serum alanine aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
70 days-84 days |
6 |
|
|
143.5 |
U/l |
68.21 |
167.09 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61443 |
527 |
FHH-Nr0b2m1Mcwi |
serum alanine aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
70 days-84 days |
10 |
|
|
56.8 |
U/l |
4.88 |
15.43 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61449 |
527 |
F344-Plce1Tn(sb-T2/Bart3)2.146Mcwi |
serum alanine aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
female |
70 days-84 days |
5 |
|
|
40.0 |
U/l |
3.27 |
7.31 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61452 |
527 |
FHH-Htr1am1Mcwi |
serum alanine aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
female |
70 days-84 days |
13 |
|
|
39.54 |
U/l |
6.27 |
22.59 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61458 |
527 |
F344-Brinp3Tn(sb-T2/Bart3)2.189Mcwi |
serum alanine aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
female |
70 days-84 days |
1 |
|
|
36.0 |
U/l |
|
|
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61461 |
527 |
F344-Myo9aTn(sb-T2/Bart3)2.186Mcwi |
serum alanine aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
70 days-84 days |
1 |
|
|
63.0 |
U/l |
|
|
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61473 |
527 |
F344-Fam19a2Tn(sb-T2/Bart3)2.184Mcwi |
serum alanine aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
female |
70 days-84 days |
2 |
|
|
39.5 |
U/l |
4.5 |
6.36 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61480 |
527 |
SS-Cpt2m1Mcwi |
red blood cell count |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
70 days-84 days |
6 |
|
|
8.69 |
x 10E6 cells/ul |
0.18 |
0.44 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61506 |
527 |
SS-Klf4m3Mcwi |
red blood cell count |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
70 days-84 days |
7 |
|
|
7.81 |
x 10E6 cells/ul |
0.18 |
0.48 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61509 |
527 |
SS/JrHsdMcwi |
red blood cell count |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
70 days-84 days |
17 |
|
|
7.87 |
x 10E6 cells/ul |
0.11 |
0.46 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61513 |
527 |
SS-Cpt2m1Mcwi |
plasma creatinine level |
controlled sodium content diet (1 %) (for 14 days) then fasting (between 16 and 1 hours) |
PhysGen Biochemistry data |
blood creatinine amount |
male |
70 days-84 days |
6 |
|
|
0.62 |
mg/dl |
0.11 |
0.26 |
automated plasma creatinine analysis |
|
|
|
0 |
|
|
|
|
61516 |
527 |
SS-Sod3m1Mcwi |
plasma creatinine level |
controlled sodium content diet (1 %) (for 14 days) then fasting (between 16 and 1 hours) |
PhysGen Biochemistry data |
blood creatinine amount |
female |
70 days-84 days |
11 |
|
|
0.4 |
mg/dl |
0.04 |
0.12 |
automated plasma creatinine analysis |
|
|
|
0 |
|
|
|
|
61524 |
527 |
SS-Cpt2m1Mcwi |
plasma creatinine level |
controlled sodium content diet (1 %) (for 14 days) then fasting (between 16 and 1 hours) |
PhysGen Biochemistry data |
blood creatinine amount |
female |
70 days-84 days |
1 |
|
|
0.8 |
mg/dl |
|
|
automated plasma creatinine analysis |
|
|
|
0 |
|
|
|
|
61521 |
527 |
FHH-Nr0b2m1Mcwi |
serum phosphate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
70 days-84 days |
10 |
|
|
7.85 |
mg/dl |
0.27 |
0.86 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61541 |
527 |
FHH-Ccr2m1Mcwi |
serum phosphate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
70 days-84 days |
4 |
|
|
6.65 |
mg/dl |
0.2 |
0.4 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61546 |
527 |
FHH-Htr1am1Mcwi |
serum phosphate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
70 days-84 days |
13 |
|
|
7.82 |
mg/dl |
0.32 |
1.16 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61550 |
527 |
FHH-F10m2Mcwi |
serum phosphate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
70 days-84 days |
16 |
|
|
9.38 |
mg/dl |
0.79 |
3.15 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61552 |
527 |
FHH-Htr1am1Mcwi |
serum phosphate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
70 days-84 days |
19 |
|
|
7.72 |
mg/dl |
0.14 |
0.6 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61558 |
527 |
F344-Myo9aTn(sb-T2/Bart3)2.186Mcwi |
serum phosphate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
70 days-84 days |
1 |
|
|
6.2 |
mg/dl |
|
|
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61565 |
527 |
F344-Myo9aTn(sb-T2/Bart3)2.186Mcwi |
serum phosphate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
70 days-84 days |
4 |
|
|
8.53 |
mg/dl |
1.18 |
2.35 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61566 |
527 |
FHH-Tlr4m1Mcwi |
serum phosphate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
70 days-84 days |
5 |
|
|
8.04 |
mg/dl |
0.37 |
0.83 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61584 |
527 |
F344-Elmod3Tn(sb-T2/Bart3)2.42Mcwi |
serum bicarbonate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
70 days-84 days |
5 |
|
|
23.8 |
mmol/l |
0.37 |
0.84 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61604 |
527 |
FHH-Adipoqm1Mcwi |
serum bicarbonate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
70 days-84 days |
8 |
|
|
15.63 |
mmol/l |
1.19 |
3.38 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61615 |
527 |
F344-Plce1Tn(sb-T2/Bart3)2.146Mcwi |
serum bicarbonate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bicarbonate amount |
female |
70 days-84 days |
5 |
|
|
21.4 |
mmol/l |
0.68 |
1.52 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61616 |
527 |
F344/NHsd |
serum bicarbonate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
70 days-84 days |
7 |
|
|
20.43 |
mmol/l |
0.75 |
1.99 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61623 |
527 |
FHH-Nr4a1m1Mcwi |
serum bicarbonate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
70 days-84 days |
11 |
|
|
16.36 |
mmol/l |
0.65 |
2.16 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61627 |
527 |
FHH-F10m1Mcwi |
serum bicarbonate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
70 days-84 days |
10 |
|
|
17.3 |
mmol/l |
1.02 |
3.23 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61634 |
527 |
F344-Plcb3Tn(sb-T2/Bart3)2.69Mcwi |
serum bicarbonate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
70 days-84 days |
1 |
|
|
23.0 |
mmol/l |
|
|
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61643 |
527 |
SS-Plcd3em4Mcwi-/- |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
13 |
|
|
310.8 |
g |
5.1 |
18.4 |
whole body digital scale |
|
|
|
0 |
|
|
|
- |
43914 |
441 |
SS-Plcd3em7Mcwi-/- |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
11 |
|
|
291.4 |
g |
3.7 |
12.3 |
whole body digital scale |
|
|
|
0 |
|
|
|
- |
43926 |
441 |
SS-Sh2b3em2Mcwi-/- |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
9 |
|
|
303.9 |
g |
4.5 |
13.4 |
whole body digital scale |
|
|
|
0 |
|
|
|
- |
43930 |
441 |
SS-Plod1em1Mcwi+/+ |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
5 |
|
|
307.2 |
g |
14.7 |
32.9 |
whole body digital scale |
|
|
|
0 |
|
|
|
- |
43933 |
441 |
SS-Aldh2em2Mcwi-/- |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
6 |
|
|
92.17 |
mg/d |
9.55 |
23.4 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
43984 |
441 |
SS-Cyp1a1em1Mcwi-/- |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
7 |
|
|
72.43 |
mg/d |
9.46 |
25.04 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
43992 |
441 |
SS-Agtr1aem1Mcwi-/- |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
9 |
|
|
110.26 |
mg/d |
23.02 |
69.07 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44002 |
441 |
SS-Tcf7l2em1Mcwi-/- |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
10 |
|
|
145.98 |
mg/d |
12.98 |
41.04 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44003 |
441 |
SS-Nppaem4Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
10 |
|
|
343.31 |
beats/min |
5.47 |
17.3 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44011 |
441 |
SS-Plcd3em4Mcwi+/+ |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
3 |
|
|
145.77 |
mg/d |
15.03 |
26.03 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44010 |
441 |
SS-Prokr1em2Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
5 |
|
|
359.0 |
beats/min |
7.2 |
16.11 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44013 |
441 |
SS-Stk39em2Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
3 |
|
|
363.0 |
beats/min |
2.89 |
5.0 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44014 |
441 |
SS-Cyp1a1em5Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
2 |
|
|
352.0 |
beats/min |
12.0 |
16.97 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44018 |
441 |
SS-Cdh13em1Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
4 |
|
|
348.0 |
beats/min |
19.15 |
38.3 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44023 |
441 |
SS-Ulk3em1Mcwi-/+ |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
3 |
|
|
350.33 |
beats/min |
7.31 |
12.66 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44026 |
441 |
SS-Agtr1aem5Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
2 |
|
|
376.5 |
beats/min |
12.5 |
17.68 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44042 |
441 |
SS-Prokr1em1Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
4 |
|
|
317.0 |
beats/min |
24.82 |
49.65 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44044 |
441 |
SS-Msraem3Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
2 |
|
|
374.0 |
beats/min |
14.0 |
19.8 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44069 |
441 |
SS-Agtr1aem1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
6 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
134.5 |
mmHg |
6.66 |
16.32 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44074 |
441 |
SS-Plekha7em1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
6 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
137.17 |
mmHg |
4.8 |
11.75 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44079 |
441 |
SS-Agtrapem8Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
8 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
122.68 |
mmHg |
3.35 |
9.48 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44084 |
441 |
SS-Plekha7em4Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
11 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
143.36 |
mmHg |
3.15 |
10.45 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44100 |
441 |
SS-Mstnem3Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
7 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
132.14 |
mmHg |
5.47 |
14.47 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44109 |
441 |
SS-Plekha7em1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
9 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
146.78 |
mmHg |
5.63 |
16.9 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44103 |
441 |
SS-Plod1em1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
4 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
145.75 |
mmHg |
6.05 |
12.09 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44117 |
441 |
SS-Agtr1aem1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
9 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
134.67 |
mmHg |
4.68 |
14.03 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44125 |
441 |
WKY/NCrl |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
14 |
|
|
99.29 |
% |
0.27 |
0.99 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
56851 |
522 |
F344/DuCrl |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
14 |
|
|
99.71 |
% |
0.29 |
1.07 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
56854 |
522 |
LE/BluGill |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
14 |
|
|
100.0 |
% |
0.0 |
0.0 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
56856 |
522 |
LEW/Crl |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
25 |
|
|
1.65 |
g/mg |
0.08 |
0.42 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
56862 |
522 |
F344/DuCrl |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
11 |
|
|
99.91 |
% |
0.09 |
0.3 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
56859 |
522 |
Crl:CD(SD) |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
10 |
|
|
1.47 |
g/mg |
0.1 |
0.31 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
56865 |
522 |
SS/JrHsdMcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
15 |
|
|
0.19 |
umol/l |
0.07 |
0.28 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
56883 |
522 |
Hsd:SD |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
13 |
|
|
48.4 |
% |
6.98 |
25.18 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
56887 |
522 |
SS-Chr 9BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
10 |
|
|
-6.88 |
null |
0.09 |
0.29 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56898 |
522 |
SS-Chr 9BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
|
-6.54 |
null |
0.09 |
0.26 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56903 |
522 |
FHH-Chr 12BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
16 |
|
|
-6.99 |
null |
0.11 |
0.44 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56905 |
522 |
SS-Chr 10BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
7 |
|
|
-6.41 |
null |
0.07 |
0.18 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56906 |
522 |
FHH-Chr 10BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
9 |
|
|
-6.8 |
null |
0.07 |
0.21 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56923 |
522 |
SS-Chr 16BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
14 |
|
|
-6.8 |
null |
0.22 |
0.82 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56930 |
522 |
SS-Chr 15BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
8 |
|
|
-6.72 |
null |
0.1 |
0.28 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56932 |
522 |
SS-Chr YBN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
18 |
|
|
-6.98 |
null |
0.04 |
0.19 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56952 |
522 |
SS-Chr 19BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
5 |
|
|
-6.72 |
null |
0.03 |
0.07 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56965 |
522 |
FHH-Chr 7BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
10 |
|
|
-6.96 |
null |
0.07 |
0.22 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56970 |
522 |
SS-Chr 16BN/Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
10 |
|
|
1.17 |
g/mg |
0.15 |
0.47 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
56989 |
522 |
GH/OmrMcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
10 |
|
|
1.0 |
g/mg |
0.08 |
0.26 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
56993 |
522 |
FHH-Slc8a2m1Mcwi |
serum urea nitrogen level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
70 days-84 days |
10 |
|
|
22.4 |
mg/dl |
0.62 |
1.96 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60203 |
527 |
BN/NHsdMcwi |
serum urea nitrogen level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
70 days-84 days |
44 |
|
|
25.52 |
mg/dl |
0.63 |
4.17 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60209 |
527 |
BN/NHsdMcwi |
serum urea nitrogen level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
female |
70 days-84 days |
27 |
|
|
24.59 |
mg/dl |
0.82 |
4.27 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60210 |
527 |
F344-Trpc4Tn(sb-T2/Bart3)2.192Mcwi |
serum calcium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood calcium amount |
male |
70 days-84 days |
1 |
|
|
9.8 |
mg/dl |
|
|
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60217 |
527 |
F344-Elmod3Tn(sb-T2/Bart3)2.42Mcwi |
serum calcium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood calcium amount |
male |
70 days-84 days |
5 |
|
|
10.26 |
mg/dl |
0.15 |
0.34 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60220 |
527 |
F344-Plce1Tn(sb-T2/Bart3)2.146Mcwi |
serum calcium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood calcium amount |
male |
70 days-84 days |
6 |
|
|
10.63 |
mg/dl |
0.08 |
0.19 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60223 |
527 |
F344-Trpc4Tn(sb-T2/Bart3)2.192Mcwi |
serum calcium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood calcium amount |
female |
70 days-84 days |
2 |
|
|
9.9 |
mg/dl |
0.1 |
0.14 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60224 |
527 |
F344/NHsd |
serum calcium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood calcium amount |
male |
70 days-84 days |
7 |
|
|
9.64 |
mg/dl |
0.12 |
0.3 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60239 |
527 |
FHH-Ccr2m1Mcwi |
serum calcium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood calcium amount |
male |
70 days-84 days |
8 |
|
|
9.94 |
mg/dl |
0.13 |
0.36 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60242 |
527 |
FHH-Nr4a1m1Mcwi |
serum calcium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood calcium amount |
female |
70 days-84 days |
11 |
|
|
9.95 |
mg/dl |
0.14 |
0.46 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60251 |
527 |
F344-Myo9aTn(sb-T2/Bart3)2.186Mcwi |
serum calcium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood calcium amount |
male |
70 days-84 days |
1 |
|
|
8.7 |
mg/dl |
|
|
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60253 |
527 |
F344-DccTn(sb-T2/Bart3)2.205Mcwi |
serum calcium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood calcium amount |
female |
70 days-84 days |
4 |
|
|
10.03 |
mg/dl |
0.51 |
1.01 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60252 |
527 |
F344-Fam19a2Tn(sb-T2/Bart3)2.184Mcwi |
serum calcium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood calcium amount |
male |
70 days-84 days |
7 |
|
|
10.4 |
mg/dl |
0.22 |
0.58 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60256 |
527 |
F344-Fam19a2Tn(sb-T2/Bart3)2.184Mcwi |
serum calcium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood calcium amount |
female |
70 days-84 days |
2 |
|
|
10.3 |
mg/dl |
0.2 |
0.28 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60260 |
527 |
FHH-Ghsrm1Mcwi |
serum calcium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood calcium amount |
male |
70 days-84 days |
15 |
|
|
9.82 |
mg/dl |
0.13 |
0.48 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60263 |
527 |
FHH-Adipoqm3Mcwi |
serum calcium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood calcium amount |
female |
70 days-84 days |
6 |
|
|
9.95 |
mg/dl |
0.14 |
0.34 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60266 |
527 |
FHH-Adra1am1Mcwi |
serum calcium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood calcium amount |
male |
70 days-84 days |
8 |
|
|
9.8 |
mg/dl |
0.21 |
0.6 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60269 |
527 |
F344-Nrg1Tn(sb-T2/Bart3)2.183Mcwi |
serum calcium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood calcium amount |
male |
70 days-84 days |
5 |
|
|
10.66 |
mg/dl |
0.16 |
0.36 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60283 |
527 |
FHH-Htr1am1Mcwi |
blood hemoglobin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
13 |
|
|
13.52 |
g/dl |
0.18 |
0.64 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60320 |
527 |
F344-Brinp3Tn(sb-T2/Bart3)2.189Mcwi |
blood hemoglobin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
70 days-84 days |
3 |
|
|
13.7 |
g/dl |
0.46 |
0.79 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60318 |
527 |
F344-Lims1Tn(sb-T2/Bart3)2.169Mcwi |
blood hemoglobin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
7 |
|
|
14.64 |
g/dl |
0.33 |
0.88 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60327 |
527 |
FHH-Procm1Mcwi |
blood hemoglobin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
70 days-84 days |
9 |
|
|
15.79 |
g/dl |
1.01 |
3.03 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60326 |
527 |
F344-DccTn(sb-T2/Bart3)2.205Mcwi |
blood hemoglobin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
4 |
|
|
14.78 |
g/dl |
0.24 |
0.48 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60334 |
527 |
F344-Fam19a2Tn(sb-T2/Bart3)2.184Mcwi |
blood hemoglobin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
70 days-84 days |
7 |
|
|
15.43 |
g/dl |
0.14 |
0.38 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60338 |
527 |
BN-Lcatm3Mcwi |
blood hemoglobin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
2 |
|
|
14.6 |
g/dl |
0.1 |
0.14 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60340 |
527 |
FHH-Tlr4m1Mcwi |
blood hemoglobin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
70 days-84 days |
7 |
|
|
16.21 |
g/dl |
0.84 |
2.23 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60354 |
527 |
FHH-Adra1am1Mcwi |
blood hemoglobin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
70 days-84 days |
8 |
|
|
14.59 |
g/dl |
0.27 |
0.78 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60351 |
527 |
FHH-Egln3m1Mcwi |
blood hemoglobin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
14 |
|
|
13.56 |
g/dl |
0.18 |
0.66 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60360 |
527 |
SS-Cpt2m1Mcwi |
mean corpuscular hemoglobin |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
1 |
|
|
18.7 |
pg |
|
|
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60373 |
527 |
SS/JrHsdMcwi |
mean corpuscular hemoglobin |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
17 |
|
|
19.45 |
pg |
0.1 |
0.41 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60375 |
527 |
FHH-Lcatm1Mcwi |
serum alkaline phosphatase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
male |
70 days-84 days |
13 |
|
|
264.23 |
U/l |
10.78 |
38.85 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60392 |
527 |
SS/JrHsdMcwi |
serum globulin level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood globulin amount |
male |
70 days-84 days |
41 |
|
|
2.14 |
g/dl |
0.03 |
0.22 |
standard blood chemistry panel |
|
|
|
0 |
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
61865 |
527 |
SS-Klf4m3Mcwi |
serum globulin level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood globulin amount |
male |
70 days-84 days |
8 |
|
|
2.26 |
g/dl |
0.07 |
0.18 |
standard blood chemistry panel |
|
|
|
0 |
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
61868 |
527 |
SS-Sod3m1Mcwi |
serum globulin level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood globulin amount |
female |
70 days-84 days |
11 |
|
|
1.91 |
g/dl |
0.06 |
0.2 |
standard blood chemistry panel |
|
|
|
0 |
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
61872 |
527 |
SS-Klf4m3Mcwi |
blood hemoglobin level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
70 days-84 days |
8 |
|
|
14.98 |
g/dl |
0.28 |
0.78 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61878 |
527 |
SS-Klf4m3Mcwi |
blood hemoglobin level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
7 |
|
|
14.91 |
g/dl |
0.35 |
0.92 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61877 |
527 |
SS/JrHsdMcwi |
blood hemoglobin level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
17 |
|
|
15.31 |
g/dl |
0.22 |
0.89 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61881 |
527 |
SS/JrHsdMcwi |
plasma anion gap |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
ion homeostasis trait |
female |
70 days-84 days |
17 |
|
|
24.94 |
mmol/l |
0.54 |
2.22 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61891 |
527 |
F344-Trpc4Tn(sb-T2/Bart3)2.192Mcwi |
serum albumin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood albumin amount |
male |
70 days-84 days |
1 |
|
|
4.1 |
g/dl |
|
|
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61897 |
527 |
BN-Tgfbr2m1Mcwi |
serum albumin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood albumin amount |
female |
70 days-84 days |
3 |
|
|
3.57 |
g/dl |
0.2 |
0.35 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61899 |
527 |
F344-Trpc4Tn(sb-T2/Bart3)2.192Mcwi |
serum albumin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood albumin amount |
female |
70 days-84 days |
2 |
|
|
3.75 |
g/dl |
0.05 |
0.07 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61904 |
527 |
FHH-Slc8a2m1Mcwi |
serum albumin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood albumin amount |
female |
70 days-84 days |
12 |
|
|
3.81 |
g/dl |
0.03 |
0.09 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61906 |
527 |
FHH-Ccr2m1Mcwi |
serum albumin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood albumin amount |
female |
70 days-84 days |
5 |
|
|
3.7 |
g/dl |
0.03 |
0.07 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61914 |
527 |
FHH-Ccr2m1Mcwi |
serum albumin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood albumin amount |
male |
70 days-84 days |
8 |
|
|
3.81 |
g/dl |
0.04 |
0.11 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61922 |
527 |
F344-Fam19a2Tn(sb-T2/Bart3)2.184Mcwi |
serum albumin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood albumin amount |
male |
70 days-84 days |
7 |
|
|
3.89 |
g/dl |
0.05 |
0.12 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61936 |
527 |
FHH-Adra1am1Mcwi |
serum albumin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood albumin amount |
male |
70 days-84 days |
8 |
|
|
3.76 |
g/dl |
0.05 |
0.15 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61949 |
527 |
F344-Inpp4bTn(sb-T2/Bart3)2.143Mcwi |
serum albumin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood albumin amount |
male |
70 days-84 days |
7 |
|
|
3.9 |
g/dl |
0.09 |
0.24 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61959 |
527 |
FHH-Lcatm1Mcwi |
serum aspartate aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
70 days-84 days |
13 |
|
|
213.62 |
U/l |
31.65 |
114.12 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61970 |
527 |
FHH-Adipoqm1Mcwi |
serum aspartate aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
70 days-84 days |
9 |
|
|
224.44 |
U/l |
23.7 |
71.09 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61966 |
527 |
BN-Tgfbr2m1Mcwi |
serum aspartate aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
70 days-84 days |
3 |
|
|
166.33 |
U/l |
18.66 |
32.32 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61971 |
527 |
FHH-Tgfbr2m2Mcwi |
serum aspartate aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
70 days-84 days |
14 |
|
|
207.64 |
U/l |
12.63 |
47.24 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61974 |
527 |
FHH-Slc8a2m1Mcwi |
serum aspartate aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
70 days-84 days |
12 |
|
|
185.58 |
U/l |
18.35 |
63.58 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61978 |
527 |
FHH-Htr1am1Mcwi |
serum aspartate aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
70 days-84 days |
13 |
|
|
184.54 |
U/l |
17.67 |
63.71 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61990 |
527 |
F344-Lims1Tn(sb-T2/Bart3)2.169Mcwi |
serum aspartate aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
70 days-84 days |
7 |
|
|
232.29 |
U/l |
21.33 |
56.43 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61997 |
527 |
F344-Myo9aTn(sb-T2/Bart3)2.186Mcwi |
serum aspartate aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
70 days-84 days |
1 |
|
|
278.0 |
U/l |
|
|
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62005 |
527 |
FHH-Nr4a1m1Mcwi |
serum aspartate aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
70 days-84 days |
11 |
|
|
157.45 |
U/l |
9.95 |
33.02 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62003 |
527 |
FHH/EurMcwi |
serum aspartate aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
70 days-84 days |
25 |
|
|
190.28 |
U/l |
26.43 |
132.17 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62009 |
527 |
FHH/EurMcwi |
serum aspartate aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
70 days-84 days |
158 |
|
|
230.06 |
U/l |
18.8 |
236.33 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62020 |
527 |
FHH-Slc8a2m1Mcwi |
serum aspartate aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
70 days-84 days |
10 |
|
|
240.3 |
U/l |
15.59 |
49.29 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62027 |
527 |
FHH-Egln3m1Mcwi |
serum aspartate aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
70 days-84 days |
14 |
|
|
216.86 |
U/l |
23.35 |
87.37 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62030 |
527 |
FHH-Tlr4m1Mcwi |
serum aspartate aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
70 days-84 days |
9 |
|
|
216.22 |
U/l |
21.38 |
64.14 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62028 |
527 |
F344-Stxbp5lTn(sb-T2/Bart3)2.202Mcwi |
serum aspartate aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
70 days-84 days |
4 |
|
|
190.5 |
U/l |
32.26 |
64.53 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62036 |
527 |
SS-Klf4m3Mcwi |
blood lymphocyte count |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
70 days-84 days |
8 |
|
|
6.87 |
x 1000 cells/ul |
0.78 |
2.2 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62042 |
527 |
FHH-Lcatm1Mcwi |
blood lymphocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
70 days-84 days |
13 |
|
|
3.51 |
x 1000 cells/ul |
0.35 |
1.27 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62052 |
527 |
SS-Plcd3em4Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
3 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
135.33 |
mmHg |
13.32 |
23.07 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44133 |
441 |
SS-Agtr1aem1Mcwi+/+ |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
6 |
|
|
10.49 |
mg/d |
0.59 |
1.44 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44135 |
441 |
SS-Kcnq1em14Mcwi-/- |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
7 |
|
|
7.87 |
mg/d |
0.42 |
1.12 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44139 |
441 |
SS-Nppaem4Mcwi-/- |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
11 |
|
|
10.15 |
mg/d |
0.31 |
1.01 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44134 |
441 |
SS-Cyp1a1em5Mcwi+/+ |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
2 |
|
|
9.3 |
mg/d |
1.15 |
1.62 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44141 |
441 |
SS-Slc30a8em1Mcwi+/+ |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
4 |
|
|
14.02 |
mg/d |
0.87 |
1.73 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44147 |
441 |
SS-Stk39em2Mcwi-/+ |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
1 |
|
|
9.13 |
mg/d |
|
|
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44152 |
441 |
SS-Plekha7em4Mcwi+/+ |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
2 |
|
|
10.11 |
mg/d |
0.61 |
0.86 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44159 |
441 |
SS-Prokr1em2Mcwi-/- |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
8 |
|
|
10.42 |
mg/d |
0.59 |
1.67 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44163 |
441 |
SS-Plekha7em4Mcwi-/- |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
12 |
|
|
10.0 |
mg/d |
0.75 |
2.6 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44161 |
441 |
SS-Plod1em1Mcwi-/- |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
12 |
|
|
9.0 |
mg/d |
0.42 |
1.45 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44162 |
441 |
SS-Cyp1a1em5Mcwi-/- |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
2 |
|
|
9.62 |
mg/d |
0.34 |
0.47 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44168 |
441 |
SS-Plcd3em7Mcwi+/+ |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
3 |
|
|
9.91 |
mg/d |
0.94 |
1.63 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44174 |
441 |
SS-Plcd3em7Mcwi-/- |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
10 |
|
|
9.4 |
mg/d |
0.63 |
2.0 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44172 |
441 |
SS-Msraem3Mcwi+/+ |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
2 |
|
|
11.16 |
mg/d |
0.97 |
1.37 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44175 |
441 |
SS-Slc30a8em2Mcwi+/+ |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
1 |
|
|
10.77 |
mg/d |
|
|
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44182 |
441 |
SS-Slc30a8em1Mcwi-/- |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
9 |
|
|
11.01 |
mg/d |
0.53 |
1.58 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44186 |
441 |
SS-Nppbem4Mcwi+/+ |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
9 |
|
|
12.05 |
mEq/d |
0.75 |
2.26 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44206 |
441 |
SS-Stk39em2Mcwi-/+ |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
1 |
|
|
9.46 |
mEq/d |
|
|
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44214 |
441 |
SS-Wdr72em1Mcwi-/- |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
1 |
|
|
12.63 |
mEq/d |
|
|
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44216 |
441 |
SS-Plekha7em4Mcwi+/+ |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
2 |
|
|
11.67 |
mEq/d |
1.11 |
1.57 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44221 |
441 |
SS-Mstnem3Mcwi+/+ |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
8 |
|
|
10.54 |
mEq/d |
0.88 |
2.48 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44232 |
441 |
SS-Wdr72em1Mcwi+/+ |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
2 |
|
|
11.21 |
mEq/d |
0.0 |
0.0 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44242 |
441 |
SS-Msraem3Mcwi+/+ |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
2 |
|
|
10.64 |
mEq/d |
1.7 |
2.41 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44237 |
441 |
SS-Tcf7l2em1Mcwi-/+ |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
2 |
|
|
12.34 |
mEq/d |
1.25 |
1.76 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44245 |
441 |
SS-Slc30a8em2Mcwi-/- |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
11 |
|
|
10.43 |
mEq/d |
0.56 |
1.84 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44253 |
441 |
SS-Tcf7l2em1Mcwi-/- |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
10 |
|
|
9.71 |
mEq/d |
0.94 |
2.98 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44250 |
441 |
SS-Nppaem4Mcwi-/- |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
12 |
|
|
25.37 |
mg/d |
2.78 |
9.62 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44258 |
441 |
SS-Mstnem1Mcwi+/+ |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
3 |
|
|
10.27 |
mEq/d |
0.43 |
0.75 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44251 |
441 |
SS-Agtr1aem1Mcwi+/+ |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
6 |
|
|
50.27 |
mg/d |
20.21 |
49.51 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44259 |
441 |
SS-Msraem4Mcwi-/- |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
7 |
|
|
43.19 |
mg/d |
7.88 |
20.85 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44272 |
441 |
SS-Mstnem3Mcwi-/- |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
3 |
|
|
24.79 |
mg/d |
3.02 |
5.23 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44277 |
441 |
SS-Mstnem3Mcwi+/+ |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
8 |
|
|
32.1 |
mg/d |
1.62 |
4.58 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44294 |
441 |
SS-Plcd3em7Mcwi-/- |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
10 |
|
|
59.6 |
mg/d |
8.7 |
27.51 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44296 |
441 |
SS-Slc30a8em2Mcwi+/+ |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
1 |
|
|
11.57 |
mg/d |
|
|
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44306 |
441 |
SS-Nppbem2Mcwi-/- |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
16 |
|
|
58.99 |
mg/d |
9.31 |
37.24 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44309 |
441 |
SS-Nppaem4Mcwi+/+ |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
2 |
|
|
67.01 |
mg/d |
4.01 |
5.68 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44317 |
441 |
SS-Kcnq1em14Mcwi+/+ |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
1 |
|
|
89.9 |
mg/d |
|
|
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44318 |
441 |
SS-Nppbem2Mcwi+/+ |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
4 |
|
|
1.49 |
g |
0.04 |
0.08 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44328 |
441 |
Hsd:SD |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
16 |
|
|
1.37 |
g/mg |
0.23 |
0.92 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
57114 |
522 |
SS-Chr 16BN/Mcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (0 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
10 |
|
|
64.0 |
% |
4.65 |
14.7 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
57137 |
522 |
SS/JrHsdMcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (0 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
40 |
|
|
54.13 |
% |
2.52 |
15.94 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
57149 |
522 |
SS/JrHsdMcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (0 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
5 |
|
|
50.0 |
% |
6.77 |
15.13 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
57153 |
522 |
BN/NHsdMcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (0 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
7 |
|
|
43.77 |
% |
9.19 |
24.32 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
57158 |
522 |
F344-Plce1Tn(sb-T2/Bart3)2.146Mcwi |
serum alkaline phosphatase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
70 days-84 days |
5 |
|
|
106.8 |
U/l |
4.1 |
9.18 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60406 |
527 |
FHH-Adipoqm2Mcwi |
serum alkaline phosphatase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
male |
70 days-84 days |
7 |
|
|
290.43 |
U/l |
19.11 |
50.57 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60407 |
527 |
FHH-F10m1Mcwi |
serum alkaline phosphatase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
male |
70 days-84 days |
10 |
|
|
204.9 |
U/l |
12.09 |
38.22 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60424 |
527 |
FHH/EurMcwi |
serum alkaline phosphatase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
70 days-84 days |
25 |
|
|
143.96 |
U/l |
8.55 |
42.73 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60431 |
527 |
F344-Plcb3Tn(sb-T2/Bart3)2.69Mcwi |
serum alkaline phosphatase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
male |
70 days-84 days |
1 |
|
|
143.0 |
U/l |
|
|
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60433 |
527 |
FHH-Adipoqm3Mcwi |
serum alkaline phosphatase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
male |
70 days-84 days |
5 |
|
|
182.4 |
U/l |
38.74 |
86.62 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60441 |
527 |
FHH-Adra1am1Mcwi |
serum alkaline phosphatase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
70 days-84 days |
9 |
|
|
145.89 |
U/l |
11.53 |
34.58 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60445 |
527 |
FHH-Agtr1bm1Mcwi |
mean corpuscular hemoglobin |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
70 days-84 days |
15 |
|
|
17.45 |
pg |
0.1 |
0.37 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60467 |
527 |
F344-Trpc4Tn(sb-T2/Bart3)2.192Mcwi |
mean corpuscular hemoglobin |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
2 |
|
|
18.0 |
pg |
0.0 |
0.0 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60470 |
527 |
FHH-Nr4a1m1Mcwi |
mean corpuscular hemoglobin |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
70 days-84 days |
11 |
|
|
17.89 |
pg |
0.1 |
0.34 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60489 |
527 |
F344-Plcb3Tn(sb-T2/Bart3)2.69Mcwi |
mean corpuscular hemoglobin |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
70 days-84 days |
1 |
|
|
17.6 |
pg |
|
|
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60505 |
527 |
F344-Plcb3Tn(sb-T2/Bart3)2.69Mcwi |
mean corpuscular hemoglobin |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
3 |
|
|
18.0 |
pg |
0.15 |
0.26 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60508 |
527 |
BN/NHsdMcwi |
mean corpuscular hemoglobin |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
27 |
|
|
17.76 |
pg |
0.07 |
0.39 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60528 |
527 |
SS-Klf4m3Mcwi |
serum total cholesterol level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
70 days-84 days |
8 |
|
|
92.25 |
mg/dl |
9.86 |
27.88 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60536 |
527 |
FHH-Tgfbr2m2Mcwi |
red blood cell count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
70 days-84 days |
13 |
|
|
8.55 |
x 10E6 cells/ul |
0.1 |
0.35 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60544 |
527 |
FHH-F10m2Mcwi |
red blood cell count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
70 days-84 days |
12 |
|
|
7.6 |
x 10E6 cells/ul |
0.15 |
0.51 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60577 |
527 |
FHH-Ghsrm1Mcwi |
red blood cell count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
70 days-84 days |
15 |
|
|
8.62 |
x 10E6 cells/ul |
0.1 |
0.39 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60591 |
527 |
F344-DccTn(sb-T2/Bart3)2.205Mcwi |
red blood cell count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
70 days-84 days |
6 |
|
|
8.62 |
x 10E6 cells/ul |
0.19 |
0.46 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60593 |
527 |
FHH-Adipoqm3Mcwi |
red blood cell count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
70 days-84 days |
6 |
|
|
7.73 |
x 10E6 cells/ul |
0.13 |
0.31 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60594 |
527 |
SS-Cyp1a1em1Mcwi+/+ |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
3 |
|
|
1.46 |
g |
0.06 |
0.11 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44342 |
441 |
SS-Plekha7em4Mcwi-/- |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
12 |
|
|
1.33 |
g |
0.05 |
0.16 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44347 |
441 |
SS-Plekha7em1Mcwi-/- |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
9 |
|
|
1.41 |
g |
0.04 |
0.12 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44350 |
441 |
SS-Prokr1em1Mcwi-/- |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
5 |
|
|
1.46 |
g |
0.04 |
0.08 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44353 |
441 |
SS-Aldh2em2Mcwi+/+ |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
6 |
|
|
1.62 |
g |
0.15 |
0.36 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44359 |
441 |
SS-Aldh2em2Mcwi-/- |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
6 |
|
|
1.42 |
g |
0.04 |
0.1 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44355 |
441 |
SS-Mstnem3Mcwi-/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
1 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
129.0 |
mmHg |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44406 |
441 |
SS-Agtr1aem1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
9 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
131.89 |
mmHg |
4.34 |
13.02 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44434 |
441 |
SS-Msraem3Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
3 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
143.33 |
mmHg |
10.53 |
18.23 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44439 |
441 |
SS-Msraem4Mcwi-/- |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
7 |
|
|
1.43 |
g |
0.05 |
0.14 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44457 |
441 |
SS-Tcf7l2em1Mcwi+/+ |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
5 |
|
|
1.45 |
g |
0.07 |
0.16 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44460 |
441 |
SS-Plekha7em1Mcwi-/- |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
9 |
|
|
1.38 |
g |
0.03 |
0.1 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44473 |
441 |
SS-Cyp1a1em2Mcwi+/+ |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
3 |
|
|
1.55 |
g |
0.07 |
0.11 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44466 |
441 |
SS-Wdr72em1Mcwi+/+ |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
2 |
|
|
1.56 |
g |
0.08 |
0.11 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44489 |
441 |
SS-Nppbem2Mcwi-/- |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
16 |
|
|
1.49 |
g |
0.04 |
0.14 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44494 |
441 |
SS-Mstnem1Mcwi+/+ |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
3 |
|
|
1.67 |
g |
0.06 |
0.11 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44498 |
441 |
SS-Prokr1em2Mcwi+/+ |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
7 |
|
|
1.12 |
g |
0.03 |
0.08 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44507 |
441 |
SS-Cyp1a1em5Mcwi+/+ |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
2 |
|
|
1.1 |
g |
0.05 |
0.07 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44512 |
441 |
SS-Stk39em2Mcwi-/+ |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
1 |
|
|
1.17 |
g |
|
|
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44523 |
441 |
SS-Wdr72em1Mcwi-/- |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
1 |
|
|
1.0 |
g |
|
|
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44525 |
441 |
SS-Ulk3em1Mcwi-/- |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
11 |
|
|
1.09 |
g |
0.02 |
0.07 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44526 |
441 |
SS-Plcd3em4Mcwi-/- |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
13 |
|
|
1.1 |
g |
0.02 |
0.05 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44531 |
441 |
SS-Plod1em1Mcwi-/- |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
12 |
|
|
1.14 |
g |
0.03 |
0.09 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44533 |
441 |
SS-Prokr1em2Mcwi-/- |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
8 |
|
|
1.18 |
g |
0.05 |
0.14 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44534 |
441 |
SS-Plekha7em4Mcwi-/- |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
13 |
|
|
1.04 |
g |
0.03 |
0.12 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44532 |
441 |
SS-Cyp1a1em5Mcwi-/- |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
2 |
|
|
1.09 |
g |
0.04 |
0.06 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44539 |
441 |
SS-Cdh13em1Mcwi-/- |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
8 |
|
|
1.09 |
g |
0.04 |
0.11 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44561 |
441 |
SS-Kcnq1em14Mcwi+/+ |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
1 |
|
|
1.24 |
g |
|
|
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44565 |
441 |
SS-Nppbem4Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
9 |
|
|
352.56 |
beats/min |
9.85 |
29.56 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44577 |
441 |
SS-Mstnem3Mcwi-/+ |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
1 |
|
|
358.0 |
beats/min |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44591 |
441 |
SS-Plcd3em4Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
11 |
|
|
338.73 |
beats/min |
9.57 |
31.74 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44593 |
441 |
SS-Plcd3em7Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
1 |
|
|
358.0 |
beats/min |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44607 |
441 |
SS/JrHsdMcwi |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
7 |
|
|
362.0 |
beats/min |
6.26 |
16.56 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44610 |
441 |
SS-Nppbem2Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
14 |
|
|
354.71 |
beats/min |
6.54 |
24.45 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44617 |
441 |
SS-Slc30a8em1Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
8 |
|
|
355.5 |
beats/min |
12.21 |
34.53 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44618 |
441 |
SS-Mstnem1Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
3 |
|
|
348.0 |
beats/min |
14.73 |
25.51 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44621 |
441 |
SS-Slc30a8em2Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
11 |
|
|
365.55 |
beats/min |
5.98 |
19.84 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44623 |
441 |
SS-Tcf7l2em1Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
9 |
|
|
364.33 |
beats/min |
7.03 |
21.08 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44620 |
441 |
SS-Stk39em2Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
4 |
|
|
390.75 |
beats/min |
5.5 |
11.0 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44631 |
441 |
SS-Plekha7em4Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
11 |
|
|
385.73 |
beats/min |
6.12 |
20.31 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44655 |
441 |
SS-Prokr1em2Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
7 |
|
|
364.29 |
beats/min |
8.64 |
22.86 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44657 |
441 |
SS-Plcd3em7Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
1 |
|
|
347.0 |
beats/min |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44668 |
441 |
SS-Ulk3em1Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
3 |
|
|
372.67 |
beats/min |
5.78 |
10.02 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44665 |
441 |
SS-Agtrapem8Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
2 |
|
|
365.5 |
beats/min |
0.5 |
0.71 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44674 |
441 |
SS-Kcnq1em14Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
1 |
|
|
382.0 |
beats/min |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44687 |
441 |
SS-Plcd3em4Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
3 |
|
|
368.0 |
beats/min |
26.27 |
45.51 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44688 |
441 |
SS/Hsd |
cubic root of body weight to nasoanal length ratio |
controlled sodium content diet (0.3 %) then fasting (for 16 hours) |
Herrera VL, et al., Circ Res 2004 Mar 5; 94(4):446-52 |
body mass |
male |
180 days
| 20 |
|
|
315.4 |
g/mm x 10000 |
1.87 |
8.36 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
67893 |
204 |
SS.LEW-(D10Got112-Igfbp4)/Ayd |
heart left atrium end-systolic diameter |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left atrium diameter |
male |
77 days
| 5 |
|
|
4.66 |
mm |
0.11 |
0.24 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
|
|
|
68304 |
542 |
SS.LEW-(D16Chm36-D16Mit2)/Ayd |
heart left atrium end-systolic diameter |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left atrium diameter |
male |
77 days
| 18 |
|
|
4.65 |
mm |
0.14 |
0.6 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
|
|
|
68302 |
542 |
SS.LEW-(D10Got112-Igfbp4)/Ayd |
heart left atrium end-diastolic diameter |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left atrium diameter |
male |
77 days
| 5 |
|
|
3.13 |
mm |
0.24 |
0.53 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
|
|
|
68312 |
542 |
SS.LEW-(D5Mco39-D5Mco41)(D5Mco42-D5Mco47)/Mco |
systolic blood pressure |
controlled sodium content diet (2 %) (between 24 and 28 days) |
Pillai R, et al., Physiol Genomics. 2013 Aug 15;45(16):729-36. doi: 10.1152/physiolgenomics.00077.2013. Epub 2013 Jun 11. |
arterial blood pressure trait |
male |
62 days-66 days |
0 |
|
|
157.0 |
mmHg |
4.3 |
|
tail cuff plethysmography |
|
0.0 |
|
0 |
|
restrained, 28 degrees C |
|
|
70595 |
1482 |
SR/JrHsd |
systolic blood pressure |
controlled sodium content diet (8 %) (between 83 and 84 days) |
Herrera VL, et al., Physiol Genomics. 2006 Aug 16;26(3):172-9. Epub 2006 May 23. |
arterial blood pressure trait |
female |
167 days-168 days |
5 |
|
|
120.8 |
mmHg |
3.4 |
7.6 |
intra-aortic abdominal radiotelemetry |
|
0.0 |
|
0 |
|
|
|
|
67858 |
810 |
SS.LEW-(D17Chm131-D17Chm93)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (between 10 and 24 days) |
Chauvet C, et al., Hum Mol Genet. 2013 Nov 15;22(22):4451-9. doi: 10.1093/hmg/ddt294. Epub 2013 Jun 28. |
arterial blood pressure trait |
male |
66 days-80 days |
5 |
|
|
129.0 |
mmHg |
8.0 |
17.89 |
intra-aortic abdominal radiotelemetry |
abdominal aorta |
0.0 |
|
0 |
|
|
|
|
70443 |
1438 |
SS.LEW-(D17Chm131-D17Chm93)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (between 10 and 24 days) |
Chauvet C, et al., Hum Mol Genet. 2013 Nov 15;22(22):4451-9. doi: 10.1093/hmg/ddt294. Epub 2013 Jun 28. |
arterial blood pressure trait |
male |
66 days-80 days |
5 |
|
|
137.0 |
mmHg |
2.0 |
4.47 |
intra-aortic abdominal radiotelemetry |
abdominal aorta |
0.0 |
|
0 |
|
|
|
|
70444 |
1438 |
SS.LEW-(D18Chm41-D18Rat92)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (between 10 and 24 days) |
Chauvet C, et al., Hum Mol Genet. 2013 Nov 15;22(22):4451-9. doi: 10.1093/hmg/ddt294. Epub 2013 Jun 28. |
arterial blood pressure trait |
male |
66 days-80 days |
5 |
|
|
124.0 |
mmHg |
4.0 |
8.94 |
intra-aortic abdominal radiotelemetry |
abdominal aorta |
0.0 |
|
0 |
|
|
|
|
70448 |
1438 |
SS.LEW-(Prlr-D2Rat143)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (between 10 and 24 days) |
Chauvet C, et al., Hum Mol Genet. 2013 Nov 15;22(22):4451-9. doi: 10.1093/hmg/ddt294. Epub 2013 Jun 28. |
arterial blood pressure trait |
male |
66 days-80 days |
5 |
|
|
184.0 |
mmHg |
|
|
intra-aortic abdominal radiotelemetry |
abdominal aorta |
0.0 |
|
0 |
|
|
|
|
70474 |
1438 |
SS.MNS-(D2Got93-D2Rat222)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (between 10 and 24 days) |
Chauvet C, et al., Hum Mol Genet. 2013 Nov 15;22(22):4451-9. doi: 10.1093/hmg/ddt294. Epub 2013 Jun 28. |
arterial blood pressure trait |
male |
66 days-80 days |
10 |
|
|
163.0 |
mmHg |
|
|
intra-aortic abdominal radiotelemetry |
abdominal aorta |
0.0 |
|
0 |
|
|
|
|
70476 |
1438 |
SHRSR/Bbb |
systolic blood pressure |
controlled sodium content diet (3.7 mg/g) (for 70 days) and controlled sodium content drinking water (1 %) (for 70 days) and controlled potassium content diet (6.3 mg/g) (for 70 days) |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
arterial blood pressure trait |
not specified |
112 days
| 18 |
|
|
199.0 |
mmHg |
0.24 |
1.0 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
|
69130 |
1126 |
SHRSR/Bbb |
systolic blood pressure |
controlled sodium content diet (3.7 mg/g) (for 84 days) and controlled sodium content drinking water (1 %) (for 84 days) and controlled potassium content diet (6.3 mg/g) (for 84 days) |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
arterial blood pressure trait |
not specified |
126 days
| 18 |
|
|
188.0 |
mmHg |
2.83 |
12.0 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
|
69131 |
1126 |
SS |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (between 10 and 24 days) |
Chauvet C, et al., Hum Mol Genet. 2013 Nov 15;22(22):4451-9. doi: 10.1093/hmg/ddt294. Epub 2013 Jun 28. |
arterial blood pressure trait |
male |
66 days-80 days |
12 |
|
|
178.0 |
mmHg |
4.0 |
13.86 |
intra-aortic abdominal radiotelemetry |
abdominal aorta |
0.0 |
|
0 |
|
|
|
|
70466 |
1438 |
SS/JrSeac |
heart left ventricle end-systolic posterior wall thickness |
controlled sodium content diet (8 %) (for 35 days) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
heart left ventricle wall thickness |
not specified |
77 days
| 5 |
|
|
2.1 |
mm |
0.21 |
0.46 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
|
End-systole posterior wall thickening |
|
68584 |
733 |
SS/JrSeac |
heart left ventricle end-systolic posterior wall thickness |
controlled sodium content diet (0.3 %) (for 84 days) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
heart left ventricle wall thickness |
not specified |
126 days
| 5 |
|
|
1.24 |
mm |
0.16 |
0.36 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
|
End-systole posterior wall thickening |
|
68585 |
733 |
SS/JrSeac |
heart rate |
controlled sodium content diet (0.3 %) (for 35 days) then controlled oxygen content Kreb's solution perfusate |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
heart pumping trait |
not specified |
77 days
| 5 |
|
|
264.0 |
beats/min |
37.12 |
83.0 |
isolated perfused heart method |
|
0.0 |
|
0 |
|
|
|
|
68591 |
733 |
BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then angiotensin II (20 ng/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
20 |
|
serial mean |
118.9 |
mmHg |
4.4 |
19.68 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69529 |
151 |
BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then norepinephrine (0.5 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
21 |
|
serial mean |
120.4 |
mmHg |
5.3 |
24.29 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69535 |
151 |
SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then NG-nitroarginine methyl ester (5 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
9 |
|
serial mean |
159.0 |
mmHg |
7.1 |
21.3 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69546 |
151 |
SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then NG-nitroarginine methyl ester (5 mg/kg) then acetylcholine (0.1 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
9 |
|
serial mean |
160.0 |
mmHg |
6.7 |
20.1 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69548 |
151 |
SS/Jr |
peak aortic velocity |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
aorta blood flow trait |
male |
77 days
| 40 |
|
|
110.5 |
cm/s |
2.59 |
16.4 |
pulsed wave doppler ultrasound |
|
0.0 |
|
0 |
|
|
peak aortic velocity |
|
68242 |
542 |
SS.LEW-(D18Rat29-D18Rat55)/Ayd |
heart left ventricle anterior wall thickness |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle anterior wall thickness |
male |
77 days
| 11 |
|
|
0.18 |
mm |
0.01 |
0.02 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
|
|
|
68251 |
542 |
SS.LEW-(D18Rat29-D18Rat55)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle mass |
male |
77 days
| 11 |
|
|
2.75 |
mg/g |
0.11 |
0.37 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
68259 |
542 |
SS.LEW-(D3Rat52-D3Chm57)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle mass |
male |
77 days
| 8 |
|
|
2.69 |
mg/g |
0.09 |
0.26 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
68264 |
542 |
SS/Jr |
heart left ventricle end-systolic area |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) |
Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4. |
heart left ventricle size trait |
not specified |
0 days
| 6 |
|
|
0.25 |
cm2 |
0.07 |
0.17 |
echocardiography |
|
0.0 |
|
0 |
|
|
|
|
69602 |
749 |
SS/Jr |
age at time of death |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 66 and 68 days) |
Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4. |
total life span |
not specified |
0 days
| 8 |
|
median |
108.0 |
d |
|
|
necropsy |
|
0.0 |
|
0 |
|
visual observation |
|
|
69608 |
749 |
SS/JrHsd |
pulse pressure |
controlled sodium content diet (8 %) (between 24 and 28 days) |
Herrera VL, et al., PLoS One. 2013 Jul 4;8(7):e67673. doi: 10.1371/journal.pone.0067673. Print 2013. |
arterial blood pressure trait |
male |
108 days-112 days |
8 |
|
|
57.1 |
mmHg |
0.4 |
1.13 |
intra-aortic abdominal radiotelemetry |
|
0.0 |
|
0 |
|
|
|
|
70504 |
1458 |
SS.MNS-(D2Rat183-D2Chm113)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (between 10 and 24 days) |
Chauvet C, et al., Hum Mol Genet. 2013 Nov 15;22(22):4451-9. doi: 10.1093/hmg/ddt294. Epub 2013 Jun 28. |
arterial blood pressure trait |
male |
66 days-80 days |
12 |
|
|
136.0 |
mmHg |
|
|
intra-aortic abdominal radiotelemetry |
abdominal aorta |
0.0 |
|
0 |
|
|
|
|
70480 |
1438 |
SS/Jr |
mean arterial blood pressure |
controlled sodium content diet (2 %) (for 21 days) |
Charron S, et al., Hypertension. 2005 Dec;46(6):1300-8. Epub 2005 Nov 14. |
arterial blood pressure trait |
male |
56 days-59 days |
16 |
|
|
177.0 |
mmHg |
|
|
intra-aortic abdominal radiotelemetry |
|
86400.0 |
|
0 |
|
|
|
|
68086 |
830 |
SHRSR/Bbb |
urine total protein excretion rate |
controlled sodium content diet (3.7 mg/g) (for 84 days) and controlled sodium content drinking water (1 %) (for 84 days) and controlled potassium content diet (6.3 mg/g) (for 84 days) |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
total urine protein amount |
not specified |
126 days
| 18 |
|
|
89.0 |
mg/d |
2.12 |
9.0 |
Bradford protein assay |
|
0.0 |
|
0 |
|
|
|
|
69214 |
1126 |
SHRSR/Bbb |
urine total protein excretion rate |
controlled sodium content diet (3.7 mg/g) (for 70 days) and controlled sodium content drinking water (1 %) (for 70 days) and controlled potassium content diet (6.3 mg/g) (for 70 days) |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
total urine protein amount |
not specified |
112 days
| 18 |
|
|
80.0 |
mg/d |
1.06 |
4.5 |
Bradford protein assay |
|
0.0 |
|
0 |
|
|
|
|
69213 |
1126 |
SHRSR.SHRSP-(Klk1-Mt1-ps1)/Bbb |
urine total protein excretion rate |
controlled sodium content diet (3.7 mg/g) (for 70 days) and controlled sodium content drinking water (1 %) (for 70 days) and controlled potassium content diet (6.3 mg/g) (for 70 days) |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
total urine protein amount |
not specified |
112 days
| 29 |
|
|
241.0 |
mg/d |
4.09 |
22.0 |
Bradford protein assay |
|
0.0 |
|
0 |
|
|
|
|
69224 |
1126 |
BN/NHsdMcwi |
timed urine volume |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
urine output |
female |
92 days-94 days |
25 |
|
|
9.86 |
ml/d |
0.4 |
2.0 |
urine volume measurement method |
|
0.0 |
|
0 |
|
|
needs ml/d default |
|
69464 |
151 |
SS/JrHsdMcwi |
urine creatinine excretion rate |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
urine creatinine amount |
female |
92 days-94 days |
16 |
|
|
0.0 |
mg/d |
0.0 |
0.0 |
urine creatinine analysis |
|
0.0 |
|
0 |
|
|
mg/min |
|
69478 |
151 |
BN/NHsdMcwi |
creatinine clearance |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
glomerular filtration trait |
female |
92 days-94 days |
8 |
|
|
1.1 |
ml/min |
0.2 |
0.57 |
urine creatinine analysis |
|
0.0 |
|
0 |
|
|
mg/min |
|
69479 |
151 |
SS/JrHsdMcwi |
hematocrit |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
erythrocyte quantity |
female |
89 days-92 days |
15 |
|
|
38.8 |
% |
1.4 |
5.42 |
hematocrit analysis |
|
0.0 |
|
0 |
|
|
|
|
69482 |
151 |
LEW |
heart left ventricle end-diastolic diameter |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle end-diastolic diameter |
male |
77 days
| 14 |
|
|
7.16 |
mm |
0.25 |
0.93 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
|
heart left ventricle anterior wall thickness |
|
68265 |
542 |
SS.LEW-(D18Chm41-D18Rat92)/Ayd |
heart left ventricle end-diastolic diameter |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle end-diastolic diameter |
male |
77 days
| 8 |
|
|
7.36 |
mm |
0.1 |
0.27 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
|
|
|
68268 |
542 |
SS.LEW-(D16Chm36-D16Mit2)/Ayd |
heart left ventricle end-systolic diameter |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle end-systolic diameter |
male |
77 days
| 18 |
|
|
4.35 |
mm |
0.18 |
0.76 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
|
|
|
68277 |
542 |
BN/NHsdMcwi |
plasma total protein level |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
blood total protein amount |
female |
89 days-92 days |
13 |
|
|
38.6 |
mg/ml |
2.0 |
7.21 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
|
69483 |
151 |
SS/NEisSlc |
plasma aldosterone level |
controlled sodium content diet (8 %) and controlled tempol content drinking water (0.5 mmol/l) |
Kitada K, et al., PLoS One. 2012;7(7):e41896. Epub 2012 Jul 24. |
blood aldosterone amount |
male |
42 days
| 4 |
|
|
157.3 |
pg/ml |
45.2 |
90.4 |
radioimmunoassay |
|
0.0 |
|
0 |
|
|
|
|
69654 |
736 |
SHRSR.SHRSP-(D1Rat134-Mt1-ps1)/Bbb |
urine total protein excretion rate |
controlled sodium content diet (3.7 mg/g) (for 28 days) and controlled sodium content drinking water (1 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days) |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
total urine protein amount |
not specified |
70 days
| 31 |
|
|
60.0 |
mg/d |
2.51 |
14.0 |
Bradford protein assay |
|
0.0 |
|
0 |
|
|
|
|
70251 |
1126 |
SHRSR.SHRSP-(Klk1-D1Mit3)/Bbb |
urine total protein excretion rate |
controlled sodium content diet (3.7 mg/g) (for 56 days) and controlled sodium content drinking water (1 %) (for 56 days) and controlled potassium content diet (6.3 mg/g) (for 56 days) |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
total urine protein amount |
not specified |
98 days
| 31 |
|
|
81.0 |
mg/d |
4.13 |
23.0 |
Bradford protein assay |
|
0.0 |
|
0 |
|
|
|
|
70246 |
1126 |
SHRSP.SHRSR-(Klk1-Mt1-ps1)/Bbb |
urine total protein excretion rate |
controlled sodium content diet (3.7 mg/g) (for 14 days) and controlled sodium content drinking water (1 %) (for 14 days) and controlled potassium content diet (6.3 mg/g) (for 14 days) |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
total urine protein amount |
not specified |
56 days
| 33 |
|
|
38.0 |
mg/d |
1.91 |
11.0 |
Bradford protein assay |
|
0.0 |
|
0 |
|
|
|
|
70257 |
1126 |
SS/JrSeac |
myocardial flow rate |
controlled sodium content diet (8 %) (for 35 days) then controlled oxygen content Kreb's solution perfusate (for 0.2 hours) then 99mTc-sestamibi (37 MBq/l) (for 0.3 hours) then controlled oxygen content Kreb's solution perfusate (for 0.4 hours) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
coronary blood flow trait |
not specified |
77 days
| 5 |
|
|
2.36 |
ml/min |
0.48 |
1.07 |
isolated perfused heart method |
|
0.0 |
|
0 |
|
|
K1, myocardial flow rate |
|
68596 |
733 |
SS/JrSeac |
myocardial clearance rate |
controlled sodium content diet (0.3 %) (for 35 days) then controlled oxygen content Kreb's solution perfusate (for 0.2 hours) then 99mTc-sestamibi (37 MBq/l) (for 0.3 hours) then Kreb's solution perfusate (for 0.4 hours) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
heart muscle physiology trait |
not specified |
126 days
| 5 |
|
|
0.0 |
/min |
0.0 |
0.0 |
isolated perfused heart method |
|
0.0 |
|
0 |
|
|
K2, myocardial clearance rate |
|
68601 |
733 |
BN/NHsdMcwi |
white blood cell count |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
leukocyte quantity |
female |
92 days-94 days |
13 |
|
|
0.02 |
x 1000 cells/ul |
1306.0 |
4708.85 |
isolated cell counting method |
|
0.0 |
|
0 |
|
|
|
|
69495 |
151 |
SS/JrHsdMcwi |
heart rate |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
heart pumping trait |
female |
93 days
| 11 |
|
serial mean |
446.8 |
beats/min |
9.7 |
32.17 |
vascular indwelling catheter method |
left femoral artery |
10800.0 |
|
0 |
|
|
|
|
69520 |
151 |
BN/NHsdMcwi |
diastolic blood pressure |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
94 days
| 17 |
|
serial mean |
91.6 |
mmHg |
3.6 |
14.84 |
vascular indwelling catheter method |
left femoral artery |
10800.0 |
|
0 |
|
|
|
|
69523 |
151 |
SS/JrHsdMcwi |
heart rate |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
heart pumping trait |
female |
94 days
| 10 |
|
serial mean |
411.7 |
beats/min |
10.6 |
33.52 |
vascular indwelling catheter method |
left femoral artery |
10800.0 |
|
0 |
|
|
|
|
69526 |
151 |
LEW/Crlc |
cerebrospinal fluid chloride level |
controlled sodium content diet (8 %) (between 8 and 10 days) |
Huang BS, et al., Hypertension. 2007 Apr 9;. |
cerebrospinal fluid mineral amount |
male |
43 days-52 days |
0 |
|
|
121.0 |
mmol/l |
1.0 |
|
chloride ion-selective electrode method |
|
0.0 |
|
0 |
|
|
|
|
69694 |
344 |
SS/JrHsd |
diastolic blood pressure |
controlled sodium content diet (8 %) (between 55 and 56 days) |
Herrera VL, et al., Physiol Genomics. 2006 Aug 16;26(3):172-9. Epub 2006 May 23. |
arterial blood pressure trait |
male |
139 days-140 days |
6 |
|
|
162.7 |
mmHg |
7.88 |
19.3 |
intra-aortic abdominal radiotelemetry |
|
0.0 |
|
0 |
|
|
|
|
67869 |
810 |
SR/JrHsd |
diastolic blood pressure |
controlled sodium content diet (8 %) (between 55 and 56 days) |
Herrera VL, et al., Physiol Genomics. 2006 Aug 16;26(3):172-9. Epub 2006 May 23. |
arterial blood pressure trait |
male |
139 days-140 days |
5 |
|
|
93.4 |
mmHg |
1.61 |
3.6 |
intra-aortic abdominal radiotelemetry |
|
0.0 |
|
0 |
|
|
|
|
67870 |
810 |
SS/JrHsd |
diastolic blood pressure |
controlled sodium content diet (8 %) (between 83 and 84 days) |
Herrera VL, et al., Physiol Genomics. 2006 Aug 16;26(3):172-9. Epub 2006 May 23. |
arterial blood pressure trait |
female |
167 days-168 days |
8 |
|
|
143.0 |
mmHg |
4.88 |
13.8 |
intra-aortic abdominal radiotelemetry |
|
0.0 |
|
0 |
|
|
|
|
67871 |
810 |
SHRSP/Bbb |
systolic blood pressure |
controlled sodium content diet (3.7 mg/g) (for 14 days) and controlled sodium content drinking water (1 %) (for 14 days) and controlled potassium content diet (6.3 mg/g) (for 14 days) |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
arterial blood pressure trait |
not specified |
56 days
| 31 |
|
|
151.0 |
mmHg |
1.44 |
8.0 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
|
69162 |
1126 |
SHRSP/Bbb |
systolic blood pressure |
controlled sodium content diet (3.7 mg/g) (for 28 days) and controlled sodium content drinking water (1 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days) |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
arterial blood pressure trait |
not specified |
70 days
| 26 |
|
|
187.0 |
mmHg |
2.55 |
13.0 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
|
69163 |
1126 |
SHRSR.SHRSP-(Klk1-Mt1-ps1)/Bbb |
systolic blood pressure |
controlled sodium content diet (3.7 mg/g) (for 14 days) and controlled sodium content drinking water (1 %) (for 14 days) and controlled potassium content diet (6.3 mg/g) (for 14 days) |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
arterial blood pressure trait |
not specified |
56 days
| 33 |
|
|
148.0 |
mmHg |
3.13 |
18.0 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
|
69166 |
1126 |
SHRSR.SHRSP-(Klk1-Mt1-ps1)/Bbb |
systolic blood pressure |
controlled sodium content diet (3.7 mg/g) (for 28 days) and controlled sodium content drinking water (1 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days) |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
arterial blood pressure trait |
not specified |
70 days
| 33 |
|
|
174.0 |
mmHg |
3.31 |
19.0 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
|
69167 |
1126 |
SHRSR.SHRSP-(Klk1-Mt1-ps1)/Bbb |
systolic blood pressure |
controlled sodium content diet (3.7 mg/g) (for 70 days) and controlled sodium content drinking water (1 %) (for 70 days) and controlled potassium content diet (6.3 mg/g) (for 70 days) |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
arterial blood pressure trait |
not specified |
112 days
| 29 |
|
|
202.0 |
mmHg |
1.67 |
9.0 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
|
69170 |
1126 |
SHRSR.SHRSP-(Klk1-D1Mit3)/Bbb |
systolic blood pressure |
controlled sodium content diet (3.7 mg/g) (for 84 days) and controlled sodium content drinking water (1 %) (for 84 days) and controlled potassium content diet (6.3 mg/g) (for 84 days) |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
arterial blood pressure trait |
not specified |
126 days
| 31 |
|
|
208.0 |
mmHg |
1.44 |
8.0 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
|
69178 |
1126 |
SHRSR.SHRSP-(D1Rat134-Mt1-ps1)/Bbb |
systolic blood pressure |
controlled sodium content diet (3.7 mg/g) (for 42 days) and controlled sodium content drinking water (1 %) (for 42 days) and controlled potassium content diet (6.3 mg/g) (for 42 days) |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
arterial blood pressure trait |
not specified |
84 days
| 31 |
|
|
191.0 |
mmHg |
0.72 |
4.0 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
|
69182 |
1126 |
SHRSR.SHRSP-(D1Rat134-Mt1-ps1)/Bbb |
systolic blood pressure |
controlled sodium content diet (3.7 mg/g) (for 56 days) and controlled sodium content drinking water (1 %) (for 56 days) and controlled potassium content diet (6.3 mg/g) (for 56 days) |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
arterial blood pressure trait |
not specified |
98 days
| 30 |
|
|
195.0 |
mmHg |
1.46 |
8.0 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
|
69183 |
1126 |
SHRSP.SHRSR-(D1Rat134-Mt1-ps1)/Bbb |
systolic blood pressure |
controlled sodium content diet (3.7 mg/g) (for 56 days) and controlled sodium content drinking water (1 %) (for 56 days) and controlled potassium content diet (6.3 mg/g) (for 56 days) |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
arterial blood pressure trait |
not specified |
98 days
| 14 |
|
|
192.0 |
mmHg |
1.6 |
6.0 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
|
69199 |
1126 |
SS/JrHsdMcwi |
thymus wet weight |
controlled sodium content diet (4 %) (for 21 days) |
Mattson DL, et al., Am J Physiol Regul Integr Comp Physiol. 2013 Jan 30. |
thymus mass |
not specified |
84 days
| 0 |
|
|
560.0 |
mg |
30.0 |
|
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
69204 |
1057 |
WKY.SHR-(D1Mgh14-D1Rat77)/Iwai |
diastolic blood pressure |
controlled sodium content diet (8 %) (for 14 days) then controlled exposure to ambient light (for 12 hours) |
Iwai N, et al., Circulation 1999 Nov 2;100(18):1923-9. |
arterial blood pressure trait |
male |
126 days
| 8 |
|
|
90.6 |
mmHg |
1.27 |
3.6 |
vascular indwelling catheter method |
left common carotid artery |
0.0 |
|
0 |
|
|
daytime (7 AM - 7 PM) |
|
70095 |
1281 |
SS.LEW-(D17Chm131-D17Chm93)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (between 10 and 24 days) |
Chauvet C, et al., Hum Mol Genet. 2013 Nov 15;22(22):4451-9. doi: 10.1093/hmg/ddt294. Epub 2013 Jun 28. |
arterial blood pressure trait |
male |
66 days-80 days |
12 |
|
|
147.0 |
mmHg |
8.0 |
27.71 |
intra-aortic abdominal radiotelemetry |
abdominal aorta |
0.0 |
|
0 |
|
|
|
|
70495 |
1438 |
SS.SR-(D2Rat352-rs63922710)/Opaz |
pulse pressure |
controlled sodium content diet (8 %) (between 24 and 28 days) |
Herrera VL, et al., PLoS One. 2013 Jul 4;8(7):e67673. doi: 10.1371/journal.pone.0067673. Print 2013. |
arterial blood pressure trait |
male |
108 days-112 days |
6 |
|
|
51.8 |
mmHg |
2.3 |
5.63 |
intra-aortic abdominal radiotelemetry |
|
0.0 |
|
0 |
|
|
|
|
70565 |
1458 |
SS.MNS-(D2Chm90-D2Rat38)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (between 10 and 24 days) |
Chauvet C, et al., Hum Mol Genet. 2013 Nov 15;22(22):4451-9. doi: 10.1093/hmg/ddt294. Epub 2013 Jun 28. |
arterial blood pressure trait |
male |
66 days-80 days |
8 |
|
|
144.0 |
mmHg |
4.0 |
11.31 |
intra-aortic abdominal radiotelemetry |
abdominal aorta |
0.0 |
|
0 |
|
|
|
|
70455 |
1438 |
BN/NHsdMcwi |
systolic blood pressure |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) then controlled exposure to darkness (for 12 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
89 days-91 days |
20 |
|
serial mean |
130.0 |
mmHg |
3.5 |
15.65 |
vascular indwelling catheter method |
left femoral artery |
0.0 |
|
0 |
|
|
|
|
69443 |
151 |
BN/NHsdMcwi |
timed urine volume |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
urine output |
female |
89 days-92 days |
25 |
|
|
35.0 |
ml/d |
2.0 |
10.0 |
urine volume measurement method |
|
0.0 |
|
0 |
|
|
|
|
69451 |
151 |
BN/NHsdMcwi |
heart rate |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) then controlled exposure to darkness (for 12 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
heart pumping trait |
female |
89 days-91 days |
18 |
|
serial mean |
386.0 |
beats/min |
4.1 |
17.39 |
vascular indwelling catheter method |
left femoral artery |
0.0 |
|
0 |
|
|
|
|
69449 |
151 |
SS/JrHsdMcwi |
urine total protein level |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (0.4 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
total urine protein amount |
female |
90 days-94 days |
18 |
|
|
2.63 |
mg/ml |
0.47 |
1.99 |
urine total protein analysis |
|
0.0 |
|
0 |
|
|
mg/ml |
|
69458 |
151 |
BN/NHsdMcwi |
urine potassium excretion rate |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
urine potassium amount |
female |
89 days-92 days |
24 |
|
|
0.96 |
mEq/d |
0.04 |
0.21 |
unspecified method |
|
0.0 |
|
0 |
|
urine potassium analysis |
|
|
69461 |
151 |
SS/Jr |
heart left ventricle end-diastolic area |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) |
Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4. |
heart left ventricle size trait |
not specified |
0 days
| 6 |
|
|
0.62 |
cm2 |
0.11 |
0.27 |
echocardiography |
|
0.0 |
|
0 |
|
|
|
|
69596 |
749 |
WKY.SHR-(D1Mgh14-D1Rat77)/Iwai |
diastolic blood pressure |
controlled sodium content diet (8 %) (for 14 days) then controlled exposure to darkness (for 12 hours) |
Iwai N, et al., Circulation 1999 Nov 2;100(18):1923-9. |
arterial blood pressure trait |
male |
126 days
| 8 |
|
|
96.8 |
mmHg |
0.88 |
2.5 |
vascular indwelling catheter method |
left common carotid artery |
0.0 |
|
0 |
|
|
nighttime (7 PM - 7 AM) |
|
70096 |
1281 |
SS.SR-(D2Rat352-rs63922710)/Opaz |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 24 and 28 days) |
Herrera VL, et al., PLoS One. 2013 Jul 4;8(7):e67673. doi: 10.1371/journal.pone.0067673. Print 2013. |
arterial blood pressure trait |
female |
108 days-112 days |
6 |
|
|
142.0 |
mmHg |
2.1 |
5.14 |
intra-aortic abdominal radiotelemetry |
|
0.0 |
|
0 |
|
|
|
|
70559 |
1458 |
SS.SR-(D2Rat352-rs63922710)/Opaz |
diastolic blood pressure |
controlled sodium content diet (8 %) (between 24 and 28 days) |
Herrera VL, et al., PLoS One. 2013 Jul 4;8(7):e67673. doi: 10.1371/journal.pone.0067673. Print 2013. |
arterial blood pressure trait |
female |
108 days-112 days |
6 |
|
|
118.5 |
mmHg |
2.2 |
5.39 |
intra-aortic abdominal radiotelemetry |
|
0.0 |
|
0 |
|
|
|
|
70560 |
1458 |
SS.SR-(D2Rat352-rs63922710)/Opaz |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 24 and 28 days) |
Herrera VL, et al., PLoS One. 2013 Jul 4;8(7):e67673. doi: 10.1371/journal.pone.0067673. Print 2013. |
arterial blood pressure trait |
male |
108 days-112 days |
6 |
|
|
153.7 |
mmHg |
3.1 |
7.59 |
intra-aortic abdominal radiotelemetry |
|
0.0 |
|
0 |
|
|
|
|
70564 |
1458 |
SS/JrTol |
systolic blood pressure |
controlled sodium content diet (2 %) (between 24 and 28 days) |
Pillai R, et al., Physiol Genomics. 2013 Aug 15;45(16):729-36. doi: 10.1152/physiolgenomics.00077.2013. Epub 2013 Jun 11. |
arterial blood pressure trait |
male |
62 days-66 days |
0 |
|
|
196.0 |
mmHg |
6.8 |
|
tail cuff plethysmography |
|
0.0 |
|
0 |
|
restrained, 28 degrees C |
|
|
70583 |
1482 |
SS.LEW-(D10Rat119-D10Rat133)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (between 10 and 24 days) |
Chauvet C, et al., Hum Mol Genet. 2013 Nov 15;22(22):4451-9. doi: 10.1093/hmg/ddt294. Epub 2013 Jun 28. |
arterial blood pressure trait |
male |
66 days-80 days |
6 |
|
|
183.0 |
mmHg |
9.0 |
22.05 |
intra-aortic abdominal radiotelemetry |
abdominal aorta |
0.0 |
|
0 |
|
|
|
|
84479 |
1438 |
SS-Chr 12BN.SS-(D12Arb13-D12Mit2)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (1 %) (for 77 days) |
Flister MJ, et al., Hypertension. 2012 Oct;60(4):942-8. doi: 10.1161/HYPERTENSIONAHA.112.198200. Epub 2012 Aug 6. |
arterial blood pressure trait |
male |
67 days-77 days |
8 |
|
serial mean |
114.0 |
mmHg |
2.0 |
5.66 |
intra-aortic abdominal radiotelemetry |
|
14400.0 |
|
0 |
|
abdominal aorta |
4 hrs for 3 consecutive days |
|
96864 |
1718 |
SS-Chr 12BN.SS-(D12Hmgc3-D12Hmgc6)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (1 %) (for 77 days) |
Flister MJ, et al., Hypertension. 2012 Oct;60(4):942-8. doi: 10.1161/HYPERTENSIONAHA.112.198200. Epub 2012 Aug 6. |
arterial blood pressure trait |
male |
67 days-77 days |
11 |
|
serial mean |
146.0 |
mmHg |
6.0 |
19.9 |
intra-aortic abdominal radiotelemetry |
|
14400.0 |
|
0 |
|
abdominal aorta |
4 hrs for 3 consecutive days |
|
96868 |
1718 |
SS.LEW-(D10Rat194-D10Chm243)(D10Chm10-D10Rat11)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (between 10 and 24 days) |
Chauvet C, et al., Hum Mol Genet. 2013 Nov 15;22(22):4451-9. doi: 10.1093/hmg/ddt294. Epub 2013 Jun 28. |
arterial blood pressure trait |
male |
66 days-80 days |
5 |
|
|
109.0 |
mmHg |
8.0 |
17.89 |
intra-aortic abdominal radiotelemetry |
abdominal aorta |
0.0 |
|
0 |
|
|
|
|
84485 |
1438 |
SS.LEW-(D3Rat2-D3Chm79)(D10Chm10-D10Rat11)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (between 10 and 24 days) |
Chauvet C, et al., Hum Mol Genet. 2013 Nov 15;22(22):4451-9. doi: 10.1093/hmg/ddt294. Epub 2013 Jun 28. |
arterial blood pressure trait |
male |
66 days-80 days |
5 |
|
|
133.0 |
mmHg |
5.0 |
11.18 |
intra-aortic abdominal radiotelemetry |
abdominal aorta |
0.0 |
|
0 |
|
|
|
|
84493 |
1438 |
SS.LEW-(D7Uia3-D7Mgh1)(D10Rat194-D10Chm243)(D10Chm10-D10Rat11)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (between 10 and 24 days) |
Chauvet C, et al., Hum Mol Genet. 2013 Nov 15;22(22):4451-9. doi: 10.1093/hmg/ddt294. Epub 2013 Jun 28. |
arterial blood pressure trait |
male |
66 days-80 days |
5 |
|
|
125.0 |
mmHg |
3.0 |
6.71 |
intra-aortic abdominal radiotelemetry |
abdominal aorta |
0.0 |
|
0 |
|
|
|
|
84503 |
1438 |
SHRSP.SHRSR-(Klk1-D1Mit3)/Bbb |
urine total protein excretion rate |
controlled sodium content diet (3.7 mg/g) (for 14 days) and controlled sodium content drinking water (1 %) (for 14 days) and controlled potassium content diet (6.3 mg/g) (for 14 days) |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
total urine protein amount |
not specified |
56 days
| 31 |
|
|
39.0 |
mg/d |
4.31 |
24.0 |
Bradford protein assay |
|
0.0 |
|
0 |
|
|
|
|
84578 |
1126 |
SHRSP.SHRSR-(D1Rat134-Mt1-ps1)/Bbb |
urine total protein excretion rate |
controlled sodium content diet (3.7 mg/g) (for 84 days) and controlled sodium content drinking water (1 %) (for 84 days) and controlled potassium content diet (6.3 mg/g) (for 84 days) |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
total urine protein amount |
not specified |
126 days
| 1 |
|
|
400.0 |
mg/d |
|
|
Bradford protein assay |
|
0.0 |
|
0 |
|
|
|
|
84587 |
1126 |
SS.MNS-(D2Rat155-D2Chm161)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 12 days) |
Chauvet C, et al., Hypertens Res. 2009 Jul;32(7):631-7. doi: 10.1038/hr.2009.70. Epub 2009 May 22. |
arterial blood pressure trait |
male |
68 days
| 9 |
|
serial mean |
125.0 |
mmHg |
6.0 |
18.0 |
radiotelemetry |
|
1036800.0 |
|
0 |
|
telemetry probe |
averaged over 12 days |
has records that will be duplicated if entered need to add multiple refs once the functionality is in |
96575 |
1664 |
SS.MNS-(D2Chm366-D2Rat52)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 12 days) |
Chauvet C, et al., Hypertens Res. 2009 Jul;32(7):631-7. doi: 10.1038/hr.2009.70. Epub 2009 May 22. |
arterial blood pressure trait |
male |
68 days
| 9 |
|
serial mean |
139.0 |
mmHg |
4.0 |
12.0 |
radiotelemetry |
|
1036800.0 |
|
0 |
|
telemetry probe |
averaged over 12 days |
has records that will be duplicated if entered need to add multiple refs once the functionality is in |
96578 |
1664 |
SS-Chr 12BN/Mcwi |
artery wall thickness to artery inner diameter ratio |
controlled sodium content diet (0.3 %) then controlled ex vivo artery perfusion pressure (140 mmHg) |
Prisco SZ, et al., Am J Physiol Heart Circ Physiol. 2014 Oct 15;307(8):H1103-10. doi: 10.1152/ajpheart.00464.2014. Epub 2014 Aug 22. |
mesenteric artery morphology trait |
male |
63 days-70 days |
7 |
|
|
7.8 |
% |
0.4 |
1.06 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
mesenteric artery morphology trait |
96879 |
1719 |
SS-Chr 12BN.SS-(D12Hmgc3-D12Hmgc6)/Mcwi |
artery wall thickness to artery inner diameter ratio |
controlled sodium content diet (0.3 %) then controlled ex vivo artery perfusion pressure (40 mmHg) |
Prisco SZ, et al., Am J Physiol Heart Circ Physiol. 2014 Oct 15;307(8):H1103-10. doi: 10.1152/ajpheart.00464.2014. Epub 2014 Aug 22. |
mesenteric artery morphology trait |
male |
63 days-70 days |
5 |
|
|
15.6 |
% |
0.5 |
1.12 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
mesenteric artery morphology trait |
96882 |
1719 |
SS-Chr 12BN/Mcwi |
artery wall thickness to artery inner diameter ratio |
controlled sodium content diet (0.3 %) then controlled ex vivo artery perfusion pressure (120 mmHg) |
Prisco SZ, et al., Am J Physiol Heart Circ Physiol. 2014 Oct 15;307(8):H1103-10. doi: 10.1152/ajpheart.00464.2014. Epub 2014 Aug 22. |
mesenteric artery morphology trait |
male |
63 days-70 days |
7 |
|
|
8.7 |
% |
0.4 |
1.06 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
mesenteric artery morphology trait |
96878 |
1719 |
SS.BN-(D12Hmgc3-AU047911)/Mcwi |
artery wall thickness to artery inner diameter ratio |
controlled sodium content diet (0.3 %) then controlled ex vivo artery perfusion pressure (80 mmHg) |
Prisco SZ, et al., Am J Physiol Heart Circ Physiol. 2014 Oct 15;307(8):H1103-10. doi: 10.1152/ajpheart.00464.2014. Epub 2014 Aug 22. |
mesenteric artery morphology trait |
male |
63 days-70 days |
12 |
|
|
9.5 |
% |
0.4 |
1.39 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
mesenteric artery morphology trait |
96892 |
1719 |
SS.BN-(D12Hmgc3-AU047911)/Mcwi |
artery wall thickness to artery inner diameter ratio |
controlled sodium content diet (0.3 %) then controlled ex vivo artery perfusion pressure (100 mmHg) |
Prisco SZ, et al., Am J Physiol Heart Circ Physiol. 2014 Oct 15;307(8):H1103-10. doi: 10.1152/ajpheart.00464.2014. Epub 2014 Aug 22. |
mesenteric artery morphology trait |
male |
63 days-70 days |
12 |
|
|
8.6 |
% |
0.3 |
1.04 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
mesenteric artery morphology trait |
96893 |
1719 |
SS.MNS-(D2Chm25-D2Mit14)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 12 days) |
Chauvet C, et al., Hypertens Res. 2009 Jul;32(7):631-7. doi: 10.1038/hr.2009.70. Epub 2009 May 22. |
arterial blood pressure trait |
male |
68 days
| 7 |
|
serial mean |
136.0 |
mmHg |
6.0 |
15.87 |
radiotelemetry |
|
1036800.0 |
|
0 |
|
telemetry probe |
averaged over 12 days |
has records that will be duplicated if entered need to add multiple refs once the functionality is in |
96574 |
1664 |
SS.LEW-(D10Chm280-D10Chm216)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (2 %) (between 35 and 105 days) |
Crespo K, et al., J Hypertens. 2013 May;31(5):927-35. doi: 10.1097/HJH.0b013e32835edc7e. |
arterial blood pressure trait |
male |
66 days-86 days |
12 |
|
serial mean |
149.0 |
mmHg |
1.15 |
4.0 |
intra-aortic abdominal radiotelemetry |
|
2.0 |
|
0 |
|
|
for 2 wks |
has records that will be duplicated if entered need to add multiple refs once the functionality is in |
96579 |
1665 |
SS.BN-(D12Hmgc7-D12Hmgc6)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (1 %) (between 42 and 49 days) then controlled sodium content diet (8 %) (for 21 days) |
Prisco SZ, et al., Hypertension. 2014 Jul 7. pii: HYPERTENSIONAHA.114.03550. |
arterial blood pressure trait |
male |
92 days-98 days |
6 |
|
|
150.0 |
mmHg |
2.0 |
4.9 |
intra-aortic abdominal radiotelemetry |
|
0.0 |
|
0 |
|
|
|
|
96807 |
1698 |
SHR-Ndufc2em1Mcwi+/+ |
body weight |
controlled protein content diet (19.7 %) (for 84 days) and controlled potassium content diet (6.3 mg/g) (for 84 days) and controlled sodium content diet (3.7 mg/g) (for 84 days) |
Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701. |
body mass |
not specified |
126 days
| 10 |
|
|
309.0 |
g |
8.54 |
27.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
97879 |
1938 |
LEW.SS-(D17Rat15-D17Rat51)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (between 31 and 41 days) |
Crespo K, et al., Circ Cardiovasc Genet. 2015 Aug;8(4):610-7. doi: 10.1161/CIRCGENETICS.114.000965. Epub 2015 May 11. |
arterial blood pressure trait |
male |
67 days-77 days |
5 |
|
|
89.0 |
mmHg |
2.0 |
4.47 |
intra-aortic abdominal radiotelemetry |
abdominal aorta |
864000.0 |
|
0 |
|
|
|
|
97143 |
1878 |
SHR-Ndufc2em1Mcwi-/+ |
body weight |
controlled protein content diet (19.7 %) (for 84 days) and controlled potassium content diet (6.3 mg/g) (for 84 days) and controlled sodium content diet (3.7 mg/g) (for 84 days) |
Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701. |
body mass |
not specified |
126 days
| 17 |
|
|
308.0 |
g |
5.09 |
21.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
97897 |
1938 |
SHR-Ndufc2em2Mcwi-/+ |
body weight |
controlled protein content diet (19.7 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days) and controlled sodium content diet (3.7 mg/g) (for 28 days) |
Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701. |
body mass |
not specified |
70 days
| 26 |
|
|
237.0 |
g |
5.3 |
27.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
97903 |
1938 |
SHR-Ndufc2em2Mcwi+/+ |
body weight |
controlled protein content diet (19.7 %) (for 84 days) and controlled potassium content diet (6.3 mg/g) (for 84 days) and controlled sodium content diet (3.7 mg/g) (for 84 days) |
Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701. |
body mass |
not specified |
126 days
| 12 |
|
|
314.0 |
g |
14.15 |
49.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
97902 |
1938 |
SHR/Bbb |
body weight |
controlled protein content diet (19.7 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days) and controlled sodium content diet (3.7 mg/g) (for 28 days) |
Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701. |
body mass |
not specified |
70 days
| 18 |
|
|
220.0 |
g |
3.06 |
13.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
97906 |
1938 |
SS/JrTol |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) and housing in pairs (between 26 and 66 days) then controlled sodium content diet (2 %) (for 24 days) |
Mell B, et al., Hypertens Res. 2015 Jan;38(1):61-7. doi: 10.1038/hr.2014.134. Epub 2014 Sep 18. |
arterial blood pressure trait |
male |
64 days-66 days |
30 |
|
continuous mean |
198.0 |
mmHg |
8.0 |
43.82 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
restrained, 28 degrees C |
average of 2-3 readings/day over 4 days |
|
96920 |
1778 |
SS/JrTol |
heart rate |
controlled sodium content diet (0.3 %) (between 10 and 12 days) and housing in pairs (between 28 and 66 days) then controlled sodium content diet (2 %) (for 24 days) |
Personal communication between Dr. Bina Joe's group and the RGD curators |
heart pumping trait |
male |
73 days-75 days |
10 |
|
serial mean |
376.0 |
beats/min |
15.0 |
47.43 |
radiotelemetry |
|
345600.0 |
|
0 |
|
C-40 transmitter (Data Sciences International, St. Paul, MN) |
average of 4-hour interval averages over 4 days |
|
97022 |
1798 |
SS.LEW-(D1Mco134-D1Wox6)/Bj |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) and housing in pairs (between 28 and 66 days) then controlled sodium content diet (2 %) (for 24 days) |
Mell B, et al., Hypertens Res. 2015 Jan;38(1):61-7. doi: 10.1038/hr.2014.134. Epub 2014 Sep 18. |
arterial blood pressure trait |
male |
64 days-66 days |
30 |
|
continuous mean |
155.0 |
mmHg |
16.0 |
87.64 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
restrained, 28 degrees C |
average of 2-3 readings/day over 4 days |
|
96945 |
1778 |
SS/JrTol |
diastolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) and housing in pairs (between 28 and 66 days) then controlled sodium content diet (2 %) (for 24 days) |
Mell B, et al., Hypertens Res. 2015 Jan;38(1):61-7. doi: 10.1038/hr.2014.134. Epub 2014 Sep 18. |
arterial blood pressure trait |
male |
73 days-75 days |
10 |
|
serial mean |
131.0 |
mmHg |
5.0 |
15.81 |
radiotelemetry |
|
345600.0 |
|
0 |
|
C-40 transmitter (Data Sciences International, St. Paul, MN) |
average of 4-hour interval averages over 4 days |
|
96949 |
1778 |
SS/JrTol |
mean arterial blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) and housing in pairs (between 28 and 66 days) then controlled sodium content diet (2 %) (for 24 days) |
Mell B, et al., Hypertens Res. 2015 Jan;38(1):61-7. doi: 10.1038/hr.2014.134. Epub 2014 Sep 18. |
arterial blood pressure trait |
male |
73 days-75 days |
10 |
|
|
159.0 |
mmHg |
7.0 |
22.14 |
radiotelemetry |
|
345600.0 |
|
0 |
|
C-40 transmitter (Data Sciences International, St. Paul, MN) |
average of 24 hour |
|
96957 |
1778 |
SS.LEW-(D1Rat200-D1Mco136)/Bj |
mean arterial blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) and housing in pairs (between 28 and 66 days) then controlled sodium content diet (2 %) (for 24 days) |
Mell B, et al., Hypertens Res. 2015 Jan;38(1):61-7. doi: 10.1038/hr.2014.134. Epub 2014 Sep 18. |
arterial blood pressure trait |
male |
73 days-75 days |
10 |
|
|
174.0 |
mmHg |
5.0 |
15.81 |
radiotelemetry |
|
345600.0 |
|
0 |
|
C-40 transmitter (Data Sciences International, St. Paul, MN) |
average of 24 hour |
|
96958 |
1778 |
SS/JrTol |
pulse pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) and housing in pairs (between 28 and 66 days) then controlled sodium content diet (2 %) (for 24 days) |
Mell B, et al., Hypertens Res. 2015 Jan;38(1):61-7. doi: 10.1038/hr.2014.134. Epub 2014 Sep 18. |
arterial blood pressure trait |
male |
73 days-75 days |
10 |
|
|
58.0 |
mmHg |
4.0 |
12.65 |
radiotelemetry |
|
345600.0 |
|
0 |
|
C-40 transmitter (Data Sciences International, St. Paul, MN) |
average of 24 hour |
|
96961 |
1778 |
SS/JrTol |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) and housing in pairs (between 26 and 66 days) then controlled sodium content diet (2 %) (for 24 days) |
Mell B, et al., Hypertens Res. 2015 Jan;38(1):61-7. doi: 10.1038/hr.2014.134. Epub 2014 Sep 18. |
arterial blood pressure trait |
male |
64 days-66 days |
30 |
|
continuous mean |
208.0 |
mmHg |
6.0 |
32.86 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
restrained, 28 degrees C |
average of 2-3 readings/day over 4 days |
|
96982 |
1778 |
SHR-Ndufc2em2Mcwi+/+ |
systolic blood pressure |
controlled protein content diet (19.7 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days) and controlled sodium content diet (3.7 mg/g) (for 28 days) |
Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701. |
arterial blood pressure trait |
not specified |
70 days
| 12 |
undefined |
|
181.0 |
mmHg |
0.87 |
3.0 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
|
97922 |
1938 |
SHR-Ndufc2em2Mcwi-/+ |
systolic blood pressure |
controlled protein content diet (19.7 %) (for 84 days) and controlled potassium content diet (6.3 mg/g) (for 84 days) and controlled sodium content diet (3.7 mg/g) (for 84 days) |
Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701. |
arterial blood pressure trait |
not specified |
126 days
| 16 |
undefined |
|
186.0 |
mmHg |
1.5 |
6.0 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
|
97927 |
1938 |
SHRSP/Bbb |
urine total protein excretion rate |
controlled protein content diet (19.7 %) (for 49 days) and controlled potassium content diet (6.3 mg/g) (for 49 days) and controlled sodium content diet (3.7 mg/g) (for 49 days) |
Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701. |
total urine protein amount |
not specified |
91 days
| 5 |
|
|
240.0 |
mg/d |
13.42 |
30.0 |
urine analysis |
|
0.0 |
|
0 |
|
|
|
|
97932 |
1938 |
SHR-Ndufc2em1Mcwi+/+ |
urine total protein excretion rate |
controlled protein content diet (19.7 %) (for 84 days) and controlled potassium content diet (6.3 mg/g) (for 84 days) and controlled sodium content diet (3.7 mg/g) (for 84 days) |
Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701. |
total urine protein amount |
not specified |
126 days
| 10 |
|
|
67.0 |
mg/d |
1.9 |
6.0 |
urine analysis |
|
0.0 |
|
0 |
|
|
|
|
97935 |
1938 |
SHR-Ndufc2em2Mcwi-/+ |
urine total protein excretion rate |
controlled protein content diet (19.7 %) (for 84 days) and controlled potassium content diet (6.3 mg/g) (for 84 days) and controlled sodium content diet (3.7 mg/g) (for 84 days) |
Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701. |
total urine protein amount |
not specified |
126 days
| 16 |
|
|
126.0 |
mg/d |
6.75 |
27.0 |
urine analysis |
|
0.0 |
|
0 |
|
|
|
|
97944 |
1938 |
SR/JrHsd |
plasma estradiol level |
controlled sodium content diet (0.1 %) (for 112 days) then bilateral ovariectomy (between 56 and 63 days) |
Esqueda ME, et al., Hypertension. 2007 Oct;50(4):768-72. Epub 2007 Aug 13. |
blood estradiol amount |
female |
112 days
| 6 |
|
|
7.6 |
pg/ml |
0.7 |
1.71 |
radioimmunoassay |
|
0.0 |
ovx |
63 |
days |
|
|
|
102362 |
2686 |
SS/NEisSlc |
ratio of change in renal sympathetic nerve activity |
controlled sodium content diet (8 %) (for 28 days) then tempol (4 mol/l) (between 0 and 0 hours) |
Fujita M, et al., Hypertension. 2007 Aug;50(2):360-7. Epub 2007 Jun 18. |
kidney sympathetic nerve activity |
male |
63 days-70 days |
8 |
|
|
-18.7 |
% |
2.0 |
5.66 |
implanted wire electrode recording method |
|
0.0 |
|
0 |
|
|
|
|
102373 |
2687 |
SS/NEisSlc |
percent change in heart rate |
controlled sodium content diet (8 %) (for 28 days) then tempol (4 mol/l) (between 0 and 0 hours) |
Fujita M, et al., Hypertension. 2007 Aug;50(2):360-7. Epub 2007 Jun 18. |
heart pumping trait |
male |
63 days-70 days |
8 |
|
|
-10.7 |
% |
2.8 |
7.92 |
vascular fluid filled catheter |
|
0.0 |
|
0 |
|
|
|
|
102381 |
2687 |
SR/NEisSlc |
both kidneys wet weight to body weight ratio |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) |
Ishikawa M, et al., Int Heart J. 2013;54(2):98-106. |
kidney mass |
male |
126 days
| 8 |
|
|
3.53 |
g/kg |
0.04 |
0.11 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
102322 |
2684 |
SS/NEisSlc |
both kidneys wet weight to body weight ratio |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) then vehicle control condition (for 49 days) |
Ishikawa M, et al., Int Heart J. 2013;54(2):98-106. |
kidney mass |
male |
126 days
| 8 |
|
|
5.19 |
g/kg |
0.19 |
0.54 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
102323 |
2684 |
SR/NEisSlc |
creatinine clearance |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) |
Ishikawa M, et al., Int Heart J. 2013;54(2):98-106. |
glomerular filtration trait |
male |
126 days
| 8 |
|
|
3.9 |
ml/min |
0.8 |
2.26 |
serum creatinine analysis |
|
0.0 |
|
0 |
|
|
|
|
102331 |
2684 |
SS/NEisSlc |
creatinine clearance |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) then tolvaptan (0.05 %) (for 49 days) |
Ishikawa M, et al., Int Heart J. 2013;54(2):98-106. |
glomerular filtration trait |
male |
126 days
| 8 |
|
|
3.6 |
ml/min |
0.7 |
1.98 |
serum creatinine analysis |
|
0.0 |
|
0 |
|
|
|
|
102333 |
2684 |
SS/NEisSlc |
timed urine volume |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) then tolvaptan (0.05 %) (for 49 days) |
Ishikawa M, et al., Int Heart J. 2013;54(2):98-106. |
urine output |
male |
126 days
| 8 |
|
|
83.3 |
ml/d |
7.9 |
22.34 |
urine volume measurement method |
|
0.0 |
|
0 |
|
|
|
|
102336 |
2684 |
SS/NEisSlc |
urine total protein excretion rate |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) then vehicle control condition (for 49 days) |
Ishikawa M, et al., Int Heart J. 2013;54(2):98-106. |
total urine protein amount |
male |
126 days
| 8 |
|
|
307.0 |
mg/d |
46.0 |
130.11 |
urine protein analysis |
|
0.0 |
|
0 |
|
|
|
|
102338 |
2684 |
SS/NEisSlc |
urine total protein excretion rate |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) then tolvaptan (0.05 %) (for 49 days) |
Ishikawa M, et al., Int Heart J. 2013;54(2):98-106. |
total urine protein amount |
male |
126 days
| 8 |
|
|
124.0 |
mg/d |
21.0 |
59.4 |
urine protein analysis |
|
0.0 |
|
0 |
|
|
|
|
102339 |
2684 |
SS/Jr |
respiration rate |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 42 days) then 10% CO2, 20% O2, 70% N2 (10 %) (for 0.4 hours) then ambient air (for 0.1 hours) |
Sobajima M, et al., Am J Physiol Heart Circ Physiol. 2011 Jun;300(6):H2214-20. doi: 10.1152/ajpheart.00615.2010. Epub 2011 Mar 18. |
respiratory function trait |
not specified |
86 days
| 5 |
sampling once per minute |
|
122.0 |
breaths/min |
1.79 |
4.0 |
spirometry |
|
0.0 |
|
0 |
|
|
|
|
103179 |
2787 |
SS/Jr |
respiration rate |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 42 days) then atropine (1 mg/kg) then 10% CO2, 20% O2, 70% N2 (10 %) (for 0.4 hours) then ambient air (for 0.1 hours) |
Sobajima M, et al., Am J Physiol Heart Circ Physiol. 2011 Jun;300(6):H2214-20. doi: 10.1152/ajpheart.00615.2010. Epub 2011 Mar 18. |
respiratory function trait |
not specified |
86 days
| 4 |
sampling once per minute |
|
96.0 |
breaths/min |
4.0 |
8.0 |
spirometry |
|
0.0 |
|
0 |
|
|
|
|
103212 |
2787 |
SS |
heart rate |
controlled sodium content diet (0.3 %) (for 42 days) |
Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18. |
heart pumping trait |
male |
42 days
| 5 |
|
|
438.0 |
beats/min |
5.37 |
12.0 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
|
103278 |
2803 |
SR/Jr |
respiration rate |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 42 days) then atropine (1 mg/kg) then 10% CO2, 20% O2, 70% N2 (10 %) (for 0.4 hours) then ambient air (for 0.1 hours) |
Sobajima M, et al., Am J Physiol Heart Circ Physiol. 2011 Jun;300(6):H2214-20. doi: 10.1152/ajpheart.00615.2010. Epub 2011 Mar 18. |
respiratory function trait |
not specified |
86 days
| 5 |
sampling once per minute |
|
89.0 |
breaths/min |
6.26 |
14.0 |
spirometry |
|
0.0 |
|
0 |
|
|
|
|
103213 |
2787 |
SS |
systolic blood pressure |
controlled sodium content diet (0.3 %) (for 42 days) |
Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18. |
arterial blood pressure trait |
male |
42 days
| 5 |
|
|
113.0 |
mmHg |
2.24 |
5.0 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
|
103284 |
2803 |
SS-Mthfrem1Mcwi-/+ |
heart wet weight |
controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 12 days) |
Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4. |
heart mass |
male |
60 days-69 days |
0 |
|
|
1.24 |
g |
0.06 |
|
digital scale post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
98462 |
2059 |
SS-Plod1em1Mcwi-/- |
body weight |
controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 12 days) |
Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4. |
body mass |
male |
60 days-69 days |
0 |
|
|
298.0 |
g |
6.0 |
|
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
98465 |
2059 |
SS.BN-(D13Hmgc1048-D13Hmgc1045)/Mcwi |
diastolic blood pressure |
controlled sodium content diet (0.4 %) (between 23 and 32 days) |
Cowley AW Jr, et al., Physiol Genomics. 2016 Jan;48(1):62-72. doi: 10.1152/physiolgenomics.00097.2015. Epub 2015 Nov 3. |
arterial blood pressure trait |
male |
44 days-53 days |
11 |
|
serial mean |
86.0 |
mmHg |
2.0 |
6.63 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
carotid a. to thoracic aorta implant |
strain 26-O |
|
98488 |
2079 |
SS.BN-(D13Hmgc885-D13Hmgc664)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (between 23 and 32 days) |
Cowley AW Jr, et al., Physiol Genomics. 2016 Jan;48(1):62-72. doi: 10.1152/physiolgenomics.00097.2015. Epub 2015 Nov 3. |
arterial blood pressure trait |
male |
44 days-53 days |
10 |
|
serial mean |
105.0 |
mmHg |
2.0 |
6.32 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
carotid a. to thoracic aorta implant |
strain 26-R |
|
98477 |
2079 |
SS.BN-(D13Hmgc1041-D13Hmgc664)/Mcwi |
systolic blood pressure |
controlled sodium content diet (0.4 %) (between 23 and 32 days) |
Cowley AW Jr, et al., Physiol Genomics. 2016 Jan;48(1):62-72. doi: 10.1152/physiolgenomics.00097.2015. Epub 2015 Nov 3. |
arterial blood pressure trait |
male |
44 days-53 days |
13 |
|
serial mean |
121.0 |
mmHg |
1.0 |
3.61 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
carotid a. to thoracic aorta implant |
strain 26-Q |
|
98483 |
2079 |
SS.BN-(D13Got42-D13Hmgc885)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (between 46 and 50.8 days) |
Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8. |
arterial blood pressure trait |
male |
46 days-53 days |
3 |
|
serial mean |
106.0 |
mmHg |
2.31 |
4.0 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
intra-carotid radiotelemetry |
strain 26-F |
|
98605 |
2098 |
SS.BN-(D13Got42-D13Got45)/Mcwi |
heart rate |
controlled sodium content diet (0.4 %) (between 46 and 50.8 days) then controlled sodium content diet (8 %) (for 13.4 days) |
Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8. |
heart pumping trait |
male |
60 days-67 days |
13 |
|
serial mean |
399.0 |
beats/min |
9.0 |
32.45 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
intra-carotid radiotelemetry |
intra-carotid radiotelemetry |
|
98612 |
2098 |
SS/NEisSlc |
serum total protein level |
controlled sodium content diet (8 %) (for 42 days) then cilazapril (10 mg/kg/d) (for 42 days) |
Otsuka F, et al., Am J Physiol. 1998 Jun;274(6 Pt 2):R1797-806. |
blood total protein amount |
male |
91 days
| 6 |
|
|
5.42 |
g/dl |
0.11 |
0.27 |
serum total protein analysis |
|
0.0 |
|
0 |
|
|
|
|
100670 |
2519 |
SS-Agtrapem4Mcwi-/- |
heart rate |
controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 10 days) |
Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4. |
heart pumping trait |
male |
58 days-67 days |
0 |
|
serial mean |
350.0 |
beats/min |
6.0 |
|
intra-aortic abdominal radiotelemetry |
|
32400.0 |
|
0 |
|
|
|
|
98423 |
2059 |
SS |
body weight |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 42 days) |
Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18. |
body mass |
male |
84 days
| 7 |
|
|
287.0 |
g |
9.45 |
25.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
103298 |
2803 |
SR |
heart weight to body weight ratio |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 84 days) |
Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18. |
heart mass |
male |
126 days
| 6 |
|
|
2.68 |
g/kg |
0.24 |
0.58 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
103307 |
2803 |
SS |
heart weight to body weight ratio |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 42 days) |
Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18. |
heart mass |
male |
84 days
| 7 |
|
|
4.16 |
g/kg |
0.15 |
0.41 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
103304 |
2803 |
SS |
heart left ventricle end-systolic diameter |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 42 days) |
Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18. |
heart left ventricle end-systolic diameter |
male |
84 days
| 7 |
|
|
4.3 |
mm |
0.11 |
0.3 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
|
|
|
103312 |
2803 |
SS |
plasma glucose level |
controlled sodium content diet (0.3 %) (for 42 days) |
Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18. |
blood glucose amount |
male |
42 days
| 12 |
|
|
96.0 |
mg/dl |
4.62 |
16.0 |
plasma glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
103320 |
2803 |
SS/Jr |
mean arterial blood pressure |
controlled sodium content diet (0.3 %) (for 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Nie Y, et al., Physiol Genomics. 2016 Jun;48(6):409-19. doi: 10.1152/physiolgenomics.00004.2016. Epub 2016 Apr 25. |
arterial blood pressure trait |
male |
68 days-70 days |
7 |
|
serial mean |
174.0 |
mmHg |
1.74 |
4.6 |
radiotelemetry |
|
0.0 |
|
0 |
|
|
|
|
97989 |
1958 |
SS |
plasma free fatty acids level |
controlled sodium content diet (0.3 %) (for 42 days) |
Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18. |
blood free fatty acid amount |
male |
42 days
| 12 |
|
|
1.4 |
mmol/l |
0.06 |
0.2 |
thin layer chromatography |
|
0.0 |
|
0 |
|
|
|
|
103332 |
2803 |
SS |
plasma free fatty acids level |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 84 days) |
Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18. |
blood free fatty acid amount |
male |
126 days
| 12 |
|
|
0.8 |
mmol/l |
0.06 |
0.2 |
thin layer chromatography |
|
0.0 |
|
0 |
|
|
|
|
103336 |
2803 |
SS |
plasma triglyceride level |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 42 days) |
Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18. |
blood triglyceride amount |
male |
84 days
| 13 |
|
|
1.28 |
mmol/l |
0.12 |
0.44 |
thin layer chromatography |
|
0.0 |
|
0 |
|
|
|
|
103340 |
2803 |
SR |
body weight |
controlled sodium content diet (6 %) (between 56 and 70 days) |
Kamei K, et al., Circ J. 2007 Mar;71(3):390-6. |
body mass |
male |
98 days-132 days |
7 |
|
|
405.0 |
g |
15.5 |
41.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
103346 |
2804 |
SS |
heart ventricle septal wall thickness |
controlled sodium content diet (6 %) (between 56 and 70 days) then pentobarbital (50 mg/kg) |
Kamei K, et al., Circ J. 2007 Mar;71(3):390-6. |
heart left ventricle wall thickness |
male |
98 days-132 days |
7 |
|
|
0.17 |
cm |
0.02 |
0.05 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
|
|
|
103367 |
2804 |
SR |
conduction velocity |
controlled sodium content diet (6 %) (between 35 and 49 days) then pentobarbital (50 mg/kg) |
Kamei K, et al., Circ J. 2007 Mar;71(3):390-6. |
heart electrical impulse conduction trait |
male |
77 days-91 days |
7 |
|
|
77.0 |
cm/min |
1.89 |
5.0 |
electrocardiography |
|
0.0 |
|
0 |
|
|
conduction velocity |
|
103387 |
2804 |
SS |
conduction velocity |
controlled sodium content diet (6 %) (between 35 and 49 days) then pentobarbital (50 mg/kg) |
Kamei K, et al., Circ J. 2007 Mar;71(3):390-6. |
heart electrical impulse conduction trait |
male |
77 days-91 days |
7 |
|
|
56.0 |
cm/min |
2.65 |
7.0 |
electrocardiography |
|
0.0 |
|
0 |
|
|
conduction velocity |
|
103390 |
2804 |
SR/Hsd |
plasma osmolality |
controlled sodium content diet (0.4 %) (for 21 days) then intracerebroventricular cannula implantation then scrambled control oligodeoxynucleotide (4.17 ug/d) (for 21 days) |
Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. |
blood molecular composition trait |
male |
91 days-119 days |
6 |
|
|
299.6 |
umol/g |
4.5 |
11.02 |
osmometry |
|
0.0 |
|
0 |
|
|
p osmolality mosm/kg |
|
102237 |
2682 |
SR/Hsd |
plasma osmolality |
controlled sodium content diet (0.4 %) (for 21 days) then intracerebroventricular cannula implantation then Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days) |
Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. |
blood molecular composition trait |
male |
91 days-119 days |
6 |
|
|
302.4 |
umol/g |
4.2 |
10.29 |
osmometry |
|
0.0 |
|
0 |
|
|
p osmolality mosm/kg |
|
102238 |
2682 |
SR/Hsd |
plasma sodium level |
controlled sodium content diet (0.4 %) (for 21 days) then intracerebroventricular cannula implantation then scrambled control oligodeoxynucleotide (4.17 ug/d) (for 21 days) then sham surgical control condition (for 21 days) |
Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. |
blood sodium amount |
male |
91 days-119 days |
6 |
|
|
140.8 |
mmol/l |
1.6 |
3.92 |
flame atomic emission spectrometry |
|
0.0 |
|
0 |
|
|
|
|
102249 |
2682 |
SR/Hsd |
plasma sodium level |
controlled sodium content diet (8 %) (for 21 days) then intracerebroventricular cannula implantation then scrambled control oligodeoxynucleotide (4.17 ug/d) (for 21 days) then sham surgical control condition (for 21 days) |
Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. |
blood sodium amount |
male |
91 days-119 days |
6 |
|
|
139.8 |
mmol/l |
0.7 |
1.71 |
flame atomic emission spectrometry |
|
0.0 |
|
0 |
|
|
|
|
102251 |
2682 |
SR/Hsd |
plasma osmolality |
controlled sodium content diet (0.4 %) (for 21 days) then intracerebroventricular cannula implantation then scrambled control oligodeoxynucleotide (4.17 ug/d) (for 21 days) then sham surgical control condition (for 21 days) |
Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. |
blood molecular composition trait |
male |
91 days-119 days |
6 |
|
|
298.6 |
umol/g |
3.8 |
9.31 |
osmometry |
|
0.0 |
|
0 |
|
|
p osmolality mosm/kg |
|
102257 |
2682 |
SR/Hsd |
plasma osmolality |
controlled sodium content diet (8 %) (for 21 days) then intracerebroventricular cannula implantation then Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days) then surgical denervation (for 21 days) |
Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. |
blood molecular composition trait |
male |
91 days-119 days |
6 |
|
|
300.9 |
umol/g |
3.7 |
9.06 |
osmometry |
|
0.0 |
|
0 |
|
|
p osmolality mosm/kg |
|
102260 |
2682 |
SS/Hsd |
plasma osmolality |
controlled sodium content diet (0.4 %) (for 21 days) then intracerebroventricular cannula implantation then scrambled control oligodeoxynucleotide (4.17 ug/d) (for 21 days) then sham surgical control condition (for 21 days) |
Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. |
blood molecular composition trait |
male |
91 days-119 days |
6 |
|
|
301.4 |
umol/g |
4.2 |
10.29 |
osmometry |
|
0.0 |
|
0 |
|
|
p osmolality mosm/kg |
|
102261 |
2682 |
SS.BN-(D13Hmgc1041-D13Hmgc664)/Mcwi |
heart rate |
controlled sodium content diet (0.4 %) (between 23 and 32 days) |
Cowley AW Jr, et al., Physiol Genomics. 2016 Jan;48(1):62-72. doi: 10.1152/physiolgenomics.00097.2015. Epub 2015 Nov 3. |
heart pumping trait |
male |
44 days-53 days |
13 |
|
serial mean |
413.0 |
beats/min |
5.0 |
18.03 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
carotid a. to thoracic aorta implant |
strain 26-Q |
|
98518 |
2079 |
SS-Nppbem2Mcwi+/+ |
heart left ventricle end-diastolic diameter |
controlled sodium content diet (for 21 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-diastolic diameter |
male |
98 days
| 4 |
|
|
8.75 |
mm |
0.66 |
1.32 |
echocardiography |
|
0.0 |
|
0 |
|
|
|
|
99712 |
2319 |
SS.BN-(D13Rat151-D13Rat197)/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (0.4 %) (between 46 and 50.8 days) then controlled sodium content diet (8 %) (for 13.4 days) |
Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8. |
urine albumin amount |
male |
60 days-67 days |
14 |
|
|
147.0 |
mg/d |
18.0 |
67.35 |
urine microalbumin analysis |
|
0.0 |
|
0 |
|
|
|
|
98625 |
2098 |
SS.BN-(D13Hmgc5885-D13Rat32)/Mcwi |
heart rate |
controlled sodium content diet (0.4 %) (between 46 and 50.8 days) then controlled sodium content diet (8 %) (for 13.4 days) |
Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8. |
heart pumping trait |
male |
60 days-67 days |
14 |
|
serial mean |
402.0 |
beats/min |
9.0 |
33.67 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
intra-carotid radiotelemetry |
intra-carotid radiotelemetry |
|
98619 |
2098 |
SS.BN-(D13Got42-D13Rat130)/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (0.4 %) (between 46 and 50.8 days) then controlled sodium content diet (8 %) (for 13.4 days) |
Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8. |
urine albumin amount |
male |
60 days-67 days |
14 |
|
|
239.0 |
mg/d |
29.0 |
108.51 |
urine microalbumin analysis |
|
0.0 |
|
0 |
|
|
strain 26-C |
|
98628 |
2098 |
SS.BN-(D13Got42-D13Hmgc497)/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (0.4 %) (between 46 and 50.8 days) then controlled sodium content diet (8 %) (for 13.4 days) |
Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8. |
urine albumin amount |
male |
60 days-67 days |
7 |
|
|
75.0 |
mg/d |
18.0 |
47.62 |
urine microalbumin analysis |
|
0.0 |
|
0 |
|
|
strain 26-E |
|
98630 |
2098 |
SS.BN-(D13Hmgc5885-D13Rat32)/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (0.4 %) (between 46 and 50.8 days) then controlled sodium content diet (8 %) (for 13.4 days) |
Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8. |
urine albumin amount |
male |
60 days-67 days |
14 |
|
|
288.0 |
mg/d |
28.0 |
104.77 |
urine microalbumin analysis |
|
0.0 |
|
0 |
|
|
strain 26-I |
|
98634 |
2098 |
SS.BN-(D13Got45-D13Hmgc664)/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (0.4 %) (between 46 and 50.8 days) then controlled sodium content diet (8 %) (for 13.4 days) |
Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8. |
urine albumin amount |
male |
60 days-67 days |
14 |
|
|
167.0 |
mg/d |
28.0 |
104.77 |
urine microalbumin analysis |
|
0.0 |
|
0 |
|
|
strain 26-M |
|
98638 |
2098 |
LH/MavRrrcAek |
serum low density lipoprotein cholesterol level |
controlled sodium content diet (0.3 %) (for 105 days) then controlled sodium content diet (4 %) (for 21 days) |
Ma MCJ, et al., PLoS One. 2017 Aug 8;12(8):e0182650. doi: 10.1371/journal.pone.0182650. eCollection 2017. |
blood LDL cholesterol amount |
male |
126 days
| 7 |
|
|
33.5 |
mg/dl |
4.4 |
11.64 |
serum low-density lipoprotein-cholesterol measurement test |
|
0.0 |
|
0 |
|
|
|
|
102784 |
2722 |
SS/JrHsdMcwi |
urine albumin excretion rate |
controlled sodium content diet (0.4 %) (for 70 days) then controlled sodium content diet (8 %) (for 21 days) |
Flister MJ, et al., Hypertension. 2013 Apr;61(4):850-6. doi: 10.1161/HYPERTENSIONAHA.111.01008. Epub 2013 Mar 4. |
urine albumin amount |
male |
91 days
| 10 |
|
|
231.0 |
mg/d |
30.0 |
94.87 |
urine microalbumin analysis |
|
10800.0 |
|
0 |
|
|
|
|
98725 |
2142 |
SS.BN-(D13Hmgc64-4582)/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (0.4 %) (for 70 days) then controlled sodium content diet (8 %) (for 21 days) |
Flister MJ, et al., Hypertension. 2013 Apr;61(4):850-6. doi: 10.1161/HYPERTENSIONAHA.111.01008. Epub 2013 Mar 4. |
urine albumin amount |
male |
91 days
| 24 |
|
|
242.0 |
mg/d |
23.0 |
112.68 |
urine microalbumin analysis |
|
10800.0 |
|
0 |
|
|
Strain 9B |
|
98728 |
2142 |
SS.BN-(D13Hmgc64-RN34_13048990782)/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (0.4 %) (for 70 days) then controlled sodium content diet (8 %) (for 21 days) |
Flister MJ, et al., Hypertension. 2013 Apr;61(4):850-6. doi: 10.1161/HYPERTENSIONAHA.111.01008. Epub 2013 Mar 4. |
urine albumin amount |
male |
91 days
| 10 |
|
|
243.0 |
mg/d |
30.0 |
94.87 |
urine microalbumin analysis |
|
10800.0 |
|
0 |
|
|
|
|
98726 |
2142 |
SR/JrHsd |
both kidneys wet weight |
controlled sodium content diet (0.1 %) (for 112 days) then sham surgical control condition (between 56 and 63 days) |
Esqueda ME, et al., Hypertension. 2007 Oct;50(4):768-72. Epub 2007 Aug 13. |
kidney mass |
female |
112 days
| 6 |
|
|
1.57 |
g |
0.04 |
0.1 |
post excision weight measurement |
|
0.0 |
sham ovx |
63 |
days |
|
|
|
102349 |
2686 |
SS/JrHsd |
uterus weight |
controlled sodium content diet (0.1 %) (for 112 days) then bilateral ovariectomy (between 56 and 63 days) and 17 beta-estradiol (5 mg) (between 56 and 63 days) |
Esqueda ME, et al., Hypertension. 2007 Oct;50(4):768-72. Epub 2007 Aug 13. |
uterus mass |
female |
112 days
| 6 |
|
|
0.44 |
g |
0.01 |
0.02 |
post excision weight measurement |
|
0.0 |
ovx |
63 |
days |
|
|
|
102354 |
2686 |
SS-Renem1Mcwi+/+ |
body weight |
controlled sodium content diet (0.4 %) (for 49 days) |
Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17. |
body mass |
female |
70 days
| 8 |
|
|
204.5 |
g |
3.31 |
9.36 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
98292 |
2038 |
SS-Renem1Mcwi-/- |
heart weight to body weight ratio |
controlled sodium content diet (0.4 %) (for 49 days) |
Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17. |
heart mass |
male |
70 days
| 8 |
|
|
3.1 |
g/kg |
0.1 |
0.28 |
digital scale post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
98297 |
2038 |
SS-Renem1Mcwi+/- |
heart weight to body weight ratio |
controlled sodium content diet (0.4 %) (for 49 days) |
Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17. |
heart mass |
male |
70 days
| 9 |
|
|
3.6 |
g/kg |
0.1 |
0.3 |
digital scale post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
98296 |
2038 |
SS.SHR-(D9Mco113-D9Mco124)/Bj |
bone section surface density |
controlled sodium content diet (2 %) (between 38 and 42 days) |
Nie Y, et al., Physiol Genomics. 2016 Jun;48(6):409-19. doi: 10.1152/physiolgenomics.00004.2016. Epub 2016 Apr 25. |
tibia morphology trait |
male |
66 days-70 days |
0 |
|
|
954.9 |
mg/cm3 |
12.9 |
|
micro-computed tomography |
|
0.0 |
|
0 |
|
|
mg HA/ccm |
|
98015 |
1958 |
SS-Agtrapem4Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 10 days) |
Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4. |
arterial blood pressure trait |
male |
58 days-67 days |
0 |
|
serial mean |
131.0 |
mmHg |
3.0 |
|
intra-aortic abdominal radiotelemetry |
|
32400.0 |
|
0 |
|
|
|
|
98402 |
2059 |
SS-Clcn6em2Mcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 10 days) |
Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4. |
arterial blood pressure trait |
male |
58 days-67 days |
0 |
|
serial mean |
123.0 |
mmHg |
1.0 |
|
intra-aortic abdominal radiotelemetry |
|
32400.0 |
|
0 |
|
|
|
|
98400 |
2059 |
SS.BN-(D13Hmgc885-D13Hmgc664)/Mcwi |
diastolic blood pressure |
controlled sodium content diet (0.4 %) (between 23 and 32 days) |
Cowley AW Jr, et al., Physiol Genomics. 2016 Jan;48(1):62-72. doi: 10.1152/physiolgenomics.00097.2015. Epub 2015 Nov 3. |
arterial blood pressure trait |
male |
44 days-53 days |
10 |
|
serial mean |
86.0 |
mmHg |
2.0 |
6.32 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
carotid a. to thoracic aorta implant |
strain 26-R |
|
98491 |
2079 |
SS-Nppaem4Mcwi-/- |
diastolic blood pressure |
controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 10 days) |
Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4. |
arterial blood pressure trait |
male |
58 days-67 days |
0 |
|
serial mean |
143.0 |
mmHg |
5.0 |
|
intra-aortic abdominal radiotelemetry |
|
32400.0 |
|
0 |
|
|
|
|
98406 |
2059 |
SS.BN-(D13Hmgc1041-D13Hmgc664)/Mcwi |
diastolic blood pressure |
controlled sodium content diet (0.4 %) (between 23 and 32 days) then controlled sodium content diet (8 %) (for 14 days) |
Cowley AW Jr, et al., Physiol Genomics. 2016 Jan;48(1):62-72. doi: 10.1152/physiolgenomics.00097.2015. Epub 2015 Nov 3. |
arterial blood pressure trait |
male |
58 days-67 days |
13 |
|
serial mean |
141.0 |
mmHg |
4.0 |
14.42 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
carotid a. to thoracic aorta implant |
strain 26-Q |
|
98511 |
2079 |
SS.BN-(D13Hmgc1041-D13Hmgc664)/Mcwi |
systolic blood pressure |
controlled sodium content diet (0.4 %) (between 23 and 32 days) then controlled sodium content diet (8 %) (for 14 days) |
Cowley AW Jr, et al., Physiol Genomics. 2016 Jan;48(1):62-72. doi: 10.1152/physiolgenomics.00097.2015. Epub 2015 Nov 3. |
arterial blood pressure trait |
male |
58 days-67 days |
13 |
|
serial mean |
185.0 |
mmHg |
4.0 |
14.42 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
carotid a. to thoracic aorta implant |
strain 26-Q |
|
98504 |
2079 |
SS.BN-(D13Got42-D13Rat130)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (between 46 and 50.8 days) then controlled sodium content diet (8 %) (for 13.4 days) |
Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8. |
arterial blood pressure trait |
male |
60 days-67 days |
14 |
|
serial mean |
160.0 |
mmHg |
3.0 |
11.22 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
intra-carotid radiotelemetry |
strain 26-C |
|
98555 |
2098 |
SS.BN-(D13Hmgc86-D13Got22)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 68 days) then controlled sodium content diet (8 %) (for 21 days) |
Moreno C, et al., Am J Physiol Heart Circ Physiol. 2011 Apr;300(4):H1530-5. doi: 10.1152/ajpheart.01026.2010. Epub 2011 Jan 21. |
arterial blood pressure trait |
male |
89 days
| 16 |
|
serial mean |
161.0 |
mmHg |
4.0 |
16.0 |
intra-aortic abdominal radiotelemetry via femoral cannulation |
|
10800.0 |
|
0 |
|
|
strain 5-3 |
|
98676 |
2138 |
SS.BN-(D13Hmgc85-D13Got22)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 68 days) then controlled sodium content diet (8 %) (for 21 days) |
Moreno C, et al., Am J Physiol Heart Circ Physiol. 2011 Apr;300(4):H1530-5. doi: 10.1152/ajpheart.01026.2010. Epub 2011 Jan 21. |
arterial blood pressure trait |
male |
89 days
| 14 |
|
serial mean |
184.0 |
mmHg |
6.0 |
22.45 |
intra-aortic abdominal radiotelemetry via femoral cannulation |
|
10800.0 |
|
0 |
|
|
strain 5-6 |
|
98680 |
2138 |
SS.BN-(D13Rat111-D13Rat115)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 68 days) then controlled sodium content diet (8 %) (for 21 days) |
Moreno C, et al., Am J Physiol Heart Circ Physiol. 2011 Apr;300(4):H1530-5. doi: 10.1152/ajpheart.01026.2010. Epub 2011 Jan 21. |
arterial blood pressure trait |
male |
89 days
| 10 |
|
serial mean |
179.0 |
mmHg |
5.0 |
15.81 |
intra-aortic abdominal radiotelemetry via femoral cannulation |
|
10800.0 |
|
0 |
|
|
strain 5-8 |
|
98682 |
2138 |
SS.BN-(D13Hmgc86-D13Got22)/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (0.4 %) (for 68 days) then controlled sodium content diet (8 %) (for 21 days) |
Moreno C, et al., Am J Physiol Heart Circ Physiol. 2011 Apr;300(4):H1530-5. doi: 10.1152/ajpheart.01026.2010. Epub 2011 Jan 21. |
total urine protein amount |
male |
89 days
| 18 |
|
|
208.0 |
mg/d |
20.0 |
84.85 |
Bradford protein assay |
|
1.0 |
|
0 |
|
|
strain 5-3 |
|
98690 |
2138 |
SS/JrHsdMcwi |
urine total protein excretion rate |
controlled sodium content diet (0.4 %) (for 68 days) then controlled sodium content diet (8 %) (for 21 days) |
Moreno C, et al., Am J Physiol Heart Circ Physiol. 2011 Apr;300(4):H1530-5. doi: 10.1152/ajpheart.01026.2010. Epub 2011 Jan 21. |
total urine protein amount |
male |
89 days
| 16 |
|
|
365.0 |
mg/d |
37.0 |
148.0 |
Bradford protein assay |
|
1.0 |
|
0 |
|
|
|
|
98685 |
2138 |
SS-Chr 13BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (0.4 %) (for 68 days) then controlled sodium content diet (8 %) (for 21 days) |
Moreno C, et al., Am J Physiol Heart Circ Physiol. 2011 Apr;300(4):H1530-5. doi: 10.1152/ajpheart.01026.2010. Epub 2011 Jan 21. |
total urine protein amount |
male |
89 days
| 9 |
|
|
162.0 |
mg/d |
24.0 |
72.0 |
Bradford protein assay |
|
1.0 |
|
0 |
|
|
|
|
98686 |
2138 |
SS.BN-(D13Rat111-D13Got22)/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (0.4 %) (for 68 days) then controlled sodium content diet (8 %) (for 21 days) |
Moreno C, et al., Am J Physiol Heart Circ Physiol. 2011 Apr;300(4):H1530-5. doi: 10.1152/ajpheart.01026.2010. Epub 2011 Jan 21. |
total urine protein amount |
male |
89 days
| 12 |
|
|
304.0 |
mg/d |
53.0 |
183.6 |
Bradford protein assay |
|
1.0 |
|
0 |
|
|
|
|
98687 |
2138 |
SS.BN-(D13Hmgc40-D13Got22)/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (0.4 %) (for 68 days) then controlled sodium content diet (8 %) (for 21 days) |
Moreno C, et al., Am J Physiol Heart Circ Physiol. 2011 Apr;300(4):H1530-5. doi: 10.1152/ajpheart.01026.2010. Epub 2011 Jan 21. |
total urine protein amount |
male |
89 days
| 16 |
|
|
380.0 |
mg/d |
41.0 |
164.0 |
Bradford protein assay |
|
1.0 |
|
0 |
|
|
strain 5-5 |
|
98693 |
2138 |
SS.BN-(D13Rat77-D13Got22)/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (0.4 %) (for 68 days) then controlled sodium content diet (8 %) (for 21 days) |
Moreno C, et al., Am J Physiol Heart Circ Physiol. 2011 Apr;300(4):H1530-5. doi: 10.1152/ajpheart.01026.2010. Epub 2011 Jan 21. |
total urine protein amount |
male |
89 days
| 16 |
|
|
519.0 |
mg/d |
69.0 |
276.0 |
Bradford protein assay |
|
1.0 |
|
0 |
|
|
strain 5-7 |
|
98695 |
2138 |
SS.BN-(D13Rat25-RN34_13048990782)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 70 days) then controlled sodium content diet (8 %) (for 21 days) |
Hoffman MJ, et al., Hypertension. 2013 Sep;62(3):557-63. doi: 10.1161/HYPERTENSIONAHA.113.01708. Epub 2013 Jul 1. |
arterial blood pressure trait |
male |
91 days
| 21 |
|
serial mean |
169.0 |
mmHg |
6.0 |
27.5 |
intra-aortic abdominal radiotelemetry via femoral cannulation |
|
10800.0 |
|
0 |
|
|
strain 9C |
|
98703 |
2141 |
SS.BN-(D13Rat25-rs198199323)/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (0.4 %) (for 70 days) then controlled sodium content diet (8 %) (for 21 days) |
Hoffman MJ, et al., Hypertension. 2013 Sep;62(3):557-63. doi: 10.1161/HYPERTENSIONAHA.113.01708. Epub 2013 Jul 1. |
urine albumin amount |
male |
91 days
| 12 |
|
|
224.0 |
mg/d |
31.0 |
107.39 |
urine microalbumin analysis |
|
1.0 |
|
0 |
|
|
strain 9F |
|
98717 |
2141 |
SS/Jr |
heart rate |
controlled sodium content diet (0.3 %) (for 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Nie Y, et al., Physiol Genomics. 2016 Jun;48(6):409-19. doi: 10.1152/physiolgenomics.00004.2016. Epub 2016 Apr 25. |
heart pumping trait |
male |
68 days-70 days |
6 |
|
serial mean |
394.0 |
beats/min |
5.97 |
14.62 |
radiotelemetry |
|
0.0 |
|
0 |
|
|
|
|
98193 |
1958 |
SS/JrHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (between 23 and 32 days) then controlled sodium content diet (8 %) (for 14 days) |
Cowley AW Jr, et al., Physiol Genomics. 2016 Jan;48(1):62-72. doi: 10.1152/physiolgenomics.00097.2015. Epub 2015 Nov 3. |
arterial blood pressure trait |
male |
58 days-67 days |
14 |
|
serial mean |
163.0 |
mmHg |
4.0 |
14.97 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
carotid a. to thoracic aorta implant |
|
|
98493 |
2079 |
SS/NEisSlc |
systolic blood pressure |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) then tolvaptan (0.05 %) (for 49 days) |
Ishikawa M, et al., Int Heart J. 2013;54(2):98-106. |
arterial blood pressure trait |
male |
126 days
| 8 |
undefined |
|
235.0 |
mmHg |
13.0 |
36.77 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
|
102315 |
2684 |
SS/NEisSlc |
heart left ventricle fractional shortening |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) then vehicle control condition (for 49 days) |
Ishikawa M, et al., Int Heart J. 2013;54(2):98-106. |
heart left ventricle end-diastolic diameter |
male |
126 days
| 8 |
|
|
24.8 |
% |
1.2 |
3.39 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
|
|
|
102317 |
2684 |
SS/JrHsdMcwi |
urine albumin excretion rate |
controlled sodium content diet (0.4 %) (between 20 and 29 days) |
Cowley AW Jr, et al., Physiol Genomics. 2016 Jan;48(1):62-72. doi: 10.1152/physiolgenomics.00097.2015. Epub 2015 Nov 3. |
urine albumin amount |
male |
41 days-50 days |
14 |
|
|
2.8 |
mg/d |
0.5 |
1.87 |
urine microalbumin analysis |
|
86400.0 |
|
0 |
|
|
|
|
98528 |
2079 |
SS.BN-(D13Hmgc1048-D13Hmgc664)/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (0.4 %) (between 20 and 29 days) |
Cowley AW Jr, et al., Physiol Genomics. 2016 Jan;48(1):62-72. doi: 10.1152/physiolgenomics.00097.2015. Epub 2015 Nov 3. |
urine albumin amount |
male |
41 days-50 days |
15 |
|
|
1.7 |
mg/d |
0.4 |
1.55 |
urine microalbumin analysis |
|
86400.0 |
|
0 |
|
|
strain 26-N |
|
98529 |
2079 |
SS.BN-(D13Hmgc1048-D13Hmgc1045)/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (0.4 %) (between 20 and 29 days) |
Cowley AW Jr, et al., Physiol Genomics. 2016 Jan;48(1):62-72. doi: 10.1152/physiolgenomics.00097.2015. Epub 2015 Nov 3. |
urine albumin amount |
male |
41 days-50 days |
11 |
|
|
1.2 |
mg/d |
0.3 |
0.99 |
urine microalbumin analysis |
|
86400.0 |
|
0 |
|
|
strain 26-N |
|
98530 |
2079 |
SS.BN-(D13Hmgc1048-D13Hmgc1050)/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (0.4 %) (between 20 and 29 days) |
Cowley AW Jr, et al., Physiol Genomics. 2016 Jan;48(1):62-72. doi: 10.1152/physiolgenomics.00097.2015. Epub 2015 Nov 3. |
urine albumin amount |
male |
41 days-50 days |
11 |
|
|
2.2 |
mg/d |
0.3 |
0.99 |
urine microalbumin analysis |
|
86400.0 |
|
0 |
|
|
strain 26-P |
|
98531 |
2079 |
SS-Renem1Mcwi+/+ |
serum alanine aminotransferase activity level |
controlled sodium content diet (0.4 %) (for 42 days) |
Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17. |
blood alanine transaminase amount |
male |
63 days
| 5 |
|
|
33.4 |
U/l |
1.93 |
4.32 |
automated serum analysis |
|
0.0 |
|
0 |
|
|
|
|
98355 |
2038 |
SS-Renem1Mcwi+/+ |
serum chloride level |
controlled sodium content diet (0.4 %) (for 42 days) |
Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17. |
blood chloride amount |
female |
63 days
| 8 |
|
|
96.88 |
mmol/l |
0.56 |
1.58 |
automated serum electrolyte analysis |
|
0.0 |
|
0 |
|
|
|
|
98364 |
2038 |
SS.BN-(D13Hmgc5885-D13Rat32)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (between 46 and 50.8 days) then controlled sodium content diet (8 %) (for 13.4 days) |
Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8. |
arterial blood pressure trait |
male |
60 days-67 days |
14 |
|
serial mean |
170.0 |
mmHg |
5.0 |
18.71 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
intra-carotid radiotelemetry |
strain 26-I |
|
98561 |
2098 |
SS-Nppbem2Mcwi-/- |
heart left ventricle end-diastolic posterior wall thickness |
controlled sodium content diet (for 21 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle posterior wall thickness |
male |
98 days
| 4 |
|
|
1.87 |
mm |
0.2 |
0.4 |
echocardiography |
|
0.0 |
|
0 |
|
|
|
|
99715 |
2319 |
SS.SHR-(D9Mco113-D9Mco124)/Bj |
bone section mineralized tissue volume |
controlled sodium content diet (2 %) (between 38 and 42 days) |
Nie Y, et al., Physiol Genomics. 2016 Jun;48(6):409-19. doi: 10.1152/physiolgenomics.00004.2016. Epub 2016 Apr 25. |
tibia morphology trait |
male |
66 days-70 days |
0 |
|
|
2.04 |
mm3 |
0.14 |
|
micro-computed tomography |
|
0.0 |
|
0 |
|
|
bone volume |
|
98020 |
1958 |
SS/JrIpcv |
plasma triglyceride level |
controlled sodium content diet (0.3 %) |
Hojn¿ S, et al., Physiol Res. 2005;54(2):201-6. |
blood triglyceride amount |
male |
0 days
| 0 |
|
|
1.2 |
mmol/l |
0.16 |
|
plasma triglyceride analysis |
|
0.0 |
|
0 |
|
|
|
|
102402 |
2688 |
SS-Clcn6em2Mcwi |
single kidney wet weight |
controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 12 days) |
Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4. |
kidney mass |
male |
60 days-69 days |
0 |
|
|
1.53 |
g |
0.04 |
|
digital scale post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
98454 |
2059 |
SS/Hsd |
single kidney wet weight |
controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 12 days) |
Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4. |
kidney mass |
male |
60 days-69 days |
0 |
|
|
1.46 |
g |
0.02 |
|
digital scale post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
98457 |
2059 |
SS.BN-(D13Hmgc885-D13Hmgc664)/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (0.4 %) (between 23 and 32 days) then controlled sodium content diet (8 %) (for 14 days) |
Cowley AW Jr, et al., Physiol Genomics. 2016 Jan;48(1):62-72. doi: 10.1152/physiolgenomics.00097.2015. Epub 2015 Nov 3. |
urine albumin amount |
male |
59 days-68 days |
10 |
|
|
240.0 |
mg/d |
35.0 |
110.68 |
urine microalbumin analysis |
|
86400.0 |
|
0 |
|
|
strain 26-R |
|
98540 |
2079 |
SS/Hsd |
urine creatinine excretion rate |
controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 12 days) |
Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4. |
urine creatinine amount |
male |
60 days-69 days |
0 |
|
|
11.5 |
mg/d |
0.4 |
|
urine creatinine analysis |
|
0.0 |
|
0 |
|
|
|
|
98443 |
2059 |
WKY/NHsd |
skin chloride level to skin dry weight ratio |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
skin chloride amount |
male |
0 days
| 7 |
|
|
0.07 |
mmol/g |
0.01 |
0.02 |
ex vivo analysis of atomic composition following dry ashing |
|
0.0 |
|
0 |
|
ashed skin |
skin cl mmol/g |
|
99137 |
2238 |
SS-Nppaem4Mcwi-/- |
urine total protein excretion rate |
controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 12 days) |
Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4. |
total urine protein amount |
male |
60 days-69 days |
0 |
|
|
73.0 |
mg/d |
8.0 |
|
urine total protein analysis |
|
0.0 |
|
0 |
|
|
|
|
98432 |
2059 |
SS.SHR-(D9Mco113-D9Mco124)/Bj |
systolic blood pressure |
controlled sodium content diet (0.3 %) (for 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Nie Y, et al., Physiol Genomics. 2016 Jun;48(6):409-19. doi: 10.1152/physiolgenomics.00004.2016. Epub 2016 Apr 25. |
arterial blood pressure trait |
male |
68 days-70 days |
6 |
|
serial mean |
164.0 |
mmHg |
5.22 |
12.79 |
radiotelemetry |
|
0.0 |
|
0 |
|
|
|
|
97953 |
1958 |
SS/NEisSlc |
serum chloride level |
controlled sodium content diet (8 %) (for 42 days) then 0.9% sodium chloride solution (0.3 ml) (for 42 days) |
Otsuka F, et al., Am J Physiol. 1998 Jun;274(6 Pt 2):R1797-806. |
blood chloride amount |
male |
91 days
| 12 |
|
|
101.1 |
mmol/l |
1.61 |
5.58 |
automated serum chloride test |
|
0.0 |
|
0 |
|
|
|
|
100662 |
2519 |
SS/JrHsdMcwi |
systolic blood pressure |
controlled sodium content diet (0.4 %) (between 46 and 50.8 days) then controlled sodium content diet (8 %) (for 13.4 days) |
Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8. |
arterial blood pressure trait |
male |
60 days-67 days |
12 |
|
serial mean |
204.0 |
mmHg |
4.0 |
13.86 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
intra-carotid radiotelemetry |
|
|
98566 |
2098 |
SR/NEisSlc |
serum sodium level |
controlled sodium content diet (0.3 %) (for 91 days) |
Otsuka F, et al., Am J Physiol. 1998 Jun;274(6 Pt 2):R1797-806. |
blood sodium amount |
male |
91 days
| 6 |
|
|
138.0 |
mmol/l |
5.76 |
14.11 |
automated serum sodium test |
|
0.0 |
|
0 |
|
|
|
|
100653 |
2519 |
SS/NEisSlc |
urine aldosterone excretion rate |
controlled sodium content diet (8 %) (for 49 days) then 0.9% sodium chloride solution (0.3 ml) (for 42 days) |
Otsuka F, et al., Am J Physiol. 1998 Jun;274(6 Pt 2):R1797-806. |
urine aldosterone amount |
male |
49 days
| 30 |
|
|
13.84 |
ng/d |
1.27 |
6.96 |
radioimmunoassay |
|
0.0 |
|
0 |
|
|
ng/d |
|
100692 |
2519 |
SS/NEisSlc |
kidney weight |
controlled sodium content diet (8 %) (for 42 days) then 0.9% sodium chloride solution (0.3 ml) (for 42 days) |
Otsuka F, et al., Am J Physiol. 1998 Jun;274(6 Pt 2):R1797-806. |
kidney mass |
male |
91 days
| 12 |
|
|
1.83 |
g |
0.03 |
0.11 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
100701 |
2519 |
SS/NEisSlc |
heart weight |
controlled sodium content diet (8 %) (for 42 days) then candesartan (1 mg/kg/d) (for 42 days) |
Otsuka F, et al., Am J Physiol. 1998 Jun;274(6 Pt 2):R1797-806. |
heart mass |
male |
91 days
| 6 |
|
|
1.49 |
g |
0.05 |
0.12 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
100710 |
2519 |
SS/NEisSlc |
single kidney wet weight to body weight ratio |
controlled sodium content diet (8 %) (for 42 days) then candesartan (1 mg/kg/d) (for 42 days) |
Otsuka F, et al., Am J Physiol. 1998 Jun;274(6 Pt 2):R1797-806. |
kidney mass |
male |
91 days
| 6 |
|
|
5.39 |
g/kg |
0.15 |
0.37 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
100715 |
2519 |
SD-Nfe2l2em1Mcwi-/- |
body weight |
controlled sodium content diet (0.4 %) (between 70 and 84 days) |
Priestley JR, et al., Am J Physiol Heart Circ Physiol. 2016 Feb 15;310(4):H478-87. doi: 10.1152/ajpheart.00586.2015. Epub 2015 Dec 4. |
body mass |
male |
56 days-70 days |
4 |
|
|
287.0 |
g |
26.7 |
53.4 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
100732 |
2520 |
SS-Renem1Mcwi+/+ |
timed urine volume |
controlled sodium content diet (0.4 %) (for 35 days) |
Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17. |
urine output |
male |
56 days
| 5 |
|
|
7.72 |
ml/d |
1.55 |
3.47 |
metabolic cage urine volume measurement method |
|
0.0 |
|
0 |
|
|
|
|
98313 |
2038 |
SS-Renem1Mcwi+/- |
urine total protein excretion rate |
controlled sodium content diet (0.4 %) (for 35 days) |
Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17. |
total urine protein amount |
male |
56 days
| 9 |
|
|
85.47 |
mg/d |
10.93 |
32.79 |
urine total protein analysis |
|
0.0 |
|
0 |
|
|
|
|
98320 |
2038 |
SS-Renem1Mcwi-/- |
urine total protein excretion rate |
controlled sodium content diet (0.4 %) (for 35 days) |
Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17. |
total urine protein amount |
female |
56 days
| 4 |
|
|
12.75 |
mg/d |
8.08 |
16.16 |
urine total protein analysis |
|
0.0 |
|
0 |
|
|
|
|
98324 |
2038 |
SS-Renem1Mcwi+/+ |
urine sodium excretion rate |
controlled sodium content diet (0.4 %) (for 35 days) |
Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17. |
urine sodium amount |
male |
56 days
| 5 |
|
|
0.65 |
mEq/d |
0.25 |
0.56 |
urine sodium analysis |
|
0.0 |
|
0 |
|
|
|
|
98325 |
2038 |
SS-Renem1Mcwi-/- |
urine sodium excretion rate |
controlled sodium content diet (0.4 %) (for 35 days) |
Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17. |
urine sodium amount |
female |
56 days
| 4 |
|
|
0.34 |
mEq/d |
0.14 |
0.28 |
urine sodium analysis |
|
0.0 |
|
0 |
|
|
|
|
98330 |
2038 |
SS-Renem1Mcwi+/- |
serum creatinine level |
controlled sodium content diet (0.4 %) (for 42 days) |
Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17. |
blood creatinine amount |
male |
63 days
| 9 |
|
|
0.26 |
mg/dl |
0.02 |
0.06 |
serum creatinine analysis |
|
0.0 |
|
0 |
|
|
|
|
98344 |
2038 |
SS-Renem1Mcwi+/- |
serum urea nitrogen level |
controlled sodium content diet (0.4 %) (for 42 days) |
Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17. |
blood urea nitrogen amount |
female |
63 days
| 4 |
|
|
108.0 |
mg/dl |
3.24 |
6.48 |
serum urea nitrogen analysis |
|
0.0 |
|
0 |
|
|
|
|
98342 |
2038 |
SS-Renem1Mcwi+/+ |
creatinine clearance to total kidney weight ratio |
controlled sodium content diet (0.4 %) (for 42 days) |
Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17. |
glomerular filtration trait |
male |
63 days
| 5 |
|
|
0.9 |
ml/min/g |
0.1 |
0.22 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
|
98349 |
2038 |
SS-Renem1Mcwi+/- |
creatinine clearance to total kidney weight ratio |
controlled sodium content diet (0.4 %) (for 42 days) |
Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17. |
glomerular filtration trait |
female |
63 days
| 9 |
|
|
0.79 |
ml/min/g |
0.07 |
0.21 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
|
98353 |
2038 |
WKY/NHsd |
creatinine clearance |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
glomerular filtration trait |
male |
0 days
| 8 |
|
|
3.5 |
ml/min |
0.2 |
0.57 |
urine creatinine analysis |
|
0.0 |
|
0 |
|
|
|
|
99182 |
2238 |
SS/Jr |
diastolic blood pressure |
controlled sodium content diet (0.3 %) (for 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Nie Y, et al., Physiol Genomics. 2016 Jun;48(6):409-19. doi: 10.1152/physiolgenomics.00004.2016. Epub 2016 Apr 25. |
arterial blood pressure trait |
male |
68 days-70 days |
8 |
|
serial mean |
152.0 |
mmHg |
6.49 |
18.36 |
radiotelemetry |
|
0.0 |
|
0 |
|
|
|
|
97987 |
1958 |
F344-Hsd11b2em1Jmul-/- |
food intake rate |
controlled sodium content diet (0.3 %) |
Mullins LJ, et al., Hypertension. 2015 Sep;66(3):667-73. doi: 10.1161/HYPERTENSIONAHA.115.05262. Epub 2015 Jun 15. |
eating behavior trait |
male |
161 days
| 5 |
|
|
15.82 |
g/d |
0.43 |
0.96 |
food intake measuring method |
|
0.0 |
|
0 |
|
|
|
|
104998 |
3008 |
F344-Hsd11b2em1Jmul+/+ |
food intake rate |
controlled sodium content diet (0.3 %) then controlled sodium content diet (0.03 %) (between 7 and 10 days) |
Mullins LJ, et al., Hypertension. 2015 Sep;66(3):667-73. doi: 10.1161/HYPERTENSIONAHA.115.05262. Epub 2015 Jun 15. |
eating behavior trait |
male |
168 days
| 5 |
|
|
13.6 |
g/d |
0.3 |
0.67 |
food intake measuring method |
|
0.0 |
|
0 |
|
|
|
|
105001 |
3008 |
F344-Hsd11b2em1Jmul-/- |
timed urine volume |
controlled sodium content diet (0.3 %) then controlled sodium content diet (0.03 %) (between 7 and 10 days) |
Mullins LJ, et al., Hypertension. 2015 Sep;66(3):667-73. doi: 10.1161/HYPERTENSIONAHA.115.05262. Epub 2015 Jun 15. |
urine output |
male |
168 days
| 5 |
|
|
3.8 |
ml/d |
0.3 |
0.67 |
urine volume measurement method |
|
0.0 |
|
0 |
|
|
|
|
105014 |
3008 |
F344-Hsd11b2em1Jmul-/- |
urine sodium level |
controlled sodium content diet (0.3 %) |
Mullins LJ, et al., Hypertension. 2015 Sep;66(3):667-73. doi: 10.1161/HYPERTENSIONAHA.115.05262. Epub 2015 Jun 15. |
urine sodium amount |
male |
161 days
| 5 |
|
|
1075.1 |
mmol/l |
45.6 |
101.96 |
urine sodium analysis |
|
0.0 |
|
0 |
|
|
|
|
105022 |
3008 |
F344-Hsd11b2em1Jmul+/+ |
urine sodium level |
controlled sodium content diet (0.3 %) |
Mullins LJ, et al., Hypertension. 2015 Sep;66(3):667-73. doi: 10.1161/HYPERTENSIONAHA.115.05262. Epub 2015 Jun 15. |
urine sodium amount |
male |
161 days
| 4 |
|
|
817.2 |
mmol/l |
39.6 |
79.2 |
urine sodium analysis |
|
0.0 |
|
0 |
|
|
|
|
105021 |
3008 |
F344-Hsd11b2em1Jmul-/- |
urine sodium level to urine potassium level ratio |
controlled sodium content diet (0.3 %) |
Mullins LJ, et al., Hypertension. 2015 Sep;66(3):667-73. doi: 10.1161/HYPERTENSIONAHA.115.05262. Epub 2015 Jun 15. |
urine sodium amount |
male |
161 days
| 5 |
|
|
0.53 |
null |
0.01 |
0.02 |
urine electrolyte analysis |
|
0.0 |
|
0 |
|
|
|
|
105034 |
3008 |
F344-Hsd11b2em1Jmul-/- |
urine sodium level to urine potassium level ratio |
controlled sodium content diet (0.3 %) then controlled sodium content diet (3 %) (between 7 and 10 days) |
Mullins LJ, et al., Hypertension. 2015 Sep;66(3):667-73. doi: 10.1161/HYPERTENSIONAHA.115.05262. Epub 2015 Jun 15. |
urine sodium amount |
male |
168 days
| 5 |
|
|
7.54 |
null |
0.39 |
0.87 |
urine electrolyte analysis |
|
0.0 |
|
0 |
|
|
|
|
105036 |
3008 |
SS-Plekha7em4Mcwi-/- |
urine sodium level |
controlled sodium content diet (8 %) (for 28 days) |
Endres BT, et al., Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12817-22. doi: 10.1073/pnas.1410745111. Epub 2014 Aug 18. |
urine sodium amount |
male |
91 days
| 10 |
|
|
306.0 |
mmol/l |
30.0 |
94.87 |
urine sodium analysis |
|
0.0 |
|
0 |
|
|
|
|
105783 |
3022 |
SS-Plekha7em4Mcwi+/+ |
urine potassium level |
controlled sodium content diet (8 %) (for 7 days) |
Endres BT, et al., Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12817-22. doi: 10.1073/pnas.1410745111. Epub 2014 Aug 18. |
urine potassium amount |
male |
70 days
| 10 |
|
|
19.8 |
mmol/l |
1.7 |
5.38 |
urine potassium analysis |
|
0.0 |
|
0 |
|
|
|
|
105786 |
3022 |
SS-Plekha7em4Mcwi+/+ |
both kidneys wet weight as percentage of body weight |
controlled sodium content diet (8 %) (for 28 days) |
Endres BT, et al., Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12817-22. doi: 10.1073/pnas.1410745111. Epub 2014 Aug 18. |
kidney mass |
male |
91 days
| 10 |
|
|
4.31 |
% |
0.1 |
0.32 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
105744 |
3022 |
SS-Plekha7em4Mcwi+/+ |
renal medulla volume |
controlled sodium content diet (8 %) (for 28 days) |
Endres BT, et al., Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12817-22. doi: 10.1073/pnas.1410745111. Epub 2014 Aug 18. |
kidney medulla morphology trait |
male |
91 days
| 10 |
|
|
450.0 |
mm3 |
33.0 |
104.36 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
0 |
|
|
|
|
105746 |
3022 |
SS-Plekha7em4Mcwi-/- |
renal medulla volume |
controlled sodium content diet (8 %) (for 28 days) |
Endres BT, et al., Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12817-22. doi: 10.1073/pnas.1410745111. Epub 2014 Aug 18. |
kidney medulla morphology trait |
male |
91 days
| 10 |
|
|
497.0 |
mm3 |
14.0 |
44.27 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
0 |
|
|
|
|
105747 |
3022 |
SS-Plekha7em4Mcwi-/- |
heart weight |
controlled sodium content diet (8 %) (for 28 days) |
Endres BT, et al., Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12817-22. doi: 10.1073/pnas.1410745111. Epub 2014 Aug 18. |
heart mass |
male |
91 days
| 10 |
|
|
1.71 |
g |
0.04 |
0.13 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
105755 |
3022 |
SS-Plekha7em4Mcwi-/- |
timed urine volume |
controlled sodium content diet (8 %) (for 21 days) |
Endres BT, et al., Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12817-22. doi: 10.1073/pnas.1410745111. Epub 2014 Aug 18. |
urine output |
male |
84 days
| 10 |
|
|
71.34 |
ml/d |
2.26 |
7.15 |
urine volume measurement method |
|
0.0 |
|
0 |
|
|
|
|
105771 |
3022 |
SS-Plekha7em4Mcwi+/+ |
urine potassium level |
controlled sodium content diet (8 %) (for 14 days) |
Endres BT, et al., Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12817-22. doi: 10.1073/pnas.1410745111. Epub 2014 Aug 18. |
urine potassium amount |
male |
77 days
| 10 |
|
|
20.9 |
mmol/l |
1.5 |
4.74 |
urine potassium analysis |
|
0.0 |
|
0 |
|
|
|
|
105788 |
3022 |
SS-Plekha7em4Mcwi+/+ |
body weight |
controlled sodium content diet (0.4 %) (for 42 days) |
Endres BT, et al., Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12817-22. doi: 10.1073/pnas.1410745111. Epub 2014 Aug 18. |
body mass |
male |
63 days
| 10 |
|
|
250.0 |
g |
8.0 |
25.3 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
105736 |
3022 |
SS-Plekha7em4Mcwi+/+ |
body weight |
controlled sodium content diet (8 %) (for 28 days) |
Endres BT, et al., Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12817-22. doi: 10.1073/pnas.1410745111. Epub 2014 Aug 18. |
body mass |
male |
91 days
| 10 |
|
|
371.0 |
g |
5.0 |
15.81 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
105742 |
3022 |
SS-Plekha7em4Mcwi+/+ |
urine albumin excretion rate |
controlled sodium content diet (8 %) (for 28 days) |
Endres BT, et al., Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12817-22. doi: 10.1073/pnas.1410745111. Epub 2014 Aug 18. |
urine albumin amount |
male |
91 days
| 10 |
|
|
211.0 |
mg/d |
22.0 |
69.57 |
urine albumin analysis |
|
0.0 |
|
0 |
|
|
|
|
105738 |
3022 |
SHRSP/A3NCrl |
brain infarction volume |
controlled protein content diet (16 %) (for 63 days) and controlled sodium content diet (4 %) (for 63 days) and controlled potassium content diet (0.75 %) (for 63 days) and unilateral carotid artery occlusion (for 63 days) then dimethyl sulfoxide (30 %) (for 63 days) and Kolliphor HS 15 (25 %) (for 0 hours) |
Yang Y, etal., Neurobiol Dis. 2018 Jun;114:95-110. doi: 10.1016/j.nbd.2018.02.012. Epub 2018 Feb 24. |
brain integrity trait |
male |
147 days
| 8 |
|
|
53.0 |
mm3 |
7.4 |
20.93 |
magnetic resonance imaging |
corpus callosum |
0.0 |
|
0 |
|
corpus callosum-right hemisphere |
corpus callosum-right hemisphere |
|
107287 |
3079 |
SHRSP/A3NCrl |
partial pressure of brain white matter oxygen |
right carotid artery occlusion then controlled protein content diet (16 %) (for 7 days) and controlled sodium content diet (4 %) (for 7 days) and controlled potassium content diet (0.75 %) (for 7 days) and controlled sodium chloride content drinking water (1 %) (for 7 days) |
Weaver J, etal., J Cereb Blood Flow Metab. 2014 May;34(5):890-6. doi: 10.1038/jcbfm.2014.35. Epub 2014 Feb 19. |
brain oxygen amount |
male |
91 days
| 17 |
|
|
19.5 |
mmHg |
1.2 |
4.95 |
electron paramagnetic resonance oximetry |
white matter |
40.0 |
|
0 |
|
5 scans x 40 seconds |
|
|
107325 |
3080 |
SHRSP/A3NCrl |
partial pressure of brain white matter oxygen |
right carotid artery occlusion then controlled protein content diet (16 %) (for 14 days) and controlled sodium content diet (4 %) (for 14 days) and controlled potassium content diet (0.75 %) (for 14 days) and controlled sodium chloride content drinking water (1 %) (for 14 days) |
Weaver J, etal., J Cereb Blood Flow Metab. 2014 May;34(5):890-6. doi: 10.1038/jcbfm.2014.35. Epub 2014 Feb 19. |
brain oxygen amount |
male |
98 days
| 17 |
|
|
15.1 |
mmHg |
1.2 |
4.95 |
electron paramagnetic resonance oximetry |
white matter |
40.0 |
|
0 |
|
5 scans x 40 seconds |
|
|
107326 |
3080 |
SS-Chr 7BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
female |
80 days-99 days |
11 |
|
|
14.58 |
mEq/d |
1.41 |
4.68 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52745 |
482 |
SS-Chr 13BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
female |
80 days-99 days |
20 |
|
|
8.83 |
mEq/d |
0.82 |
3.65 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52753 |
482 |
SS-Chr 12BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
female |
80 days-99 days |
8 |
|
|
19.17 |
mEq/d |
2.94 |
8.3 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52775 |
482 |
SS-Chr 18BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
renin activity |
male |
87 days-120 days |
5 |
|
|
0.3 |
ng/ml/h |
0.03 |
0.07 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50535 |
481 |
SS-Chr 16BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
renin activity |
female |
87 days-120 days |
5 |
|
|
1.57 |
ng/ml/h |
0.07 |
0.16 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50538 |
481 |
WKY/NCrl |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
9 |
|
|
118.22 |
mmHg |
2.65 |
7.94 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
50546 |
481 |
SHR/NCrl |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
9 |
|
|
-11.11 |
beats/min |
8.75 |
26.25 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50618 |
481 |
BN/NHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
9 |
|
|
0.28 |
beats/min |
13.27 |
39.81 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50624 |
481 |
SS/JrHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
10 |
|
|
-17.53 |
mmHg |
2.45 |
7.75 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50632 |
481 |
GH/OmrMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
5 |
|
|
161.63 |
mmHg |
6.61 |
14.78 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50643 |
481 |
FHH/EurMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
10 |
|
|
124.75 |
mmHg |
1.05 |
3.31 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50649 |
481 |
SS-Chr 9BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
6 |
|
|
46.25 |
mmHg |
3.11 |
7.61 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50660 |
481 |
SS/JrHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
13 |
|
|
17.49 |
beats/min |
12.18 |
43.9 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50680 |
481 |
SS-Chr 9BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
5 |
|
|
6.32 |
mmHg |
3.54 |
7.91 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50702 |
481 |
SHR/NCrl |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
1 |
|
|
-21.2 |
beats/min |
|
|
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50682 |
481 |
BN/NHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
4 |
|
|
34.55 |
beats/min |
25.93 |
51.86 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50688 |
481 |
SS-Chr 9BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
15 |
|
|
131.76 |
mmHg |
1.99 |
7.71 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50741 |
481 |
FHH/EurMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
4 |
|
|
2.03 |
mmHg |
7.31 |
14.61 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50811 |
481 |
SS/JrHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
5 |
|
|
8.29 |
beats/min |
21.22 |
47.46 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50905 |
481 |
SS/JrHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
15 |
|
|
10.04 |
mmHg |
1.85 |
7.15 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50913 |
481 |
SS-Chr 9BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
12 |
|
|
6.66 |
mmHg |
2.3 |
7.96 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50918 |
481 |
FHH/EurMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
5 |
|
|
122.29 |
mmHg |
2.81 |
6.29 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50938 |
481 |
SS-Chr 9BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
6 |
|
|
128.48 |
mmHg |
4.68 |
11.46 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50946 |
481 |
Hsd:SD |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
14 |
|
|
13.28 |
mmHg |
2.14 |
8.01 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
50958 |
481 |
Hsd:SD |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
14 |
|
|
1.22 |
mmHg |
1.8 |
6.74 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
51039 |
481 |
Crl:CD(SD) |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
7 |
|
|
-15.09 |
beats/min |
14.75 |
39.03 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51036 |
481 |
FHH/EurMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
6 |
|
|
-15.33 |
beats/min |
20.43 |
50.04 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51071 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
5 |
|
|
0.91 |
mmHg |
0.96 |
2.14 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51082 |
481 |
GH/OmrMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
3 |
|
|
-11.72 |
beats/min |
10.1 |
17.5 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51090 |
481 |
GH/OmrMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
7 |
|
|
8.62 |
mmHg |
1.62 |
4.27 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51107 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
7 |
|
|
-18.16 |
beats/min |
10.99 |
29.07 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51215 |
481 |
BN/NHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
8 |
|
|
-1.39 |
beats/min |
7.41 |
20.95 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51240 |
481 |
BN/NHsdMcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
1 |
|
|
432.84 |
beats/min |
|
|
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51254 |
481 |
GH/OmrMcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
10 |
|
|
415.95 |
beats/min |
4.14 |
13.08 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51282 |
481 |
SHR/NCrl |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
male |
87 days-120 days |
5 |
|
|
0.28 |
mg/dl |
0.01 |
0.03 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51315 |
481 |
SS-Chr 16BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
5 |
|
|
108.6 |
mmHg |
0.71 |
1.58 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51326 |
481 |
SS.SHR-(D9Mco72-D9Uia4)/Mco |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days) |
Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4. |
arterial blood pressure trait |
not specified |
65 days-70 days |
0 |
|
|
181.0 |
mmHg |
3.91 |
|
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
|
67516 |
749 |
SS.SHR-(D9Rat7-D9Got111)/Mco |
body weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days) |
Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4. |
body mass |
not specified |
0 days
| 0 |
|
|
347.0 |
g |
4.08 |
|
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
67539 |
749 |
SS.SHR-(D9Mco72-D9Mco106)/Mco |
body weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days) |
Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4. |
body mass |
not specified |
0 days
| 0 |
|
|
300.0 |
g |
4.41 |
|
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
67536 |
749 |
SS/Jr |
heart wet weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) |
Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4. |
heart mass |
not specified |
0 days
| 0 |
|
|
1.68 |
g |
0.06 |
|
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
67552 |
749 |
SS.SHR-(D9Rat7-D9Rat84)/Mco |
heart wet weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) |
Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4. |
heart mass |
not specified |
0 days
| 0 |
|
|
1.38 |
g |
0.02 |
|
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
67557 |
749 |
SS.SHR-(D9Rat7-D9Mco91)/Mco |
heart wet weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) |
Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4. |
heart mass |
not specified |
0 days
| 0 |
|
|
1.52 |
g |
0.01 |
|
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
67560 |
749 |
SS.SHR-(D9Mco72-D9Mco109)/Mco |
heart weight to body weight ratio |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) |
Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4. |
heart mass |
not specified |
0 days
| 0 |
|
|
4.01 |
g/kg |
0.03 |
|
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
67565 |
749 |
SS/Jr |
heart weight to body weight ratio |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) |
Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4. |
heart mass |
not specified |
0 days
| 0 |
|
|
4.19 |
g/kg |
0.08 |
|
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
67562 |
749 |
SS/Jr |
heart weight to body weight ratio |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) |
Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4. |
heart mass |
not specified |
0 days
| 0 |
|
|
4.24 |
g/kg |
0.1 |
|
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
67575 |
749 |
SS/Jr |
urine total protein excretion rate |
controlled sodium content diet (2 %) (between 30 and 33 days) |
Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4. |
total urine protein amount |
not specified |
78 days-83 days |
0 |
|
|
102.0 |
mg/d |
6.81 |
|
pyrogallol red-molybdate complex-based urine total protein analysis |
|
0.0 |
|
0 |
|
|
|
|
67588 |
749 |
SS/JrHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
3 |
|
|
-20.8 |
beats/min |
34.71 |
60.12 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51405 |
481 |
F344/DuCrl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
7 |
|
|
2.02 |
mmHg |
2.22 |
5.88 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51418 |
481 |
GH/OmrMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
6 |
|
|
38.71 |
mmHg |
5.37 |
13.15 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51424 |
481 |
SS/JrHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
17 |
|
|
30.86 |
mmHg |
2.26 |
9.32 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51421 |
481 |
SS/JrHsdMcwi |
urine total protein excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
total urine protein amount |
male |
87 days-120 days |
20 |
|
|
132.7 |
mg/d |
21.27 |
95.13 |
automated urine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51435 |
481 |
SS/JrHsdMcwi |
urine total protein excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
total urine protein amount |
female |
87 days-120 days |
11 |
|
|
41.53 |
mg/d |
8.23 |
27.31 |
automated urine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51441 |
481 |
SHR/NCrl |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
male |
87 days-120 days |
8 |
|
|
1.08 |
mEq/d |
0.16 |
0.45 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51521 |
481 |
BN/NHsdMcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
male |
87 days-120 days |
10 |
|
|
1.17 |
mEq/d |
0.16 |
0.49 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51527 |
481 |
FHH/EurMcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
female |
87 days-120 days |
6 |
|
|
0.27 |
mg/dl |
0.01 |
0.02 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51535 |
481 |
SS-Chr 16BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
male |
87 days-120 days |
6 |
|
|
0.3 |
mg/dl |
0.06 |
0.15 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51538 |
481 |
SS-Chr 16BN/Mcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
female |
87 days-120 days |
5 |
|
|
1.27 |
ml/min |
0.09 |
0.19 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51543 |
481 |
SS-Chr 16BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
total urine protein amount |
female |
87 days-120 days |
6 |
|
|
19.21 |
mg/d |
2.42 |
5.92 |
automated urine analysis |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51555 |
481 |
SS-Chr 16BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
total urine protein amount |
male |
87 days-120 days |
8 |
|
|
24.09 |
mg/d |
2.71 |
7.66 |
automated urine analysis |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51557 |
481 |
SS/JrHsdMcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
18 |
|
|
400.82 |
beats/min |
9.27 |
39.31 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51577 |
481 |
SS-Chr 18BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
1 |
|
|
129.04 |
mmHg |
|
|
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51630 |
481 |
WKY/NCrl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
9 |
|
|
-1.31 |
mmHg |
3.14 |
9.41 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
51622 |
481 |
SS.LEW-(D8Rat56-D8Rat51)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
arterial blood pressure trait |
male |
68 days-98 days |
9 |
|
|
197.0 |
mmHg |
6.0 |
18.0 |
radiotelemetry |
|
30 |
|
0 |
|
|
|
|
11950 |
226 |
SS.LEW-(D16Rat12-D16Chm23)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
arterial blood pressure trait |
male |
68 days-98 days |
10 |
|
|
167.0 |
mmHg |
8.0 |
25.3 |
radiotelemetry |
|
30 |
|
0 |
|
|
|
|
11959 |
226 |
SS/JrHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 28 days) then controlled sodium content diet (8 %) (for 31 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 1.5 days) then controlled exposure to ambient light (for 12 hours) |
Cowley AW Jr, et al., Physiol Genomics 2000 Apr 27;2(3):107-15. |
arterial blood pressure trait |
male |
96 days
| 24 |
|
continuous mean |
141.0 |
mmHg |
5.0 |
24.49 |
vascular indwelling catheter method |
femoral artery |
10800.0 |
|
0 |
|
left femoral artery |
|
|
12038 |
229 |
Crl:CD(SD) |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
urine sodium amount |
male |
87 days-120 days |
9 |
|
|
13.41 |
mEq/d |
1.64 |
4.91 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51639 |
481 |
FHH/EurMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
8 |
|
|
-33.0 |
beats/min |
25.62 |
72.46 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50348 |
481 |
SS-Chr 20BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
1 |
|
|
8.0 |
beats/min |
|
|
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50354 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
5 |
|
|
-40.59 |
beats/min |
39.51 |
88.34 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50345 |
481 |
BN/NHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
8 |
|
|
-34.84 |
beats/min |
18.09 |
51.17 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50362 |
481 |
FHH/EurMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
6 |
|
|
4.74 |
mmHg |
3.69 |
9.04 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50376 |
481 |
SS-Chr 16BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
male |
87 days-120 days |
8 |
|
|
3.34 |
ng/ml/h |
0.14 |
0.39 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50393 |
481 |
F344/DuCrl |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
male |
87 days-120 days |
7 |
|
|
15.17 |
ng/ml/h |
1.06 |
2.81 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
50414 |
481 |
SS.LEW-(D17Chm9-D17Rat97)/Ayd |
both kidneys wet weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
kidney mass |
male |
98 days
| 10 |
|
|
10.3 |
g/kg |
0.4 |
1.26 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
64777 |
226 |
SS.LEW-(D16Rat38-D16Chm66)/Ayd |
both kidneys wet weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
kidney mass |
male |
98 days
| 8 |
|
|
10.5 |
g/kg |
0.4 |
1.13 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
64782 |
226 |
SS/JrHsdMcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
renin activity |
female |
87 days-120 days |
7 |
|
|
1.67 |
ng/ml/h |
0.24 |
0.62 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50463 |
481 |
WKY/NCrl |
urine albumin excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
urine albumin amount |
male |
87 days-120 days |
9 |
|
|
0.76 |
mg/d |
0.07 |
0.21 |
automated urine analysis |
|
|
|
0 |
|
|
|
|
50466 |
481 |
SS.LEW-(D10Rat27-Igfbp4)/Ayd |
both kidneys wet weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
kidney mass |
male |
98 days
| 7 |
|
|
10.9 |
g/kg |
0.4 |
1.06 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
64787 |
226 |
SS.MNS-(D2Rat183-D2Chm113)/Ayd |
both kidneys wet weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
kidney mass |
male |
98 days
| 8 |
|
|
9.9 |
g/kg |
0.2 |
0.57 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
64798 |
226 |
SS.MNS-(D2Wox27-Adh1)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart left ventricle mass |
male |
98 days
| 5 |
|
|
3.1 |
mg/g |
0.1 |
0.22 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
64956 |
226 |
SS.LEW-(D10Chm128-D10Chm121)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart left ventricle mass |
male |
98 days
| 9 |
|
|
2.9 |
mg/g |
0.2 |
0.6 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
64918 |
226 |
SS/Jr |
systolic blood pressure |
controlled sodium content diet (2 %) (for 24 days) |
Rapp JP, et al., Genomics 1998 Jul 15;51(2):191-6 |
arterial blood pressure trait |
male |
62 days
| 20 |
|
|
195.0 |
mmHg |
2.7 |
12.07 |
tail cuff plethysmography |
|
0 |
|
0 |
|
|
only mentioned blood pressure |
|
65829 |
633 |
SS.LEW-(D10Mco84-D10Mco134)/Mco |
heart weight to body weight ratio |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Saad Y, et al., Hypertension. 2007 |
heart mass |
male |
64 days-66 days |
0 |
|
|
3.95 |
g/kg |
0.02 |
|
post excision weight measurement |
|
|
|
0 |
|
|
|
|
12051 |
205 |
SS.LEW-(D2Rat18-D2Chm277)/Ayd |
heart weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart mass |
male |
98 days
| 6 |
|
|
4.2 |
g/kg |
0.1 |
0.24 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12089 |
226 |
SS.LEW-(D10Rat27-Igfbp4)/Ayd |
heart weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart mass |
male |
98 days
| 7 |
|
|
3.6 |
g/kg |
0.1 |
0.26 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12109 |
226 |
SS.LEW-(D17Chm14-D17Rat181)/Ayd |
heart weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart mass |
male |
98 days
| 5 |
|
|
3.3 |
g/kg |
0.1 |
0.22 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12117 |
226 |
SS.MNS-(D10Mco62-D10Got99)/Mco |
body weight |
controlled sodium content diet (2 %) (for 24 days) |
Saad Y, et al., Mamm Genome. 2008 Jan 4 |
body mass |
male |
64 days-68 days |
20 |
|
|
304.0 |
g |
2.1 |
9.39 |
body weighing method |
|
0 |
|
0 |
|
|
|
|
12147 |
232 |
SS.SR-(D3Mco36-D3Got166)/Jr |
body weight |
controlled sodium content diet (0.4 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days) |
Lee SJ, et al., Genetics 2006 Dec;174(4):2203-13. |
body mass |
male |
70 days-72 days |
40 |
|
|
303.9 |
g |
2.0 |
12.65 |
body weighing method |
|
|
|
0 |
|
|
|
|
12283 |
237 |
SR/JrHsd |
plasma total cholesterol level |
controlled sodium content diet (0.3 %) (for 180 days) then fasting (for 16 hours) |
Herrera VL, et al., J Hypertens. 2007 Aug;25(8):1608-12 |
blood cholesterol amount |
male |
180 days
| 6 |
|
|
61.0 |
mg/dl |
8.11 |
19.86 |
plasma total cholesterol measurement test |
|
|
|
0 |
|
|
|
|
12291 |
238 |
SHR/NHsd |
body weight |
controlled sodium content diet (0.3 %) |
Packard M, et al., Am J Physiol Renal Physiol. 2009 Apr;296(4):F839-46. Epub 2009 Jan 28. |
body mass |
male |
84 days
| 12 |
|
|
292.0 |
g |
3.6 |
12.47 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
12334 |
246 |
SS/Jr |
body weight |
controlled sodium content diet (0.3 %) |
Packard M, et al., Am J Physiol Renal Physiol. 2009 Apr;296(4):F839-46. Epub 2009 Jan 28. |
body mass |
male |
84 days
| 12 |
|
|
375.0 |
g |
6.0 |
20.78 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
12331 |
246 |
SS.LEW-(D3Rat52-D3Chm57)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 23 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
arterial blood pressure trait |
male |
56 days-60 days |
5 |
|
|
135.0 |
mmHg |
0.89 |
2.0 |
radiotelemetry |
|
86400 |
|
0 |
|
|
two 24 hours widely separated periods, data represent averages of all readings over the 24-h measurements |
|
65003 |
542 |
SS.BN-(D13Rat111-D13Rat127)/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (for 18 days) |
Moreno et al. Physiol Genomics 2007 Oct 22;31(2):228-35. Epub 2007 Jun 12. |
urine albumin amount |
female |
84 days-88 days |
12 |
|
|
36.4 |
mg/d |
6.7 |
23.21 |
urine analysis |
|
86400 |
|
0 |
|
|
|
|
65215 |
15 |
SS.BN-(D13Rat91-D13Rat179)/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (for 18 days) |
Moreno et al. Physiol Genomics 2007 Oct 22;31(2):228-35. Epub 2007 Jun 12. |
urine albumin amount |
male |
84 days-88 days |
12 |
|
|
74.5 |
mg/d |
7.5 |
25.98 |
urine analysis |
|
86400 |
|
0 |
|
|
|
|
65226 |
15 |
SS.BN-(D13Rat127-D13Rat61)/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (for 18 days) |
Moreno et al. Physiol Genomics 2007 Oct 22;31(2):228-35. Epub 2007 Jun 12. |
urine albumin amount |
male |
84 days-88 days |
12 |
|
|
70.8 |
mg/d |
12.2 |
42.26 |
urine analysis |
|
86400 |
|
0 |
|
|
|
|
65229 |
15 |
SS.BN-(D13Rat127-D13Rat46)/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (for 18 days) |
Moreno et al. Physiol Genomics 2007 Oct 22;31(2):228-35. Epub 2007 Jun 12. |
urine albumin amount |
male |
84 days-88 days |
12 |
|
|
43.4 |
mg/d |
6.4 |
22.17 |
urine analysis |
|
86400 |
|
0 |
|
|
|
|
65237 |
15 |
SS.BN-(D13Rat183-D13Rat192)/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (for 18 days) |
Moreno et al. Physiol Genomics 2007 Oct 22;31(2):228-35. Epub 2007 Jun 12. |
urine albumin amount |
male |
84 days-88 days |
12 |
|
|
137.1 |
mg/d |
27.8 |
96.3 |
urine analysis |
|
86400 |
|
0 |
|
|
|
|
65245 |
15 |
SS.LEW-(D3Mco21-D3Rat17)/Ayd |
diastolic blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 42 days) |
Palijan A, et al., Physiol Genomics 2003 Sep 29;15(1):1-8. |
arterial blood pressure trait |
male |
66 days-77 days |
6 |
measurement taken every 4 hours during a 24-hour period |
serial mean |
140.0 |
mmHg |
8.0 |
19.6 |
radiotelemetry |
|
86400.0 |
|
0 |
|
|
|
|
65558 |
615 |
SS.LEW-(D3Rat52-D3Rat130)/Ayd |
diastolic blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 42 days) |
Palijan A, et al., Physiol Genomics 2003 Sep 29;15(1):1-8. |
arterial blood pressure trait |
male |
66 days-77 days |
7 |
measurement taken every 4 hours during a 24-hour period |
serial mean |
121.0 |
mmHg |
4.0 |
10.58 |
radiotelemetry |
|
86400.0 |
|
0 |
|
|
|
|
65556 |
615 |
SS.BN-(D13Rat111-D13Got22)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 16 and 19 days) |
Moreno et al. Physiol Genomics 2007 Oct 22;31(2):228-35. Epub 2007 Jun 12. |
arterial blood pressure trait |
male |
86 days-89 days |
12 |
|
|
159.0 |
mmHg |
5.6 |
19.4 |
vascular fluid filled catheter |
left femoral artery |
14400 |
|
0 |
|
on 3 consecutive days |
|
|
5398 |
15 |
SS.BN-(D13Rat7-D13Rat60)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 16 and 19 days) |
Moreno et al. Physiol Genomics 2007 Oct 22;31(2):228-35. Epub 2007 Jun 12. |
arterial blood pressure trait |
male |
86 days-89 days |
12 |
|
|
165.0 |
mmHg |
6.6 |
22.86 |
vascular fluid filled catheter |
left femoral artery |
14400 |
|
0 |
|
on 3 consecutive days |
|
|
5396 |
15 |
SS.LEW-(D18Chm41-D18Rat92)/Ayd |
heart left ventricle wet weight |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle mass |
male |
77 days
| 8 |
|
|
0.92 |
g |
0.02 |
0.05 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
65030 |
542 |
SS.LEW-(D18Rat29-D18Rat55)/Ayd |
heart rate |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart pumping trait |
male |
77 days
| 11 |
|
|
427.1 |
beats/min |
3.59 |
11.9 |
transthoracic echocardiography |
|
0 |
|
0 |
|
|
|
|
65014 |
542 |
SS.BN-(D13Rat20-D13Got22)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 16 and 19 days) |
Moreno et al. Physiol Genomics 2007 Oct 22;31(2):228-35. Epub 2007 Jun 12. |
arterial blood pressure trait |
male |
86 days-89 days |
12 |
|
|
192.0 |
mmHg |
2.8 |
9.7 |
vascular fluid filled catheter |
left femoral artery |
14400 |
|
0 |
|
on 3 consecutive days |
|
|
65164 |
15 |
SS-Tfdp2em2Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
3 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
150.33 |
mmHg |
14.89 |
25.79 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66675 |
717 |
SS-Nckap5em3Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
3 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
140.33 |
mmHg |
6.23 |
10.79 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66680 |
717 |
SS-Mas1em1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
2 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
154.0 |
mmHg |
17.0 |
24.04 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66685 |
717 |
SS-Ube2q2em3Mcwi-/- |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
2 |
|
|
12.16 |
mg/d |
0.11 |
0.15 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66749 |
717 |
SS-Acad10em2Mcwi+/+ |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
5 |
|
|
11.26 |
mg/d |
0.74 |
1.65 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66747 |
717 |
SS-Mmp2em1Mcwi-/- |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
6 |
|
|
1.36 |
g |
0.09 |
0.23 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66752 |
717 |
SS-Bcas3em4Mcwi-/- |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
3 |
|
|
1.26 |
g |
0.06 |
0.11 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66765 |
717 |
SS-Apoeem7Mcwi-/- |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
5 |
|
|
1.36 |
g |
0.08 |
0.18 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66779 |
717 |
SS-Rag1em2Mcwi+/+ |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
1 |
|
|
1.36 |
g |
|
|
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66797 |
717 |
SS-Nckap5em3Mcwi-/- |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
3 |
|
|
1.58 |
g |
0.1 |
0.17 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66803 |
717 |
SS.LEW-(D17Mco3-D17Mco10)/Jr |
body weight |
controlled sodium content diet (2 %) (between 24 and 27 days) |
Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23 |
body mass |
not specified |
64 days-71 days |
20 |
|
|
287.0 |
g |
2.2 |
9.84 |
body weighing method |
|
0 |
|
0 |
|
|
|
4 rats per cage, 2 SR/Jr 2 LEW/NCrl |
64730 |
222 |
SS.LEW-(D1Mco2-D1Mco35)/Jr |
body weight |
controlled sodium content diet (2 %) (between 24 and 27 days) |
Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23 |
body mass |
not specified |
64 days-71 days |
39 |
|
|
300.0 |
g |
2.7 |
16.86 |
body weighing method |
|
0 |
|
0 |
|
|
|
4 rats per cage, 2 SR/Jr 2 LEW/NCrl |
64715 |
222 |
SS-Bcas3em4Mcwi+/+ |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
1 |
|
|
11.56 |
mEq/d |
|
|
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66857 |
717 |
SS-Cybaem1Mcwi+/+ |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
2 |
|
|
8.17 |
mEq/d |
4.75 |
6.71 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66860 |
717 |
SS-Itga9em1Mcwi+/+ |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
4 |
|
|
9.81 |
mEq/d |
0.91 |
1.82 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66862 |
717 |
SS-Alms1em1Mcwi-/- |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
6 |
|
|
56.84 |
mg/d |
11.13 |
27.26 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66876 |
717 |
SS-Gpr183em1Mcwi-/- |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
6 |
|
|
74.12 |
mg/d |
15.44 |
37.81 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66878 |
717 |
SS-Acad10em2Mcwi-/- |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
13 |
|
|
57.42 |
mg/d |
8.55 |
30.84 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66881 |
717 |
SS-Nckap5em2Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
2 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
134.0 |
mmHg |
1.0 |
1.41 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66967 |
717 |
SS-Itga9em1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
3 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
144.33 |
mmHg |
8.09 |
14.01 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66983 |
717 |
SS/HsdMcwiCrl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (0.15 %) (for 21 days) then ruthenium red (3 mg/kg) then dihydrocapsaicin (30 ug/kg) and pentobarbital (50 mg/kg) |
Gao F and Wang DH, Hypertension. 2010 Apr;55(4):1018-25. Epub 2010 Mar 1. |
arterial blood pressure trait |
male |
35 days-56 days |
0 |
|
|
-22.0 |
mmHg |
1.0 |
|
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
DR strain is from Charles River Laboratory, Wilmington, MA |
67267 |
731 |
SS/JrHsdMcwi |
creatinine clearance |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
glomerular filtration trait |
female |
90 days-94 days |
13 |
|
|
1.2 |
ml/min |
0.2 |
0.72 |
urine creatinine analysis |
|
0.0 |
|
0 |
|
plasma creatinine analysis |
|
|
67284 |
151 |
BN/NHsdMcwi |
ratio of change in renal blood flow rate to kidney weight |
controlled sodium content diet (0.4 %) (for 16 hours) then norepinephrine (3 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
renal blood flow trait |
female |
97 days-101 days |
19 |
|
|
-1.4 |
ml/min/g |
0.2 |
0.87 |
electromagnetic flowmetry |
|
0.0 |
|
0 |
|
electromagnetic flowmetry |
|
|
67307 |
151 |
SS-Acad10em2Mcwi-/- |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
12 |
|
|
1.13 |
g |
0.01 |
0.05 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
67002 |
717 |
SS-Chr 5BN-Cyp4a2em1Mcwi+/+ |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
3 |
|
|
1.25 |
g |
0.06 |
0.11 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
67016 |
717 |
SS.BN-(D13Rat20-D13Got22)/Mcwi-Nckap5em4Mcwi-/- |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
4 |
|
|
1.13 |
g |
0.06 |
0.11 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
67037 |
717 |
SS-Acad10em2Mcwi+/+ |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
5 |
|
|
1.07 |
g |
0.04 |
0.09 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
67053 |
717 |
SS.LEW-(D10Chm224-D10Chm6)/Ayd |
heart right ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart right ventricle mass |
male |
98 days
| 11 |
|
|
0.59 |
mg/g |
0.01 |
0.03 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
64887 |
226 |
SS/Jr |
heart right ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart right ventricle mass |
male |
98 days
| 16 |
|
|
0.69 |
mg/g |
0.02 |
0.08 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
64893 |
226 |
SS.LEW-(D16Rat12-D16Chm23)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart left ventricle mass |
male |
98 days
| 10 |
|
|
3.54 |
mg/g |
0.05 |
0.16 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
64910 |
226 |
SS.LEW-(D3Got33-D3Chm68)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart left ventricle mass |
male |
98 days
| 10 |
|
|
2.99 |
mg/g |
0.08 |
0.25 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
64944 |
226 |
SS/Jr |
diastolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) then controlled sodium content diet (4 %) (between 9 and 10 days) |
Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2. |
arterial blood pressure trait |
male |
76 days-78 days |
4 |
|
|
153.0 |
mmHg |
1.6 |
3.2 |
intra-aortic abdominal radiotelemetry |
|
86400 |
|
0 |
|
|
|
|
65060 |
283 |
SS.SR-(D3Arb14-D3Mco36)(D7Mco19-D7Mco7)/Mco |
diastolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) then controlled sodium content diet (4 %) (between 79 and 80 days) |
Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2. |
arterial blood pressure trait |
male |
147 days-149 days |
2 |
|
|
172.9 |
mmHg |
3.5 |
4.95 |
intra-aortic abdominal radiotelemetry |
|
86400 |
|
0 |
|
|
|
|
65071 |
283 |
SS/Jr |
plasma urea nitrogen level |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) then controlled sodium content diet (4 %) (between 46 and 48 days) |
Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2. |
blood urea nitrogen amount |
male |
114 days-118 days |
4 |
|
|
9.9 |
mmol/l |
2.1 |
4.2 |
plasma urea nitrogen analysis |
|
0 |
|
0 |
|
|
|
|
65088 |
283 |
SS.SR-(D7Mco19-D7Mco7)/Jr |
plasma urea nitrogen level |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) then controlled sodium content diet (4 %) (between 46 and 48 days) |
Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2. |
blood urea nitrogen amount |
male |
114 days-118 days |
3 |
|
|
11.6 |
mmol/l |
0.6 |
1.04 |
plasma urea nitrogen analysis |
|
0 |
|
0 |
|
|
|
|
65091 |
283 |
SS-Ncf2em1Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
6 |
|
|
373.83 |
beats/min |
9.78 |
23.95 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
67116 |
717 |
Crl:CD(SD) |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
glomerular filtration trait |
female |
87 days-120 days |
5 |
|
|
1.19 |
ml/min |
0.22 |
0.48 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51685 |
481 |
SHR/NCrl |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
8 |
|
|
-49.56 |
beats/min |
32.32 |
91.43 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51699 |
481 |
SHR/NCrl |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
9 |
|
|
-12.33 |
beats/min |
17.47 |
52.4 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51696 |
481 |
BN/NHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
9 |
|
|
-63.92 |
beats/min |
13.12 |
39.35 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51702 |
481 |
SS/JrHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
16 |
|
|
-61.58 |
beats/min |
12.05 |
48.19 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51704 |
481 |
SS/JrHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
16 |
|
|
-24.39 |
beats/min |
8.55 |
34.19 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51718 |
481 |
F344/DuCrl |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
9 |
|
|
111.8 |
mmHg |
2.06 |
6.17 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51732 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
5 |
|
|
13.75 |
mmHg |
2.88 |
6.44 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51737 |
481 |
SS-Chr 18BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
1 |
|
|
24.22 |
mmHg |
|
|
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51771 |
481 |
SS.MNS-(Aldoc-D10Mco1)/Jr |
heart weight to body weight ratio |
controlled sodium content diet (2 %) (between 25 and 28 days) |
Dukhanina OI, et al., Mamm Genome 1997 Apr;8(4):229-35. |
heart mass |
not specified |
64 days-68 days |
38 |
|
|
4.09 |
g/kg |
0.04 |
0.25 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
11891 |
148 |
SS-Chr 18BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
7 |
|
|
119.18 |
mmHg |
4.9 |
12.98 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51819 |
481 |
SS-Chr 20BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
urine sodium amount |
female |
87 days-120 days |
19 |
|
|
7.55 |
mEq/d |
0.78 |
3.41 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51883 |
481 |
Crl:CD(SD) |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
blood creatinine amount |
female |
87 days-120 days |
5 |
|
|
0.33 |
mg/dl |
0.02 |
0.04 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51897 |
481 |
WKY/NCrl |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
6 |
|
|
119.18 |
mmHg |
4.08 |
10.0 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
51909 |
481 |
SS/JrHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
15 |
|
|
131.99 |
mmHg |
3.79 |
14.69 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51997 |
481 |
BN/NHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
5 |
|
|
91.89 |
mmHg |
3.36 |
7.51 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
52008 |
481 |
FHH-Chr 18BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
female |
80 days-99 days |
9 |
|
|
64.77 |
mg/d |
14.16 |
42.49 |
automated urine total protein analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52114 |
482 |
FHH-Chr 20BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
male |
80 days-99 days |
8 |
|
|
282.08 |
mg/d |
60.18 |
170.22 |
automated urine total protein analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52109 |
482 |
FHH-Chr 1BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
male |
80 days-99 days |
10 |
|
|
189.0 |
mg/d |
36.58 |
115.68 |
automated urine total protein analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52123 |
482 |
FHH-Chr 17BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
male |
80 days-99 days |
10 |
|
|
538.16 |
mg/d |
64.09 |
202.66 |
automated urine total protein analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52125 |
482 |
FHH-Chr 8BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
male |
80 days-99 days |
4 |
|
|
21.15 |
mEq/d |
6.39 |
12.78 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52793 |
482 |
FHH-Chr 14BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
male |
80 days-99 days |
7 |
|
|
30.48 |
mEq/d |
3.7 |
9.8 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52804 |
482 |
FHH-Chr 9BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
male |
80 days-99 days |
6 |
|
|
19.96 |
mEq/d |
1.86 |
4.56 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52823 |
482 |
FHH-Chr 16BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
male |
80 days-99 days |
8 |
|
|
8.0 |
mEq/d |
3.18 |
9.0 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52825 |
482 |
LE/BluGill |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
male |
80 days-99 days |
7 |
|
|
23.29 |
mEq/d |
1.27 |
3.37 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
52828 |
482 |
SS/Jr |
heart weight to body weight ratio |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) |
Saad Y, et al., Genomics. 2007 Mar;89(3):343-53. Epub 2007 Jan 10. |
heart mass |
male |
68 days-70 days |
20 |
|
|
4.26 |
g/kg |
0.16 |
0.73 |
digital scale post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12709 |
282 |
SS.SHR-(D9Wox16-D9Rat64)/Mco |
diastolic blood pressure |
controlled sodium content diet (2 %) (between 35 and 37 days) |
Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41. |
arterial blood pressure trait |
male |
75 days-79 days |
5 |
|
serial mean |
103.0 |
mmHg |
1.15 |
2.57 |
intra-aortic abdominal radiotelemetry |
lower abdominal aorta |
172800 |
|
0 |
|
C-40 transmitter (Data Sciences International, St. Paul, MN) |
average of 12 4-hour averages over 48 hours using 5 or 6 rats |
|
13032 |
305 |
SS.LEW-(D1Mco36-D1Rat49)/Jr |
body weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) |
Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14. |
body mass |
male |
68 days-70 days |
20 |
|
|
307.0 |
g |
3.23 |
14.44 |
body weighing method |
|
|
|
0 |
|
|
|
|
12497 |
266 |
SS.LEW-(D1Uia2-D1Rat49)/Jr |
body weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) |
Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14. |
body mass |
male |
68 days-70 days |
20 |
|
|
307.0 |
g |
5.02 |
22.45 |
body weighing method |
|
|
|
0 |
|
|
|
|
12500 |
266 |
SS.LEW-(D1Rat196-D1Mco36)/Jr |
heart weight to body weight ratio |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) |
Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14. |
heart mass |
male |
68 days-70 days |
20 |
|
|
3.86 |
g/kg |
0.03 |
0.15 |
post excision weight measurement |
|
|
|
0 |
|
|
|
|
12565 |
266 |
SS.LEW-(D18Chm56-D18Rat55)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 21 days) |
Charron S, et al., Hum Mol Genet. 2005 Dec 15;14(24):3877-84. Epub 2005 Nov 8. |
arterial blood pressure trait |
male |
56 days
| 7 |
|
|
167.0 |
mmHg |
9.0 |
23.81 |
intra-aortic abdominal radiotelemetry |
aorta |
|
|
0 |
|
|
|
|
12605 |
269 |
SS.LEW-(D5Rat130-D5Rat31)/JrMcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 21 and 25 days) |
Roman RJ, et al., Am J Physiol Renal Physiol. 2006 Jun;290(6):F1463-71. Epub 2006 Jan 5. |
arterial blood pressure trait |
male |
82 days-86 days |
32 |
|
serial mean |
159.0 |
mmHg |
|
|
vascular fluid filled catheter |
femoral artery |
345600 |
|
0 |
|
connected to solid-state transducer (Argon Medical Technologies, Athens, TX) |
5 hr recording session - 1 min. averages, averaged over 4 days |
|
12618 |
272 |
F344-AbatTn(sb-T2/Bart3)2.163Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body mass |
female |
70 days-84 days |
5 |
|
|
168.0 |
g |
2.77 |
6.2 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
63639 |
529 |
FHH-Adipoqm2Mcwi |
body length, nose to tail |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
female |
70 days-84 days |
15 |
|
|
39.17 |
cm |
0.21 |
0.79 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63656 |
529 |
FHH-Lcatm1Mcwi |
body length, nose to tail |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
male |
70 days-84 days |
13 |
|
|
41.92 |
cm |
0.41 |
1.47 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63659 |
529 |
F344-Elmod3Tn(sb-T2/Bart3)2.42Mcwi |
body length, nose to tail |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
male |
70 days-84 days |
7 |
|
|
38.86 |
cm |
1.02 |
2.7 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63661 |
529 |
FHH-Ccr2m1Mcwi |
body length, nose to tail |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
female |
70 days-84 days |
7 |
|
|
38.0 |
cm |
0.27 |
0.71 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63675 |
529 |
F344/NHsd |
body length, nose to tail |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
male |
70 days-84 days |
10 |
|
|
27.55 |
cm |
2.79 |
8.81 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63680 |
529 |
BN-Lcatm3Mcwi |
body length, nose to tail |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
male |
70 days-84 days |
1 |
|
|
37.5 |
cm |
|
|
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63702 |
529 |
FHH-Egln3m1Mcwi |
body length, nose to tail |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
male |
70 days-84 days |
6 |
|
|
42.58 |
cm |
0.42 |
1.02 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63705 |
529 |
FHH-Adipoqm3Mcwi |
body length, nose to tail |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
male |
70 days-84 days |
5 |
|
|
41.1 |
cm |
0.98 |
2.19 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63708 |
529 |
FHH-Adipoqm3Mcwi |
heart left ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart left ventricle mass |
male |
70 days-84 days |
5 |
|
|
0.68 |
g |
0.05 |
0.1 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63780 |
529 |
SS-Chr 5BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
male |
80 days-99 days |
7 |
|
|
130.42 |
mmHg |
2.59 |
6.85 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52844 |
482 |
SS-Chr 16BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
male |
80 days-99 days |
9 |
|
|
155.24 |
mmHg |
2.9 |
8.7 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52850 |
482 |
FHH-Chr 1BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
renin activity |
female |
80 days-99 days |
9 |
|
|
3.7 |
ng/ml/h |
0.8 |
2.4 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52924 |
482 |
SS-Chr 13BN/Mcwi |
urine potassium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine potassium amount |
female |
80 days-99 days |
20 |
|
|
0.76 |
mEq/d |
0.05 |
0.24 |
flame atomic emission spectrometry |
|
|
|
0 |
|
urine potassium analysis |
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52949 |
482 |
SS-Chr 18BN/Mcwi |
creatinine clearance |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
glomerular filtration trait |
male |
80 days-99 days |
8 |
|
|
1.75 |
ml/min |
0.2 |
0.58 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52170 |
482 |
SS-Chr 19BN/Mcwi |
creatinine clearance |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
glomerular filtration trait |
female |
80 days-99 days |
7 |
|
|
1.05 |
ml/min |
0.32 |
0.85 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52181 |
482 |
SS-Chr 2BN/Mcwi |
creatinine clearance |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
glomerular filtration trait |
female |
80 days-99 days |
10 |
|
|
1.53 |
ml/min |
0.14 |
0.44 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52183 |
482 |
SS.BN-(D12Arb13-D12Rat79)/Mcwi |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
male |
80 days-99 days |
9 |
|
|
0.38 |
mg/dl |
0.03 |
0.08 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52191 |
482 |
SS-Chr 9BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
female |
80 days-99 days |
8 |
|
|
0.4 |
mg/dl |
0.01 |
0.04 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52197 |
482 |
SS-Chr 3BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
female |
80 days-99 days |
5 |
|
|
0.34 |
mg/dl |
0.03 |
0.07 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52213 |
482 |
SS-Chr 3BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
male |
80 days-99 days |
8 |
|
|
0.45 |
mg/dl |
0.04 |
0.1 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52210 |
482 |
SS-Chr 1BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
female |
80 days-99 days |
13 |
|
|
0.32 |
mg/dl |
0.02 |
0.08 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52224 |
482 |
BN/NHsdMcwi |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
male |
80 days-99 days |
8 |
|
|
0.41 |
mg/dl |
0.02 |
0.06 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52235 |
482 |
FHH-Chr 18BN/Mcwi |
urine potassium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine potassium amount |
female |
80 days-99 days |
9 |
|
|
0.66 |
mEq/d |
0.11 |
0.33 |
flame atomic emission spectrometry |
|
|
|
0 |
|
urine potassium analysis |
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52312 |
482 |
FHH-Chr 17BN/Mcwi |
urine potassium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine potassium amount |
male |
80 days-99 days |
10 |
|
|
1.18 |
mEq/d |
0.1 |
0.3 |
flame atomic emission spectrometry |
|
|
|
0 |
|
urine potassium analysis |
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52323 |
482 |
FHH/EurMcwi |
creatinine clearance |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
glomerular filtration trait |
female |
80 days-99 days |
12 |
|
|
1.47 |
ml/min |
0.25 |
0.85 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52342 |
482 |
FHH-Chr 15BN/Mcwi |
creatinine clearance |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
glomerular filtration trait |
female |
80 days-99 days |
7 |
|
|
2.4 |
ml/min |
0.46 |
1.23 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52361 |
482 |
SS/Jr |
heart wet weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7. |
heart mass |
male |
64 days-66 days |
20 |
|
|
1.25 |
g |
0.01 |
0.04 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
12843 |
313 |
SS.LEW-(D1Mco36-D1Mco101)/Mco |
body weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7. |
body mass |
male |
64 days-66 days |
30 |
|
|
323.0 |
g |
2.25 |
12.32 |
body weighing method |
|
0 |
|
0 |
|
|
|
|
12877 |
313 |
SS/Jr |
body weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7. |
body mass |
male |
64 days-66 days |
20 |
|
|
309.0 |
g |
2.53 |
11.31 |
body weighing method |
|
0 |
|
0 |
|
|
|
|
12864 |
313 |
SS/Jr |
heart weight to body weight ratio |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7. |
heart mass |
male |
64 days-66 days |
20 |
|
|
4.04 |
g/kg |
0.03 |
0.13 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12883 |
313 |
SS.LEW-(D1Mco36-D1Mco77)/Mco |
heart weight to body weight ratio |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7. |
heart mass |
male |
64 days-66 days |
20 |
|
|
3.8 |
g/kg |
0.03 |
0.15 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12899 |
313 |
SS.LEW-(D1Mco36-D1Rat106)/Mco |
heart weight to body weight ratio |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7. |
heart mass |
male |
64 days-66 days |
30 |
|
|
3.71 |
g/kg |
0.03 |
0.17 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12901 |
313 |
SHR |
systolic blood pressure |
controlled sodium content diet (0.4 %) (for 63 days) |
Inomata H, et al., Hypertens Res 2005 Mar;28(3):273-81. |
arterial blood pressure trait |
male |
91 days
| 4 |
|
serial mean |
181.8 |
mmHg |
1.75 |
3.5 |
tail cuff photoplethysmography |
|
0 |
|
0 |
|
UR1000; Ueda |
average of 3 consistent readings |
|
12582 |
268 |
SS.LEW-(D1Mco36-D1Mco101)/Mco |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 33 days) |
Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7. |
arterial blood pressure trait |
male |
73 days-75 days |
10 |
|
|
178.0 |
mmHg |
1.56 |
4.93 |
radiotelemetry |
|
345600 |
|
0 |
|
C-40 transmitter (Data Sciences International, St. Paul, MN) |
aveerage of 4-hour interval averages over 4 days |
|
12919 |
313 |
SS.BN-(D13Rat115-D13Rat61)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 16 and 19 days) |
Moreno et al. Physiol Genomics 2007 Oct 22;31(2):228-35. Epub 2007 Jun 12. |
arterial blood pressure trait |
male |
86 days-89 days |
12 |
|
|
166.0 |
mmHg |
3.0 |
10.39 |
vascular fluid filled catheter |
left femoral artery |
14400 |
|
0 |
|
on 3 consecutive days |
|
|
65173 |
15 |
SS.BN-(D13Rat101-D13Rat46)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 16 and 19 days) |
Moreno et al. Physiol Genomics 2007 Oct 22;31(2):228-35. Epub 2007 Jun 12. |
arterial blood pressure trait |
male |
86 days-89 days |
12 |
|
|
153.0 |
mmHg |
3.5 |
12.12 |
vascular fluid filled catheter |
left femoral artery |
14400 |
|
0 |
|
on 3 consecutive days |
|
|
65186 |
15 |
FHH-Chr 3BN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine albumin amount |
female |
80 days-99 days |
2 |
|
|
100.4 |
mg/d |
43.43 |
61.41 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52391 |
482 |
FHH-Chr 14BN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine albumin amount |
female |
80 days-99 days |
6 |
|
|
66.49 |
mg/d |
34.22 |
83.82 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52394 |
482 |
FHH-Chr 11BN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine albumin amount |
female |
80 days-99 days |
6 |
|
|
70.1 |
mg/d |
24.53 |
60.08 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52422 |
482 |
FHH-Chr 18BN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
male |
80 days-99 days |
9 |
|
|
442.33 |
beats/min |
16.64 |
49.92 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52501 |
482 |
FHH-Chr 4BN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
female |
80 days-99 days |
9 |
|
|
444.42 |
beats/min |
7.91 |
23.74 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52517 |
482 |
FHH-Chr 6BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
male |
80 days-99 days |
9 |
|
|
177.43 |
mmHg |
5.03 |
15.09 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52540 |
482 |
SS-Chr 6BN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine albumin amount |
female |
80 days-99 days |
10 |
|
|
11.6 |
mg/d |
4.48 |
14.16 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52583 |
482 |
SS-Chr 16BN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine albumin amount |
female |
80 days-99 days |
9 |
|
|
4.75 |
mg/d |
0.73 |
2.18 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52597 |
482 |
SS-Chr 15BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
male |
80 days-99 days |
7 |
|
|
139.22 |
mg/d |
35.75 |
94.58 |
automated urine total protein analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52698 |
482 |
SS-Chr 1BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
female |
80 days-99 days |
19 |
|
|
24.59 |
mg/d |
2.66 |
11.61 |
automated urine total protein analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52714 |
482 |
SS.BN-(D8Rat163-D8Rat81)/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
female |
80 days-99 days |
13 |
|
|
70.6 |
mg/d |
8.59 |
30.96 |
automated urine total protein analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52717 |
482 |
SS.SR-(D13Mit9-D13Mit1)/Jr |
systolic blood pressure |
controlled sodium content diet (8 %) (between 48 and 55 days) then controlled exposure to darkness |
St. Lezin EM, et al., J Clin Invest 1996 Jan 15;97(2):522-7 |
arterial blood pressure trait |
male |
70 days-77 days |
8 |
|
serial mean |
136.0 |
mmHg |
1.0 |
2.83 |
intra-aortic abdominal radiotelemetry |
|
604800.0 |
|
0 |
|
5 s every 5 min nightly for a week |
|
|
11703 |
119 |
SS/Jr |
systolic blood pressure |
controlled sodium content diet (2 %) (between 35 and 37 days) |
Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41. |
arterial blood pressure trait |
male |
75 days-79 days |
5 |
|
serial mean |
185.0 |
mmHg |
1.97 |
4.41 |
intra-aortic abdominal radiotelemetry |
lower abdominal aorta |
172800 |
|
0 |
|
C-40 transmitter (Data Sciences International, St. Paul, MN) |
average of 12 4-hour averages over 48 hours using 5 or 6 rats |
|
13026 |
305 |
SS.SR-(rs65785750-rs106808193)/Opaz |
systolic blood pressure |
controlled sodium content diet (8 %) (between 24 and 28 days) |
Herrera VL, et al., PLoS One. 2012;7(7):e42214. doi: 10.1371/journal.pone.0042214. Epub 2012 Jul 30. |
arterial blood pressure trait |
female |
108 days-112 days |
8 |
|
|
167.9 |
mmHg |
3.2 |
9.05 |
intra-aortic abdominal radiotelemetry |
|
0.0 |
|
0 |
|
|
|
|
70353 |
1358 |
SS.SR-(rs65785750-rs106808193)/Opaz |
diastolic blood pressure |
controlled sodium content diet (8 %) (between 24 and 28 days) |
Herrera VL, et al., PLoS One. 2012;7(7):e42214. doi: 10.1371/journal.pone.0042214. Epub 2012 Jul 30. |
arterial blood pressure trait |
female |
108 days-112 days |
8 |
|
|
116.0 |
mmHg |
3.3 |
9.33 |
intra-aortic abdominal radiotelemetry |
|
0.0 |
|
0 |
|
|
|
|
70356 |
1358 |
BN/NHsdMcwi |
urine sodium level |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
urine sodium amount |
female |
92 days-94 days |
22 |
|
|
100.4 |
mmol/l |
6.5 |
30.49 |
unspecified method |
|
0.0 |
|
0 |
|
urine sodium analysis |
|
|
69466 |
151 |
SS.LEW-(D10Got112-Igfbp4)/Ayd |
heart left ventricle fractional shortening |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle end-diastolic diameter |
male |
77 days
| 5 |
(LVDdLVDs)/LVDd x 100 |
|
49.9 |
% |
1.77 |
3.96 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
|
|
|
68287 |
542 |
SS/NEisSlc |
plasma aldosterone level |
controlled sodium content diet (8 %) (for 28 days) then controlled sodium content diet (0.3 %) (for 28 days) |
Kitada K, et al., PLoS One. 2012;7(7):e41896. Epub 2012 Jul 24. |
blood aldosterone amount |
male |
98 days
| 4 |
|
|
295.0 |
pg/ml |
54.3 |
108.6 |
radioimmunoassay |
|
0.0 |
|
0 |
|
|
|
|
69657 |
736 |
SS/NEisSlc |
urine total protein excretion rate |
controlled sodium content diet (0.3 %) (for 28 days) |
Kitada K, et al., PLoS One. 2012;7(7):e41896. Epub 2012 Jul 24. |
total urine protein amount |
male |
98 days
| 10 |
|
|
20.9 |
mg/d |
3.3 |
10.44 |
urine total protein analysis |
|
0.0 |
|
0 |
|
|
|
|
69684 |
736 |
SS/NEisSlc |
systolic blood pressure |
controlled sodium content diet (8 %) (for 28 days) then controlled sodium content diet (0.3 %) (for 28 days) |
Kitada K, et al., PLoS One. 2012;7(7):e41896. Epub 2012 Jul 24. |
arterial blood pressure trait |
male |
98 days
| 10 |
|
|
144.0 |
mmHg |
4.0 |
12.65 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
|
69687 |
736 |
SS.MNS-(D2Mit6-D2Rat166)/Ayd |
heart left ventricle deoxyribonucleic acid level to body weight ratio |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 63 days) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
heart left ventricle DNA amount |
male |
98 days
| 4 |
|
|
5.0 |
ug/g |
0.5 |
1.0 |
spectrophotometry |
|
0.0 |
|
0 |
|
|
|
|
69036 |
1096 |
BN/NHsdMcwi |
left kidney wet weight |
controlled sodium content diet (0.4 %) (for 35 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
kidney mass |
female |
97 days-101 days |
27 |
|
|
0.86 |
g |
0.03 |
0.16 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
69505 |
151 |
SS/JrHsdMcwi |
right kidney wet weight |
controlled sodium content diet (0.4 %) (for 35 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
kidney mass |
female |
97 days-101 days |
21 |
|
|
1.32 |
g |
0.08 |
0.37 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
69508 |
151 |
SS/JrHsdMcwi |
diastolic blood pressure |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
94 days
| 11 |
|
serial mean |
140.0 |
mmHg |
7.0 |
23.22 |
vascular indwelling catheter method |
left femoral artery |
10800.0 |
|
0 |
|
|
|
|
69524 |
151 |
SS.LEW-(D17Chm14-D17Rat181)/Ayd |
cerebrospinal fluid chloride level |
controlled sodium content diet (8 %) (between 8 and 10 days) |
Huang BS, et al., Hypertension. 2007 Apr 9;. |
cerebrospinal fluid mineral amount |
male |
43 days-52 days |
0 |
|
|
123.0 |
mmol/l |
2.0 |
|
chloride ion-selective electrode method |
|
0.0 |
|
0 |
|
|
|
|
69693 |
344 |
SS-Rag1em1Mcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (for 21 days) |
Mattson DL, et al., Am J Physiol Regul Integr Comp Physiol. 2013 Jan 30. |
blood creatinine amount |
not specified |
84 days
| 0 |
|
|
0.25 |
mg/dl |
0.03 |
|
unspecified method |
|
0.0 |
|
0 |
|
|
|
|
69285 |
1057 |
F344-DccTn(sb-T2/Bart3)2.205Mcwi |
serum alkaline phosphatase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
male |
70 days-84 days |
6 |
|
|
158.17 |
U/l |
10.73 |
26.29 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60439 |
527 |
FHH-Tlr4m1Mcwi |
serum alkaline phosphatase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
70 days-84 days |
9 |
|
|
145.67 |
U/l |
7.7 |
23.1 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60450 |
527 |
F344-Brinp3Tn(sb-T2/Bart3)2.189Mcwi |
mean corpuscular hemoglobin |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
70 days-84 days |
3 |
|
|
17.8 |
pg |
0.12 |
0.2 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60482 |
527 |
FHH-Ccr2m1Mcwi |
mean corpuscular hemoglobin |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
70 days-84 days |
8 |
|
|
17.58 |
pg |
0.09 |
0.27 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60488 |
527 |
SS-Sod3m1Mcwi |
serum total cholesterol level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
70 days-84 days |
10 |
|
|
101.4 |
mg/dl |
9.38 |
29.66 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60534 |
527 |
F344-Trpc4Tn(sb-T2/Bart3)2.192Mcwi |
red blood cell count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
70 days-84 days |
1 |
|
|
8.44 |
x 10E6 cells/ul |
|
|
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60545 |
527 |
FHH-Tgfbr2m2Mcwi |
red blood cell count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
70 days-84 days |
14 |
|
|
7.96 |
x 10E6 cells/ul |
0.14 |
0.51 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60550 |
527 |
FHH-Lcatm1Mcwi |
red blood cell count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
70 days-84 days |
15 |
|
|
7.71 |
x 10E6 cells/ul |
0.09 |
0.34 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60553 |
527 |
SS/JrHsdMcwi |
body weight |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) and controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
body mass |
female |
84 days
| 28 |
|
|
221.0 |
g |
2.7 |
14.29 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
69442 |
151 |
BN/NHsdMcwi |
diastolic blood pressure |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) then controlled exposure to darkness (for 12 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
89 days-91 days |
20 |
|
serial mean |
96.0 |
mmHg |
2.7 |
12.07 |
vascular indwelling catheter method |
left femoral artery |
0.0 |
|
0 |
|
|
|
|
69445 |
151 |
SS.SR-(rs106870553-rs63922710)/Opaz |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 24 and 28 days) |
Herrera VL, et al., PLoS One. 2013 Jul 4;8(7):e67673. doi: 10.1371/journal.pone.0067673. Print 2013. |
arterial blood pressure trait |
female |
108 days-112 days |
10 |
|
|
159.6 |
mmHg |
2.8 |
8.85 |
intra-aortic abdominal radiotelemetry |
|
0.0 |
|
0 |
|
|
|
|
70567 |
1458 |
SS.SR-(D2Rat352-rs63922710)/Opaz |
pulse pressure |
controlled sodium content diet (8 %) (between 24 and 28 days) |
Herrera VL, et al., PLoS One. 2013 Jul 4;8(7):e67673. doi: 10.1371/journal.pone.0067673. Print 2013. |
arterial blood pressure trait |
female |
108 days-112 days |
6 |
|
|
50.0 |
mmHg |
1.0 |
2.45 |
intra-aortic abdominal radiotelemetry |
|
0.0 |
|
0 |
|
|
|
|
70561 |
1458 |
SS-Cyp1a1em1Mcwi-/- |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
7 |
|
|
1.42 |
g |
0.05 |
0.13 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44363 |
441 |
SS-Nppbem2Mcwi-/- |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
16 |
|
|
1.54 |
g |
0.03 |
0.13 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44371 |
441 |
SS-Prokr1em2Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
7 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
137.57 |
mmHg |
6.49 |
17.16 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44411 |
441 |
SS-Ulk3em1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
11 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
141.55 |
mmHg |
4.91 |
16.28 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44403 |
441 |
SS-Cyp1a1em1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
7 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
130.57 |
mmHg |
2.45 |
6.48 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44424 |
441 |
SS-Plcd3em4Mcwi+/+ |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
3 |
|
|
1.54 |
g |
0.08 |
0.14 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44504 |
441 |
SS.LEW-(D18Chm90-D18Chm4)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (between 10 and 24 days) |
Chauvet C, et al., Hum Mol Genet. 2013 Nov 15;22(22):4451-9. doi: 10.1093/hmg/ddt294. Epub 2013 Jun 28. |
arterial blood pressure trait |
male |
66 days-80 days |
5 |
|
|
170.0 |
mmHg |
8.0 |
17.89 |
intra-aortic abdominal radiotelemetry |
abdominal aorta |
0.0 |
|
0 |
|
|
|
|
84481 |
1438 |
SS.LEW-(D10Chm224-D10Chm6)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (2 %) (for 21 days) |
Charron S, et al., Hypertension. 2005 Dec;46(6):1300-8. Epub 2005 Nov 14. |
arterial blood pressure trait |
male |
56 days-59 days |
11 |
|
|
144.0 |
mmHg |
|
|
intra-aortic abdominal radiotelemetry |
|
86400.0 |
|
0 |
|
|
|
|
67885 |
830 |
SS.LEW-(D10Rat204-D10Rat9)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (2 %) (for 21 days) |
Charron S, et al., Hypertension. 2005 Dec;46(6):1300-8. Epub 2005 Nov 14. |
arterial blood pressure trait |
male |
56 days-59 days |
5 |
|
|
146.0 |
mmHg |
|
|
intra-aortic abdominal radiotelemetry |
|
86400.0 |
|
0 |
|
|
|
|
67888 |
830 |
SS.LEW-(D16Rat112-D16Chm60)/Ayd |
heart left atrium end-systolic diameter |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left atrium diameter |
male |
77 days
| 14 |
|
|
4.87 |
mm |
0.16 |
0.59 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
|
|
|
68303 |
542 |
SS.LEW-(D18Rat29-D18Rat55)/Ayd |
heart left atrium end-diastolic diameter |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left atrium diameter |
male |
77 days
| 11 |
|
|
3.6 |
mm |
0.19 |
0.62 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
|
|
|
68308 |
542 |
SS.LEW-(D18Chm41-D18Rat92)/Ayd |
heart isovolumetric relaxation time |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart muscle relaxation trait |
male |
77 days
| 8 |
|
|
18.8 |
ms |
0.92 |
2.61 |
continuous wave doppler ultrasound |
|
0.0 |
|
0 |
|
|
isovolumetric relaxation time |
|
68316 |
542 |
SS/Jr |
heart left atrium fractional shortening |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left atrium diameter |
male |
77 days
| 40 |
(LADs - LADd)/ LADs x 100 |
|
31.4 |
% |
0.95 |
5.98 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
|
heart left atrium fractional shortening |
|
68322 |
542 |
SR/JrHsd |
heart weight to body weight ratio |
controlled sodium content diet (8 %) (for 56 days) |
Herrera VL, et al., Physiol Genomics. 2006 Aug 16;26(3):172-9. Epub 2006 May 23. |
heart mass |
male |
140 days
| 5 |
|
|
2.67 |
g/kg |
0.03 |
0.07 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
67865 |
810 |
SS/JrHsd |
heart weight to body weight ratio |
controlled sodium content diet (8 %) (for 84 days) |
Herrera VL, et al., Physiol Genomics. 2006 Aug 16;26(3):172-9. Epub 2006 May 23. |
heart mass |
female |
168 days
| 8 |
|
|
3.65 |
g/kg |
0.11 |
0.31 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
67868 |
810 |
SS.LEW-(D17Chm131-D17Chm93)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (2 %) (between 35 and 105 days) |
Crespo K, et al., J Hypertens. 2013 May;31(5):927-35. doi: 10.1097/HJH.0b013e32835edc7e. |
arterial blood pressure trait |
male |
66 days-86 days |
12 |
|
serial mean |
147.0 |
mmHg |
2.31 |
8.0 |
intra-aortic abdominal radiotelemetry |
|
2.0 |
|
0 |
|
|
for 2 wks |
has records that will be duplicated if entered need to add multiple refs once the functionality is in |
96580 |
1665 |
SS-Chr 12BN.SS-(D12Arb13-D12Mit2)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (1 %) (for 77 days) then controlled sodium content diet (8 %) (for 7 days) |
Flister MJ, et al., Hypertension. 2012 Oct;60(4):942-8. doi: 10.1161/HYPERTENSIONAHA.112.198200. Epub 2012 Aug 6. |
arterial blood pressure trait |
male |
74 days-84 days |
8 |
|
serial mean |
136.0 |
mmHg |
5.0 |
14.14 |
intra-aortic abdominal radiotelemetry |
|
14400.0 |
|
0 |
|
abdominal aorta |
4 hrs for 3 consecutive days |
|
96865 |
1718 |
SS-Msraem3Mcwi-/- |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
3 |
|
|
1.14 |
g |
0.05 |
0.09 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44563 |
441 |
SS-Mstnem1Mcwi+/+ |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
3 |
|
|
1.14 |
g |
0.01 |
0.02 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44560 |
441 |
SS-Tcf7l2em1Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
5 |
|
|
369.8 |
beats/min |
11.89 |
26.59 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44584 |
441 |
SS-Agtr1aem5Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
2 |
|
|
376.5 |
beats/min |
0.5 |
0.71 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44598 |
441 |
SS-Plcd3em4Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
3 |
|
|
343.67 |
beats/min |
10.33 |
17.9 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44627 |
441 |
SS-Plod1em1Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
11 |
|
|
362.7 |
beats/min |
7.75 |
25.71 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44656 |
441 |
SS-Cyp1a1em5Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
2 |
|
|
357.5 |
beats/min |
0.5 |
0.71 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44662 |
441 |
SHRSP/Bbb |
percentage of study population developing cerebrovascular lesions during a period of time |
controlled sodium content diet (3.7 mg/g) (between 70 and 88 days) and controlled sodium content drinking water (1 %) (between 70 and 88 days) and controlled potassium content diet (6.3 mg/g) (between 70 and 88 days) |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
cerebrovascular system integrity trait |
not specified |
70 days-88 days |
31 |
|
|
100.0 |
% |
|
|
ex vivo light microscopy |
|
0.0 |
|
0 |
|
|
|
|
69119 |
1126 |
SHRSR/Bbb |
systolic blood pressure |
controlled sodium content diet (3.7 mg/g) (for 56 days) and controlled sodium content drinking water (1 %) (for 56 days) and controlled potassium content diet (6.3 mg/g) (for 56 days) |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
arterial blood pressure trait |
not specified |
98 days
| 18 |
|
|
191.0 |
mmHg |
1.65 |
7.0 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
|
69129 |
1126 |
SS/JrSeac |
heart left ventricle end-systolic posterior wall thickness |
controlled sodium content diet (8 %) (for 84 days) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
heart left ventricle wall thickness |
not specified |
126 days
| 5 |
|
|
1.2 |
mm |
0.11 |
0.24 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
|
End-systole posterior wall thickening |
|
68586 |
733 |
SS/JrSeac |
heart rate |
controlled sodium content diet (8 %) (for 84 days) then controlled oxygen content Kreb's solution perfusate |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
heart pumping trait |
not specified |
77 days
| 5 |
|
|
268.0 |
beats/min |
45.62 |
102.0 |
isolated perfused heart method |
|
0.0 |
|
0 |
|
|
|
|
68592 |
733 |
LEW |
peak aortic velocity |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
aorta blood flow trait |
male |
77 days
| 14 |
|
|
94.6 |
cm/s |
3.1 |
11.6 |
pulsed wave doppler ultrasound |
|
0.0 |
|
0 |
|
|
peak aortic velocity |
|
68241 |
542 |
LEW |
heart left ventricle anterior wall thickness |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle anterior wall thickness |
male |
77 days
| 14 |
|
|
0.15 |
mm |
0.0 |
0.01 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
|
heart left ventricle anterior wall thickness |
|
68249 |
542 |
SS.LEW-(D18Chm41-D18Rat92)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle mass |
male |
77 days
| 8 |
|
|
2.81 |
mg/g |
0.05 |
0.14 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
68260 |
542 |
SS.LEW-(D3Chm64-D3Rat17)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (between 10 and 24 days) |
Chauvet C, et al., Hum Mol Genet. 2013 Nov 15;22(22):4451-9. doi: 10.1093/hmg/ddt294. Epub 2013 Jun 28. |
arterial blood pressure trait |
male |
66 days-80 days |
8 |
|
|
195.0 |
mmHg |
9.0 |
25.46 |
intra-aortic abdominal radiotelemetry |
abdominal aorta |
0.0 |
|
0 |
|
|
|
|
84478 |
1438 |
SS.LEW-(D1Uia4-D1Rat320)(D10Chm10-D10Rat11)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (between 10 and 24 days) |
Chauvet C, et al., Hum Mol Genet. 2013 Nov 15;22(22):4451-9. doi: 10.1093/hmg/ddt294. Epub 2013 Jun 28. |
arterial blood pressure trait |
male |
66 days-80 days |
6 |
|
|
138.0 |
mmHg |
5.0 |
12.25 |
intra-aortic abdominal radiotelemetry |
abdominal aorta |
0.0 |
|
0 |
|
|
|
|
84500 |
1438 |
SS.LEW-(D1Chm64-D1Rat19)(D10Rat194-D10Chm243)(D10Chm10-D10Rat11)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (between 10 and 24 days) |
Chauvet C, et al., Hum Mol Genet. 2013 Nov 15;22(22):4451-9. doi: 10.1093/hmg/ddt294. Epub 2013 Jun 28. |
arterial blood pressure trait |
male |
66 days-80 days |
5 |
|
|
118.0 |
mmHg |
3.0 |
6.71 |
intra-aortic abdominal radiotelemetry |
abdominal aorta |
0.0 |
|
0 |
|
|
|
|
84502 |
1438 |
SS.MNS-(D2Chm33-Tm2sf1),LEW-(D10Rat194-D10Chm243)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (between 10 and 24 days) |
Chauvet C, et al., Hum Mol Genet. 2013 Nov 15;22(22):4451-9. doi: 10.1093/hmg/ddt294. Epub 2013 Jun 28. |
arterial blood pressure trait |
male |
66 days-80 days |
7 |
|
|
131.0 |
mmHg |
3.0 |
7.94 |
intra-aortic abdominal radiotelemetry |
abdominal aorta |
0.0 |
|
0 |
|
|
|
|
84510 |
1438 |
SS.SHR-(D9Mco72-D9Mco105)/Mco |
heart left ventricle end-systolic area |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) |
Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4. |
heart left ventricle size trait |
not specified |
0 days
| 7 |
|
|
0.44 |
cm2 |
0.05 |
0.13 |
echocardiography |
|
0.0 |
|
0 |
|
|
|
|
69603 |
749 |
SS.LEW-(D10Chm10-D10Rat11)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (between 10 and 24 days) |
Chauvet C, et al., Hum Mol Genet. 2013 Nov 15;22(22):4451-9. doi: 10.1093/hmg/ddt294. Epub 2013 Jun 28. |
arterial blood pressure trait |
male |
66 days-80 days |
16 |
|
|
150.0 |
mmHg |
|
|
intra-aortic abdominal radiotelemetry |
abdominal aorta |
0.0 |
|
0 |
|
|
|
|
70489 |
1438 |
F344-Myo9aTn(sb-T2/Bart3)2.186Mcwi |
blood neutrophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
70 days-84 days |
4 |
|
|
0.78 |
x 1000 cells/ul |
0.16 |
0.33 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60868 |
527 |
FHH/EurMcwi |
blood neutrophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
70 days-84 days |
25 |
|
|
0.87 |
x 1000 cells/ul |
0.13 |
0.64 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60871 |
527 |
F344-Fam19a2Tn(sb-T2/Bart3)2.184Mcwi |
blood neutrophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
70 days-84 days |
2 |
|
|
0.92 |
x 1000 cells/ul |
0.23 |
0.33 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60874 |
527 |
SS-Klf4m3Mcwi |
serum sodium level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood sodium amount |
male |
70 days-84 days |
8 |
|
|
139.5 |
mmol/l |
1.35 |
3.82 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
60904 |
527 |
FHH-Tgfbr2m2Mcwi |
serum globulin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood globulin amount |
male |
70 days-84 days |
11 |
|
|
1.65 |
g/dl |
0.05 |
0.16 |
standard blood chemistry panel |
|
|
|
0 |
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
60912 |
527 |
BN-Tgfbr2m1Mcwi |
serum globulin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood globulin amount |
female |
70 days-84 days |
3 |
|
|
1.5 |
g/dl |
0.15 |
0.26 |
standard blood chemistry panel |
|
|
|
0 |
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
60915 |
527 |
F344-Plce1Tn(sb-T2/Bart3)2.146Mcwi |
serum globulin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood globulin amount |
female |
70 days-84 days |
5 |
|
|
1.9 |
g/dl |
0.1 |
0.23 |
standard blood chemistry panel |
|
|
|
0 |
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
60928 |
527 |
FHH-Adipoqm1Mcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (for 14 days) then fasting (between 16 and 1 hours) |
PhysGen Biochemistry data |
blood creatinine amount |
female |
70 days-84 days |
8 |
|
|
0.29 |
mg/dl |
0.08 |
0.22 |
automated plasma creatinine analysis |
|
|
|
0 |
|
|
|
|
60992 |
527 |
FHH-Adipoqm1Mcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (for 14 days) then fasting (between 16 and 1 hours) |
PhysGen Biochemistry data |
blood creatinine amount |
male |
70 days-84 days |
8 |
|
|
0.25 |
mg/dl |
0.03 |
0.09 |
automated plasma creatinine analysis |
|
|
|
0 |
|
|
|
|
61009 |
527 |
F344/NHsd |
plasma creatinine level |
controlled sodium content diet (4 %) (for 14 days) then fasting (between 16 and 1 hours) |
PhysGen Biochemistry data |
blood creatinine amount |
male |
70 days-84 days |
7 |
|
|
0.31 |
mg/dl |
0.03 |
0.07 |
automated plasma creatinine analysis |
|
|
|
0 |
|
|
|
|
61017 |
527 |
SS-Tcf7l2em1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
9 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
138.44 |
mmHg |
2.91 |
8.73 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44126 |
441 |
WKY/NCrl |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
|
99.33 |
% |
0.37 |
1.12 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
56858 |
522 |
SS-Chr 18BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
10 |
|
|
0.1 |
umol/l |
0.02 |
0.06 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
56874 |
522 |
SS/JrHsdMcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
79 |
|
|
-6.98 |
null |
0.06 |
0.49 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56955 |
522 |
SS-Chr 2BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
9 |
|
|
-7.3 |
null |
0.07 |
0.22 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56980 |
522 |
SS/JrHsdMcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
7 |
|
|
49.86 |
% |
7.38 |
19.53 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
56996 |
522 |
F344-Stxbp5lTn(sb-T2/Bart3)2.202Mcwi |
serum urea nitrogen level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
female |
70 days-84 days |
2 |
|
|
26.5 |
mg/dl |
0.5 |
0.71 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60202 |
527 |
FHH-Lcatm1Mcwi |
blood hemoglobin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
70 days-84 days |
13 |
|
|
14.75 |
g/dl |
0.41 |
1.5 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60300 |
527 |
F344-Trpc4Tn(sb-T2/Bart3)2.192Mcwi |
blood hemoglobin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
2 |
|
|
14.25 |
g/dl |
0.05 |
0.07 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60306 |
527 |
FHH-F10m2Mcwi |
blood hemoglobin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
70 days-84 days |
16 |
|
|
14.18 |
g/dl |
0.19 |
0.74 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60322 |
527 |
F344/NHsd |
blood hemoglobin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
4 |
|
|
15.05 |
g/dl |
1.0 |
1.99 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60330 |
527 |
SS-Mmp2em1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
1 |
/3 systolic pressure + 2/3 diastolic pressure |
|
139.0 |
mmHg |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66472 |
717 |
SS-Nox4em2Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
3 |
/3 systolic pressure + 2/3 diastolic pressure |
|
116.33 |
mmHg |
3.67 |
6.35 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66478 |
717 |
SS-Renem1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
5 |
/3 systolic pressure + 2/3 diastolic pressure |
|
126.8 |
mmHg |
11.56 |
25.85 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66496 |
717 |
SS-Gpr183em3Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
7 |
/3 systolic pressure + 2/3 diastolic pressure |
|
150.14 |
mmHg |
7.29 |
19.28 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66499 |
717 |
FHH.BN-(D1Hmgc14-D1Hmgc15)/Mcwi-Rab38em1Mcwi+/+ |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
5 |
|
|
43.77 |
mg/d |
13.05 |
29.18 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66507 |
717 |
SS-Rag1em1Mcwi-/- |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
3 |
|
|
98.1 |
mg/d |
22.03 |
38.16 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66510 |
717 |
SS-Chr 5BN-Cyp4a2em1Mcwi+/+ |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
3 |
|
|
165.66 |
mg/d |
7.8 |
13.51 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66528 |
717 |
SS-Cybaem1Mcwi-/- |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
6 |
|
|
54.67 |
mg/d |
7.61 |
18.64 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66531 |
717 |
SS-Apoeem7Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
3 |
|
|
344.0 |
beats/min |
18.25 |
31.61 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66590 |
717 |
SS-Mmp2em1Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
1 |
|
|
370.0 |
beats/min |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66593 |
717 |
SS-Chr 5BN-Cyp4a2em1Mcwi-/+ |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
2 |
|
|
359.5 |
beats/min |
3.5 |
4.95 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66606 |
717 |
SS-Nckap5em2Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
2 |
|
|
324.5 |
beats/min |
3.5 |
4.95 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66601 |
717 |
F344-AbatTn(sb-T2/Bart3)2.163Mcwi |
blood hemoglobin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
4 |
|
|
14.23 |
g/dl |
0.18 |
0.36 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60352 |
527 |
SS-Ghsrm3Mcwi |
mean corpuscular hemoglobin |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
1 |
|
|
19.1 |
pg |
|
|
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60374 |
527 |
SS-Cpt2m1Mcwi |
mean corpuscular hemoglobin concentration |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
1 |
|
|
31.8 |
g/dl |
|
|
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61859 |
527 |
FHH-Egln3m1Mcwi |
serum albumin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood albumin amount |
female |
70 days-84 days |
13 |
|
|
3.67 |
g/dl |
0.08 |
0.3 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61958 |
527 |
F344-Trpc4Tn(sb-T2/Bart3)2.192Mcwi |
serum aspartate aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
70 days-84 days |
1 |
|
|
90.0 |
U/l |
|
|
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61969 |
527 |
BN-Lcatm3Mcwi |
serum aspartate aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
70 days-84 days |
1 |
|
|
183.0 |
U/l |
|
|
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62013 |
527 |
F344-Stxbp5lTn(sb-T2/Bart3)2.202Mcwi |
serum aspartate aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
70 days-84 days |
2 |
|
|
233.0 |
U/l |
30.0 |
42.43 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62026 |
527 |
FHH-Tlr4m1Mcwi |
serum aspartate aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
70 days-84 days |
7 |
|
|
208.71 |
U/l |
25.39 |
67.19 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62024 |
527 |
F344-Nrg1Tn(sb-T2/Bart3)2.183Mcwi |
serum aspartate aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
70 days-84 days |
5 |
|
|
202.2 |
U/l |
38.72 |
86.59 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62032 |
527 |
FHH-Adipoqm1Mcwi |
blood lymphocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
70 days-84 days |
9 |
|
|
3.31 |
x 1000 cells/ul |
0.35 |
1.06 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62048 |
527 |
F344-Trpc4Tn(sb-T2/Bart3)2.192Mcwi |
blood lymphocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
70 days-84 days |
1 |
|
|
5.52 |
x 1000 cells/ul |
|
|
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62051 |
527 |
SS-Nppaem4Mcwi-/- |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
12 |
|
|
7.91 |
mEq/d |
1.1 |
3.81 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44196 |
441 |
SS-Ulk4em3Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
4 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
172.5 |
mmHg |
13.73 |
27.45 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66633 |
717 |
SS-Alms1em1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
5 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
154.8 |
mmHg |
8.35 |
18.67 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66630 |
717 |
SR/Hsd |
absolute change in mean arterial blood pressure |
controlled sodium content diet (0.15 %) then ruthenium red (3 mg/kg) then 4-alpha-phorbol 12,13-didecanoate (2.5 mg/kg) |
Gao F and Wang DH, Hypertension. 2010 Apr;55(4):1018-25. Epub 2010 Mar 1. |
arterial blood pressure trait |
male |
35 days-56 days |
0 |
|
|
-5.0 |
mmHg |
3.0 |
|
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
DR strain is from Charles River Laboratory, Wilmington, MA |
67239 |
731 |
FHH-Htr1am1Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
18 |
|
|
0.04 |
umol/l |
0.01 |
0.04 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62764 |
528 |
F344-DccTn(sb-T2/Bart3)2.205Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
5 |
|
|
0.01 |
umol/l |
0.0 |
0.01 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62770 |
528 |
F344-Brinp3Tn(sb-T2/Bart3)2.189Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
1 |
|
|
0.01 |
umol/l |
|
|
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62759 |
528 |
F344-DccTn(sb-T2/Bart3)2.205Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
7 |
|
|
0.01 |
umol/l |
0.0 |
0.01 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62781 |
528 |
FHH-Tlr4m1Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
12 |
|
|
0.01 |
umol/l |
0.0 |
0.0 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62789 |
528 |
FHH-F10m2Mcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (for 14 days) then fasting (between 16 and 1 hours) |
PhysGen Biochemistry data |
blood creatinine amount |
female |
70 days-84 days |
12 |
|
|
0.23 |
mg/dl |
0.03 |
0.11 |
automated plasma creatinine analysis |
|
|
|
0 |
|
|
|
|
61027 |
527 |
BN-Lcatm3Mcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (for 14 days) then fasting (between 16 and 1 hours) |
PhysGen Biochemistry data |
blood creatinine amount |
female |
70 days-84 days |
2 |
|
|
0.4 |
mg/dl |
0.0 |
0.0 |
automated plasma creatinine analysis |
|
|
|
0 |
|
|
|
|
61036 |
527 |
BN-Tgfbr2m1Mcwi |
plasma anion gap |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
ion homeostasis trait |
female |
70 days-84 days |
3 |
|
|
17.67 |
mmol/l |
1.45 |
2.52 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61069 |
527 |
F344-DccTn(sb-T2/Bart3)2.205Mcwi |
plasma anion gap |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
ion homeostasis trait |
female |
70 days-84 days |
4 |
|
|
23.25 |
mmol/l |
1.65 |
3.3 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61102 |
527 |
FHH-Nr4a1m1Mcwi |
mean corpuscular hemoglobin concentration |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
70 days-84 days |
11 |
|
|
33.06 |
g/dl |
0.52 |
1.72 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61165 |
527 |
F344-Plcb3Tn(sb-T2/Bart3)2.69Mcwi |
mean corpuscular hemoglobin concentration |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
3 |
|
|
31.73 |
g/dl |
0.42 |
0.72 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61184 |
527 |
SS-Ghsrm3Mcwi |
serum aspartate aminotransferase activity level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
70 days-84 days |
1 |
|
|
159.0 |
U/l |
|
|
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61214 |
527 |
SS-Mstnem3Mcwi-/+ |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
1 |
|
|
11.77 |
mEq/d |
|
|
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44220 |
441 |
SS-Plcd3em7Mcwi+/+ |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
3 |
|
|
10.3 |
mEq/d |
2.07 |
3.59 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44236 |
441 |
SS-Nppbem2Mcwi-/- |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
16 |
|
|
9.97 |
mEq/d |
0.61 |
2.45 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44247 |
441 |
SS-Cdh13em1Mcwi-/- |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
8 |
|
|
9.37 |
mEq/d |
1.21 |
3.43 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44252 |
441 |
SS-Prokr1em2Mcwi-/- |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
7 |
|
|
43.52 |
mg/d |
7.99 |
21.13 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44287 |
441 |
SS-Ulk3em1Mcwi+/+ |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
3 |
|
|
69.07 |
mg/d |
18.34 |
31.77 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44295 |
441 |
SS-Cyp1a1em5Mcwi+/+ |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
2 |
|
|
1.32 |
g |
0.02 |
0.03 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44327 |
441 |
SS-Msraem4Mcwi+/+ |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
5 |
|
|
1.44 |
g |
0.04 |
0.08 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44329 |
441 |
FHH/EurMcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
112 |
|
|
-7.0 |
null |
0.03 |
0.34 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62861 |
528 |
F344-Plcb3Tn(sb-T2/Bart3)2.69Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
2 |
|
|
-7.02 |
null |
0.12 |
0.18 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62856 |
528 |
SS/JrHsdMcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (1 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
5 |
|
|
-7.25 |
null |
0.1 |
0.22 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62886 |
528 |
F344-Brinp3Tn(sb-T2/Bart3)2.189Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Vascular data |
body mass |
female |
70 days-84 days |
1 |
|
|
130.0 |
g |
|
|
whole body digital scale |
|
|
|
0 |
|
|
|
|
62925 |
528 |
FHH-Adra1am1Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Vascular data |
body mass |
male |
70 days-84 days |
9 |
|
|
272.67 |
g |
2.23 |
6.69 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
62952 |
528 |
FHH-Adipoqm3Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
5 |
|
|
3.67 |
E-7mole |
1.0 |
2.24 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
63037 |
528 |
Crl:CD(SD) |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
10 |
|
|
1.75 |
E-7mole |
0.27 |
0.86 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
55982 |
522 |
SS-Chr 16BN/Mcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
4 |
|
|
26.25 |
% |
7.85 |
15.69 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
55996 |
522 |
FHH-Adipoqm2Mcwi |
serum total protein level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood total protein amount |
male |
70 days-84 days |
7 |
|
|
5.27 |
g/dl |
0.13 |
0.35 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61237 |
527 |
FHH-F10m2Mcwi |
serum total protein level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood total protein amount |
female |
70 days-84 days |
12 |
|
|
5.3 |
g/dl |
0.09 |
0.3 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61253 |
527 |
FHH-Adipoqm3Mcwi |
serum total protein level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood total protein amount |
female |
70 days-84 days |
6 |
|
|
5.65 |
g/dl |
0.18 |
0.45 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61270 |
527 |
F344-Plcb3Tn(sb-T2/Bart3)2.69Mcwi |
serum potassium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood potassium amount |
female |
70 days-84 days |
3 |
|
|
3.3 |
mmol/l |
0.35 |
0.61 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61338 |
527 |
F344-AbatTn(sb-T2/Bart3)2.163Mcwi |
serum potassium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood potassium amount |
male |
70 days-84 days |
3 |
|
|
4.17 |
mmol/l |
0.27 |
0.46 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61349 |
527 |
FHH-Ccr2m1Mcwi |
total white blood cell count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
70 days-84 days |
5 |
|
|
4.02 |
x 1000 cells/ul |
0.39 |
0.86 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61382 |
527 |
BN-Lcatm3Mcwi |
total white blood cell count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
70 days-84 days |
2 |
|
|
8.9 |
x 1000 cells/ul |
2.5 |
3.54 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61406 |
527 |
F344-Stxbp5lTn(sb-T2/Bart3)2.202Mcwi |
total white blood cell count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
70 days-84 days |
2 |
|
|
5.7 |
x 1000 cells/ul |
0.5 |
0.71 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61422 |
527 |
F344-Nrg1Tn(sb-T2/Bart3)2.183Mcwi |
total white blood cell count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
70 days-84 days |
5 |
|
|
4.84 |
x 1000 cells/ul |
0.38 |
0.84 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61428 |
527 |
F344-Nrg1Tn(sb-T2/Bart3)2.183Mcwi |
total white blood cell count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
leukocyte quantity |
male |
70 days-84 days |
5 |
|
|
8.52 |
x 1000 cells/ul |
1.32 |
2.95 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61431 |
527 |
GH/OmrMcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
|
0.9 |
E-7mole |
0.26 |
0.79 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
54593 |
522 |
GH/OmrMcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
8 |
|
|
1.1 |
E-7mole |
0.23 |
0.65 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
54598 |
522 |
Crl:CD(SD) |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
8 |
|
|
-6.84 |
null |
0.09 |
0.27 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
54745 |
522 |
F344/DuCrl |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
12 |
|
|
-6.99 |
null |
0.12 |
0.42 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
54751 |
522 |
FHH-Chr 15BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
6 |
|
|
77.67 |
% |
5.9 |
14.46 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54753 |
522 |
FHH-Chr 6BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
8 |
|
|
92.25 |
% |
3.64 |
10.29 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54761 |
522 |
SS-Chr 16BN/Mcwi |
logarithm of the concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
|
-8.98 |
null |
0.13 |
0.4 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56019 |
522 |
FHH-Chr 1BN/Mcwi |
logarithm of the concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
18 |
|
|
-8.5 |
null |
0.12 |
0.5 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56032 |
522 |
SS-Chr 5BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
7 |
|
|
-7.35 |
null |
0.08 |
0.21 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56112 |
522 |
SS-Chr 20BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
10 |
|
|
-7.41 |
null |
0.08 |
0.25 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56117 |
522 |
SS-Chr 16BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
15 |
|
|
-7.68 |
null |
0.08 |
0.33 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56120 |
522 |
SS-Chr 3BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
9 |
|
|
-7.21 |
null |
0.13 |
0.38 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56123 |
522 |
FHH-Chr 9BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
9 |
|
|
-8.4 |
null |
0.12 |
0.37 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56161 |
522 |
SS-Chr 16BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
5 |
|
|
-7.64 |
null |
0.05 |
0.1 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
56180 |
522 |
SS-Chr 18BN/Mcwi |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
10 |
|
|
99.7 |
% |
0.3 |
0.95 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
56197 |
522 |
SHR/NCrl |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
10 |
|
|
96.9 |
% |
1.87 |
5.92 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
56202 |
522 |
F344-Nrg1Tn(sb-T2/Bart3)2.183Mcwi |
blood eosinophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
eosinophil quantity |
female |
70 days-84 days |
5 |
|
|
0.01 |
x 1000 cells/ul |
0.01 |
0.03 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62268 |
527 |
FHH-Slc8a2m1Mcwi |
serum chloride level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood chloride amount |
male |
70 days-84 days |
10 |
|
|
102.9 |
mmol/l |
0.81 |
2.56 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62345 |
527 |
FHH-Agtr1bm1Mcwi |
serum total cholesterol level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
70 days-84 days |
14 |
|
|
58.5 |
mg/dl |
1.73 |
6.49 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62370 |
527 |
F344-Brinp3Tn(sb-T2/Bart3)2.189Mcwi |
serum total cholesterol level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
70 days-84 days |
1 |
|
|
74.0 |
mg/dl |
|
|
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62383 |
527 |
BN-Lcatm3Mcwi |
serum total cholesterol level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
70 days-84 days |
2 |
|
|
38.5 |
mg/dl |
1.5 |
2.12 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62400 |
527 |
FHH-Ghsrm1Mcwi |
serum total cholesterol level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
70 days-84 days |
9 |
|
|
66.11 |
mg/dl |
2.02 |
6.07 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62397 |
527 |
F344-DccTn(sb-T2/Bart3)2.205Mcwi |
serum total cholesterol level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
70 days-84 days |
4 |
|
|
74.5 |
mg/dl |
7.1 |
14.2 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62394 |
527 |
F344-Fam19a2Tn(sb-T2/Bart3)2.184Mcwi |
serum total cholesterol level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
70 days-84 days |
2 |
|
|
51.0 |
mg/dl |
31.0 |
43.84 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62402 |
527 |
FHH-Adra1am1Mcwi |
serum total cholesterol level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
70 days-84 days |
9 |
|
|
59.67 |
mg/dl |
2.61 |
7.84 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62413 |
527 |
F344-Nrg1Tn(sb-T2/Bart3)2.183Mcwi |
serum total cholesterol level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
70 days-84 days |
5 |
|
|
69.2 |
mg/dl |
5.11 |
11.43 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62425 |
527 |
F344-Nrg1Tn(sb-T2/Bart3)2.183Mcwi |
serum total cholesterol level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
70 days-84 days |
5 |
|
|
86.2 |
mg/dl |
3.25 |
7.26 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62422 |
527 |
SS-Ghsrm3Mcwi |
serum total bilirubin level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bilirubin amount |
male |
70 days-84 days |
2 |
|
|
0.1 |
mg/dl |
0.0 |
0.0 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62427 |
527 |
SS-Sod3m1Mcwi |
serum total bilirubin level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bilirubin amount |
male |
70 days-84 days |
10 |
|
|
0.1 |
mg/dl |
0.01 |
0.04 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62430 |
527 |
FHH-Slc8a2m1Mcwi |
serum glucose level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood glucose amount |
female |
70 days-84 days |
12 |
|
|
122.0 |
mg/dl |
11.39 |
39.45 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62460 |
527 |
BN/NHsdMcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
20 |
|
|
66.8 |
% |
3.88 |
17.34 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54841 |
522 |
FHH-Chr 1BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
18 |
|
|
41.5 |
% |
5.45 |
23.12 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54846 |
522 |
SS-Chr 14BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
10 |
|
|
0.08 |
umol/l |
0.03 |
0.09 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54893 |
522 |
SS-Chr 7BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
8 |
|
|
0.02 |
umol/l |
0.01 |
0.02 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54904 |
522 |
SS-Chr 15BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
9 |
|
|
0.02 |
umol/l |
0.01 |
0.02 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54923 |
522 |
SS-Chr 13BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
15 |
|
|
0.08 |
umol/l |
0.03 |
0.12 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54931 |
522 |
FHH-Chr YBN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
11 |
|
|
0.02 |
umol/l |
0.0 |
0.01 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54942 |
522 |
FHH-Chr 11BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
10 |
|
|
0.01 |
umol/l |
0.0 |
0.0 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54953 |
522 |
FHH/EurMcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
5 |
|
|
32.2 |
% |
9.09 |
20.33 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56271 |
522 |
SS-Chr 9BN/Mcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
|
14.44 |
% |
3.42 |
10.25 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56279 |
522 |
SS-Chr 6BN/Mcwi |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
|
100.0 |
% |
0.0 |
0.0 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56307 |
522 |
SS/JrHsdMcwi |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
54 |
|
|
99.5 |
% |
0.33 |
2.41 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56318 |
522 |
SS.BN-(D8Rat163-D8Rat81)/Mcwi |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
10 |
|
|
99.3 |
% |
0.37 |
1.16 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56326 |
522 |
SS-Ghsrm3Mcwi |
body weight |
controlled sodium content diet (1 %) (for 14 days) |
PhysGen General data |
body mass |
female |
70 days-84 days |
2 |
|
|
190.5 |
g |
4.5 |
6.36 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
63241 |
529 |
F344-Nrg1Tn(sb-T2/Bart3)2.183Mcwi |
heart right ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart right ventricle mass |
male |
70 days-84 days |
5 |
|
|
0.13 |
g |
0.01 |
0.02 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63334 |
529 |
FHH-Nr0b2m1Mcwi |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
kidney mass |
female |
70 days-84 days |
8 |
|
|
0.81 |
g |
0.02 |
0.05 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63336 |
529 |
F344-Nrg1Tn(sb-T2/Bart3)2.183Mcwi |
heart right ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart right ventricle mass |
female |
70 days-84 days |
5 |
|
|
0.1 |
g |
0.01 |
0.02 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63331 |
529 |
BN-Tgfbr2m1Mcwi |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
kidney mass |
female |
70 days-84 days |
3 |
|
|
0.5 |
g |
0.03 |
0.06 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63342 |
529 |
SS-Wdr72em2Mcwi+/+ |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
7 |
|
|
305.6 |
g |
9.6 |
25.4 |
whole body digital scale |
|
|
|
0 |
|
|
|
- |
43493 |
421 |
SS-Rasgrp3em1Mcwi-/- |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
10 |
|
|
151.39 |
mg/d |
17.0 |
53.77 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
43507 |
421 |
SS-Wdr72em2Mcwi+/+ |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
7 |
|
|
126.17 |
mg/d |
17.74 |
46.93 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
43509 |
421 |
SS-Adra2aem1Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
4 |
|
|
336.0 |
beats/min |
8.69 |
17.38 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43533 |
421 |
SS-Hexim2em4Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
3 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
137.33 |
mmHg |
4.33 |
7.51 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43544 |
421 |
SS-Agtrapem4Mcwi+/+ |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
3 |
|
|
10.12 |
mEq/d |
1.35 |
2.33 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
43579 |
421 |
F344-Trpc4Tn(sb-T2/Bart3)2.192Mcwi |
blood monocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
monocyte quantity |
female |
70 days-84 days |
2 |
|
|
0.11 |
x 1000 cells/ul |
0.06 |
0.08 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61680 |
527 |
F344-Plce1Tn(sb-T2/Bart3)2.146Mcwi |
blood monocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
monocyte quantity |
female |
70 days-84 days |
5 |
|
|
0.05 |
x 1000 cells/ul |
0.02 |
0.04 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61688 |
527 |
FHH-Nr0b2m1Mcwi |
blood monocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
monocyte quantity |
male |
70 days-84 days |
10 |
|
|
0.22 |
x 1000 cells/ul |
0.07 |
0.21 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61685 |
527 |
FHH-Nr4a1m1Mcwi |
blood monocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
monocyte quantity |
male |
70 days-84 days |
11 |
|
|
0.15 |
x 1000 cells/ul |
0.05 |
0.17 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61699 |
527 |
FHH-F10m1Mcwi |
blood monocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
monocyte quantity |
female |
70 days-84 days |
11 |
|
|
0.07 |
x 1000 cells/ul |
0.02 |
0.08 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61691 |
527 |
F344-Plcb3Tn(sb-T2/Bart3)2.69Mcwi |
blood monocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
monocyte quantity |
male |
70 days-84 days |
1 |
|
|
0.07 |
x 1000 cells/ul |
|
|
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61715 |
527 |
F344-Inpp4bTn(sb-T2/Bart3)2.143Mcwi |
blood monocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
monocyte quantity |
male |
70 days-84 days |
7 |
|
|
0.09 |
x 1000 cells/ul |
0.03 |
0.07 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61735 |
527 |
FHH-Adipoqm2Mcwi |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
kidney mass |
male |
70 days-84 days |
9 |
|
|
1.24 |
g |
0.03 |
0.08 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63356 |
529 |
FHH-Ghsrm1Mcwi |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
kidney mass |
female |
70 days-84 days |
10 |
|
|
0.95 |
g |
0.02 |
0.07 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63378 |
529 |
BN-Lcatm3Mcwi |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
kidney mass |
female |
70 days-84 days |
6 |
|
|
0.55 |
g |
0.02 |
0.06 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63381 |
529 |
F344-Fam19a2Tn(sb-T2/Bart3)2.184Mcwi |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
kidney mass |
female |
70 days-84 days |
3 |
|
|
0.6 |
g |
0.03 |
0.05 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63383 |
529 |
FHH-Procm1Mcwi |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart mass |
female |
70 days-84 days |
9 |
|
|
0.96 |
g |
0.11 |
0.34 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63432 |
529 |
FHH-F10m2Mcwi |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart mass |
female |
70 days-84 days |
10 |
|
|
0.82 |
g |
0.02 |
0.07 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63444 |
529 |
FHH-Lcatm1Mcwi |
body length, nose to rump |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
male |
70 days-84 days |
13 |
|
|
24.23 |
cm |
0.19 |
0.7 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63505 |
529 |
F344/NHsd |
body length, nose to rump |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
female |
70 days-84 days |
10 |
|
|
26.9 |
cm |
2.32 |
7.32 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63535 |
529 |
FHH-F10m1Mcwi |
body length, nose to rump |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
male |
70 days-84 days |
10 |
|
|
24.2 |
cm |
0.17 |
0.54 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63537 |
529 |
F344-Lims1Tn(sb-T2/Bart3)2.169Mcwi |
body length, nose to rump |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
female |
70 days-84 days |
8 |
|
|
19.88 |
cm |
0.21 |
0.58 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63532 |
529 |
BN-Lcatm3Mcwi |
body length, nose to rump |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
male |
70 days-84 days |
1 |
|
|
22.0 |
cm |
|
|
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63548 |
529 |
FHH-Slc8a2m1Mcwi |
body length, nose to rump |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
male |
70 days-84 days |
15 |
|
|
24.2 |
cm |
0.14 |
0.53 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63562 |
529 |
SS-Sod3m1Mcwi |
left kidney wet weight |
controlled sodium content diet (1 %) (for 14 days) |
PhysGen General data |
kidney mass |
female |
70 days-84 days |
13 |
|
|
1.01 |
g |
0.02 |
0.09 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63581 |
529 |
SS-Sod3m1Mcwi |
left kidney wet weight |
controlled sodium content diet (1 %) (for 14 days) |
PhysGen General data |
kidney mass |
male |
70 days-84 days |
11 |
|
|
1.63 |
g |
0.07 |
0.22 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63575 |
529 |
BN-Lcatm3Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body mass |
male |
70 days-84 days |
1 |
|
|
253.0 |
g |
|
|
whole body digital scale |
|
|
|
0 |
|
|
|
|
63630 |
529 |
FHH-Adipoqm3Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body mass |
female |
70 days-84 days |
7 |
|
|
209.14 |
g |
4.02 |
10.64 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
63635 |
529 |
BN-Lcatm3Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body mass |
female |
70 days-84 days |
6 |
|
|
158.83 |
g |
3.63 |
8.89 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
63627 |
529 |
SS-Agtrapem4Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
3 |
|
|
359.67 |
beats/min |
18.68 |
32.35 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43669 |
421 |
SS-Hexim2em4Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
10 |
|
|
387.0 |
beats/min |
9.54 |
30.16 |
radiotelemetry |
carotid artery |
0 |
|
0 |
|
|
|
- |
43688 |
421 |
SS-Cpt2m1Mcwi |
serum urea nitrogen level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
70 days-84 days |
6 |
|
|
31.5 |
mg/dl |
1.89 |
4.64 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61762 |
527 |
SS-Cpt2m1Mcwi |
serum urea nitrogen level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
female |
70 days-84 days |
1 |
|
|
44.0 |
mg/dl |
|
|
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61767 |
527 |
F344-Trpc4Tn(sb-T2/Bart3)2.192Mcwi |
serum sodium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood sodium amount |
male |
70 days-84 days |
1 |
|
|
144.0 |
mmol/l |
|
|
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61775 |
527 |
F344-Elmod3Tn(sb-T2/Bart3)2.42Mcwi |
serum sodium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood sodium amount |
male |
70 days-84 days |
5 |
|
|
135.4 |
mmol/l |
1.75 |
3.91 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61778 |
527 |
FHH-Ccr2m1Mcwi |
serum sodium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood sodium amount |
female |
70 days-84 days |
5 |
|
|
138.2 |
mmol/l |
1.74 |
3.9 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61792 |
527 |
SS-Chr 6BN/Mcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
8 |
|
|
24.25 |
% |
4.97 |
14.05 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
55080 |
522 |
SS-Chr 18BN/Mcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
10 |
|
|
33.1 |
% |
6.52 |
20.6 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
55085 |
522 |
WKY/NCrl |
logarithm of the concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
|
-8.34 |
null |
0.07 |
0.21 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
55118 |
522 |
FHH-Chr 6BN/Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
9 |
|
|
1.15 |
g/mg |
0.15 |
0.45 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
57315 |
522 |
FHH-Chr 17BN/Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
10 |
|
|
0.67 |
g/mg |
0.08 |
0.26 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
57334 |
522 |
SS-Chr 13BN/Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
15 |
|
|
0.87 |
g/mg |
0.1 |
0.38 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
57359 |
522 |
FHH-Chr YBN/Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
11 |
|
|
0.79 |
g/mg |
0.08 |
0.26 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
57370 |
522 |
SS-Chr 20BN/Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
10 |
|
|
1.48 |
g/mg |
0.05 |
0.15 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
57364 |
522 |
FHH-Chr 4BN/Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
10 |
|
|
1.39 |
g/mg |
0.15 |
0.47 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
57378 |
522 |
SS/JrHsdMcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
15 |
|
|
1.25 |
g/mg |
0.12 |
0.46 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
57380 |
522 |
FHH-Chr 1BN/Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
28 |
|
|
1.96 |
g/mg |
0.16 |
0.86 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
57400 |
522 |
SHR/NCrl |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
8 |
|
|
-7.19 |
null |
0.06 |
0.18 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
57405 |
522 |
FHH-Chr 14BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
10 |
|
|
1.76 |
E-7mole |
0.37 |
1.18 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56497 |
522 |
SS-Chr 5BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
11 |
|
|
1.34 |
E-7mole |
0.1 |
0.32 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56522 |
522 |
SS-Chr 9BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
|
3.39 |
E-7mole |
0.65 |
1.96 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56508 |
522 |
SS-Chr 16BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
11 |
|
|
2.8 |
E-7mole |
1.24 |
4.11 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56541 |
522 |
SS-Chr 3BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
|
1.53 |
E-7mole |
0.22 |
0.66 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56544 |
522 |
SS-Chr 11BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
|
1.63 |
E-7mole |
0.18 |
0.55 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56552 |
522 |
BN-Lcatm3Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
5 |
|
|
-7.76 |
null |
0.14 |
0.32 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
|
63098 |
528 |
FHH-Adipoqm3Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
5 |
|
|
-8.41 |
null |
0.23 |
0.52 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
|
63107 |
528 |
F344-DccTn(sb-T2/Bart3)2.205Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
7 |
|
|
-8.19 |
null |
0.16 |
0.41 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
|
63104 |
528 |
FHH-Adipoqm1Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 14 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
10 |
|
|
1.71 |
g/mg |
0.05 |
0.17 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
63126 |
528 |
FHH-Adipoqm1Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 14 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
8 |
|
|
1.46 |
g/mg |
0.08 |
0.24 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
63142 |
528 |
SS-Ghsrm3Mcwi |
body weight |
controlled sodium content diet (1 %) (for 14 days) |
PhysGen Vascular data |
body mass |
male |
70 days-84 days |
2 |
|
|
302.5 |
g |
17.5 |
24.75 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
63194 |
528 |
FHH-Adra1am1Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 14 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
8 |
|
|
1.7 |
g/mg |
0.09 |
0.26 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
63180 |
528 |
SS/Jr |
systolic blood pressure |
controlled sodium content diet (2 %) (between 24 and 27 days) |
Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23 |
arterial blood pressure trait |
not specified |
64 days-71 days |
40 |
|
serial mean |
216.0 |
mmHg |
2.4 |
15.18 |
tail cuff plethysmography |
tail |
0 |
|
0 |
|
|
|
|
64736 |
222 |
SS/JrHsdMcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (1 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
5 |
|
|
0.63 |
E-7mole |
0.18 |
0.41 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
63222 |
528 |
SS-Klf4m3Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (1 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
9 |
|
|
3.8 |
E-7mole |
1.13 |
3.4 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
63219 |
528 |
FHH-Slc8a2m1Mcwi |
blood lymphocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
70 days-84 days |
11 |
|
|
2.82 |
x 1000 cells/ul |
0.21 |
0.7 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62060 |
527 |
FHH-Adipoqm1Mcwi |
blood lymphocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
70 days-84 days |
8 |
|
|
3.57 |
x 1000 cells/ul |
0.22 |
0.62 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62065 |
527 |
FHH-Ccr2m1Mcwi |
blood lymphocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
70 days-84 days |
8 |
|
|
3.88 |
x 1000 cells/ul |
0.3 |
0.85 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62076 |
527 |
FHH-Adra1am1Mcwi |
blood lymphocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
70 days-84 days |
8 |
|
|
3.71 |
x 1000 cells/ul |
0.15 |
0.43 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62103 |
527 |
FHH-Egln3m1Mcwi |
blood lymphocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
70 days-84 days |
6 |
|
|
3.74 |
x 1000 cells/ul |
0.27 |
0.65 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62098 |
527 |
FHH-Lcatm1Mcwi |
serum total bilirubin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bilirubin amount |
female |
70 days-84 days |
15 |
|
|
0.14 |
mg/dl |
0.01 |
0.06 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62131 |
527 |
FHH-F10m2Mcwi |
serum total bilirubin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bilirubin amount |
female |
70 days-84 days |
12 |
|
|
0.18 |
mg/dl |
0.01 |
0.05 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62155 |
527 |
FHH-Ghsrm1Mcwi |
blood eosinophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
eosinophil quantity |
female |
70 days-84 days |
9 |
|
|
0.08 |
x 1000 cells/ul |
0.03 |
0.08 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62243 |
527 |
F344-Lims1Tn(sb-T2/Bart3)2.169Mcwi |
blood eosinophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
70 days-84 days |
2 |
|
|
0.05 |
x 1000 cells/ul |
0.05 |
0.06 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62235 |
527 |
BN-Lcatm3Mcwi |
blood eosinophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
70 days-84 days |
1 |
|
|
0.04 |
x 1000 cells/ul |
|
|
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62249 |
527 |
SS-Nppaem4Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
11 |
|
|
342.11 |
beats/min |
7.43 |
24.64 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43701 |
441 |
F344-Stxbp5lTn(sb-T2/Bart3)2.202Mcwi |
blood eosinophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
eosinophil quantity |
female |
70 days-84 days |
2 |
|
|
0.11 |
x 1000 cells/ul |
0.11 |
0.15 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62262 |
527 |
SS-Cyp1a1em2Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
10 |
|
|
371.3 |
beats/min |
7.54 |
23.83 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43705 |
441 |
SS-Cdh13em1Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
4 |
|
|
364.5 |
beats/min |
16.9 |
33.81 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43713 |
441 |
SS-Msraem4Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
6 |
|
|
348.5 |
beats/min |
15.51 |
37.99 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43715 |
441 |
SS-Tcf7l2em1Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
5 |
|
|
338.8 |
beats/min |
17.63 |
39.42 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43718 |
441 |
SS-Prokr1em1Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
4 |
|
|
340.5 |
beats/min |
13.05 |
26.11 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43734 |
441 |
SS-Plcd3em7Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
9 |
|
|
349.89 |
beats/min |
6.75 |
20.26 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43739 |
441 |
SS-Chr 4BN/Mcwi |
body weight |
controlled sodium content diet (4 %) (for 21 days) |
PhysGen Vascular data |
body mass |
female |
70 days-84 days |
10 |
|
|
204.6 |
g |
3.9 |
12.2 |
whole body digital scale |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
55232 |
522 |
Hsd:SD |
logarithm of the concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
16 |
|
|
-7.54 |
null |
0.06 |
0.26 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
55246 |
522 |
SS-Stk39em2Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
4 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
137.75 |
mmHg |
12.75 |
25.5 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43766 |
441 |
SS-Nppbem2Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
4 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
134.25 |
mmHg |
5.01 |
10.01 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43771 |
441 |
SS-Msraem4Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
6 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
132.0 |
mmHg |
5.51 |
13.51 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43777 |
441 |
SS-Mstnem1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
10 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
132.3 |
mmHg |
4.88 |
15.43 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43779 |
441 |
SS-Plekha7em4Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
11 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
140.09 |
mmHg |
6.7 |
22.21 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43790 |
441 |
SS-Plekha7em1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
9 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
131.0 |
mmHg |
5.72 |
17.16 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43793 |
441 |
SS-Plcd3em7Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
9 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
142.78 |
mmHg |
4.69 |
14.06 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43801 |
441 |
SS-Plcd3em7Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
9 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
149.56 |
mmHg |
5.16 |
15.48 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43863 |
441 |
SS-Tcf7l2em1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
9 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
138.44 |
mmHg |
2.82 |
8.46 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43879 |
441 |
SS-Nppaem4Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
2 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
142.5 |
mmHg |
4.5 |
6.36 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43884 |
441 |
SS-Agtr1aem1Mcwi+/+ |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
6 |
|
|
334.0 |
g |
6.1 |
14.9 |
whole body digital scale |
|
|
|
0 |
|
|
|
- |
43889 |
441 |
WKY/NCrl |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (0 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
13 |
|
|
73.77 |
% |
2.67 |
9.63 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
56703 |
522 |
SS-Chr 16BN/Mcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
3 |
|
|
44.67 |
% |
1.86 |
3.21 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
56720 |
522 |
SS.SR-(Syt2-D13Mit1)/Jr |
systolic blood pressure |
controlled sodium content diet (0.2 %) (for 24 days) then controlled sodium content diet (4 %) (for 24 days) |
Zhang QY, et al., Mamm Genome 1997 Sep;8(9):636-41 |
arterial blood pressure trait |
not specified |
65 days-68 days |
25 |
data obtained at three consistent sessions per day |
serial mean |
219.0 |
mmHg |
|
|
tail cuff plethysmography |
|
345600 |
|
0 |
|
|
|
|
66030 |
650 |
FHH-Ccr2m1Mcwi |
hematocrit |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
70 days-84 days |
5 |
|
|
43.62 |
% |
2.19 |
4.9 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60644 |
527 |
FHH-Ccr2m1Mcwi |
hematocrit |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
70 days-84 days |
8 |
|
|
46.94 |
% |
1.66 |
4.7 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60652 |
527 |
FHH-Tlr4m1Mcwi |
hematocrit |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
70 days-84 days |
7 |
|
|
48.7 |
% |
2.59 |
6.85 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60682 |
527 |
F344-Nrg1Tn(sb-T2/Bart3)2.183Mcwi |
hematocrit |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
70 days-84 days |
5 |
|
|
44.74 |
% |
0.95 |
2.13 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60690 |
527 |
SS-Sod3m1Mcwi |
serum alkaline phosphatase activity level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
male |
70 days-84 days |
10 |
|
|
63.6 |
U/l |
2.68 |
8.47 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60698 |
527 |
SS/JrHsdMcwi |
serum alkaline phosphatase activity level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
70 days-84 days |
17 |
|
|
56.53 |
U/l |
2.15 |
8.85 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60703 |
527 |
SS-Klf4m3Mcwi |
blood monocyte count |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
monocyte quantity |
female |
70 days-84 days |
7 |
|
|
0.14 |
x 1000 cells/ul |
0.03 |
0.09 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60709 |
527 |
SS-Sod3m1Mcwi |
blood monocyte count |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
monocyte quantity |
female |
70 days-84 days |
10 |
|
|
0.15 |
x 1000 cells/ul |
0.03 |
0.1 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60714 |
527 |
SS-Ghsrm3Mcwi |
serum phosphate level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
70 days-84 days |
2 |
|
|
8.15 |
mg/dl |
0.25 |
0.35 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60725 |
527 |
SS/JrHsdMcwi |
serum albumin level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood albumin amount |
female |
70 days-84 days |
17 |
|
|
3.81 |
g/dl |
0.07 |
0.28 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60723 |
527 |
FHH-Lcatm1Mcwi |
mean corpuscular volume |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte size trait |
female |
70 days-84 days |
15 |
|
|
52.75 |
fl |
0.41 |
1.58 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60747 |
527 |
FHH-Agtr1bm1Mcwi |
mean corpuscular volume |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte size trait |
female |
70 days-84 days |
14 |
|
|
54.11 |
fl |
0.42 |
1.57 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60750 |
527 |
LEW/Crl |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
|
52.44 |
% |
4.83 |
14.48 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
56826 |
522 |
Crl:CD(SD) |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
|
56.78 |
% |
4.79 |
14.37 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
56829 |
522 |
FHH-Lcatm1Mcwi |
serum urea nitrogen level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
female |
70 days-84 days |
15 |
|
|
17.73 |
mg/dl |
0.52 |
2.02 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60153 |
527 |
FHH-Adipoqm2Mcwi |
serum urea nitrogen level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
70 days-84 days |
7 |
|
|
19.43 |
mg/dl |
1.25 |
3.31 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60161 |
527 |
F344-Brinp3Tn(sb-T2/Bart3)2.189Mcwi |
serum urea nitrogen level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
70 days-84 days |
3 |
|
|
17.67 |
mg/dl |
0.67 |
1.15 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60164 |
527 |
FHH-Procm1Mcwi |
serum urea nitrogen level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
70 days-84 days |
10 |
|
|
18.31 |
mg/dl |
2.16 |
6.84 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60172 |
527 |
FHH-Adipoqm3Mcwi |
serum urea nitrogen level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
female |
70 days-84 days |
6 |
|
|
16.0 |
mg/dl |
1.15 |
2.83 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60194 |
527 |
FHH-Ghsrm1Mcwi |
serum alanine aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
female |
70 days-84 days |
9 |
|
|
47.67 |
U/l |
2.13 |
6.38 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61475 |
527 |
SS-Mthfrem1Mcwi+/+ |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
1 |
|
|
346.0 |
g |
|
|
whole body digital scale |
|
|
|
0 |
|
|
|
- |
66273 |
717 |
SS-Gpr183em2Mcwi-/- |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
11 |
|
|
311.5 |
g |
7.8 |
25.8 |
whole body digital scale |
|
|
|
0 |
|
|
|
- |
66278 |
717 |
SS-Nox4em2Mcwi+/+ |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
3 |
|
|
337.0 |
g |
8.5 |
14.8 |
whole body digital scale |
|
|
|
0 |
|
|
|
- |
66297 |
717 |
SS-Nox4em2Mcwi-/+ |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
2 |
|
|
322.5 |
g |
11.5 |
16.3 |
whole body digital scale |
|
|
|
0 |
|
|
|
- |
66324 |
717 |
SS-Mthfrem1Mcwi-/+ |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
8 |
|
|
333.2 |
g |
10.0 |
28.2 |
whole body digital scale |
|
|
|
0 |
|
|
|
- |
66321 |
717 |
SS-Tgfb1em3Mcwi+/- |
heart rate |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
3 |
|
|
336.67 |
beats/min |
19.32 |
33.47 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66337 |
717 |
SS.LEW-(D18Chm41-D18Rat92)/Ayd |
heart left ventricle posterior wall thickness |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle posterior wall thickness |
male |
77 days
| 8 |
|
|
0.18 |
mm |
0.0 |
0.01 |
transthoracic echocardiography |
|
0 |
|
0 |
|
|
|
|
65117 |
542 |
SS.LEW-(D10Got112-Igfbp4)/Ayd |
heart left ventricle posterior wall thickness |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle posterior wall thickness |
male |
77 days
| 5 |
|
|
0.17 |
mm |
0.01 |
0.02 |
transthoracic echocardiography |
|
0 |
|
0 |
|
|
|
|
65120 |
542 |
SS.SR-(D7Mco19-D7Mco7)/Jr |
both kidneys wet weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) then controlled sodium content diet (4 %) (between 46 and 48 days) |
Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2. |
kidney mass |
male |
114 days-118 days |
3 |
|
|
3.79 |
g |
0.14 |
0.24 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
65125 |
283 |
WKY.SHRSP-(Asgr1-Vamp2)/Bbb |
diastolic blood pressure |
controlled sodium content diet |
Kreutz R, et al., Proc Natl Acad Sci U S A 1995 Sep 12;92(19):8778-82 |
arterial blood pressure trait |
not specified |
0 days
| 9 |
|
|
89.4 |
mmHg |
0.63 |
1.9 |
radiotelemetry |
|
0.0 |
|
0 |
|
|
|
|
67199 |
116 |
FHH-Adra1am1Mcwi |
serum phosphate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
70 days-84 days |
8 |
|
|
7.99 |
mg/dl |
0.22 |
0.62 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61581 |
527 |
F344-Stxbp5lTn(sb-T2/Bart3)2.202Mcwi |
serum phosphate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
70 days-84 days |
2 |
|
|
8.5 |
mg/dl |
1.0 |
1.41 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61586 |
527 |
FHH-Nr0b2m1Mcwi |
serum bicarbonate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bicarbonate amount |
female |
70 days-84 days |
6 |
|
|
17.5 |
mmol/l |
0.85 |
2.07 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61597 |
527 |
F344-Trpc4Tn(sb-T2/Bart3)2.192Mcwi |
serum bicarbonate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bicarbonate amount |
female |
70 days-84 days |
2 |
|
|
21.0 |
mmol/l |
0.0 |
0.0 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61608 |
527 |
FHH-F10m1Mcwi |
serum bicarbonate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bicarbonate amount |
female |
70 days-84 days |
11 |
|
|
20.18 |
mmol/l |
1.02 |
3.37 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61619 |
527 |
F344-DccTn(sb-T2/Bart3)2.205Mcwi |
serum bicarbonate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bicarbonate amount |
female |
70 days-84 days |
4 |
|
|
21.75 |
mmol/l |
0.48 |
0.96 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61636 |
527 |
SS-Mstnem3Mcwi+/+ |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
8 |
|
|
332.6 |
g |
2.2 |
6.2 |
whole body digital scale |
|
|
|
0 |
|
|
|
- |
43924 |
441 |
SS-Plekha7em4Mcwi-/- |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
13 |
|
|
309.6 |
g |
6.8 |
24.6 |
whole body digital scale |
|
|
|
0 |
|
|
|
- |
43915 |
441 |
SS-Slc30a8em2Mcwi-/- |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
11 |
|
|
318.9 |
g |
5.7 |
18.8 |
whole body digital scale |
|
|
|
0 |
|
|
|
- |
43945 |
441 |
SS-Ulk3em1Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
11 |
|
|
348.27 |
beats/min |
5.62 |
18.65 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44032 |
441 |
SS-Nppbem4Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
8 |
|
|
352.51 |
beats/min |
9.93 |
28.1 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44043 |
441 |
SS-Aldh2em2Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
6 |
|
|
349.17 |
beats/min |
5.36 |
13.12 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44046 |
441 |
SS-Plcd3em4Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
3 |
|
|
333.33 |
beats/min |
7.54 |
13.05 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44072 |
441 |
SS-Prokr1em2Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
6 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
147.17 |
mmHg |
2.85 |
6.97 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44075 |
441 |
SS-Nppbem4Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
9 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
130.89 |
mmHg |
3.37 |
10.11 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44083 |
441 |
SS-Stk39em2Mcwi-/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
1 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
170.0 |
mmHg |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44091 |
441 |
SS-Ulk3em1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
3 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
128.67 |
mmHg |
6.06 |
10.5 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44110 |
441 |
SS-Nppbem2Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
14 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
125.8 |
mmHg |
5.14 |
19.24 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44123 |
441 |
SS-Aldh2em2Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
6 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
154.5 |
mmHg |
11.34 |
27.78 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44112 |
441 |
SS-Mmp2em1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
1 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
136.0 |
mmHg |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66412 |
717 |
SS-Nckap5em1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
5 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
149.6 |
mmHg |
14.09 |
31.52 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66415 |
717 |
SS-Gpr183em3Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
3 |
|
|
349.0 |
beats/min |
1.15 |
2.0 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66356 |
717 |
SS-Rag1em2Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
1 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
128.0 |
mmHg |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66431 |
717 |
SS-Cybaem1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
2 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
140.5 |
mmHg |
24.5 |
34.65 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66433 |
717 |
SS-Gpr183em3Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
7 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
148.14 |
mmHg |
5.8 |
15.36 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66439 |
717 |
FHH.BN-(D1Hmgc14-D1Hmgc15)/Mcwi-Rab38em1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
3 |
/3 systolic pressure + 2/3 diastolic pressure |
|
140.0 |
mmHg |
14.57 |
25.24 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66447 |
717 |
F344-Lims1Tn(sb-T2/Bart3)2.169Mcwi |
serum glucose level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood glucose amount |
male |
70 days-84 days |
2 |
|
|
229.0 |
mg/dl |
1.0 |
1.41 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62481 |
527 |
F344-DccTn(sb-T2/Bart3)2.205Mcwi |
serum glucose level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood glucose amount |
female |
70 days-84 days |
4 |
|
|
138.25 |
mg/dl |
24.59 |
49.18 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62486 |
527 |
BN-Lcatm3Mcwi |
serum glucose level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood glucose amount |
female |
70 days-84 days |
2 |
|
|
134.0 |
mg/dl |
7.0 |
9.9 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62492 |
527 |
F344-Stxbp5lTn(sb-T2/Bart3)2.202Mcwi |
serum glucose level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood glucose amount |
female |
70 days-84 days |
2 |
|
|
171.5 |
mg/dl |
19.5 |
27.58 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62508 |
527 |
SS-Klf4m3Mcwi |
blood eosinophil count |
controlled sodium content diet (1 %) (for 14 days) then fasting (between 16 and 1 hours) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
70 days-84 days |
8 |
|
|
0.1 |
x 1000 cells/ul |
0.04 |
0.1 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60822 |
527 |
SS/JrHsdMcwi |
blood eosinophil count |
controlled sodium content diet (1 %) (for 14 days) then fasting (between 16 and 1 hours) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
70 days-84 days |
41 |
|
|
0.07 |
x 1000 cells/ul |
0.02 |
0.1 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60819 |
527 |
FHH-Nr0b2m1Mcwi |
blood neutrophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
70 days-84 days |
6 |
|
|
1.19 |
x 1000 cells/ul |
0.17 |
0.42 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60827 |
527 |
FHH-Htr1am1Mcwi |
blood neutrophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
70 days-84 days |
13 |
|
|
0.58 |
x 1000 cells/ul |
0.08 |
0.28 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60852 |
527 |
SS/NEisSlc |
plasma renin activity level |
controlled sodium content diet (0.3 %) (for 91 days) |
Otsuka F, et al., Am J Physiol. 1998 Jun;274(6 Pt 2):R1797-806. |
renin activity |
male |
91 days
| 6 |
|
|
2.49 |
ng/ml/h |
0.63 |
1.53 |
radioimmunoassay |
|
0.0 |
|
0 |
|
|
|
|
100688 |
2519 |
SS/NEisSlc |
kidney weight |
controlled sodium content diet (0.3 %) (for 91 days) |
Otsuka F, et al., Am J Physiol. 1998 Jun;274(6 Pt 2):R1797-806. |
kidney mass |
male |
91 days
| 6 |
|
|
1.51 |
g |
0.02 |
0.06 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
100702 |
2519 |
SS/NEisSlc |
body weight |
controlled sodium content diet (8 %) (for 42 days) then cilazapril (10 mg/kg/d) (for 42 days) |
Otsuka F, et al., Am J Physiol. 1998 Jun;274(6 Pt 2):R1797-806. |
body mass |
male |
91 days
| 6 |
|
|
319.3 |
g |
7.49 |
18.35 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
100699 |
2519 |
SS-Renem1Mcwi-/- |
urine total protein excretion rate |
controlled sodium content diet (0.4 %) (for 35 days) |
Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17. |
total urine protein amount |
male |
56 days
| 8 |
|
|
7.83 |
mg/d |
0.95 |
2.69 |
urine total protein analysis |
|
0.0 |
|
0 |
|
|
|
|
98321 |
2038 |
SS/Jr |
systolic blood pressure |
controlled sodium content diet (0.3 %) (for 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Nie Y, et al., Physiol Genomics. 2016 Jun;48(6):409-19. doi: 10.1152/physiolgenomics.00004.2016. Epub 2016 Apr 25. |
arterial blood pressure trait |
male |
68 days-70 days |
8 |
|
serial mean |
201.0 |
mmHg |
7.4 |
20.93 |
radiotelemetry |
|
0.0 |
|
0 |
|
|
|
|
97983 |
1958 |
SS/Jr |
heart rate |
controlled sodium content diet (0.3 %) (for 12 days) then controlled sodium content diet (2 %) (for 28 days) |
Nie Y, et al., Physiol Genomics. 2016 Jun;48(6):409-19. doi: 10.1152/physiolgenomics.00004.2016. Epub 2016 Apr 25. |
heart pumping trait |
male |
68 days-70 days |
8 |
|
serial mean |
397.0 |
beats/min |
9.01 |
25.48 |
radiotelemetry |
|
0.0 |
|
0 |
|
|
|
|
97979 |
1958 |
SS.BN-(D12Hmgc7-D12Hmgc6)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (1 %) (between 42 and 49 days) |
Prisco SZ, et al., Hypertension. 2014 Jul 7. pii: HYPERTENSIONAHA.114.03550. |
arterial blood pressure trait |
male |
71 days-77 days |
6 |
|
|
110.0 |
mmHg |
1.0 |
2.45 |
intra-aortic abdominal radiotelemetry |
|
0.0 |
|
0 |
|
|
|
|
96806 |
1698 |
LEW.SS-(D8Chm12-D8Rat15)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (between 31 and 41 days) |
Crespo K, et al., Circ Cardiovasc Genet. 2015 Aug;8(4):610-7. doi: 10.1161/CIRCGENETICS.114.000965. Epub 2015 May 11. |
arterial blood pressure trait |
male |
67 days-77 days |
5 |
|
|
96.0 |
mmHg |
3.0 |
6.71 |
intra-aortic abdominal radiotelemetry |
abdominal aorta |
864000.0 |
|
0 |
|
|
|
|
97147 |
1878 |
SS.LEW-(D1Mco55-D1Wox6)/Bj |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) and housing in pairs (between 28 and 66 days) then controlled sodium content diet (2 %) (for 24 days) |
Mell B, et al., Hypertens Res. 2015 Jan;38(1):61-7. doi: 10.1038/hr.2014.134. Epub 2014 Sep 18. |
arterial blood pressure trait |
male |
64 days-66 days |
30 |
|
continuous mean |
157.0 |
mmHg |
6.0 |
32.86 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
restrained, 28 degrees C |
average of 2-3 readings/day over 4 days |
|
96944 |
1778 |
LEW/Crl |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (between 31 and 46 days) |
Crespo K, et al., Circ Cardiovasc Genet. 2015 Aug;8(4):610-7. doi: 10.1161/CIRCGENETICS.114.000965. Epub 2015 May 11. |
arterial blood pressure trait |
male |
67 days-82 days |
9 |
|
|
98.0 |
mmHg |
2.0 |
6.0 |
intra-aortic abdominal radiotelemetry |
abdominal aorta |
1296000.0 |
|
0 |
|
|
|
|
97142 |
1878 |
F344-Hsd11b2em1Jmul-/- |
urine potassium level |
controlled sodium content diet (0.3 %) then controlled sodium content diet (0.03 %) (between 7 and 10 days) |
Mullins LJ, et al., Hypertension. 2015 Sep;66(3):667-73. doi: 10.1161/HYPERTENSIONAHA.115.05262. Epub 2015 Jun 15. |
urine potassium amount |
male |
168 days
| 5 |
|
|
1013.7 |
mmol/l |
85.5 |
191.18 |
urine potassium analysis |
|
0.0 |
|
0 |
|
|
|
|
105032 |
3008 |
SS/JrTol |
pulse pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) and housing in pairs (between 28 and 66 days) then controlled sodium content diet (2 %) (for 24 days) |
Mell B, et al., Hypertens Res. 2015 Jan;38(1):61-7. doi: 10.1038/hr.2014.134. Epub 2014 Sep 18. |
arterial blood pressure trait |
male |
73 days-75 days |
10 |
|
|
41.0 |
mmHg |
5.0 |
15.81 |
radiotelemetry |
|
345600.0 |
|
0 |
|
C-40 transmitter (Data Sciences International, St. Paul, MN) |
average of 24 hour |
|
97026 |
1778 |
SS.LEW-(D1Rat200-D1Mco136)/Bj |
pulse pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) and housing in pairs (between 28 and 66 days) then controlled sodium content diet (2 %) (for 24 days) |
Mell B, et al., Hypertens Res. 2015 Jan;38(1):61-7. doi: 10.1038/hr.2014.134. Epub 2014 Sep 18. |
arterial blood pressure trait |
male |
73 days-75 days |
10 |
|
|
49.0 |
mmHg |
3.0 |
9.49 |
radiotelemetry |
|
345600.0 |
|
0 |
|
C-40 transmitter (Data Sciences International, St. Paul, MN) |
average of 24 hour |
|
96962 |
1778 |
SHR-Ndufc2em1Mcwi-/+ |
urine total protein excretion rate |
controlled protein content diet (19.7 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days) and controlled sodium content diet (3.7 mg/g) (for 28 days) |
Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701. |
total urine protein amount |
not specified |
70 days
| 17 |
|
|
24.0 |
mg/d |
1.7 |
7.0 |
urine analysis |
|
0.0 |
|
0 |
|
|
|
|
97936 |
1938 |
SS-Plekha7em4Mcwi+/+ |
heart weight |
controlled sodium content diet (8 %) (for 28 days) |
Endres BT, et al., Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12817-22. doi: 10.1073/pnas.1410745111. Epub 2014 Aug 18. |
heart mass |
male |
91 days
| 10 |
|
|
1.54 |
g |
0.08 |
0.25 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
105754 |
3022 |
SS-Plekha7em4Mcwi+/+ |
systolic blood pressure |
controlled sodium content diet (8 %) (for 28 days) |
Endres BT, et al., Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12817-22. doi: 10.1073/pnas.1410745111. Epub 2014 Aug 18. |
arterial blood pressure trait |
male |
91 days
| 10 |
|
|
213.0 |
mmHg |
8.0 |
25.3 |
intra-aortic abdominal radiotelemetry via femoral cannulation |
|
0.0 |
|
0 |
|
|
|
|
105762 |
3022 |
SS-Plekha7em4Mcwi+/+ |
timed urine volume |
controlled sodium content diet (8 %) (for 28 days) |
Endres BT, et al., Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12817-22. doi: 10.1073/pnas.1410745111. Epub 2014 Aug 18. |
urine output |
male |
91 days
| 10 |
|
|
72.03 |
ml/d |
2.71 |
8.57 |
urine volume measurement method |
|
0.0 |
|
0 |
|
|
|
|
105772 |
3022 |
SS-Plekha7em4Mcwi+/+ |
timed urine volume |
controlled sodium content diet (0.4 %) (for 63 days) |
Endres BT, et al., Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12817-22. doi: 10.1073/pnas.1410745111. Epub 2014 Aug 18. |
urine output |
male |
63 days
| 10 |
|
|
7.93 |
ml/d |
1.49 |
4.71 |
urine volume measurement method |
|
0.0 |
|
0 |
|
|
|
|
105764 |
3022 |
SS-Plekha7em4Mcwi+/+ |
urine sodium level |
controlled sodium content diet (8 %) (for 21 days) |
Endres BT, et al., Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12817-22. doi: 10.1073/pnas.1410745111. Epub 2014 Aug 18. |
urine sodium amount |
male |
84 days
| 10 |
|
|
311.0 |
mmol/l |
23.0 |
72.73 |
urine sodium analysis |
|
0.0 |
|
0 |
|
|
|
|
105780 |
3022 |
SR/NEisSlc |
percent change in heart rate |
controlled sodium content diet (8 %) (for 28 days) then tempol (4 mol/l) (between 0 and 0 hours) |
Fujita M, et al., Hypertension. 2007 Aug;50(2):360-7. Epub 2007 Jun 18. |
heart pumping trait |
male |
63 days-70 days |
6 |
|
|
-3.0 |
% |
1.9 |
4.65 |
vascular fluid filled catheter |
|
0.0 |
|
0 |
|
|
|
|
102383 |
2687 |
SS-Nppaem4Mcwi-/- |
heart rate |
controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 10 days) |
Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4. |
heart pumping trait |
male |
58 days-67 days |
0 |
|
serial mean |
343.0 |
beats/min |
5.0 |
|
intra-aortic abdominal radiotelemetry |
|
32400.0 |
|
0 |
|
|
|
|
98420 |
2059 |
SS-Plod1em1Mcwi-/- |
urine total protein excretion rate |
controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 12 days) |
Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4. |
total urine protein amount |
male |
60 days-69 days |
0 |
|
|
147.0 |
mg/d |
12.0 |
|
urine total protein analysis |
|
0.0 |
|
0 |
|
|
|
|
98425 |
2059 |
SS-Mthfrem1Mcwi-/+ |
heart rate |
controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 10 days) |
Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4. |
heart pumping trait |
male |
58 days-67 days |
0 |
|
serial mean |
330.0 |
beats/min |
12.0 |
|
intra-aortic abdominal radiotelemetry |
|
32400.0 |
|
0 |
|
|
|
|
98422 |
2059 |
SR |
heart weight to body weight ratio |
controlled sodium content diet (0.3 %) (for 42 days) |
Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18. |
heart mass |
male |
42 days
| 5 |
|
|
2.83 |
g/kg |
0.05 |
0.12 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
103303 |
2803 |
SR |
body weight |
controlled sodium content diet (0.3 %) (for 42 days) |
Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18. |
body mass |
male |
42 days
| 5 |
|
|
185.0 |
g |
7.16 |
16.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
103297 |
2803 |
SR |
plasma glucose level |
controlled sodium content diet (0.3 %) (for 42 days) |
Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18. |
blood glucose amount |
male |
42 days
| 13 |
|
|
104.0 |
mg/dl |
3.61 |
13.0 |
plasma glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
103321 |
2803 |
SS |
plasma glucose level |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 84 days) |
Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18. |
blood glucose amount |
male |
126 days
| 12 |
|
|
110.0 |
mg/dl |
5.2 |
18.0 |
plasma glucose analysis |
|
0.0 |
|
0 |
|
|
|
|
103324 |
2803 |
SR |
plasma insulin level |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 42 days) |
Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18. |
blood insulin amount |
male |
84 days
| 11 |
|
|
5.0 |
mU/l |
0.6 |
2.0 |
plasma insulin analysis |
|
0.0 |
|
0 |
|
|
|
|
103329 |
2803 |
SS/Jr |
diastolic blood pressure |
controlled sodium content diet (0.3 %) (for 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Nie Y, et al., Physiol Genomics. 2016 Jun;48(6):409-19. doi: 10.1152/physiolgenomics.00004.2016. Epub 2016 Apr 25. |
arterial blood pressure trait |
male |
68 days-70 days |
7 |
|
serial mean |
154.0 |
mmHg |
1.59 |
4.21 |
radiotelemetry |
|
0.0 |
|
0 |
|
|
|
|
97986 |
1958 |
SR |
conduction velocity |
controlled sodium content diet (6 %) (between 56 and 70 days) then pentobarbital (50 mg/kg) |
Kamei K, et al., Circ J. 2007 Mar;71(3):390-6. |
heart electrical impulse conduction trait |
male |
98 days-132 days |
7 |
|
|
77.0 |
cm/min |
4.16 |
11.0 |
electrocardiography |
|
0.0 |
|
0 |
|
|
conduction velocity |
|
103388 |
2804 |
SS.BN-(D13Hmgc1041-D13Hmgc885)/Mcwi |
heart rate |
controlled sodium content diet (0.4 %) (between 23 and 32 days) then controlled sodium content diet (8 %) (for 14 days) |
Cowley AW Jr, et al., Physiol Genomics. 2016 Jan;48(1):62-72. doi: 10.1152/physiolgenomics.00097.2015. Epub 2015 Nov 3. |
heart pumping trait |
male |
58 days-67 days |
15 |
|
serial mean |
384.0 |
beats/min |
6.0 |
23.24 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
carotid a. to thoracic aorta implant |
strain 26-S |
|
98527 |
2079 |
SS.BN-(D13Hmgc64-D13Hmgc23)/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (0.4 %) (for 70 days) then controlled sodium content diet (8 %) (for 21 days) |
Flister MJ, et al., Hypertension. 2013 Apr;61(4):850-6. doi: 10.1161/HYPERTENSIONAHA.111.01008. Epub 2013 Mar 4. |
urine albumin amount |
male |
91 days
| 13 |
|
|
121.0 |
mg/d |
17.0 |
61.29 |
urine microalbumin analysis |
|
10800.0 |
|
0 |
|
|
Strain 9A |
|
98727 |
2142 |
SS.SHR-(D9Mco113-D9Mco124)/Bj |
bone section mineralized tissue surface area |
controlled sodium content diet (2 %) (between 38 and 42 days) |
Nie Y, et al., Physiol Genomics. 2016 Jun;48(6):409-19. doi: 10.1152/physiolgenomics.00004.2016. Epub 2016 Apr 25. |
tibia morphology trait |
male |
66 days-70 days |
0 |
|
|
3.44 |
mm2 |
0.15 |
|
micro-computed tomography |
|
0.0 |
|
0 |
|
|
|
|
98122 |
1958 |
SS.BN-(D13Hmgc885-D13Hmgc664)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (between 23 and 32 days) then controlled sodium content diet (8 %) (for 14 days) |
Cowley AW Jr, et al., Physiol Genomics. 2016 Jan;48(1):62-72. doi: 10.1152/physiolgenomics.00097.2015. Epub 2015 Nov 3. |
arterial blood pressure trait |
male |
58 days-67 days |
10 |
|
serial mean |
144.0 |
mmHg |
3.0 |
9.49 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
carotid a. to thoracic aorta implant |
strain 26-R |
|
98498 |
2079 |
SS.BN-(D13Got45-D13Rat32)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (between 46 and 50.8 days) then controlled sodium content diet (8 %) (for 13.4 days) |
Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8. |
arterial blood pressure trait |
male |
60 days-67 days |
12 |
|
serial mean |
145.0 |
mmHg |
4.0 |
13.86 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
intra-carotid radiotelemetry |
strain 26-L |
|
98564 |
2098 |
SR/NEisSlc |
body weight |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) |
Ishikawa M, et al., Int Heart J. 2013;54(2):98-106. |
body mass |
male |
126 days
| 8 |
|
|
449.0 |
g |
6.0 |
16.97 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
102310 |
2684 |
SR/NEisSlc |
heart left ventricle fractional shortening |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) |
Ishikawa M, et al., Int Heart J. 2013;54(2):98-106. |
heart left ventricle end-diastolic diameter |
male |
126 days
| 8 |
|
|
52.6 |
% |
0.7 |
1.98 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
|
|
|
102316 |
2684 |
SS-Nppbem2Mcwi-/- |
heart left ventricle end-systolic diameter |
controlled sodium content diet (for 21 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle end-systolic diameter |
male |
98 days
| 4 |
|
|
4.18 |
mm |
0.19 |
0.38 |
echocardiography |
|
0.0 |
|
0 |
|
|
|
|
99719 |
2319 |
SS.BN-(D13Got42-D13Hmgc664)/Mcwi |
systolic blood pressure |
controlled sodium content diet (0.4 %) (between 46 and 50.8 days) then controlled sodium content diet (8 %) (for 13.4 days) |
Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8. |
arterial blood pressure trait |
male |
60 days-67 days |
5 |
|
serial mean |
170.0 |
mmHg |
6.0 |
13.42 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
intra-carotid radiotelemetry |
strain 26-G |
|
98574 |
2098 |
SS.BN-(D13Got42-D13Hmgc497)/Mcwi |
diastolic blood pressure |
controlled sodium content diet (0.4 %) (between 46 and 50.8 days) then controlled sodium content diet (8 %) (for 13.4 days) |
Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8. |
arterial blood pressure trait |
male |
60 days-67 days |
7 |
|
serial mean |
108.0 |
mmHg |
5.0 |
13.23 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
intra-carotid radiotelemetry |
strain 26-E |
|
98586 |
2098 |
SS.BN-(D13Got45-D13Hmgc664)/Mcwi |
heart rate |
controlled sodium content diet (0.4 %) (between 46 and 50.8 days) then controlled sodium content diet (8 %) (for 13.4 days) |
Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8. |
heart pumping trait |
male |
60 days-67 days |
14 |
|
serial mean |
370.0 |
beats/min |
6.0 |
22.45 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
intra-carotid radiotelemetry |
intra-carotid radiotelemetry |
|
98623 |
2098 |
SS.BN-(D13Hmgc354-D13Rat32)/Mcwi |
heart rate |
controlled sodium content diet (0.4 %) (between 46 and 50.8 days) then controlled sodium content diet (8 %) (for 13.4 days) |
Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8. |
heart pumping trait |
male |
60 days-67 days |
15 |
|
serial mean |
375.0 |
beats/min |
4.0 |
15.49 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
intra-carotid radiotelemetry |
intra-carotid radiotelemetry |
|
98620 |
2098 |
SS-Mthfrem1Mcwi-/+ |
single kidney wet weight |
controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 12 days) |
Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4. |
kidney mass |
male |
60 days-69 days |
0 |
|
|
1.61 |
g |
0.08 |
|
digital scale post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
98455 |
2059 |
SS.LEW-(D18Wox7-D18Rat67)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 12 days) |
Chauvet C, et al., J Hypertens. 2011 Jul;29(7):1320-6. doi: 10.1097/HJH.0b013e32834705e4. |
arterial blood pressure trait |
male |
68 days
| 5 |
|
serial mean |
157.0 |
mmHg |
8.0 |
17.89 |
radiotelemetry |
abdominal aorta |
1036800.0 |
|
0 |
|
telemetry probe |
averaged over 12 days |
has records that will be duplicated if entered need to add multiple refs once the functionality is in |
96571 |
1663 |
WKY/NHsd |
skin chloride level to skin water level ratio |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
skin chloride amount |
male |
0 days
| 8 |
|
|
50.0 |
mmol/l |
4.4 |
12.45 |
ex vivo analysis of atomic composition following dry ashing |
|
0.0 |
|
0 |
|
ashed skin |
skin cl/h2o |
|
99154 |
2238 |
SS/NEisSlc |
serum potassium level |
controlled sodium content diet (8 %) (for 42 days) then candesartan (1 mg/kg/d) (for 42 days) |
Otsuka F, et al., Am J Physiol. 1998 Jun;274(6 Pt 2):R1797-806. |
blood potassium amount |
male |
91 days
| 6 |
|
|
7.33 |
mmol/l |
0.3 |
0.73 |
automated serum potassium test |
|
0.0 |
|
0 |
|
|
|
|
100661 |
2519 |
SS.BN-(D13Got42-D13Rat61)/Mcwi |
systolic blood pressure |
controlled sodium content diet (0.4 %) (between 46 and 50.8 days) then controlled sodium content diet (8 %) (for 13.4 days) |
Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8. |
arterial blood pressure trait |
male |
60 days-67 days |
13 |
|
serial mean |
191.0 |
mmHg |
6.0 |
21.63 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
intra-carotid radiotelemetry |
strain 26-A |
|
98568 |
2098 |
WKY/NHsd |
mean arterial blood pressure |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
arterial blood pressure trait |
male |
0 days
| 8 |
|
|
124.0 |
mmHg |
4.0 |
11.31 |
intra-aortic radiotelemetry |
|
0.0 |
|
0 |
|
|
|
|
99190 |
2238 |
SS.SR-(D13Mit9-D13Mit1)/Jr |
heart weight to body weight ratio |
controlled sodium content diet (1 %) (for 60 days) then controlled sodium content diet (0.2 %) (for 40 days) |
Zhang QY, et al., Mamm Genome 1997 Sep;8(9):636-41 |
heart mass |
male |
134 days
| 11 |
|
|
3.3 |
g/kg |
|
|
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
66114 |
650 |
SS/Jr |
systolic blood pressure |
controlled sodium content diet (2 %) (between 24 and 28 days) |
Joe B, et al., J Hypertens 2003 Nov;21(11):2077-84. |
arterial blood pressure trait |
male |
63 days-70 days |
20 |
|
|
210.0 |
mmHg |
3.3 |
14.76 |
tail cuff plethysmography |
|
0 |
|
0 |
|
|
average of 4days |
|
65479 |
611 |
SS.LEW-(D1Uia8-D1Rat211)/Mco |
systolic blood pressure |
controlled sodium content diet (2 %) (between 24 and 28 days) |
Joe B, et al., J Hypertens 2003 Nov;21(11):2077-84. |
arterial blood pressure trait |
male |
63 days-70 days |
20 |
|
|
207.0 |
mmHg |
5.8 |
25.94 |
tail cuff plethysmography |
|
0 |
|
0 |
|
|
average of 4days |
|
65485 |
611 |
SS/Jr |
heart rate |
controlled sodium content diet (2 %) (between 34 and 38 days) |
Joe B, et al., J Hypertens 2003 Nov;21(11):2077-84. |
heart pumping trait |
male |
73 days-80 days |
8 |
|
|
390.0 |
beats/min |
4.1 |
11.6 |
intra-aortic abdominal radiotelemetry |
|
10 |
|
0 |
|
|
diurnal difference |
|
65503 |
611 |
SS.LEW-(D1Rat211-D1Rat18)/Mco |
systolic blood pressure |
controlled sodium content diet (2 %) (between 24 and 28 days) |
Joe B, et al., J Hypertens 2003 Nov;21(11):2077-84. |
arterial blood pressure trait |
male |
63 days-70 days |
20 |
|
|
179.0 |
mmHg |
2.9 |
12.97 |
tail cuff plethysmography |
|
0 |
|
0 |
|
|
average of 4days |
|
65490 |
611 |
SS/JrHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 28 days) then controlled sodium content diet (8 %) (for 30 days) and controlled exposure to ambient light (for 12 hours) |
Cowley AW Jr, et al., Physiol Genomics 2000 Apr 27;2(3):107-15. |
arterial blood pressure trait |
male |
91 days-93 days |
35 |
|
continuous mean |
173.0 |
mmHg |
7.0 |
41.41 |
vascular indwelling catheter method |
femoral artery |
259200.0 |
|
0 |
|
3 h per day |
decrease |
|
66140 |
229 |
BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then NG-nitroarginine methyl ester (5 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
20 |
|
serial mean |
25.0 |
mmHg |
3.0 |
13.42 |
vascular indwelling catheter method |
left femoral artery |
0.0 |
|
0 |
|
|
|
|
67303 |
151 |
BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) then tactile electric shock exposure (2 %) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
92 days-94 days |
14 |
|
serial mean |
16.0 |
mmHg |
3.0 |
11.22 |
vascular indwelling catheter method |
left femoral artery |
0 |
|
0 |
|
|
|
|
66149 |
151 |
SS/Jr |
systolic blood pressure |
controlled sodium content diet (2 %) (between 34 and 38 days) |
Joe B, et al., J Hypertens 2003 Nov;21(11):2077-84. |
arterial blood pressure trait |
male |
73 days-80 days |
8 |
|
|
199.0 |
mmHg |
5.0 |
14.14 |
intra-aortic abdominal radiotelemetry |
|
10 |
|
0 |
|
|
average of 24 hr |
|
65493 |